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Abstract 
Accumulation of damage in DNA is a characteristic feature of ageing which may 
result from a decline in DNA repair efficiency. Base excision repair (BER) is the 
primary mechanism used to repair small-scale DNA damage such as that 
caused by oxidation. I hypothesised that epigenetic events contribute to the 
ageing process through deregulation of BER gene expression and that these 
adverse effects of ageing may be modulated by dietary restriction (DR). To test 
these hypotheses, I quantified DNA methylation and histone post-translational 
modifications at BER-gene (Ogg1 and Apex) promoters, together with 
expression of these genes, in tissues from ageing mice and from mice exposed 
to DR. Phenotypic changes in DNA incision activity and oxidative damage were 
also quantified.  
Cytosine methylation was measured by pyrosequencing at the Ogg1 promoter 
in brain and livers from ad libitum (AL) and 40% DR mice at 3, 12, 24 and 30 
months of age (n=5/group). Ogg1 promoter methylation decreased with age in 
the liver (p=0.018) and brain (p=0.016) and DR significantly reduced Ogg1 
promoter methylation (p=0.014) in the brain. Additionally, in the brain there was 
a 2 fold enrichment in histone 4 acetylation (H4Ac) and histone 3 lysine 27 tri-
methylation (H3K27Me3) as measured by the ChIP assay at Ogg1 and Apex 
promoters in 30 month old AL animals compared with 3 month old animals 
(p<0.05). H4Ac was 2.5-fold higher in the Ogg1 promoter in liver in 30 month 
old DR versus 30 month old AL animals (p=0.004). Furthermore H4K27Me3 
was significantly (p=0.023) lower at the liver Ogg1 promoter in 30 month old 
compared with 3 month old animals. 
Ogg1 gene expression decreased with age in the brain (n.s.) and liver 
(p=0.005). Perhaps surprisingly, Ogg1 and Apex expression levels were higher 
in the brain (p=0.034) but lower in the liver (p=0.003) of DR compared with AL 
animals. I used a comet-based in vitro assay to quantify BER-related incision 
activity but did not observe any significant changes in the liver or in whole brain 
in response to ageing or to DR. However DNA incision activity varied 
considerably between different brain regions and DR enhanced incision 2 fold in 
the cortex (p=0.031) and subcortical regions (p=0.019). 8-oxoguanine lesions 
measured by HPLC-ECD decreased with age (AL and DR) (p<0.001) in the liver 
but no effect of age was detected in the brain. 
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This study revealed for the first time that tissue-specific epigenetic changes at 
BER genes occur during ageing and the data presented here suggest that 
epigenetic changes at BER-related gene promoters may affect BER activity in 
some tissues. Furthermore, I have shown that DR influences the epigenetic and 
transcription changes in BER-related genes observed during ageing. 
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Chapter 1: General Introduction 
1.1 The ageing population 
The World Health Organisation predicts that by 2050 there will be 2 billion 
people aged 60 and older and that the proportion of older people is increasing 
in both developed and developing countries. This increase highlights the 
economic and medical advances made over the last years which have led to 
decline in childhood mortality as well as better nutrition and improved living 
conditions. However, with age being the biggest risk factor for non-
communicable diseases, an ageing population has resulted in an increase in 
cases of cardiovascular disease, dementias, diabetes, stroke and cancer 
(Dobriansky et al., 2007). In light of this, there has been much interest into 
understanding the ageing process and in the development of interventions to 
enhance healthy ageing. 
The elderly exhibit cognitive decline and difficulties with movement (Mitchell and 
Shiri-Feshki, 2009; Rosso et al., 2013) highlighting that ageing of the brain and 
neurodegeneration are important processes to understand and sustain healthy 
ageing. Dementia, in particular is a debilitating condition characterised by 
memory loss, confusion as well as problems with speech and understanding 
which often lead to loss of independence for the elderly individuals (Alzheimer's 
Society, 2015).  The Office for National Statistics reported that in 2011 in 
England and Wales dementias contributed 5.1% of all deaths in men and 10.3% 
in women (Office for National Statistics, 2012). Furthermore the costs of 
dementia have a profound impact on an individual as well as population level. 
The Alzheimer’s Association states that in the United States caregivers of 
dementia patients, who are often the closest family, provided 17.7 billion hours 
of unpaid care in 2013 and it is the caregiver who bears majority of the cost for 
taking care of a dementia patient (Alzheimer's Association, 2014). In addition, 
the Alzheimer’s Society states that on a national level dementia costs the 
United Kingdom £23 billion per year (Alzheimer's Society, 2015).  
Despite the social and economic impact of ageing there is still limited 
understanding of the ageing process. Basic research on the cellular processes 
that contribute to the biology of ageing will be helpful in providing the evidence 
base for developing healthy ageing interventions. 
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1.2 Biology of ageing 
To date a multitude of mechanistic theories of ageing have been proposed and 
these fall mainly into either of two categories: programmed or error. The 
programmed theories of ageing state that ageing is a result of scheduled 
changes in genes being switched on or off (programmed longevity), hormone 
levels (endocrine theory) or decline in immune system (immunological theory). 
On the other hand error theories such as wear and tear, metabolic rate, somatic 
deoxyribonucleic acid (DNA) damage and free radical theory propose that 
ageing occurs due to cellular damage (Jin, 2010). Furthermore, theories such 
as that of the ‘disposable soma’ bring in an evolutionary principle. This theory 
predicts that natural selection favours allocating cellular resources to 
reproduction rather than somatic cell maintenance. As such, ageing results from 
an accumulation of molecular damage when the cell shifts resources to fuel the 
limited maintenance systems (Drenos and Kirkwood, 2005). Owing to the vast 
changes observed with age, these theories are not necessarily mutually 
exclusive. 
In multicellular organisms such as the worm Caenorhabditis elegans the rate of 
ageing is slowed by mutations in genes encoding age-1 (phosphatidylinositol-3 
kinase, PI3K) and daf-2 (homologue of insulin-like growth factor receptor, IGF-
1R) which extend lifespan (Friedman and Johnson, 1988; Kenyon et al., 1993; 
Gottlieb and Ruvkun, 1994; Kimura et al., 1997; Gems et al., 1998). In 
Drosophila melanogaster, the common fruit fly, a mutant form of the mth gene 
(related to secretin receptor family) extends lifespan by 35% (Lin et al., 1998). 
Similarly to the daf-2 mutant in C. elegans, knockout of Igf-1R extends lifespan 
by 26% in mice (Holzenberger et al., 2003). Not surprisingly mutations in some 
genes are also able to reduce lifespan; for example in mice a mutation in the 
klotho gene (related to β-glucuronidase) results in reduced lifespan (Kuro-o et 
al., 1997). Such studies highlight certain cellular pathways e.g. nutrient sensing 
via IGF-1, as key players in the ageing process.  
Furthermore, genetic variants are thought to account for approximately 25% of 
the variance in human lifespan (Finch and Tanzi, 1997; Cournil and Kirkwood, 
2001) and the decline in physiological function which is characteristic of ageing 
is influenced by both environmental and genetic factors (Brink et al., 2009) 
emphasising the complexity of cellular ageing.  
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1.3 Molecular damage and ageing 
In the current view of ageing, the process is characterised by: genomic 
instability, telomere attrition, epigenetic alterations, loss of proteostasis, 
deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, 
stem cell exhaustion and altered intercellular communication (López-Otín et al., 
2013). 
A number of the ageing hallmarks can be attributed to macromolecular damage 
and it is widely accepted that damage to macromolecules plays a major role in 
the age-related decline in physiological function (Kirkwood, 2008). Lipids, 
proteins and DNA within the cell can all serve as targets of damaging agents. 
There is a large number of damaging agents varying from extracellular 
ultraviolet (UV) radiation to intracellular reactive oxygen species (ROS). 
According to error theories of ageing, damage to macromolecules can directly 
or indirectly impair cellular function and hence lead to an ageing phenotype. In 
this section I will focus mainly on DNA damage and its importance in driving 
ageing, the role of protein and lipid damage will only be covered in brief. 
1.3.1 Damage to DNA 
An array of DNA damaging lesions can be found in the body and numerous 
studies have addressed the effect of age on DNA damage, with results being 
tissue and lesion specific (Table 1.1). Meta-analysis of studies shows a positive 
relationship between DNA damage and ageing in humans (Soares et al., 2014). 
Furthermore the telomere shortening; a characteristic feature of ageing, can be 
regarded as DNA damage. The inability of cells to replicate telomeres results in 
loss of sequence and in diminished protection of chromosome ends  (Blasco, 
2007; López-Otín et al., 2013). 
Unrepaired DNA damage can lead to somatic mutations and an increase in 
mutation load with age occurs in a tissue specific manner. Somatic mutations 
increased in ageing mouse liver, small intestine and heart, but in the brain 
mutations increased during development only (1day old to 6 month old) after 
which there was no further increases (Dolle et al., 1997; Dollé et al., 2000). 
Mutation type is also tissue specific, with point mutations being associated with 
the small intestine while chromosomal rearrangements are more common in the 
heart (Dollé et al., 2000; Busuttil et al., 2007). As well as nuclear DNA, 
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mitochondrial DNA (mtDNA) is also susceptible to DNA damage. Age-related 
accumulation of mitochondrial point mutations in colonic crypts are observed 
(Greaves et al., 2012) and these lead to dysfunction in the mitochondrial 
respiratory chain and apoptosis (Nooteboom et al., 2010). Furthermore, the 
mitochondrial mutator mouse model, defective in mtDNA polymerase, 
accumulates mtDNA mutations and shows a reduced lifespan (Trifunovic et al., 
2005). 
Lesion Description Age Tissue Author 
Micronuclei 
Small extra-nuclear 
bodies formed by 
incomplete separation of 
chromosomes 
↑ Fibroblasts (human) 
(Weirich-
Schwaiger et 
al., 1994) 
↑ Lymphocytes (human) 
(Bolognesi 
et al., 1997) 
AP site 
Apurinic/apyrimidinic 
(AP) sites generated by 
depurination 
↑ 
Leukocytes (human) 
Liver (rat) 
(Atamna et 
al., 2000) 
Oxidative 
lesion 
Oxidative damage to 
DNA 
↑ 
Muscle (rat) 
Heart (rat) 
Brain (rat) 
Liver (rat) 
Kidney (rat) 
(Sohal et al., 
1994a) 
Double strand 
breaks 
Break in DNA at both 
strands 
↑ 
Fibroblasts (human) 
Liver (mouse) 
Testes (mouse) 
Kidney (mouse) 
Lung (mouse) 
Brain (mouse) 
(Sedelnikova 
et al., 2004) 
Table 1.1 Subset of studies quantifying damaging lesions in ageing tissues. 
In 1956, Denham Harman proposed the free-radical theory of ageing where he 
postulated that reactive oxygen species (ROS) produced during cellular 
metabolism induce damage to macromolecules leading to mutations, cancer 
and ageing (Harman, 1956). Since then a large number of studies have looked 
at the role of ROS in the ageing phenotype. ROS can cause more than 100 
different types of oxidative base modifications (Cooke et al., 2003). A common 
product is 8-oxoguanine. It has been widely used as a marker in biological 
ageing and is thought to be important because of the specific repair mechanism 
to remove this lesion (Halliwell, 1999). Guanine is particularly vulnerable to 
oxidative damage due to its low redox potential (Steenken and Jovanovic, 
1997). Oxidation of a guanine molecule involves the addition of an oxygen 
group on the carbon at position 8 and a hydrogen atom on the nitrogen at 
position 7 forming 8-oxoguanine/8-hydroxyguanine/7,8-dihydro-8-oxoguanine 
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(8-oxodG). This causes a stable base pair with an adenine base (David et al., 
2007). Since 8-oxoguanine does not block DNA replication, accumulation of 8-
oxodG can lead to GC to TA transversion mutations if unrepaired (Thomas et 
al., 1997). It has been estimated that around 180 guanines are oxidised to 8-
oxoguanine per mammalian genome per day (Lindahl, 1993).  
Oxidative damage may play an integral role in ageing and in the development of 
age-related diseases. Increased levels of 8oxodG have been reported in 
nuclear and mitochondrial DNA in the ageing human brain (Mecocci et al., 
1993) and in patients with Alzheimer’s disease (AD)(Lovell and Markesbery, 
2007) as well as in brain, kidney, liver and heart of rats (Kaneko et al., 1997; 
Hamilton et al., 2001) and in brain, muscle, heart, liver and kidney of mice 
(Sohal et al., 1994a). Other DNA oxidative damage such as 8,5’-cyclopurines, 
thymine glycol and 8-hydroxyadenine also accumulate in ageing mice in a 
tissue-specific manner (Wang et al., 1995; Wang et al., 2012a). 
1.3.2 Protein and lipid damage 
Although not covered in much detail in this thesis it is also important to note the 
effect of damage on proteins and lipids and the consequences of such damage 
on cellular function.  
Increased protein oxidation has been demonstrated in older individuals and in 
AD patients (Smith et al., 1991) and in the brain, heart and testis of the 
Mongolian gerbil (Sohal et al., 1995). Oxidised proteins increase in ageing 
mouse cartilage (Scharf et al., 2013) and muscle  (Li et al., 2012), rat brain and 
liver (Tiana et al., 1998) as well as human lymphocytes (Gautam et al., 2010) 
and muscle (Mecocci et al., 1999). An age-related accumulation of oxidative 
damage measured as protein carbonyls is tissues specific (Davies et al., 2001). 
Furthermore oxidative damage to proteins in the brain correlates with an age-
related impairment in cognitive function and motor skills (Forster et al., 1996).  
Protein aggregates where misfolded proteins accumulate together are 
characteristic of neurodegenerative diseases such as AD. An increase in 
insoluble proteins and protein aggregates is observed with age in C. elegans 
(David et al., 2010). AD features extracellular aggregates of  amyloid β-peptide 
and intracellular aggregates of Tau (Ross and Poirier, 2004).  
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Damage to lipids is also observed during ageing. Lipid peroxidation increases 
with age in human lymphocytes (Gautam et al., 2010) and muscle (Mecocci et 
al., 1999). Malondialdehyde (MDA), a marker of lipid peroxidation increases in 
ageing mouse muscle (Li et al., 2012). Furthermore, MDA increases with age in 
human erythrocytes and this increase is more pronounced in AD patients 
(Casado et al., 2008).  
Accumulation of macromolecular damage is likely a result of down-regulation of 
cell homeostatic mechanisms. The proteasome, is a complex which degrades 
damaged and undamaged proteins and dysregulation of proteostasis is also 
considered a hallmark for ageing (López-Otín et al., 2013). The resulting 
accumulation of damaged proteins may occur because of lower proteosomal 
activity, which is observed in aged rat liver (Agarwal and Sohal, 1994), 
senescent fibroblasts (Sitte et al., 2000) and keratinocytes (Petropoulos et al., 
2000). Furthermore, autophagy also maintains the homeostatic environment of 
the cell by degrading and recycling damaged molecules and organelles (Pyo et 
al., 2013b). Autophagy-related genes are down-regulated in the ageing brain 
(Lipinski et al., 2010). However, overexpression of the gene encoding 
autophagy protein 5 in mice extends their lifespan emphasising autophagy as 
being an important player in ageing (Pyo et al., 2013a). 
1.4 DNA repair 
The accumulation of DNA damage in the ageing cell can be modulated by a 
number of factors one of which is DNA repair efficiency. The cell has multiple 
DNA repair mechanisms to repair damage to the genome. These include base 
excision repair (BER) which removes small DNA alterations, nucleotide excision 
repair (NER) which removes bulky lesions, and mismatch repair (MMR) which 
repairs mispaired bases from replication errors. In addition, homologous 
recombination (HR) and non-homologous end joining (NHEJ) deal with double 
strand breaks. As a consequence of unrepaired damage, the cell exhibits 
inhibition of transcription, replication and chromosomal segregation which lead 
to apoptosis as well as mutations and chromosome aberrations which lead to 
cancer, disease and the ageing phenotype (Hoeijmakers, 2001). 
After DNA damage induction in proliferative cells, cell cycle checkpoints are 
activated, leading to cell cycle arrest and providing time for the activated DNA 
damage repair machinery to repair the DNA damage. These checkpoints occur 
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at G1/S and G2/M boundaries, with an additional intra-S checkpoint. In such 
cells repair is important so that incorrect information is not passed onto 
daughter cells. Post-mitotic cells which do not go through the cell cycle also 
undergo DNA repair and this process is initiated directly (Iyama and Wilson, 
2013) and also involves initiations of cell cycle machinery (Schwartz et al., 
2007). DNA repair in post-mitotic cells acts to ensure integrity of the transcribed 
genome (Houtgraaf et al., 2006). If damage remains undetected and 
unrepaired, this leads to mutations and to genomic instability. Accumulation of 
errors in DNA may contribute to both carcinogenesis and cellular ageing 
(senescence).  
1.4.1 Base excision repair 
Base excision repair is required for removal of small DNA damage induced by 
damaging agents such as reactive oxygen species. BER includes 2 sub-
pathways: short-patch repair for removal of single nucleotides and long-patch 
repair for removal of 2-13 nucleotides (Figure 1.1). DNA damage in the form of 
oxidation, alkylation or deamination of bases is removed by BER. Multiple 
enzymes contribute to BER including: DNA glycosylases, AP endonuclease, 
DNA polymerase and DNA ligase.  
The core steps of the pathway are; 
1. Recognition of a damaged base by DNA glycosylase which cleaves the 
N-glycosidic bond removing the damaged base to create an apurinic or 
apyrimidinic site (AP site). 
2. Cleavage of the DNA backbone by AP endonuclease (APEX/Ref-1) or by 
the AP lyase of bifunctional DNA glycosylases. AP endonuclease activity 
creates a single-stranded nick in the DNA backbone which is 5’ to the AP 
site generating a 5’-deoxyribose-5-phosphate (5’-dRP) and 3’-hydroxyl 
strand break product. Meanwhile an AP lyase creates a nick in the DNA 
backbone at 3’ to the AP site leaving a single strand break containing a 
3’-phospho-α,β-unsaturated aldehyde (3’-PUA) or 3’-phosphate (3’-P). 
AP endonuclease then cleaves 3’-PUA and polynucleotide kinase 3’-
phosphatase (PNKP) cuts out the 3’-P residue generating a 3’-hydroxyl 
group. 
3. A DNA polymerase β removes 5’dRP and fills in the gap with a new 
nucleotide. 
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4. Finally a DNA ligase and X-ray repair cross-complementing protein 1 
(XRCC1) complex seal the nick and complete the repair process 
(Robertson et al., 2009; Iyama and Wilson, 2013). 
In long-patch repair after cleavage by APEX, DNA polymerase (β or δ), 
proliferating cell nuclear antigen (PCNA), flap structure-specific endonuclease 1 
(FEN1) and a DNA ligase are recruited to the site to complete the strand sealing 
process (Robertson et al., 2009). 
Furthermore, repair enzymes interact with each other to allow for efficient repair 
and progression of the pathway. Enzymes at the start of the pathways initiate 
activity of enzymes down-stream in the repair process. OGG1 binds to poly 
ADP-ribose polymerase (PARP1) and stimulates its activity (German et al., 
2013). OGG1 and APEX interact with XRCC1 enhancing their incision activity 
(Marsin et al., 2003). APEX also interacts with and enhances activity of β-
polymerase, FEN1 and DNA ligase 1 (Bennett et al., 1997; Tom et al., 2001). 
Furthermore, cell signalling by OGG1 is a result of 8-oxodG activation of Ras 
GTPases and resultant phosphorylation of the downstream kinases (Boldogh et 
al., 2012; German et al., 2013). 
Many of the genes involved in BER are highly conserved from bacteria to 
humans, which indicates that BER is a fundamental repair pathway in all 
organisms. Furthermore, BER operates throughout the cell cycle suggesting it is 
important in both dividing and non-dividing cells (Wilson Iii and Bohr, 2007). 
1.4.1.1 Significance of DNA glycosylase and AP endonuclease 
The initial step of BER is performed by a DNA glycosylase, which reacts 
specifically with DNA damage. Known glycosylases and their substrates are 
summarised in Table 1.2. DNA repair enzymes (e.g. OGG1 and APEX) are 
expressed ubiquitously in all mammalian tissues but at different intensities 
(Wilson et al., 1996; Verjat et al., 2000). Activity of DNA repair enzymes varies 
between tissues. OGG1 activity in mice was reported in descending order of 
activity in testis, kidney, muscle, liver, brain and then heart whereas UDG 
activity was reported in descending order in muscle, testis, kidney, heart, liver 
and brain. In contrast, NTH1 activity is similar in all these tissues (Karahalil et 
al., 2002; Intano et al., 2003). 
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Figure 1.1 Overview of short-patch and long-patch mammalian BER pathways. Damage 
detection and base excision are performed by DNA glycosylases (listed in the Figure and in 
Table 1.2). The DNA glycosylase action dictates which gap filling and ligation route of the 
pathway precedes base excision. APE1, AP endonuclease; FEN1, flap structure-specific 
endonuclease 1; MBD4, methyl-CpG-binding domain protein 4; MPG, N-methylpurine-DNA 
glycosylase; MYH, muty homolog; NEIL, nei endonuclease VIII-like; NTH, nth endonuclease III-
like 1; OGG1, oxoguanine DNA glycosylase; PARP1, poly (ADP-ribose) polymerase 1; PCNA, 
proliferating cell nuclear antigen; PNKP, polynucleotide kinase 3’-phosphotase ; POL β, δ and ε, 
DNA polymerase; SMUG, single-strand-selective monofunctional uracil-DNA glycosylase; TDG, 
thymine-DNA glycosylase; UNG1 and 2, uracil-DNA glycosylase; XRCC1, X-ray repair cross-
complementing protein 1. Figure from Xu et al. (Xu et al., 2008a). 
Knockout of individual DNA glycosylases does not produce lethality. The 
similarities in substrate specificity between the different DNA glycosylases may 
mean that there is inbuilt redundancy in the system and that other glycosylases 
can compensate for the one that was knocked out (Klungland et al., 1999; 
Osterod et al., 2001). However, mice defective in DNA glycosylase activity 
develop cancers and a metabolic syndrome-like phenotype. Mice deficient in 
uracil-DNA glycosylase develop B-cell lymphomas. Double knockout (KO) mice 
of Ogg1 and Mutyh result in increased tumour development (Xie et al., 2004). 
Ogg1 inactivation leads to an increase in mutation frequency and 8-oxodG 
levels in the liver (Minowa et al., 2000). Neil1 knock out gives rise to mice 
demonstrating metabolic syndrome, with an obesogenic phenotype (Vartanian 
et al., 2006) and increased number of mtDNA deletions compared with wild type 
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(WT) controls (Vartanian et al., 2006). Finally, Nth KO mice show increased 
DNA lesions at telomeric loci compared with non-telomeric loci (Vallabhaneni et 
al., 2013). On the other hand mice with KO of genes further down the repair 
pathway such as Apex, β-polymerase or DNA ligase do not survive 
embryogenesis (Barnes and Lindahl, 2004; Larsen et al., 2007). However, 
inhibition of Apex by RNA interference, results in abasic DNA site accumulation, 
halts cell proliferation and induces apoptosis (Fung and Demple, 2005). Cells 
deficient in β polymerase have increased number of chromosomal breaks and 
are also prone to apoptosis (Ochs et al., 1999). 
Although DNA glycosylases are the primary enzymes for recognition of 
damage, APEX can also remove larger oxidative lesions such as 8,5-
cyclopurines independently of DNA glycosylase activity (Gros et al., 2004; 
Mazouzi et al., 2013). APEX is also able to stabilise telomeric DNA (Madlener et 
al., 2013) although it has reduced activity to single stranded DNA and DNA 
loops compared with double stranded DNA (Li et al., 2014). In addition to 
APEX’s repair activity it is also involved in redox regulation of transcription 
factors, enhancing transcription factor binding to DNA (Evans et al., 2000). 
In humans, single base mutations in OGG1 which cause a single amino acid 
change have been detected in lung and kidney tumours (Chevillard et al., 
1998). Patients with adenocarcinoma of the lung showed a polymorphic allele in 
OGG1 exon 1 (Ishida et al., 1999). Furthermore, OGG1 localises to a 
chromosome region often deleted in cancers (Lu et al., 1997). A mutation in the 
gene coding for MUTYH was found to be responsible for colorectal cancer 
development (Al-Tassan et al., 2002). Therefore it is apparent that BER 
dysfunction plays a role in cancer development. In the neurodegenerative 
disorder ataxia oculomotor apraxia shows reduced activity of PARP-1, APEX 
and OGG1 (Harris et al., 2009). 
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DNA glycosylase Acronym 
AP lyase 
activity 
Damage recognised Acronym 
8-oxoguanine DNA glycosylase OGG1 + 
8-oxoguanine 
2,6-diamino-4-hydroxy-5-formamidopyrimidine 
8-oxodG 
fapyG 
Uracil DNA glycosylase UDG/UNG - Uracil U 
Nei endonuclease VIII-like 1 NEIL1 + 
Thymine glycol 
2,6-diamino-4-hydroxy-5-formamidopyrimidine 
Dihydrouracil 
5-hydroxyuracil 
5-hydroxycytosine 
4,6-diamino-5-formamidopyrimidine 
8-oxoguanine 
Tg 
fapyG 
DHU 
5-OHU 
5-OHC 
fapyA 
8oxodG 
Nth endonuclease III-like 1 NTH1 + 
Thymine glycol 
2,6-diamino-4-hydroxy-5-formamidopyrimidine 
Dihydrouracil 
5-hydroxyuracil 
5-hydroxycytosine 
Tg 
fapyG 
DHU 
5-OHU 
5-OHC 
Muty homolog MUTYH/MYH + Adenine opposite 8-oxoguanine 
A opposite 8-
oxodG 
Thymine DNA glycosylase TDG - 
Thymine, uracil and ethenocytosine 
(CpG sites) 
T, U and 
ethenoC 
Single strand selective 
monofunctional uracil DNA 
glycosylase 
SMUG1 - 
Uracil 
5-hydroxymethyluracil 
U 
5-OH-meU 
Methyl CpG binding domain 
protein 
MBD4 - Thymine and uracil opposite guanine (CpG sites) 
T and U opposite 
G 
N-methylpurine-DNA glycosylase MPG - 
N3-methyladenine 
Hypoxanthine 
Ethenoadenine 
3-meA 
Hyx 
ethenoA 
Table 1.2 DNA glycosylases found in mammalian cells and the damaged bases which they recognise. Table adapted from Robertson et al. (Robertson et al., 2009). 
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1.4.1.2 Initiation of Ogg1 and Apex expression 
BER expression is initiated as a response to a number of stimuli such as 
oxidative stress (Cabelof et al., 2006), high glucose (Pang et al., 2012), ionizing 
radiation (Yang et al., 2004) and physical damage (Riis et al., 2002). 
Transcription factors such as nuclear transcription factor Y subunit alpha 
(NFYA), tumour suppressor protein 53 (p53) and nuclear factor 2 (NRF2) have 
been shown to up-regulate Ogg1 expression (Chatterjee et al., 2005; Habib et 
al., 2010; Singh et al., 2014; von der Lippen et al., 2015). Furthermore it is 
known that activation by NFYA involves the c-Jun N-terminal kinase (JNK), a 
mitogen-activated protein kinase (von der Lippen et al., 2015) and/or 5' 
adenosine monophosphate-activated protein kinase (AMPK). In addition, Apex 
expression can also been up-regulated by transcription factors such as nuclear 
factor kappa-light-chain-enhancer of activated B cells (NFκB), microphthalmia-
associated transcription factor and p53 in cancerous cells (Liu et al., 2008; Jung 
et al., 2013; Song et al., 2013). 
1.4.1.3 Post-translational modifications of OGG1 and APEX protein 
Post-translational modifications to repair enzymes can alter their function. 
Acetylation of OGG1 by p300 increases its activity and about 20% of OGG1 is 
acetylated in cultured cells (Bhakat et al., 2006). In vitro, phosphorylation of 
OGG1 by cyclin-dependant kinase 4 (Cdk4) increases its activity (Hu et al., 
2005) while phosphorylation by protein kinase C (PKC) enhances OGG1 
binding to DNA (Dantzer et al., 2002). APEX has to be in its unacetylated form 
to localise to the nucleus; however upon genotoxic stress it is acetylated which 
results in an increase in its activity (Lirussi et al., 2012). Furthermore, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) associates with APEX 
and initiates its activity (Azam et al., 2008). Paradoxically, an increase in APEX 
activity can lead to genomic instability, as observed in cancers (Evans et al., 
2000), and overexpression of this enzyme prevents repair of mismatched DNA 
(Chang et al., 2005). Therefore regulation of APEX by reducing its activity by s-
glutathionylation, phosphorylation and ubiquitination is equally important to 
prevent error prone DNA repair (Borjigin et al., 2010; Kim et al., 2011; 
Meisenberg et al., 2012). Trochostatin A-sensitive deacetylases are responsible 
for OGG1 deacetylation (Bhakat et al., 2006); furthermore these enzymes 
induce APEX secretion and translocation to the cytoplasm (Choi et al., 2013). 
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1.4.1.4 BER in ageing 
The role of DNA glycosylase dysfunction in ageing may also be important as 
shown by age-related accumulation of oxidative damage in livers from Ogg1 KO 
mice (Osterod et al., 2001). In addition, the senescence-accelerated mouse 
model (SAMM) has been reported to have mutations in the Ogg1 gene (Choi et 
al., 1999). Whether this mutation is a cause of the SAMM phenotype is difficult 
to determine as mutations in multiple other genes have also been found in 
these mice (Tanisawa et al., 2013). An age-related decline in repair has also 
been demonstrated in senescent cells where repair of AP sites was slower in 
senescent compared with young cells in culture (Atamna et al., 2000). 
Furthermore activity of human OGG1 declines with age in lymphocytes (Chen et 
al., 2003). Measurements of DNA repair activity in ageing tissues have mostly 
shown a decline in activity. OGG1, UDG and polymerase β activity declined with 
age in brain, liver, spleen and testes of mice (Cabelof et al., 2002; Intano et al., 
2003). Furthermore, repair in the brain was region specific with an age-related 
decline in BER-related incision activity of OGG1, UDG and NTH1 in nuclear 
DNA in the cerebellum and brain stem and decline in mitochondrial DNA repair 
in the caudate nucleus, frontal cortex, hippocampus, cerebellum and brain stem 
(Imam et al., 2006). However, some studies did not find evidence of age-related 
decline in DNA repair. No changes in nuclear BER activity with age were 
detected in mouse liver (de Souza-Pinto et al., 2001), kidney and heart 
(Szczesny et al., 2010). Mikkelsen et al. did not report a significant difference in 
messenger ribonucleic acid (mRNA) expression levels of Ogg1 or Neil1 in 
mouse liver (Mikkelsen et al., 2009) furthermore, Lu et al. even reported OGG1 
and UDG expression to be up-regulated with age in the frontal cortex (Lu et al., 
2004). Thus, the effect of age on BER activity requires further study. 
In humans, a reduction in BER OGG1 activity is observed in ageing 
lymphocytes (Chen et al., 2003). Polymorphisms in OGG1 and other BER-
related proteins are associated with cognitive performance and its decline 
during ageing (Lillenes et al., 2011) and age-related macular degeneration 
(Synowiec et al., 2012). Furthermore, in Alzheimer’s disease brains there is a 
decrease in OGG1 activity (Mao et al., 2007; Jacob et al., 2013) and increase in 
APEX activity (Marcon et al., 2009). 
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1.4.2 Nucleotide excision repair and ageing 
Nucleotide excision repair is the primary pathway for removal of bulky adducts 
and helix-distorting lesions such as those induced by UV light or polycyclic 
aromatic hydrocarbons (Hoeijmakers, 2001). However, when BER is defective, 
NER can also remove oxidative damage (Reardon et al., 1997; Sunesen et al., 
2002; D'Errico et al., 2006). NER is divided into global genome NER (GG-NER) 
and transcription coupled NER (TC-NER) and schematic of the pathway and the 
proteins involved in the pathway are summarised in Figure 1.2.  
Nucleotide excision repair has also been associated with ageing (Hart and 
Setlow, 1974). NER as measured by unscheduled DNA synthesis declines with 
age by 50% in hepatocytes and kidney cells (Weraarchakul et al., 1989). The 
removal of thymine dimers is slower in dermal fibroblasts from old compared 
with new-borns and in young adult (Goukassian et al., 2000). Furthermore, 
mRNA and protein levels of NER-related enzymes decline with age 
(Goukassian et al., 2000). 
Mutations in human NER-related genes cause xeroderma pigmentosum (XP), 
trichothiodystrophy (TTD), Werner syndrome and Cockayne syndrome (CS) 
with affected individuals showing sun sensitivity, delay in development and 
neurodegeneration (Kraemer et al., 2007). Many of the symptoms associated 
with mutations in NER-genes are similar to those observed in ageing. The 
syndromes characterised by premature ageing are termed progerias. Mouse 
models of NER deficiency e.g. mutation or deletion of Xpd, Ercc1 and Xpf also 
show a premature ageing phenotype and may provide a useful model for 
studies of ageing interventions. Such mice exhibit susceptibility to skin and 
other cancer, deficiency inn hematopoetic stem cells, neurological deficits and 
decreased growth hormone axis, (de Boer et al., 2002; Niedernhofer et al., 
2006; Rossi et al., 2007; Niedernhofer, 2008; Goss et al., 2011) 
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Figure 1.2 Overview of the global genome and transcription coupled NER. Lesion recognition is 
performed by XPC, DDB1 and XPE (GG-NER) or CSB, CSA and XAB2 (TC-NER). XPC or CSB 
recruit the transcription factor TFIIH complex. XPB and XPD unwind the DNA while XPA and 
RPA bind and stabilize the unwound lesion and recruit XPF-ERCC1. XPF-ERCC1 incises the 
damaged strand of DNA 5’ to the lesions while XPG makes the 3’ incision. The lesion is 
removed as a single-stranded oligonucleotide, leaving behind a gap, which is filled by 
polymerase δ and ε, PCNA, RPA and RFC. The DNA backbone is sealed by DNA ligase I or 
DNA ligase II-XRCC1. CSB, cockayne syndrome group B protein; DDB1, DNA-damage binding 
protein 1; ERCC1, excision repair cross-complementing protein 1; GG-NER, global genome 
nucleotide excision repair; PCNA, proliferating cell nuclear antigen; RPA, replication protein A; 
RFC, replication factor X; TC-NER, transcription coupled nucleotide excision repair; TFIIH, 
transcription factor II human protein; XAB2, XPA-binding protein 2; XP A-G, ;xeroderma 
pigmentosum complementation group A-G; XRCC1, X-ray repair cross complementing protein 
1. Figure from (Niedernhofer, 2008). 
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1.4.3 Other repair mechanisms and ageing 
Accumulation of DNA double strand breaks (DSB) is observed in senescent 
human fibroblasts and ageing mouse tissue (Sedelnikova et al., 2004). Two 
main pathways for repair of double strand breaks (DSB) are NHEJ and HR; the 
pathway initiated depends on cell cycle phase. Efficiency of repair also differs 
between these pathways with HR giving rise to more accurate repair compared 
with NHEJ (van Gent et al., 2001). Studies from Drosophila melanogaster 
suggest that HR repair activity increases with age while NHEJ decreases with 
age and it is hypothesised that unrepaired DSBs lead to apoptosis (Preston et 
al., 2006). 
Homologous recombination uses the undamaged sister chromatid as a template 
to give an accurate repair product; it occurs in dividing cells. This pathway is 
catalysed by the recombinase RAD52 family of proteins. Recombination 
between misaligned sequences, can result in sequence rearrangement. 
Perhaps the best known cause of defective HR, is the mutations in breast 
cancer susceptible genes (BRCA, encode proteins which recognise DSB) and 
their role in inherited cancer (Venkitaraman, 2002). Furthermore, Fanconi 
anemia is a disorder which results from a mutation in any of the FANC genes, 
encoding proteins for recognition of DNA crosslinks and leads to cancer and 
decrease in number of hematopoetic stem cells (Walden and Deans, 2014). In a 
population of cells from ageing pancreas (but not fibroblasts) there is an 
increase in number of recombinant cells  (Wiktor-Brown et al., 2006).  
In contrast, NHEJ does not use the homologous strand but rather recognises a 
DSB, which may require processing by addition or removal of nucleotides, and 
ligates the DNA strand (van Gent et al., 2001). It can occur in both dividing and 
non-dividing cells. The proteins involved in this pathway are: Ku70, Ku80, DNA-
dependent protein kinase catalytic subunit, X-ray repair cross-complementing 
protein 4 (XRCC4), DNA ligase IV and XRCC4-like factor (XLF). NHEJ is 
important for integrity of hematopoietic stem cells during aging, as cells from 
mice with a mutation in DNA ligase IV show reduced NHEJ repair and a 
decrease in proliferation (Nijnik et al., 2007). Age-related telomere shortening is 
associated with DSB; furthermore in senescent cells such sites are associated 
with a persistent DNA damage response (Hewitt et al., 2012). 
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Mismatch repair (MMR), corrects mismatched bases made during the process 
of replication. It involves the proteins mutator Sα homolog (MSH), mutator Lα, 
exonuclease 1, RPA, PCNA, replication factor C, DNA polymerase δ and DNA 
ligase I (Conde-Pérezprina et al., 2012). Deficiency in mismatch repair is 
associated with DNA microsatellite instability (Lin and Wilson, 2009) and a 
decline in MMR activity is reduced in senescent fibroblasts (Chang et al., 2008). 
Furthermore, MMR may be important in telomere function specifically telomere 
capping as Msh2 deficient mouse fibroblasts exhibit an increase in chromosome 
end fusion (Campbell et al., 2005) 
In summary, ample evidence supports the role of defective DNA repair 
mechanisms in the ageing process albeit in a tissue specific manner. Data 
suggest that the proliferative nature of the tissue may influence the 
accumulation of DNA damage, DNA repair and hence rate of ageing of the 
tissue. 
1.5 Epigenetic regulation of gene expression 
Epigenetics is defined as the study of chromatin-associated marks and 
molecules that can alter gene transcription but without altering the original DNA 
sequence. The most studied epigenetic marks are cytosine methylation and 
post-translational histone modifications. 
These marks have chromatin altering properties, being able to shift chromatin 
between transcription active and repressed states. Transcription active 
euchromatin is loosely packaged during interphase. In contrast, 
heterochromatin is associated with transcription silencing and is found tightly 
packed during interphase. Heterochromatin can be subdivided into constitutive, 
found at centromeres and telomeres which is fixed, and facultative, synthesised 
as needed, e.g. X-linked silencing (Howard, 1996). Formation of euchromatin or 
heterochromatin is determined by modifications of the histones and DNA; e.g. 
histone acetylation is associated with euchromatin and DNA methylation with 
heterochromatin (Sedivy et al., 2008). Together epigenetic marks give rise to an 
epigenetic code, which may be linked to specific functions giving rise to explicit 
gene expression patters (Turner, 2007). 
Epigenetics has been proposed as an important player in ageing and age 
related diseases (López-Otín et al., 2013). This is because of i) the effects that 
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alteration in epigenetic marks may have on genomic stability and ii) the role of 
epigenetics in regulation of gene transcription. 
1.5.1 DNA Methylation 
DNA methylation occurs by the addition of a methyl group by a DNA 
methyltransferase at the 5’ position of the carbon ring in a cytosine nucleotide. 
The majority of DNA methylation occurs in CpG dinucleotides i.e. where a 
cytosine residue is followed by a guanine residue in a 5’ direction (denoted by 
CpG for cytosine adjacent to G bound by phosphate bond and to distinguish 
from CG pairing). CpG sites occur rarely on their own in the genome but rather 
occur as clusters which are called CpG islands where the ratio of observed over 
expected CpG dinucleotides is more than 65%.  
DNA methylation functions to silence the specific gene and keep a closed 
chromatin state (Gonzalo, 2010). An estimated 80% of all CpG sites in the 
mammalian genome are methylated. This is because the majority are found in 
DNA repetitive sequences made up of transposable elements which need to be 
silenced. However, cytosines found in CpG islands within gene promoter 
regions are generally unmethylated, as depicted by Figure 1.3 (Maegawa et al., 
2010).  
DNA methylation can regulate gene expression either by inhibiting the binding 
of transcription factors to the promoter sequence (Medvedeva et al., 2014) or by 
enhancing the binding of specific proteins to the methylated DNA that block 
other proteins from binding (Razin and Cedar, 1991). DNA methyltranseferases 
(DNMT) are enzymes responsible for the addition of methyl marks to cytosine; 3 
enzymes have been identified in mammals; maintenance DNMT1 and de novo 
DNMT3a and DNMT3b. DNA methylation patterns are established during the 
early developmental period (Law and Jacobsen, 2010). Methylation patterns are 
maintained from cell to cell by the maintenance DNMT1 which copies the 
methylation pattern in the parent DNA strand to the daughter strand (Gonzalo, 
2010). Recently 5-hydroxymethyl cytosine has also been shown to occur in cells 
although at a much lower level compared with 5-methylcytosie (Kriaucionis and 
Heintz, 2009). Although the biological role of this molecule is still not known, the 
enzymes involved in this conversion were identified as the ten-eleven 
translocation methylcytosine dioxygenase (TET) enzymes (Ito et al., 2011). 
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1.5.2 Effects of age on DNA methylation 
Although methylation patterns are developed early on in embryogenesis, 
studies in monozygotic twins who start off with the same methylation show 
divergence with age indicating that environmental factors and age can influence 
DNA methylation (Fraga et al., 2005; Christensen et al., 2009). Global DNA 
methylation has been shown to decrease with age in the brain, liver and small 
intestine mucosa in mice (Singhal et al., 1987; Wilson et al., 1987; Thompson et 
al., 2010), human leukocytes (Fuke et al., 2004) and cultured cells (Wilson and 
Jones, 1983). Furthermore, assessment of individual methylated sites showed 
both hypermethylation and demethylation with age; however, less than 1/3 of 
CpG sites studied show differential methylation with age in the mouse, and 
these changes were tissue specific. Hypermethylation was observed at 21%, 
11%, 12% and 14% of sites studied in the small intestine, liver, brain and 
muscle respectively. On the other hand demethylation was observed at 13%, 
12%, 4% and 3% of sites studied in the small intestine, liver, brain and muscle 
respectively (Maegawa et al., 2010; Takasugi, 2011). It is hypothesised that 
epigenetic changes occur depending on mitotic activity of the tissue with the 
less active cells not exhibiting age-related hypermethylation (Chu et al., 2007). 
Interestingly, the difference in methylation between the tissues exceeded that of 
age related changes (Thompson et al., 2010). Differential methylation patterns 
have been reported between young and old humans. Furthermore, age-related 
changes in methylation are dependent on region studied with intron and 
intergenic regions showing >3 fold more differentially methylated regions 
compared with promoter and exon (Heyn et al., 2012).  
Changes in DNA methylation at gene promoter regions are associated with 
altered gene expression. Methylation of specific gene promoters has been 
associated with repression of transcription at those genes. One of the 
hypothesised modes of action for epigenetic gene silencing is by inhibiting 
binding of proteins involved in transcription e.g. transcription factors (TFs) at 
gene promoter regions (Watt and Molloy, 1988; Deaton and Bird, 2011). For 
example in neuroblastoma cells the N-myc transcription factor which binds to 
the E-box sequence cannot do so when the CpG within the binding sequence 
CACGTG is methylated and this prevents transcription of genes such as 
APEX1, XRCC3, nibrin and a DSB repair protein MRE11A (Perini et al., 2005).  
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A third of housekeeping genes are methylated in older individuals (Heyn et al., 
2012), and methylation-related dysregulation of expression of housekeeping 
genes may be responsible for progression of ageing. In cancer, a disease of 
which age is a risk factor, methylation of tumour suppressor genes may be 
important in tumorigenesis. Age-related cytosine methylation of tumour 
suppressor genes occurs in a number of tissues (Ahuja et al., 1998; Waki et al., 
2003; So et al., 2006). Oestrogen receptor promoter CpG island is 
hypermethylated with age and in tumours, which correlates with its repression 
of transcription observed in tumours and cancer cell lines (Issa et al., 1994). 
Furthermore, DNA methylation of sub-telomeric regions is associated with 
increased activity of telomerase in cancer cell lines (Ng et al., 2009). 
Figure 1.3 Schematic showing the effect of age on DNA methylation. Global DNA methylation 
as measured by cytosine methylation (filled lollipops) within repetitive sequences is 
demethylated during ageing (A). Site specific DNA methylation in gene promoters is usually 
unmethylated (clear lollipops) and results in active expression of genes, upon ageing promoters 
can become hypermethylated leading to gene silencing (B). 
A number of other genes whose methylation may lead to deleterious effects 
have been studied. Hernandez et al. found that in the human brain age-related 
enrichment in methylation was found in genes coding for regulatory elements 
involved in activation of transcription and DNA binding (Hernandez et al., 2011). 
IGF2 methylation has also been shown to increase with age in cultured human 
fibroblasts, colon and lymphocytes (Issa et al., 1996). Cytochrome C oxidase 
subunit VIIa polypeptide 1 promoter methylation is higher in muscle of older 
individuals and correlates with a decrease in its mRNA expression, and may be 
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important in down-regulation of oxidative phosphorylation with age (Rönn et al., 
2008).  
Epigenetic silencing of a few DNA repair genes has been observed in cancer. 
Multiple cancer cell lines have hypermethylated WRN promoter region, while 
normal tissues show unmethylated regions (Agrelo et al., 2006). In addition 
analysis of gene expression shows that these cell lines have little or no 
expression of WRN mRNA. The BRCA1 gene promoter is hypermethylated in 
some breast cancer xenografts and this is associated with silencing of BRAC1 
mRNA transcript (Esteller et al., 2000). An age-related change in methylation is 
also observed in telomerase reverse transcriptase (TERT), ERCC1, RAD50 and 
WRN in humans (Christensen et al., 2009). MLH1 DNA repair gene is 
hypermethylated in colonic mucosa, which was associated with age and cancer 
development (Nakagawa et al., 2001) and in thyroid cancer (Guan et al., 2008). 
Furthermore, it has been suggested that differential methylation state in 
Werner’s Syndrome and Huntington-Guilford progeria contributes to the 
phenotype (Heyn et al., 2013). However to date no studies have addressed 
weather epigenetic silencing of BER-related genes could be responsible for the 
age-associated decline in repair activity. 
1.5.3 Histone modifications 
The nucleosome is the basic unit of chromatin consisting of an octamer of 
histones H2A, H2B, H3 and H4 (2 copies of each globular protein) with a 146bp 
of DNA wrapped around it. Together with other proteins the nucleosome is 
packed into a spiral arrangement of 30nm fibres containing six nucleosomes 
(Zhang and Reinberg, 2001). Positively charged amino acids including lysine 
and arginine found in histone tails can be post-translationally modified by the 
addition of methyl, acetyl, phosphorous or ubiquitin moieties (Figure 1.4). This 
chemical modification can alter the structure of chromatin. Therefore, histone 
modifications are important not only in regulating gene transcription but also for 
chromosome packaging and DNA repair. 
The first experiments linking histone acetylation and methylation to gene 
transcription were conducted in 1964 (Allfrey et al., 1964). Histone 
methyltransferases and demethylases can add and remove respectively methyl 
groups to/from lysine (K) and arginine (R) molecules. Methylation at H3K4, 
H3K36 and H3K79 is associated with activation of transcription, while 
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methylation of H3K9, H3K27 and H4K20 is associated with repression (D’Aquila 
et al., 2013). Promoters are linked with high levels of H3K4me3 regardless of 
their transcription state, while gene enhancer regions are marked by H3K4me1, 
H3K4me1 or H3K27me3 (Zentner and Henikoff, 2013). Addition and removal of 
acetyl groups to lysine residues is catalysed by histone acetyltransferase (HAT) 
and histone deacetylase (HDAC) enzymes. It is hypothesised that acetylation of 
lysine neutralises its positive charge and hence weakens the bond between 
histones and DNA, allowing the transcription machinery access to the DNA 
(Bannister and Kouzarides, 2011). For example, the CHFR gene, coding for 
checkpoint forkhead-associated RING finger domain E3 ubiquitin-protein ligase, 
is silenced in a number of cancer cell lines and re-expression of this gene 
correlated with deacetylation of H3 and H4 (Toyota et al., 2003). An example of 
histone methylation is the silencing of X chromosome (Zentner and Henikoff, 
2013). 
Figure 1.4 Map of histone modifications. N-terminal domains protrude from the nucleosome in 
H3 and H4 and N and C-terminal domains protrude in H2A and H2B. These domain can be 
post-translational modified by acetylation, methylation, phosphorylation, ubiquitination, 
citrullination, etc. and therefore alter chromatin structure, and influence transcription, replication 
and DNA repair. Figure from Kawakami et al. (Kawakami et al., 2009). 
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1.5.4 Effect of age on histone modifications 
A number of studies have investigated changes in histone modification with 
age. Increased levels of H4K16 acetylation are observed in sub-telomeric 
regions in old yeast cells (Dang et al., 2009). Histone 4 methylation has been 
shown to increase in the ageing rat liver and kidney (Sarg et al., 2002). 
Furthermore, in the ageing rat liver there is a decrease in H3K9Ac, an increase 
in H3S10Ph and no changes in H3K14Ac or H3K9Me1/2/3 (Kawakami et al., 
2009). Aged mice show deregulation in H3K12 acetylation and reduced 
expression of genes associated with learning memory in the hippocampus 
(Peleg et al., 2010). In addition, an age-related DNA hypermethylation is 
associated with H3K4Me3, H3K27Me3 and H3K27Ac while DNA 
hypomethylation in associated with H3K27Ac, H3K4Me1 and H3K27Me3 
(Raddatz et al., 2013).  
On a gene specific level in rat cortical neurones there is a decrease in caspase-
3, a protease involved in cell apoptosis, expression with age and this change 
correlates with lower levels of H3K14 acetylation and H4 acetylation at the 
caspase-3 gene promoter (Yakovlev et al., 2010). Senescent cells exhibit 
transcription silent heterochromatin and decreased levels of H3 lysine 9 and 14 
acetylation at PCNA and cyclin A promoters (Narita et al., 2003). Furthermore, 
spermidine associated increase in longevity in yeast, flies and mice correlates 
with a decrease in H3 lysine 18 acetylation and increased expression of 
autophagy-related genes (Eisenberg et al., 2009). 
More studies have looked at the enzymes that are associated with addition of 
such marks. Overexpression of Sir2, a NAD-dependant histone deacetylase in 
yeast and worm extends lifespan (Hekimi and Guarente, 2003) while a mutation 
in sir4 delays aging in yeast (Kennedy et al., 1995). In mice, overexpression of 
Sirt6 is also able to extend lifespan (Kanfi et al., 2012). Furthermore, a deletion 
of the RPD3 gene encoding a histone deacetylase is also able to increase 
lifespan of yeast (Kim et al., 1999) and inhibition of histone demethylase utx-1 
increases lifespan in nematodes (Jin et al., 2011). An age-related decline in Sir2 
and its mammalian homolog SIRT1 occurs in yeast and mice respectively 
(Sasaki et al., 2006; Dang et al., 2009). In rodent hippocampus and frontal 
cortex, expression of HDAC2 increases with age as does HDAC activity 
(Chouliaras et al., 2013; dos Santos Sant’ Anna et al., 2013). Studies of other 
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epigenetic enzymes during ageing have shown that overexpression of EZH2, a 
HMT, in hematopoietic stem cells inhibits their cellular senescence (Kamminga 
et al., 2006). 
Epigenetic dysregulation has also been identified as one of the hallmarks of 
ageing and can contribute to the age-related genomic instability (López-Otín et 
al., 2013). Although the hierarchy of epigenetic events is not known, it appears 
that together DNA methylation and histone modifications form an ‘epigenetic 
code’ which governs the transcription of genes. Furthermore, evidence points to 
histone deacetylation and histone methylation as important in the ageing 
process. 
1.6 Nutritional modulation of ageing – dietary restriction as an example 
Calorie/dietary restriction (CR/DR) i.e. the reduction of food intake below ad 
libitum levels without causing malnutrition is a very powerful tool in studies of 
ageing. The phenomenon of increased lifespan in laboratory animals fed a 
calorie restricted diet was reported as far back as 1930s (McCay et al., 1935). 
Since then DR has been reported to increase lifespan in multiple animal models 
such as the worm Caenorhabditis elegans, the fruit fly Drosophila melanogaster 
and rodents such as mice and rats (Guarente and Kenyon, 2000; Swindell, 
2012). Two studies have explored the effects of DR in non-human primates, the 
rhesus monkey. However, results were conflicting as only one study 
demonstrated lifespan extension (Colman et al., 2009; Mattison et al., 2012) 
which casts doubt whether DR can have life extending properties in primates. 
Nevertheless, DR remains a powerful tool for ageing research. 
1.6.1 Cellular effects of DR  
Multiple reports have shown DR to down-regulate signalling of various 
pathways e.g. growth hormone (GH) and insulin-like growth factor-1 (Sell, 
2003), DR reduces levels of circulating IGF-1 and secretion of the growth 
hormone from the pituitary. It increases levels of glucocorticoids and reduces 
free radical accumulation and lipid peroxidation (Sohal et al., 1995; Ramsey et 
al., 2000). Animals fed a DR diet have a lower metabolic rate (Bartke et al., 
2001), higher levels of interleukin 2 (IL-2) and T-cell growth factor providing 
better immunological protection (Pahlavani, 2000). Furthermore, DR attenuates 
the age-related increase in inflammatory markers in the brain (Lee et al., 2000) 
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and protects from apoptosis (Hiona and Leeuwenburgh, 2004). A summary of 
processes up- and down-regulated with DR is presented in Figure 1.5. 
DR activates redox-sensitive transcription factors such as activator protein 1 
(AP-1), hypoxia inducible factor 1 (HIF-1) and NFκB (Kim et al., 2002). It 
reduces mitochondrial ROS production (Sohal et al., 1994b) and retards age-
associated accumulation of mutations in lymphocytes (Aidoo et al., 2003) and 8-
oxoguanine lesions in multiple organs in the rat (Kaneko, 1997; Hamilton, 
2001). DR is able to reduce the concentration of 8-oxoguanine in the brain, 
heart and muscle by 40%, although it has minimal effects on 8-oxoguanine in 
liver or kidney, of mice (Sohal et al., 1994a). 
A study of the effect of DR on gene expression measured in livers of female 
mice at 7 and 27 months found that out of 11,000 genes measured, expression 
of 46 genes changed with age. Of these genes increased expression of 
mediators of inflammation (40%) and of stress response genes (25%) were 
most prominent. Of the genes whose expression decreased with age, 23% were 
responsible for DNA replication and the cell cycle, while others were involved in 
xenobiotic metabolism. Long-term DR prevented the majority of the age-related 
changes in gene expression and short-term DR (4 weeks) was also able to 
reproduce most of the changes (Cao et al., 2001)  
 
Figure 1.5 Summary of the processes activated by calorie restriction. Nutrient and energy levels 
signal to up-regulate stress response pathways. Figure adapted from Vaquero and Reinberg 
(Vaquero and Reinberg, 2009). 
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1.6.2 Potential modes of action of DR 
DR has multifaceted effects on cells and organisms. It is believed to work by its 
action on nutrient and energy sensing pathways (Figure 1.5 and 1.6). One of 
these pathways is the mammalian target of rapamycin (TOR) signalling pathway 
(Kapahi et al., 2010). Low nutrient levels down-regulate TOR kinase and its 
inhibition is associated with down-regulation of ribosomal biogenesis and the 
process of translation (Hansen et al., 2007). Furthermore, deletions in the TOR 
pathway in yeast increase lifespan and DR is unable to further increase this 
effect (Kaeberlein et al., 2005). DR may increase longevity by enhanced insulin 
sensitivity as mouse knock-out of growth hormone receptor increases lifespan 
in AL fed mice but not in DR fed animals (Coschigano et al., 2003; Bonkowski et 
al., 2006). The insulin/insulin-like growth factor is a hormone, which binds to its 
tyrosine-kinase receptor expressed on the cell membrane. Downstream it 
activates the protein kinase B (AKT) signalling pathway; inducing proliferation 
and cell growth and inhibiting apoptosis. A mutation in homologue of IGF in C. 
elegans and inhibition of the IGF pathway in Drosophila and mice all extend 
lifespan. Furthermore, in humans mutations in the receptor have been reported 
in cohorts of centenarians (Suh et al., 2008). AMP kinase (AMPK) is also 
activated in low energy levels and expression of active form of protein kinase A 
extends lifespan via FOXO transcription factor in C. elegans (Greer et al., 
2007). Furthermore, DR is unable to extend lifespan in yeast cells not 
expressing Sir2 a NAD-dependant deacetylase, suggesting DR may in part act 
via the Sir2 pathway (Lin et al., 2000). In CR mice, reduction of oxidative stress 
is mediated by SIRT3 activation of antioxidant SOD enzyme (Qiu et al., 2010) It 
has been suggested that which pathway is activated likely depends on at what 
point and in which form DR is administered (Kenyon, 2010). Resveratrol has 
been termed a DR mimetic, in high doses it increases yeast lifespan through 
sir2 signalling (Howitz et al., 2003). Resveratrol is also able to extend lifespan in 
nematodes, mice and fruit flies (Hector et al., 2012). It prevents age-related 
DNA and RNA oxidation in non-human primates (Marchal et al., 2013). 
1.6.3 Effects of DR on DNA repair 
DR causes tissue specific changes in DNA repair genes. Up-regulation of such 
DNA repair genes as is observed in mouse brain but down-regulation was seen 
in mouse muscle tissue (Lee et al., 1999; Lee et al., 2000). DR also influences 
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the DNA repair process. DR increases the BER-related synthesis in liver and 
kidney of mice (Stuart et al., 2004). In rodents, DR ameliorates the age-related 
decline in unscheduled DNA synthesis in lymphocytes, hepatocytes, 
keratinocytes and kidney cells (Licastro et al., 1988; Lipman et al., 1989; 
Weraarchakul et al., 1989). DR prevents the age-related decrease in G:U 
mismatch repair, β polymerase activity and 8-oxoguanine incision activity in the 
brain, liver, kidney and spleen of mice (Cabelof et al., 2003; Langie et al., 2011) 
and cyclobutane pyrimidine dimer removal in the liver of rats (Guo et al., 1998). 
However, no effect of DR was observed on BER-related repair in lymphocytes 
(Gedik et al., 2005) or UDG activity, AP endonuclease activity, 8-oxoguanine 
incision or 5-OH uracil and cytosine incision in the liver and kidney of mice 
(Stuart et al., 2004). DR ameliorates the age-related decline in APE activity in 
the rat brain (Kisby et al., 2010). It may enhance neuroprotection by increasing 
DNA repair activity; for example DR is able to prevent the age-related increase 
in cleaved PARP in the frontal cortex of rats (Hiona and Leeuwenburgh, 2004; 
Heydari et al., 2007). In addition, it has been proposed that during cellular 
energy depletion (such as would be observed with DR), long-patch BER is the 
favoured pathway because it can generate ATP from poly ADP-ribosylation 
(Petermann et al., 2003). 
1.6.4 Modulation of the epigenome by dietary restriction 
Environmental factors, including nutritional factors, can alter the epigenetic 
marks and molecules (Mathers et al., 2010). Perhaps the best evidence of this 
comes from studies of epigenetic divergence observed in monozygotic twins 
(Fraga et al., 2005). A number of studies have addressed the effect of 
nutritional modulation on epigenetic changes and this has been review by 
Mathers and Ford (Mathers and Ford, 2009). However, only a few have looked 
at the effect of dietary restriction on the epigenome. 
A number of studies addressed gene specific changes after dietary restriction. 
Nutritional intervention by dietary restriction attenuates the age-related 
hypermethylation of the c-myc gene in mouse liver (Miyamura et al., 1993) and 
N-cadherin gene in rat kidney (Akintola et al., 2008). Furthermore, DR increases 
methylation and silences proto-oncogenes (Hass et al., 1993). An in vitro model 
of DR by cell culture medium glucose restriction, shows that DR decreases H3 
acetylation and H3K4 dimethylation (active marks) and increases H3K4 
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trimethylation (silencing mark) at p16 promoter in cultured fibroblasts (Li and 
Tollefsbol, 2011). Furthermore, in this model DNA methylation was also 
observed at the p16 promoter with glucose restriction (Li et al., 2010). In 
humans, a low calorie diet given to obese individuals results in a decrease in 
DNA methylation at the TNFα promoter in blood mononuclear cells (Campión et 
al., 2009). To my knowledge no study has addressed the effect of DR on global 
landscape of DNA methylation and histone modifications. 
Although many of the effects of DR take place in the cytoplasm through 
phosphorylation of proteins, DR also affects chromatin (Figure 1.6). Dietary 
restriction may exert its longevity effects by promoting genomic stability, as it 
prevents the age-associated gene silencing (Jiang et al., 2013). Reversal of 
aberrant methylation may be one of the mechanisms through which DR 
maintains genomic integrity. It may do so by activating enzymes responsible for 
generation of epigenetic marks. In fact, this hypothesis has great support from 
studies of Sirtuins. DR was not able to extend lifespan in yeast cells not 
expressing Sir2 (Lin et al., 2000) suggesting that Sir2 and DR act within the 
same pathway. These NAD dependent histone deacetylases are known to play 
a role in DR function in yeast, worm, flies and mice (Guarente, 2013). Of note, 
the Sirtuins act as protein deacetylases and can therefore either affect protein 
activity directly (e.g. deacetylation of repair proteins) or indirectly via their 
epigenetic effect of histone deacetylation. The SIRT enzyme modulates 
chromatin by deacetylation of lysine residues on histone 1, 3 and 4 (Vaquero et 
al., 2004; Vaquero et al., 2006).Only a few studies have addressed the effect of 
DR on epigenetic enzymes other than Sirtuins. One group in particular is 
leading these studies. They found that DR attenuates the age-related increase 
of DNMT3a (Chouliaras et al., 2011) and HDAC2 in the mouse hippocampus 
(Chouliaras et al., 2013). Interestingly, changes in DNA methylation by DNMT 
enzymes can result from activation of this enzyme via SIRT1 as a number of 
genes were differentially methylated with SIRT1 overexpression and knockdown 
in cultured cells (Ions et al., 2012). Furthermore SIRT1 can also regulate the 
HAT p300 and HMT SUV39H1 (Bouras et al., 2005; Vaquero et al., 2007). 
Studies of DR mimetics have also shed some light on DR mediated chromatin 
effects. Rapamycin has been found to induce TET2 which binds to promoters 
and activates expression (Liu et al., 2013). Resveratrol inhibits LSD1, a histone 
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demethylase, activity in cultured cells (Abdulla et al., 2013) and activates SIRT1 
in mouse tissues (Lagouge et al., 2006). It also alters histone acetylation at the 
BRCA1 promoter in cultured cells (Papoutsis et al., 2010). SIRT6 deficient cells 
have increased susceptibility to BER-related lesions highlighting a role of SIRT6 
in base excision repair (Mostoslavsky et al., 2006). APEX is a target for SIRT1 
deacetylation, which is important for APEX translocation (Lirussi et al., 2012). In 
addition SIRT1 deacetylates APEX and hence resveratrol can activate SIRT1 
and so promotes APEX activity (Yamamori et al., 2010). Upon genotoxic stress 
APEX is acetylated and this is prevented by SIRT1, SIRT1 promotes APEX 
association with XRCC1 (Yamamori et al., 2010).  
In addition, DNA methylation and histone modifications are said to affect the 
ability of transcription factors (TFs) to bind at gene promoters. Transcription of 
the genes is dependent on transcription factor binding and DR may act by up-
regulation of the expression or binding of transcription factors. Such an example 
is the FOXO family of transcription factors which are upregulated during DR and 
initiate a myriad of stress response genes (Nakae et al., 2008). Interestingly, 
other transcription factors which increase with age such as NFκB, AP-1 and 
HIF1α are down-regulated by DR (Kim et al., 2002). As such, TF-related gene 
expression may be either up or down-regulated via DR with the aid of 
epigenetic mechanisms. 
Together some evidence exists for DR mediating genomic integrity in a gene-
specific and global manner via several epigenetic mechanisms. However, there 
is still a lack of studies exploring this effect. Although DR enhances DNA repair 
activity, to date no studies have established the effect of DR on epigenetic 
regulation of BER repair genes.  
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Figure 1.6 Molecular pathways influenced by dietary restriction. AKT, protein kinase B; AMPK, AMP-activated protein kinase; APEX, AP endonuclease; ATG, 
autophagy-related protein; DNMT, DNA methyltransferase; FOXO, forkhead box O; HAT, histone acetyltransferase; HDAC, histone deacetylase; HIF1α, hypoxia-
inducible factor 1 alpha; HMD, histone demethylase; HMT, histone methyltransferase; IGF, insulin-like growth factor; IKK, Iκ kinase; LKB, serine/threonine kinase; 
mTOR, mammalian target of rapamycin; NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells;OGG1, 8-oxoguanine DNA glycosylase; p53, tumour 
phosphoprotein 53; PDK, 3-phosphoinositide dependent protein kinase; PI3K, phosphatidylinositol-3-kinase; ROS, reactive oxygen species; S6K, ribosomal protein 
S6 kinase; SIRT, sirtuin; TET, ten-eleven translocation methylcytosine dioxygenase; red triangles, acetyl group; blue triangles, methyl group; black filled lollipop, 
methyl cytosine; grey-filled lollipop, hydroxymethyl cytosine. Figure adapted from (Vaquero and Reinberg, 2009; Langie et al., 2012). 
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1.7 Overview 
Accumulation of damage to DNA is an integral feature of the ageing cell that 
results from exposure to damaging agents and reduced repair. Base excision 
repair is the primary mechanism for removal of small damaging lesions such as 
8-oxoguanine. An age-related silencing of BER-genes could explain the 
inefficiency of DNA repair, which could have arisen due to deleterious 
epigenetic changes associated with BER genes. DR is a powerful tool in studies 
of ageing; it has been shown to affect many pathways by which it can exert its 
life extending properties. One such pathway is DNA repair. Although DR can 
evoke changes in expression of DNA repair-related genes the mechanisms 
responsible for these changes are poorly understood. DR causes transcription 
changes and some of these may be epigenetically mediated (Mathers, 2006). 
The purpose of this thesis was to measure the effects of age and DR on BER-
gene promoter associated marks and the subsequent expression of these 
genes. Furthermore the effects of age and DR on functional activity of BER-
related incision activity were also addressed.  
1.8 Hypothesis, Aims and Objectives 
For the purpose of the current thesis, I hypothesise that: 
1. Base excision repair activity declines during ageing leading to 
accumulation of oxidation damage. 
2. This age-related dysfunction is mediated through epigenetic 
mechanisms. 
3. Dietary restriction ameliorates the decline in repair activity via effects on 
epigenetic regulation of BER gene expression. 
The aim of this work is to test the above hypothesis and to further 
understanding of the role of epigenetic mechanisms in regulation of the age-
related decline in DNA repair activity and its modulation by DR. This was 
accomplished through the following objectives: 
a) To develop pyrosequencing assays to measure Ogg1 and Apex 
promoter DNA methylation and to apply these assays to DNA from 
tissues from ageing and dietary restricted mice;  
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b) To develop ChIP based assays to measure histone acetylation and 
methylation changes corresponding to Ogg1 and Apex promoters in 
tissues from ageing and dietary restricted mice; 
c) To develop qPCR assays to measure mRNA expression of Ogg1 and 
Apex in tissues from ageing and dietary restricted mice; 
d) To use the comet-based in vitro repair assay to measure BER-related 
incision activity of oxidative damage in tissues from ageing and dietary 
restricted mice;  
e) To quantify levels of 8-oxoguanine in brain and liver from ageing and DR 
mice; 
f) To study correlations between epigenetic marks, gene expression, DNA 
repair activity and oxidative damage levels in tissues from ageing and 
DR mice; 
g) To study the difference in epigenetic marks, gene expression, DNA 
repair activity and oxidative damage levels in tissues of different 
proliferative nature (brain vs. liver); 
h) To determine if expression of transcription factors alters during ageing 
and dietary restriction; 
i) To determine if epigenetic enzyme levels alter during ageing and dietary 
restriction; 
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Chapter 2: General Methods 
2.1 Animal husbandry 
Male and female mice were taken from a long-established colony of the inbred 
C57BL/6 (ICRFa) strain. This strain provides a good model of ageing as it is 
free from specific age-related pathologies. Mice were housed at 20±2ºC under a 
12h light/12h dark photoperiod with lights on at 7am. All mice were provided 
with sawdust and paper bedding, standard rodent pelleted chow (CRM (P), 
Special Diets Services) and free access to water. Animals were subjected to 
either ad libitum (AL), 26% short-term dietary restriction (DR) or 40% long-term 
DR feeding and sacrificed at specific ages (details of individual animal study 
designs will be provided in further Chapters). Whole brain, liver, colon and lung 
tissues were collected, snap frozen in liquid nitrogen and stored at -80ºC until 
use. 
2.2 Grinding of tissue samples 
Tissue samples were ground under liquid nitrogen to give a homogenous 
mixture and to prevent tissue and macromolecule degradation. A tamper, 
mortar and a spatula were placed in the liquid nitrogen and allowed to cool. Pre-
weighed micro-centrifuge tubes and tissue samples were placed on dry ice. The 
mortar was removed from the liquid nitrogen using tongs and a tissue sample 
was placed in the mortar. Quickly the tamper was removed from the liquid 
nitrogen with tongs and placed in the mortar. Using a hammer the tamper was 
tapped 3-4 times and then twisted while in the mortar to grind the tissue. The 
tamper was cleaned with a paper towel and placed back in the liquid nitrogen. 
Using a pre-chilled spatula the ground tissue was aliquoted into the pre-
weighed micro-centrifuge tubes on dry-ice. The mortar was cleaned and placed 
back in the liquid nitrogen. Tubes containing ground tissue were weighed. This 
procedure was repeated for all tissues. Ground tissues were stored at -80˚C 
until further use. 
2.3 Chemicals and oligonucleotides 
All chemicals used for experimental procedures were purchased from Sigma 
Aldrich unless otherwise stated. Lyophilised oligonucleotides (primers) were 
purchased from Eurofins MWG Operon at 1µmol purified by HPSF or HPLC. 
Water used in preparation for buffers in protein assays was Millipure quality. 
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Nuclease-free water was used in DNA and RNA assays, furthermore buffers 
used in these assays were also passed through a filter prior to use. 
2.4 Extraction of DNA 
500μl of SET-SDS (50mM Tris-HCl, 12.5mM EDTA and 0.5% Sodium Dodecyl 
Sulphate) and 15μl proteinase K (20mg/ml, Thermo Scientific) were added to 
30mg ground whole brain or liver tissue and incubated overnight shaking at 
37˚C and 700 revolutions per minute (RPM). The following morning tissue was 
homogenised with a micro-centrifuge pestle and incubated for further 2 hours at 
56˚C. Next, 100μl of 8M potassium acetate (KAc) was added to the tissue 
suspension and mixed by inversion for 2 minutes. 600μl 
chloroform:isoamylalcohol (IAA, 24:1) was added to the suspension and mixed 
by inversion for 10 min. Samples were centrifuged at 14,000RPM for 5 min and 
400-450μl of the upper water phase was transferred to a new micro-centrifuge 
tube. 400-450µl chloroform:IAA was added and samples were mixed by 
inversion for 10 min. As before, samples were centrifuged at 14,000RPM for 5 
min and 400-450μl of the top phase was transferred to a new tube. 20μl RNase 
A/T1 mix (2mg/ml RNase A and 5000U/ml T1 RNase, Thermo Scientific) was 
added to the sample and incubated for 30 min - 1 hour at 37˚C. 900µl of cold 
100% ethanol were added to the samples and mixed by inversion for 2 min, and 
then incubated for 30min at -20˚C. Samples were centrifuged at 14,000RPM 
and the supernatant was discarded. The pellets were washed twice with 1ml 
70% ethanol and samples centrifuged at 14,000RPM for 2min. The supernatant 
was discarded and pellets were dried on air and then eluted in approx. 30μl 
2mM Tris-HCl, dissolved overnight on a shaker at 4˚C, and the following day 
concentrations were determined using Nanodrop 1000 (Thermo Scientific). 
Samples were diluted to 100ng/μl where appropriate and stored at -20˚C. 
2.5 Pyrosequencing 
Pyrosequencing of bisulphite converted DNA can be used to detect ratio of 5-
methylcytosine to cytosine nucleotides in a genomic DNA sample. Bisulphite 
modification converts any non-methylated cytosine to a uracil nucleotide, 
whereas any methylated cytosine will remain unchanged. Uracil is 
complementary to adenine and will therefore be noted as thymine after 
polymerase chain reaction (PCR). Pyrosequencing is a sequence-by-synthesis 
reaction: a single nucleotide is added in succession to a reaction mixture. Upon 
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incorporation of a complementary nucleotide by the DNA polymerase a 
pyrophosphate is released. This is then converted into ATP by ATP sulfurylase 
using adenosine 5’ phosphosulphate as a substrate. ATP drives a luciferase-
based reaction which emits light. The amount of light released is proportional to 
the amount of base incorporated and detected by a charge-coupled device and 
displayed as a peak on the pyrogram. Apyrase degrades unincorporated 
nucleotides, so that another nucleotide can be added. The variable degrees of 
methylation can be analysed as C/T polymorphisms (Tost and Gut, 2007). 
2.5.1 Identification of promoter regions and CpG islands 
Sequences of the gene promoter regions under study (Ogg1 and Apex) were 
identified using Genomatix Software. The Gene2Promoter function of this 
bioinformatics tool provides genomic data and only experimentally verified 5’ 
complete transcripts were used for analysis. Sequences were downloaded in 
FASTA format and were then run through an online software, able to detect 
CpG Islands in a nucleotide sequence, to predict the site of the CpG islands 
within the promoter region; such a region was defined as being 200bp in length 
with greater than 50% GC content and 0.6 ratio of observed/expected CpG. 
Genomatix was used to analyse the sequences for transcription factor binding 
sites; TF binding sites containing a CG in the sequence and that were specific 
for brain and liver tissue were selected. 
2.5.2 PSQ primer design 
Bisulphite modification (BM) is used in the pyrosequencing reaction to 
distinguish between methylated and unmethylated cytosine nucleotides. 
Microsoft Office Word is used to predict the BM sequence. In a Word document, 
all CpG sites are converted to C/TG then, all Cs are converted to Ts and finally, 
all T/ sites are converted to C/ to generate in-silico sequences. These BM 
sequences were inserted into the PSQ Assay Design Software v 1.0.6 (Qiagen), 
to allow the software to recognise all the possible CpG sites. Primers were 
designed with the highest possible score to identify a PCR product <350bp and 
a sequencing region of 80-100bp long. The sequencing primer was placed as 
close to the sequence start as possible. The reverse primer was labelled with 
biotin on the 5’ end. 
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2.5.3 Bisulphite modification 
EZ DNA Methylation Gold Kit (Zymo Research) was used to bisulphite modify 
the DNA. As per kit instructions the CT conversion reagent was prepared by 
adding 900μl of nuclease-free water, 300μl of M-Dilution buffer and 50μl M-
Dissolving buffer to each tube of CT conversion reagent, then shaken 
vigorously for 10min. 130μl of CT conversion reagent was added to 1μg DNA 
sample (in a 20μl volume). Samples were incubated at 98˚C for 10 min followed 
by 64˚C for 2.5 hours. Samples were then added to a Zymo-Spin IC column 
filled with 600μl of M-binding buffer and mixed by inversion. Samples were 
centrifuged at 13,000g for 30 seconds and the flow-through was discarded. 
100μl of M-wash buffer was added to the column, centrifuged at 13,000g for 30 
sec. 200μl of M-disulphonation buffer was added to each column and left to 
incubate for 20min at room temperature, columns were centrifuged at 13,000g 
for 30 sec. Columns were washed twice by adding 200μl M-wash buffer and 
spinning at 13,000g. After each centrifugation step the flow-through was 
discarded. Bisulphite modified DNA was eluted in 12μl of M-elution buffer by 
spinning columns at full speed for 1 min. 
2.5.4 Optimisation of pyrosequencing assays 
2.5.4.1 PCR of promoter regions 
To optimise the pyrosequencing assays a nested-PCR is used to amplify the 
promoter region of a gene of interest. This product is then in vitro methylated 
and used to confirm specificity of primers designed by the PSQ software. 
Primers were designed to amplify the whole promoter region, approximately 
600bp. Using the nested PCR primers, whose sequences can be found in Table 
2.1, for each region of interest 1μl of 100ng DNA was used in a PCR reaction 
with 12.5μl HotStart Taq Mastermix (Qiagen), 1μl each of forward and reverse 
primers at 10pmol and 9.5μl nuclease-free water. Firstly a gradient PCR was 
performed to determine the optimal annealing temperature for the primers with 
cycling conditions as shown in Table 2.2. The product was confirmed on a 1% 
agarose gel. Once the best annealing temperature was determined the nested 
PCR was performed with the optimal annealing temperature, shown in Table 
2.1 and previously stated cycling conditions shown in Table 2.2. 
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Name Sequence Ta (˚C) 
Ogg1 Fwd 5’-GGTTTATTTCTTGAGACAGAG 
48 
Ogg1 Rev 5’-TTTAATTTGAGTCCCTGTT 
Apex Fwd 5’-CCCCAGGTGTCTGACTCTTC 
58 
Apex Rev 5’-TTCGTTGGGAGGTCAGGTAC 
Table 2.1 Sequence and annealing temperatures of primers used for nested PCR. 
Step Temperature (˚C) Time Cycles 
Enzyme Activation 95 15 min  
Denaturation 95 15 sec 
30 Annealing 45-60 30 sec 
Extension 72 45 sec 
Elongation 72 10 min  
Table 2.2 Cycling program for nested PCR reactions. 
2.5.4.2 Generating methylated controls 
During the nested PCR reaction all methylation is wiped out creating a 0% 
methylated control. To create a 100% methylated product, 9μl of nested PCR 
product was incubated with 3μl S-adenosylmethionine (SAM, 1:8 dilution in 
water), 2μl NEB2 buffer, 1.5μl CpG Methyltransferase (enzymes obtained from 
New England BioLabs) at 30˚C for 16 hours. To check the efficiency of in vitro 
methylation a single digestion with HpaII Methyltransferase enzyme (New 
England BioLabs) was performed. This enzyme is methylation specific and only 
cleaves unmethylated CCGG sequence. 2μl NEB1 buffer, 0.5μl HpaII and 9.5μl 
of nuclease-free water were mixed with 8μl of either 0% or 100% DNA and 
incubated in a water bath at 37˚C for 2 hours. The product was run on a 1% 
agarose gel, 80V, 30 min and resulting gel compared with a virtual gel 
generated by NEB Cutter software, from New England BioLabs website, to 
confirm methylation. 
2.5.4.3 Bisulphite modification of methylated controls 
BM was performed as described in section 2.3 except that when adding the 
template 5μl of 0% control and 15μl of water or 10μl of 100% control and 10μl of 
water were added to the CT conversion reagent, the remaining steps of the 
reaction were the same. 
2.5.4.4 Pyro PCR 
A Pyro-PCR was set up: 15μl HotStart Taq Mastermix (Qiagen), 1μl each of 
forward and biotinylated reverse primers at 10pmol (sequences can be found in 
Table 2.3), 9.5μl nuclease-free water and 1μl BM DNA product. A gradient PCR 
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was performed with cycling conditions as shown in Table 2.4 to determine 
optimal annealing temperatures. The product was confirmed on a 1% agarose 
gel after electrophoresis at 80V for 30 minutes. 
Mixes of 0% and 100% in vitro methylated samples were used to give a dilution 
series of 0%, 5%, 10%, 25%, 50%, 75%, 90%, 95% and 100% and Pyro-PCR 
was performed for each methylation dilution using the cycling conditions from 
Table 2.4 and annealing temperature as seen in Table 2.3.This made up a pre 
dilution series. Another dilution series was made from 0% and 100% methylated 
product after the pyro-PCR to make up the post pyro-PCR dilution series. 
Name Sequence Ta (˚C) 
Ogg1 Fwd1 5’-GGTTTATTTTTTGAGATAGA 
42 
Ogg1 Rev1 5’BIO-ACTAAAACCACATCATTA 
Ogg1 Seq1 5’-TTTAGTTAAGTTTTAAA - 
Ogg1 Fwd2 5’-GTAGGTTTTGAGATTGTAT 
44 
Ogg1 Rev2 5’BIO-ATTTAACCCTAAAAATAAC 
Ogg1 Seq2 5’-GAAAGTTTTGAAATGGTAGA - 
Apex1 Fwd1/2 5’-GGATAGAATAAAATTGGATAAG 
53 
Apex1 Rev1/2 5’BIO-TTAATCCTCCTAACACCTC 
Apex1 Seq1 5’-GAATAAAATTGGATAAGG - 
Apex1 Seq2 5’-GTTGTTTTAGAATTTTAGTA - 
Table 2.3 Sequence and annealing temperatures of primers used in Pyro-PCR. 
Step Temperature (˚C) Time Cycles 
Enzyme Activation 95 15 min  
Denaturation 95 15 sec 
50 Annealing 40-50 30 sec 
Extension 72 45 sec 
Elongation 72 10 min  
Table 2.4 Cycling program for Pyro-PCR reactions. 
2.5.4.5 Pyrosequencing of BM DNA controls 
Both the pre and post dilution series were used as products for the 
pyrosequencing reaction. Biotinylated PCR products were immobilised on 
streptavidin-coated sepharose beads (GE Healthcare) in a 96 well PCR plate, 
5-10μl of pyro PCR product was added to 70μl bead solution (2μl beads, 38μl 
Qiagen Binding buffer and 30μl nuclease-free water) in duplicate, covered and 
shaken for 10 min. Pyrosequencing plate (Qiagen) was prepared by adding 
0.5μl 10pmol sequencing primer and 11.5μl Annealing buffer (Qiagen) to 
corresponding wells in the plate. Using a prep tool, biotinylated PCR product 
bound to streptavidin beads was aspirated from the wells, passed through 
denaturing buffer (0.2M NaOH), 70% ethanol and wash buffer (Qiagen 
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containing 10mM Tris, pH 7.6). The resulting single stranded DNA was released 
into the pyrosequencing plate which was then incubated at 80˚C for 2 minutes, 
allowing the plate to cool permitted the sequencing primer to anneal (sequences 
of primers can be found in Table 2.3). The pyrosequencing reaction was 
performed on a PyroMark MD System (Qiagen). Pyro Q CpG software version 
1.0.6 (Qiagen) was used to quantify the percentage methylation.  
The resultant methylation from the dilution series was plotted on a scatter graph 
against the expected methylation percentages. A good assay showed a linear 
trend with r2 above 0.8.  
2.5.5 Methylation analysis of DNA from brain and liver 
Once the pyrosequencing assays were optimised the methylation analysis was 
performed on bisulphite modified DNA samples from brain and liver. A Pyro-
PCR was set up: 15μl HotStart Taq Mastermix (Qiagen), 1μl each of forward 
and biotinylated reverse primers at 10pmol (sequences can be found in Table 
2.3), 9.5μl nuclease-free water and 1μl BM DNA product. Pyro-PCR was 
performed with cycling conditions as shown in Table 2.4. The product was 
confirmed on a 1% agarose gel. Biotynylated PCR products were analysed on 
the pyrosequencer as described in section 2.5.4.5. 
2.6 Extraction of RNA 
A 20-30mg aliquot of ground tissue was thawed on ice. 500μl cold TRIzol 
(Invitrogen) was added to each sample and vortexed. A micro-centrifuge pestle 
was used to homogenise the tissue for 1 min. Another 500μl of TRIzol was 
added to each sample and vortexed. Samples were then left to incubate at 
room temperature for 5 min and centrifuged at 12,000g for 10 min at 4˚C. The 
supernatant was transferred to an RNase free tube (Ambion) and 100μl 1-
bromo-3-chloropropane (BCP) was added to each tube. Samples were shaken 
for 15 seconds, incubated for 10 min at room temperature, shaken for 15 
seconds again and centrifuged at 12,000g for 10 min at 4˚C. 400μl of the top 
water phase was transferred to a new RNase free tube and RNA clean-up was 
carried out using an E.Z.N.A. Total RNA Kit (Omega, VWR) according to 
manufacturer’s protocol. 200µl of kit TRK lysis buffer and 300µl 100% ethanol 
were added to the aqueous phase and mixed by inversion. The solution was 
loaded onto an E.Z.N.A. spin column and centrifuged at 10,000g for 1 minute 
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and flow-through was discarded. 350µl kit RNA Wash Buffer I was added to the 
column, centrifuged at 10,000g and flow-through discarded. This step was then 
repeated. 500µl kit RNA Wash Buffer II was added to the column, centrifuged at 
10,000g and flow-through was discarded. This step was repeated and column 
was spun at 13,000g to remove any remaining buffer. Finally, RNA was eluted 
in RNA storage solution (Ambion) and quantified using Nanodrop 1000. RNA 
with 260/280 and 260/230 values above 1.8 were used for further experiments. 
RNA degradation was determined by running the RNA template on 1% agarose 
gel for 30 min at 80V. 
2.7 Complementary DNA synthesis 
To remove genomic DNA, 500ng of RNA was added to 1μl DNase I, 1μl 10X kit 
reaction buffer (Thermo Scientific) and made up to a final volume of 10μl with 
nuclease-free water and incubated at 37˚C for 30 min. Each sample was run in 
duplicate (one as a reverse transcriptase (RT) positive and one RT negative). 
1μl 50mM EDTA was added to the reaction and incubated further for 10 min at 
65˚C. Complementary DNA (cDNA) was synthesised using RivertAid H Minus 
First Strand cDNA Synthesis Kit (Thermo Scientific): 1μl oligo(dT)18 primer, 4μl 
5X reaction buffer, 1μl RiboLock RNase Inhibitor, 2μl 10mM dNTP Mix and 
either 1μl RevertAid H Minus M-MulV Reverse Transcriptase (RT positive) or 
1μl nuclease-free water (RT negative). Reactions were incubated at 45˚C for 60 
min and 70˚C for 5 min. Confirmation of cDNA synthesis was performed by 
running a control PCR for the GAPDH gene (forward primer 5’-
CAAGGTCATCCATGACAACTTTG and reverse primer 5’-
GTCCACCACCCTGTTGCTGTAG). 5μl cDNA (diluted 1:200), 12.5μl HotStart 
Taq Master Mix (Qiagen), 0.25μl forward primer and reverse primer each at 
10pmol/μl and 7μl nuclease-free water were mixed and run in a PCR reaction 
as shown in Table 2.5. 
Step Temperature (˚C) Time Cycles 
Enzyme Activation 95 15 min  
Denaturation 95 15 sec 
30 Annealing 58 30 sec 
Extension 72 30 sec 
Elongation 72 5 min  
Table 2.5. Cycling program for GAPDH control PCR for reverse transcription. 
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Presence of a strong product at 495bp on a 1% agarose gel confirmed if cDNA 
synthesis had worked, and no product in the RT negative samples indicated no 
genomic DNA contamination. 
2.8 Quantitative PCR 
Reverse-transcription quantitative polymerase reaction (RT-qPCR) has become 
the gold standard for measuring mRNA levels in molecular biology. This highly 
sensitive method has been used in many applications to show changes in gene 
expression. 
2.8.1 QPCR with SYBR Green 
Ogg1 and Apex gene expression was measured using qPCR with SYBR Green 
dye for fluorescence measurements. SYBR Green is a dye commonly used in 
qPCR because it emits a fluorescent signal when bound to double-stranded 
DNA. 
2.8.1.1 Primer design and validation 
Primers were designed using Primer3 online primer design software. 
Complementary DNA sequence was obtained from NCBI. Primers were 
designed to give a product size of 90-110bp with melting temperature of 59-
61˚C. UCSC website was used to check that primers did not bind at non-
specific sites and NetPrimer program was used to check that the primers did not 
or to a minor extend form duplexes or hairpin loops. 
A standard curve for each primer assay was run with 1/3rd dilutions of sample 
cDNA to check for efficiency of the reaction. The reaction contained 12.5μl 
Maxima SYBR Green Master Mix (Thermo Scientific), 0.75μl of each forward 
and reverse primer at 10pmol/μl, 6μl nuclease-free water and 5μl cDNA. Primer 
sequences and cycling conditions can be found in Table 2.6 and Table 2.7 
respectively. Assays given an efficiency 100±10% i.e. product amount doubling 
during each cycle, were required for an optimal PCR reaction. 
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Name Primer Sequence 
Product Size 
(bp) 
Ogg1 Fwd 5’-TGGCTTCCCAAACCTCCAT 
65 
Ogg1 Rev 5’-GGCCCAACTTCCTCAGGTG 
Apex Fwd 5-‘CCTAAGGGCTTTCGTCACAG 
108 
Apex Rev 5’-GCTGCCCCCTTACTCTTCTT 
Hprt Fwd 5’-AGGAGAGAAAGATGTGATTGATATT 
98 
Hprt Rev 5’-TCCACTGAGCAAAACCTCTT 
B2m Fwd 5’-ATGCTGAAGAACGGGAAAAAAA 
93 
B2m Rev 5’-CAGTGTGAGCCAGGATATAGAA 
Table 2.6 Primer Sequences for qPCR. 
2.8.1.2 Gene expression in samples of interest 
Complementary DNA was diluted 1:5 with nuclease free water. 25μl or 15μl 
reactions were set up in triplicate (depending which real-time instrument was 
used) as described in Table 2.7. Comparative delta-delta Ct program was used 
with cycling conditions as described in Table 2.8. Roche Light Cycler 480 
instrument was used for samples run in short-term DR study (Chapter 4), while 
Life Technologies Step One Plus real time instrument was used for samples 
from the long-term DR study (Chapter 5-7).  
Reaction Component 
Light Cycler 480 StepOne Plus 
25μl reaction 15μl reaction 
SYBR Green Master Mix 12.5μl 7.5μl 
Forward Primer 0.75μl 0.45μl 
Reverse Primer 0.75μl 0.45μl 
ROX - 0.03μl 
Nuclease-free water 6μl 3.57μl 
cDNA 5μl 3μl 
Table 2.7. Reaction set-up for qPCR. 
Step 
Light Cycler 480 StepOne Plus 
Temp 
(˚C) 
Time Cycles 
Temp 
(˚C) 
Time Cycles 
Enzyme 
Activation 
95 15 min  95 15 min  
Denaturation 95 15 sec 
40 
95 15 sec 
40 
Annealing 
and 
Extension 
60 1 min 60 1 min 
Melt curve 
 
95 
65 
97 
5 sec 
1 min 
continuous 
 
95 
65+0.5 
increments 
95 
15 sec 
1 min 
15 sec 
 
Table 2.8. Cycling conditions for qPCR reaction. 
The instrument’s software was used for analysis of melt curves and quality of 
data. Gene expression was determined using the equation outlined below, 
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where ΔCt represents Ct average reference gene – Ct target gene. This equation was used 
instead of ΔΔCt method as no true control group was present in the study. 
𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 = 2−∆𝐶𝑡 
2.8.2 QPCR with TaqMan assay 
Transcription factor (Hif1α and Nfya) gene expression was measured using the 
TaqMan assay (Life Technologies). These predesigned assays contain the 
forward and reverse primers as well as a probe with a fluorescent dye label. 
The probe is target specific which means a fluorescent signal will only be 
released when the target DNA is amplified. 
cDNA was diluted 5X and 15μl reactions were set up as shown in Table 2.9. 
The list of TaqMan assays used is provided in Table 2.10. Each sample was run 
in duplicate with B2m and Hprt used as reference genes. As with SYBR Green 
qPCR reactions, gene expression was measured using the 2-ΔCt method. 
Reaction Component 15μl reaction 
20X TaqMan Assay 0.75μl 
2X TaqMan Mastermix 7.5μl 
Nuclease-free water 3.75μl 
cDNA 3μl 
Table 2.9 qPCR reaction set up for TF TaqMan assays. 
Assay Gene Code 
Hif1α 
murine hypoxia inducible factor 1, alpha 
subunit 
Mm00468869_m1 
Nfya murine nuclear transcription factor-Y alpha Mm00477820_m1 
B2m murine beta-2 microglobulin Mm00437762_m1 
Hprt 
murine hypoxanthine guanine phosphoribosyl 
transferase 
Mm01545399_m1 
Table 2.10 Inventory of TaqMan assays. 
2.9 Extraction of proteins 
2.9.1 Extraction of a crude protein extract 
A crude protein extract can be used for the comet based assay, the ELISA and 
enzyme activity assays. A 20-30mg aliquot of ground tissue was thawed. 75μl of 
buffer A (45mM Hepes, 0.4M KCl, 1mM EDTA, 0.1mM DTT and 10% Glycerol, 
pH 7.8) was added per 25mg of tissue, vortexed thoroughly and snap frozen in 
liquid nitrogen. The sample was thawed and 22.5μl buffer A1 (0.1% Triton X-
100 in buffer A) was added per 25mg of tissue, vortexed thoroughly and 
incubated on ice for 5-10 min. Each sample was then homogenized using a 
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micro-centrifuge  pestle, vortexed thoroughly and incubated on ice for a further 
5-10 min. Samples were centrifuged at 14,000g and 4˚C for 5 min, supernatant 
was collected, aliquoted and stored at -80˚C until required. 
2.9.2 Protein quantification 
Bovine serum albumin (BSA) standard curve was prepared in buffer A2 
(0.0023% Triton X-100 in buffer A) at concentration ranging from 0mg/ml to 
4mg/ml. An aliquot of protein extract from each tissue sample was diluted 10 
times in buffer A2. BIO-RAD DC Protein assay was used for the colorimetric 
reaction. Kit reagent A and S were used to make reagent A’, to adjust for the 
Triton X-100 present in the buffer. Reaction was prepared by adding 
sample/control, buffer A’ and buffer B from the kit in a ratio 1:5:40. Samples 
were incubated at room temperature in the dark for 15 min. Absorbance was 
measured at 650nm using either Lowry program on Nanodrop 1000 in duplicate 
or the FLUOstar Omega Microplate reader in triplicate. 
2.10 Comet-based in vitro repair assay 
The comet assay was firstly modified to asses base excision repair (BER) in 
mononuclear cells (Collins et al., 2001). This assay quantifies the ability of a 
lymphocyte protein extract to carry out the first incision step of the BER process 
on a DNA substrate containing specific DNA lesions. Since then the protocol 
has been adapted for use with mouse tissue protein extracts to look at DNA 
incision of singlet oxygen-induced DNA damage (Langie et al., 2011). This 
technique has been used in the current project and was further optimised in 
Chapter 3. 
2.10.1 Cell culture and preparation of substrate cells 
HeLa cells were grown in 10% Foetal calf serum Dulbecco’s Modified Eagle’s 
Medium (FCS DMEM) with 1% Pencillin/Streptamycin in 175cm³ flasks (Greiner 
Bio-One) until near confluence. Media was fully removed and cells washed 
once with PBS. Next, 25ml of cold 1μM Ro 19-8022 (Ro cells) or PBS (noRo 
cells) was added to the flask and exposed to light on ice, 33cm from 500W 
halogen lamp for 5 min (under these conditions Ro 19-8022 induces DNA 
damage in form of primarily 8-oxoguanine (Will et al., 1999), Ro 19-8022 
obtained from Roche). PBS or Ro 19-8022 were removed and cells washed 
once with PBS. Cell were trypsinised for 5 min at 37˚C, trypsin was inactivated 
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with FCS DMEM and cells centrifuged at low speed, 400g at 4˚C for 5 min. 
Cells were gently re-suspended in DMEM at 6x106 cell/ml. The same volume of 
cold freezing media (20% DMSO in DMEM) was added to give a final 
concentration of 3x106 cell/ml (in DMEM plus 10% DMSO). Cells were slowly 
frozen in a thick walled polystyrene box as aliquots of 200μl and stored at -
80˚C. 
2.10.2 Embedding cells in gels 
An aliquot of 3x106 cell/ml noRo and Ro cells were washed with cold PBS and 
centrifuged at 700g, 4˚C for 5 min. Cells were re-suspended in 3ml of 0.7% low 
melting point agarose (LMP), 70μl gels were made by pipetting onto a glass 
slide (pre-coated with 1% agarose) and covered with a 22mm x 22mm cover 
slips (Leica Microsystems), 2 gels were set per slide (1 containing noRo cells 
and other containing Ro cells). Gels were left to set for 10 min at 4˚C, after 
which cover slips were removed. Slides were placed back to back in a Coplin jar 
and cells were incubated in lysis buffer (2.5M NaCl, 100mM EDTA, 10mM Tris, 
250mM NaOH at pH10; prior to use 20ml DMSO and 2ml Triton X-100 was 
added to 180ml of lysis buffer) for at least 1 hour. 
2.10.3 Incubation with protein extract 
After lysis, only the nucleoids of the noRo and Ro gel-embedded cells remain. 
Slides were washed twice with cold buffer F (40mM Hepes, 0.1M KCl, 0.5mM 
EDTA, 0.2mg/ml BSA at pH 8). Protein extracts from tissues were diluted to the 
required concentration (specified in the following Chapters) in buffer A2 to a 
volume of 50μl, 4 volumes of buffer F and Aphidicolin at 1.5μM final 
concentration were added. Formamidopyrimidine DNA glycosylase (FPG, New 
England Biolabs) was used as a positive control at a 1/3000 dilution in buffer F. 
Slides were placed on a cold plate and 100μl of the prepared protein extract 
was added to each slide and covered with a large cover slip 24mm x 50mm 
(Leica Microsystems) so that extract covers both gels. Slides were incubated in 
a humid chamber (Boekel Slide Moat) for 25 min at 37˚C. 
2.10.4 Single cell gel electrophoresis 
Slides were placed in electrophoresis tanks (Thistle Scientific) with the frosted 
label edge towards the cathode (negatively charged DNA moves towards the 
anode). Electrophoresis buffer (300mM NaOH, 1mM EDTA at pH>12) was 
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added to each tank (required volume of buffer was added to reach 1V/cm over 
the platform during electrophoresis). Slides containing nucleoids were left to 
denature/unwind in the alkaline buffer for 40 min at 4˚C before being subject to 
electrophoresis for 30 min at 25V and 4˚C. Slides were placed in the slide 
holder and washed once with PBS for 10 min and once with Millipore water for 
10 min. 
2.10.5 Staining and comet visualisation 
Slides were placed in a humid box and 500μl of 1X SYBR Gold (Life 
Technologies) diluted in pH 8 TBE buffer (Life Technologies) was added to 
each slide. Slides were left to stain for 40 min after which they were washed 2 
times for 10 min with Millipore water. Gels were left to dry overnight. Comets 
were visualised using an Olympus BX51 fluorescence microscope and the 
Comet Assay IV software (Perceptive Instruments). 50 comets were scored per 
gel. 
2.10.6 Calculation of DNA incision activity 
Tail Intensity (% DNA in Tail) were used to represent the quantification of single 
strand breaks in substrate nucleoids. DNA repair measured as DNA incision 
activity was calculated using the following equation, after subtracting 
background levels (TI from noRo cells/buffer incubation) from all values:  
𝐵𝐸𝑅 − 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑖𝑛𝑐𝑖𝑠𝑖𝑜𝑛 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦
= 𝑇𝐼(𝑅𝑜 𝑛𝑢𝑐𝑙𝑒𝑜𝑖𝑑𝑠 𝑒𝑥𝑡𝑟𝑎𝑐𝑡 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑖𝑜𝑛⁄ )
− 𝑇𝐼(𝑛𝑜𝑅𝑜 𝑛𝑢𝑐𝑙𝑒𝑜𝑖𝑑𝑠 𝑒𝑥𝑡𝑟𝑎𝑐𝑡 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑖𝑜𝑛⁄ )
− 𝑇𝐼 (𝑅𝑜 𝑛𝑢𝑐𝑙𝑒𝑜𝑖𝑑𝑠 𝑏𝑢𝑓𝑓𝑒𝑟 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑖𝑜𝑛⁄ ) 
2.11 ELISA 
To measure specific concentration of DNA repair enzymes, Enzyme-linked 
Immunosorbent Assay Kits for murine Oxoguanine Glycosylase 1 and APEX 
Nuclease 1 were obtained from Uscn Inc. (Antibodies-Online). Assays were 
performed as described in the manufacturer’s protocol. Kit standards were 
prepared in doubling dilution using Standard Diluent for OGG1 (2,000pg/ml to 
31.2pg/ml) and APEX (10ng/ml to 0.156ng/ml). Samples were diluted to 1mg/ml 
in biology-grade water. For each kit the steps were the same. 100μl of blank 
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(standard diluent), standard and samples were added to a corresponding well of 
the ELISA plate pre-coated with antibody, covered with a plate sealer and 
incubated for 2 hours at 37˚C. Liquid was removed from the plate and 100μl of 
Detection Reagent A was added to each well, the plate was covered and 
incubated for 1 hour at 37˚C. Liquid was removed and wells washed 3 times 
with 350μl of Wash solution; in between each step, the plate was snapped onto 
absorbent paper to remove all liquid. 100μl of Detection Reagent B was then 
added, plate was sealed and incubated for 30 minutes at 37˚C. Liquid was 
removed and the wells washed 5 times with 350μl Wash solution. 90μl of 
Substrate solution was added to each well, plate was covered and incubated for 
25 min at 37˚C. 50μl Stop solution was added to each well and mixed by 
tapping the side of the plate, addition of this solution turned the reaction yellow. 
To quantify OGG1 and APEX protein concentration, the absorbance was read 
at 450-480nm using a FLUOstar Omega Microplate reader. Standard curve was 
constructed and protein concentrations for each sample were extrapolated from 
the graph. 
2.12 Enzyme activity assays 
2.12.1 HAT activity assay 
Histone Acetyltransferase Activity Assay Kit (Abcam) was used to measure HAT 
activity as described in the manufacturer’s protocol. Test samples were 
prepared at 2.5 mg/ml protein in 40μl reaction (diluted with water). Kit HeLa cell 
nuclear extract was used as a positive control at 1mg/ml in a 40µl reaction. In a 
96-well flat bottomed plate (Corning), 50μl 2X HAT Assay Buffer, 5μl HAT 
Substrate I, 5μl HAT Substrate II and 8μl NADH Generating Enzyme were 
added to 40μl of each sample crude protein extract. The plate was incubated at 
37˚C for 4 hours. After incubation the absorbance was read at 440nm using the 
FLUOstar Omega Microplate reader. Activity was calculated as OD440nm/µg 
protein. 
2.12.2 HDAC activity assay 
Histone Deacetylase Assay Kit (Merck Millipore) was used to measure HDAC 
activity as described in the manufacturer’s protocol. Test samples were 
prepared at 10mg/ml in 20μl reaction.10μl of 2X HDAC Assay Buffer was added 
per well in a 96 well plate (flat bottomed). 20μl of sample protein extract or kit 
HeLa nuclear extract (2μg/μl) was added to the corresponding well and plate 
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was allowed to equilibrate to 37˚C. 10μl of 4mM HDAC Assay Substrate was 
then added to each well, mixed thoroughly and incubated at 37˚ for 1 hour. 20μl 
of Activator Solution was added to each well, mixed and incubated at room 
temperature for 10-20minutes. After incubation the absorbance was read at 
405nm using the FLUOstar Omega Microplate reader, samples were analysed 
in duplicate. Activity was calculated as OD405nm/µg protein. 
2.13 Chromatin Immunoprecipitation 
The principle of chromatin immunoprecipitation (ChIP) is the selective 
enrichment of a chromatin fraction containing a specific antigen. Antibodies that 
recognise protein modification of interest can be used to determine the relative 
abundance of that antigen at one or more loci in the genome. The chromatin 
immunoprecipitation assay was used to study epigenetic histone modifications 
relative to the promoter regions of BER-related gene. ChIP was performed for 
brain and liver tissue from 3 month old AL, 30 month old AL and 30 month old 
DR fed animals. 
2.13.1 Chromatin crosslinking 
10ml of ice-cold PBS containing protease inhibitors (Sigma Aldrich) was poured 
into a 10cm diameter petri dish. A 100 micron cell strainer (BD biosciences) was 
placed at the centre of the petri dish, so that it was immersed in the solution. 50-
100mg ground tissue was placed in the strainer and sieved with the help of a 
syringe plunger. The content of the petri dish was poured into a 15ml falcon 
tube and placed on ice. 37% Formaldehyde was added to the cell suspension 
(1% final volume), placed on a rocker and left to cross-link for 3-4 minutes. 
1/10th 1.25M glycine was added to the mixture (final concentration 0.125M) to 
quench the formaldehyde and mixture was kept on rocker for further 1 minute. 
Cell suspension was then centrifuged at 1,200RPM for 4 min at 4˚C and 
supernatant was discarded. Cells were lysed with lysis buffer (1% SDS, 10mM 
EDTA, 50mM Tris-HCl pH 8.1 and protease inhibitors; 800μl for liver and 300μl 
for brain tissue) and incubated on ice for 20 minutes. Samples were sonicated 
on ice, sonicator was set to high with program 30sec ON, 20sec OFF, for 10 
cycles. Samples were incubated on ice for few minutes then centrifuged at 
13,000g for 10 min at 4˚C, the collected supernatant contained the cross-linked 
DNA. 
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2.13.2 Immunoprecipitation 
Chromatin was quantified using Nanodrop (DNA quantification setting), 25μg of 
chromatin was used in subsequent reactions. 1 tube per sample per antibody was 
set up. Chromatin was diluted 1:10 in buffer (1.1% Triton X-100, 1.2mM EDTA, 
16.7mM Tris-HCl pH 8.1, 167mM NaCl and protease inhibitors). 10μl blocked 
Staph A cell (or protein A/G mix, Merck Milipore) were added to the chromatin for 
pre-clearing for 30 min at 4˚C. Samples were centrifuged at 6,000RPM for 5 min 
and the supernatant used for the immunoprecipitation (IP) reaction. 3μg of 
corresponding antibody (Anti-IgG, Abcam; Anti-H4Ac acetylation on lysines 5, 8, 
12 and 16, Merck Milipore; Anti-H3K27Me3, Merck Milipore) was added to the 
sample and incubated with rotation over night at 4˚C. The next day 50μl blocked 
Staph A (or protein A/G mix) were added to each sample and incubated further 
for 1 hour at 4˚C followed by 30 minutes at room temperature. Samples were 
centrifuged at 6,000RPM for 5 min at 4˚C and the supernatant was discarded. 
The pellet was re-suspended in 1ml cold low salt buffer (1% Triton X-100, 2mM 
EDTA, 20mM Tris-HCl pH 8.1, 150mM NaCl and protease inhibitors), samples 
were rotated on a wheel for 5 min at RT and then spun at 6,000RPM for 2 min, 
the supernatant was discarded. Pellets were re-suspended in 1ml of cold high 
salt buffer (1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 500mM NaCl 
and protease inhibitors), samples were rotated on a wheel for 5 min at RT and 
then spun at 6000RPM for 2 min, and the supernatant was discarded. Pellets 
were washed in lithium chloride wash buffer (0.25M LiCl, 1%NP Igepal, 1mM 
EDTA, 10mM Tris-HCl pH 8.1 and protease inhibitors), samples were rotated on 
a wheel for 5 min at RT and then spun at 6000RPM for 2 min, and the supernatant 
was discarded. Pellets were washed twice with 1ml Tris-EDTA buffer, samples 
were rotated on a wheel for 5 min at RT and then spun at 6000RPM for 2 min, 
and the supernatant was discarded. Pellets were re-suspended in 500μl elution 
buffer (100mM sodium bicarbonate and 1% SDS), vortexed and incubated at 
room temperature with rotation for 15-20 min. Samples were centrifuged at 
13,000g for 10 min and supernatant was transferred to a new tube. 20μl of 5M 
NaCl was added to each 500μl sample and incubated at 65˚C for 4 hours to 
reverse the cross-links.  
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2.13.3 DNA clean-up 
10μl 0.5M EDTA, 2μl 1M Tris-HCl pH 6.5 and 2μl 10mg/ml proteinase K 
(Thermo Scientific) was added to each sample and incubated at 45˚C for 1 
hour. DNA was extracted by adding equal volume of 
phenol:chloroform:isoamylalcohol to each sample, vortexing and spinning at 
13,000g for 5 min. The top layer was transferred to a new tube and DNA was 
cleaned up using QIAQuick Gel Extraction Kit (Qiagen) according to 
manufacturer’s protocol. 200μl isopropanol was added to each sample and 
incubated for 15 min at room temperature. 300μl kit solubilisation buffer and 4μl 
of 3M sodium acetate were added to each sample. Samples were placed in 
columns and centrifuged at 13,000g for 1 min, flow-through was discarded. 
750μl kit Buffer PE was added to each column to wash the DNA, centrifuged 
and flow-through was discarded. Columns were spun at full speed for 1 min to 
remove residual liquid. The columns were then placed in silicone 1.5ml 
centrifuge tubes, 50μl buffer EB (30μl for brain sample) was added to each 
column and centrifuged at full speed for 1 min. The eluted DNA was used in the 
qPCR reaction. 
2.13.4 ChIP-qPCR 
SYBR Green technology was used in the ChIP-qPCR assay. Firstly a standard 
curve was set up with genomic DNA to validate the primer sets (primer 
sequences can be found in Table 2.11). Reaction set up is shown in Table 2.12. 
Once the primers were validated they were used to set up the qPCR mix with 
DNA from gDNA from the ChIP reaction. Amplification of enriched regions in the 
Ogg1 and Apex promoters was performed using the StepOne Plus instrument 
(Applied Biosystems) with cycling conditions as described in Table 2.13. Fold 
enrichment was calculated compared to the 3AL group. 
Name Sequence 
Ogg1 Fwd 5’-CCCAAAGTGCTGGGATTAAA 
Ogg1 Rev 5’-AGTTCACTCCGTCCAAATGC 
Apex Fwd 5’-GCTGCCTCGGAACACATATT 
Apex Rev 5’-CTAGGTCACGTGGGTTCGTT 
Table 2.11 Primers used for ChIP-qPCR. 
Reaction Component 13μl reaction 
SYBR Green Master Mix 6.5μl 
Forward Primer 0.5μl 
Reverse Primer 0.5μl 
ROX 0.027μl 
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Nuclease-free water 3.473μl 
gDNA 2μl 
Table 2.12 Reaction set up for ChIP-qPCR with genomic DNA. 
Step 
StepOne Plus 
Temperature (˚C) Time Cycles 
Enzyme Activation 95˚C 15 min  
Denaturation 95˚C 15 sec 
45 
Annealing and Extension 55˚C 1 min 
Melt curve 
 
95˚C 
65˚C+0.5˚ increments 
95˚C 
15 sec 
1 min 
15 sec 
 
Table 2.13 qPCR cycling conditions for ChIP-qPCR. 
2.14 HPLC-ECD 
The base oxidation product 8-oxoguanine (8-oxodG) was detected by HPLC 
coupled with electrochemical detection. Genomic DNA was extracted from ~ 
50mg ground frozen tissue using a standard radical-free phenol extraction 
(Godschalk et al., 1998), to minimise artificial induction of 8-oxodG. In addition, 
exposure to oxygen was reduced by addition of 1mM deferoxamine mesykate 
and 20mM TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl), according to the 
European Standards Committee on Oxidative DNA damage ('Comparison of 
different methods of measuring 8-oxoguanine as a marker of oxidative DNA 
damage. ESCODD (European Standards Committee on Oxidative DNA 
Damage),' 2000). HPLC-ECD was performed as described by de Kok et al.  (de 
Kok et al., 1994). 30μg DNA was digested to deoxyribonucleosides by treatment 
with P1 (0.02U/μl) for 90min at 37˚C and then with alkaline phosphatase (0.014 
U/μl) for 45˚min at 37˚C. The digest was injected into a isocratic pump 
(Gynkotek) coupled with Midas injector (Spark Holland) and connected to a 250 
X 4.6mm Supelcosil LC-18S column (Supelco) and an electrochemical detector 
(Antec). The mobile phase consisted of 10% aqueous methanol containing 
94mM KH2PO4, 13mM K2HPO4, 26mM NaCl and 0.5mM EDTA. Elution was 
performed at a flow rate of 1.0ml/min. Lower absolute detection limit of 40fmol 
of 8-oxodG or 1.5 residues/106 2’-deoxyguanosine (dG) was used and dG was 
simultaneously monitored at 260nm. 
2.15 ICP-MS 
Magnesium ion concentrations in protein extracts were measured using 
inductively coupled plasma mass spectrometry (ICP-MS). 10mg/ml of crude 
tissue protein extracts were diluted to 1mg/ml in 65% HNO3 (Merck) and 
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incubated for 24h to decompose. Samples were then diluted 1:10 into 2.5% 
HNO3 (w/v) containing 20µg/L cobalt and 20µg/L silver as internal standards 
(BDH) and analysed by inductively coupled plasma mass spectrometry (Thermo 
X-series). 24Mg was measured 100 times (20ms integration time, 5 channels, 
0.02AMU separation) using the peak-jump method. Triplicate measurements 
were taken for each sample and detector pulse counts were converted to 
concentration by comparison with matrix-matched metal standards. Resulting 
data were presented as parts per billion µg/L. 
2.16 Statistical Analysis 
All analyses were performed using IBM SPSS Statistics v 19 software package. 
Data were tested for normality using the Kolmogorov-Smirnov test. Normally 
distributed data were tested for analysis of variance (ANOVA), significance was 
tested at α less than 0.05. Non-parametric Kruskal-Wallis test was used where 
data were not normally distributed. Further statistical analyses are specified in 
results Chapters.  
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Chapter 3 – Optimisation of the comet in vitro repair assay 
The data presented in this Chapter are published in the article ‘Tissue 
difference in BER-related incision activity and non-specific nuclease activity as 
measured by the comet assay’ Mutagenesis 2013, 28(6):673-681 (Gorniak et 
al., 2013), the Figures used in this Chapter are a duplication of those in the 
publication. 
3.1 Introduction 
Accumulation of damage to DNA can lead to genome instability; leading to loss 
of cell function and cell death (Dizdaroglu, 2012). Repair of DNA damage is one 
of the key pathways to maintain genomic integrity and hence phenotypic assays 
able to assess DNA repair capacity can provide a measure of genomic stability. 
Such assays can be used as biomarkers for cell survival in molecular 
epidemiology and biomonitoring studies of cancer (Goukassian et al., 2000; 
Collins et al., 2003; Paz-Elizur et al., 2007; Collins and Azqueta, 2012). 
Furthermore the DNA damage response is of particular interest in the ageing 
process when cells have progressively greater difficulty in maintaining their 
genomic stability and hence measurement of DNA repair can also be used in 
studies of cellular function (Cabelof et al., 2003; Intano et al., 2003; Imam et al., 
2006; Kisby et al., 2010). 
Numerous DNA repair pathways exist including base excision repair (BER) to 
remove single base lesions and nucleotide excision repair (NER) to remove 
bulky adducts such as those produced by UV light (Hoeijmakers, 2001). A 
number of disease states and ageing have been linked to DNA oxidative 
damage induced by intracellular reactive oxygen species (ROS) (Langie et al., 
2012). Guanine in particular is vulnerable to oxidation and it is estimated that 
approximately 180 guanine bases are oxidised to 8-oxo-7,8-dihydro-2’-
deoxyguanosine (8-oxodG) per mammalian cell per day (Lindahl, 1993). A 
specific enzyme, oxoguanine DNA glycosylase is present in the cell to 
recognise and incise this damaging lesion. Thus assays able to measure 
removal of 8-oxodG can indicate cellular repair activity of DNA oxidative 
damage. 
To date assays developed for measurement of DNA repair are mostly suitable 
for use with cells in culture or with lymphocytes but are not suited for use with 
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tissues. However, to investigate BER in vivo in animal models or in humans 
(e.g. in biopsies), functional assays which can quantify BER activity in the 
tissues of interest are needed. The comet assay is a simple and sensitive assay 
for measurements of DNA damage. Cells are embedded in an agarose gel and 
lysed to leave nucleoids of supercoiled DNA. Electrophoresis of nucleoids gives 
structures resembling comets which can be stained using a DNA dye and 
visualised under the microscope. The intensity of the comet tail is relative to the 
number of strand breaks present in the nucleoids. The assay has also been 
modified to measure DNA repair (Collins et al., 2001; Collins, 2004).  
Recently Langie et al. (Langie et al., 2011) developed the comet-based assay 
for measuring BER-related DNA incision activity in animal tissues and optimised 
its use for mouse liver and brain tissues. In this assay photosensitiser Ro-
198022 is used to induce 8-oxodG lesions in substrate cells. These cells are 
then imbedded in an agarose gel and lysed as in the standard comet assay. 
The nucleoids are then incubated with protein extracts from tissues of interest; 
then electrophoresis, staining and visualisation are performed as for the 
standard assay. The resultant quantified strand breaks (SB) provide an 
indication of recognition and incision of the damage, and incision activity of BER 
enzymes such as oxoguanine DNA glycosylase (Figure 3.1).  
 
Figure 3.1 A microscope image of example comet from noRo and Ro nucleoids incubated with 
protein extract (A) and a plot of TI corresponding to the comet % DNA in the tail (B). 
BER-related incision activity is calculated by subtracting TI in noRo nucleoids 
(control; without Ro 19-8022 and light treatment) incubated with protein extract 
and TI from Ro nucleoids (damaged, with Ro 19-8022 and light treatment) 
incubated with buffer from TI in Ro nucleoids incubated with protein extract (TI 
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in noRo nucleoids incubated with buffer i.e. the background damage, is first 
subtracted from all values). 
In the present study, the work of Langie et al. was extended to optimise the in 
vitro comet based assay in other mouse tissues, specifically colon and lung, as 
well as brain and liver (Chapter 3) and to measure and compare BER-related 
incision activity in ageing mouse tissues (Chapter 4). 
The aims of this study were to conduct a series of optimisation steps for use of 
the comet-based in vitro DNA repair assay with animal tissues. 
The objectives of the present study were to: 
a) Determine optimal tissue protein extract concentrations to use in the assay 
b) Reduce non-specific nuclease activity by: 
(i) Aphidicolin block; 
(ii) performing wash steps; 
(iii) changing buffer composition. 
3.2 Materials and methods 
3.2.1 Animal studies and human colon samples 
Methods are described in detail in Chapter 2. Whole brain, liver, lung and colon 
were collected from mice and tissues were snap frozen immediately in liquid 
nitrogen and stored at -80°C until processing. Colon tissue was either ‘clean’, 
where the tissue was flushed with PBS during collection (free of faecal matter) 
or ‘dirty’ where the tissue was not flushed at collection (faecal matter present). 
Human mucosal biopsies came from patients taking part in the Dietary 
Intervention, Stem cells and Colorectal cancer (DISC) study (Clinical trial 
NCT01075893). Ethical approval was gained from Newcastle and North 
Tyneside Research Ethics Committee 2 (09/H0907/77). Patients were recruited 
via endoscopy. After the endoscopy procedure mucosal biopsies were taken 
from the rectum, 10cm from the anal verge, with 2.3mm spiked flexible 
endoscopy forceps, biopsies were immediately snap frozen in liquid nitrogen 
and further stored at -80˚C. 
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3.2.2 Comet-based in vitro repair assay 
Before extraction of proteins from mouse tissue the ground tissue was washed 
with either 500µl PBS or buffer A. In some experiments the tissue was not 
washed. Extraction of protein from animal and human tissue was performed as 
described in Chapter 2. In case of human tissue where the weight was much 
smaller than the required 30mg, i.e. ~5mg, the subsequent volumes of buffers 
added were adjusted (1/5th of normal volume). 
The comet-based BER incision assay was performed as described in Chapter 
2. Protein extracts were diluted to the desired concentration in buffer A 
containing 0.23% Triton X-100. 50µl of this extract was further diluted in 4 
volumes of buffer. Protein extracts were either left on ice before incubation with 
substrate nucleoids or heat inactivated for 10 minutes at 100ºC. Additional, 
optimisation steps were made by changing composition of the buffer protein 
extracts are diluted in, as shown in Table 3.1. 
Data were presented as Tail Intensity (TI) which represents the percentage of 
DNA in the comet tail. Each extract was analysed in duplicate within one assay 
and in at least in 2 independent experiment where possible. 
Test 
Aphidicolin 
(µM) 
Hepes 
(mM) 
EDTA 
(mM) 
KCl 
(M) 
BSA 
(mg/ml) 
Glycerol 
(%) 
ATP 
(mM) 
polyAT 
(ng) 
Polymerase 
block 
1.5-12 40 0.5 0.1 0.2 -   
B 1.5 45 0.25 - 0.3 2   
Test 1 1.5 45 0.25 0.1 0.3 2   
Test 2 1.5 40 0.5 0.1 0.2 2   
Test 3 1.5 45 0.5 0.1 0.3 2   
ATP 1.5 40 0.5 0.1 0.2 - 2.5  
polyAT 1.5 45 0.5 0.1 0.2 -  100 
polyAT 1.5 45 0.5 0.1 0.3 2  100 
Table 3.1 Composition of buffers used in optimisation of comet-based in vitro repair assay. 
3.2.3 Statistical Analysis 
Student’s t-test and one-way ANOVA (with a Dunnett’s or Tukey’s post-hoc 
tests) were used to test for changes in TI and magnesium concentration. 
3.3 Results 
The BER-related incision is calculated by subtracting TI in noRo nucleoids from 
TI in Ro nucleoids. Thus, the specificity of the assay depends on minimising 
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non-specific nuclease activity and sensitivity relies on increasing the difference 
in TI between noRo and Ro treated nucleoids. 
3.3.1 Effect of extract protein concentration on assay sensitivity 
BER-related incision activity in the brain and liver was previously shown to be 
measurable by Langie et al. (Langie et al., 2011). To compare DNA incision 
activity in other tissues the protocol described by Langie et al. was used on lung 
and colon tissue. Figure 3.2 shows the TI in substrate nucleoids treated with 
5mg/ml of tissue protein extract from brain, liver, colon and lung. Substrate 
nucleoids incubated with protein extract from the brain showed percentage DNA 
in noRo and Ro nucleoids to be 2.50% and 8.20% respectively. Substrate 
nucleoids incubated with protein extract from the liver had 2.80% DNA in the 
comet tail of noRo nucleoids and 13.90% DNA in comet tail of Ro nucleoids. 
Substrate nucleoids treated with protein extract from colon tissue showed 
95.00% and 93.70% DNA in comet tail in noRo and Ro nucleoids respectively. 
Substrate nucleoids incubated with protein extract from lung tissue had 63.80% 
DNA in comet tail of noRo and 68.70% DNA in comet tail of Ro nucleoids.  
Figure 3.2 Effect of protein extract concentration on tail intensity. Tail Intensity measured in 
noRo (black bars) and Ro (white bars) nucleoids treated with protein extracts from brain, liver, 
colon and lung. Data are presented as mean of 2 replicates from a single assay with SD as the 
error bars. ANOVA analysis of protein extract concentration on TI in Ro nucleoids in colon 
(P=0.012) and lung (n.s.). 
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The high TI values seen in both noRo and Ro nucleoids incubated with colon 
and lung extracts reduce the sensitivity of the assay. Dilution curves of protein 
extracts were performed to determine whether TI in noRo nucleoids could thus 
be reduced and the difference between TI in noRo and Ro nucleoids can be 
maximised. Figure 3.2 shows the effect of doubling dilutions of colon and lung 
protein extracts on TI in noRo and Ro nucleoids. In noRo nucleoids, a tenfold 
dilution of colon protein extract reduced TI by 55%, while reducing lung protein 
extract tenfold decreased TI by 50%. As expected, TI in Ro nucleoids 
decreased with protein dilution of colon (P=0.012) and lung (not statistically 
significant) protein extracts. The sensitivity of the assay was thus improved by 
incubating substrate nucleoids with colon or lung extract at 0.5mg/ml and 
1.25mg/ml, respectively. 
3.3.2 Non-specific nuclease activity versus cleavage activity 
To determine whether the high TI observed in substrate nucleoids incubated 
with colon extract was due to non-specific nuclease activity (enzymatic) or non-
specific cleavage activity (non-enzymatic) the assay was performed with heat 
inactivated tissue extract. Figure 3.3 shows the TI in noRo and Ro substrate 
nucleoids treated with FPG positive control, ‘clean’ colon (PBS flushed and 
dissection) and ‘dirty colon (not PBS flushed at dissection). TI in noRo nucleoids 
incubated with heat inactivated protein extracts reduced DNA in comet tail to 
background levels with both ‘clean’ (P=0.01) and ‘dirty’ (P=0.001) colon. 
Compared with the normal assay condition, there was a decrease in TI of Ro 
nucleoids incubated with heat inactivated protein extracts relative to FPG 
(P=0.001), ‘clean’ colon (P=0.001) and ‘dirty’ colon (P=0.003). Elimination of TI 
in noRo nucleoids shows that enzymatic nuclease activity is responsible for the 
non-specific activity rather than non-enzymatic cleavage activity. 
3.3.3 Effect of Aphidicolin on non-specific nuclease activity 
Sensitivity of the assay is improved when lower concentrations of colon and 
lung protein extract are used; however, a somewhat high level of TI in noRo 
nucleoids incubated with these tissues is still observed compared to brain and 
liver. Aphidicolin (a polymerase inhibitor) has previously been shown to reduce 
non-specific nuclease activity (Speit et al., 2004; Vande Loock et al., 2010; 
Langie et al., 2011). In this assay it was already used routinely at a 
concentration of 1.5µM. However, I tested whether increasing Aphidicolin 
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concentration can further reduce TI in noRo nucleoids. Table 3.2 shows that 
increasing Aphidicolin concentration in the assay did not alter TI in substrate 
nucleoids incubated with buffer, colon or lung protein extract (all P>0.05). 
Figure 3.3 Effect of heat inactivation (HI) on comet tail intensity in cells treated with buffer 
control, FPG positive control and colon protein extract. Tail Intensity measured in noRo (black 
bars) and Ro (white bars) nucleoids. Data represent the mean values of 2 independent assays 
with error bars presenting pooled SEM, clean colon (n=2) and dirty colon (n=4), Student’s t-test 
comparison of TI in HI and untreated protein extracts; FPG (Pa=0.001 Ro nucleoids), clean 
colon (Pb=0.01 noRo and Pc=0.001 Ro nucleoids) and dirty colon (Pd=0.001 noRo and Pe=0.003 
Ro nucleoids). 
Aphidicolin 
(µM) 
TI Buffer TI Colon TI Lung 
noRo 
nucleoids 
Ro 
nucleoids 
noRo 
nucleoids 
Ro 
nucleoids 
noRo 
nucleoids 
Ro 
nucleoids 
1.5 
1.70 
±0.00 
5.85 
±1.16 
79.17 
±22.48 
86.94 
±12.81 
11.97 
±2.89 
32.83 
±5.15 
3 
1.66 
±1.05 
3.65 
±0.28 
63.49 
±19.11 
84.38 
±18.63 
9.92 
±4.55 
35.19 
±5.03 
6 
1.28 
±0.98 
4.66 
±0.48 
67.40 
±41.60 
85.79 
±12.90 
11.97 
±8.37 
37.86 
±11.79 
12 
1.56 
±0.20 
4.34 
±0.09 
81.03 
±23.55 
87.12 
±14.05 
12.24 
±3.99 
34.31 
±11.35 
Table 3.2 Effect of increasing Aphidicolin concentration on Tail Intensity in nucleoids treated 
with buffer, colon or lung protein extract at 5mg/ml (washed with PBS during protein extraction). 
Data represent the mean values of 2 independent assays with error bars presenting pooled SD. 
Increasing [Aphidicolin] had no effect on TI in noRo or Ro nucleoids for either buffer, colon or 
lung treated nucleoids. 
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3.3.4 Effect of washing tissue, during protein extraction, on non-specific 
activity and magnesium concentration 
The next step taken to reduce non-specific activity was washing the tissue 
during protein extraction. Often, after tissue is collected at dissection and snap 
frozen it still contains other materials such as blood, but by washing the tissue 
prior to protein extraction such residual matter can be removed. The effect of 
washing tissues with PBS or buffer A on non-specific nuclease activity was 
tested. Lung, colon and liver protein extract concentrations were tested at 
5mg/ml and 2.5mg/ml for each wash step. 
Figure 3.4A shows TI in substrate nucleoids treated with lung protein extract. At 
5mg/ml TI in noRo nucleoids was 30.59%, 14.86% and 9.95% for non-washed, 
PBS washed and buffer A washed tissue respectively. TI in Ro nucleoids was 
54.00% in non-washed, 41.40% in PBS washed and 43.50% in buffer A washed 
tissue. The reduction observed with washed tissue was not statistically 
significant for either noRo or Ro nucleoids. When lung protein extract was 
reduced to 2.5mg/ml, TI in noRo nucleoids was 10.30%, 4.99% and 3.20% in 
non-washed, PBS washed and buffer A washed tissue respectively. TI in Ro 
nucleoids was 33.90% in non-washed, 26.10% in PBS washed and 20.60% in 
buffer A washed tissue. The reduction observed with washes was not 
statistically significant for either noRo or Ro nucleoids. 
Figure 3.4B shows TI in substrate nucleoids incubated with colon protein 
extract. At 5mg/ml TI in noRo nucleoids was 90.20%, 76.90% and 83.40% in 
non-washed, PBS washed and buffer A washed tissue respectively. TI in Ro 
nucleoids was 92.90% in non-washed, 92.80% in PBS washed and 90.90% in 
buffer A washed tissue. The observed reduction in TI seen with washing was 
not statistically significant for both noRo and Ro nucleoids. When protein extract 
was reduced to 2.5mg/ml, TI in noRo nucleoids was 84.30%, 75.80% and 
62.20% in non-washed, PBS washed and buffer A washed tissue respectively. 
TI in Ro nucleoids was 90.80% in non-washed, 86.00% in PBS washed and 
80.70% in buffer A washed tissue. The reduction in TI observed with wash 
steps was not statistically significant for both noRo and Ro nucleoids. 
Figure 3.4C shows nucleoids incubated with liver protein extract. At 5mg/ml TI 
in noRo nucleoids was 3.20%, 7.40% and 7.50% in non-washed, PBS washed 
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and buffer A washed tissue respectively. TI in Ro nucleoids was 23.90% in non-
washed, 32.60% in PBS washed and 21.30% in buffer A washed. The different 
wash steps did not significantly affect TI. When protein extract was reduced to 
2.5mg/ml, TI in noRo nucleoids was 8.03%, 2.99% and 3.80% in non-washed, 
PBS washed and buffer A washed tissue respectively. TI in Ro nucleoids was 
23.90% in non-washed, 15.30% in PBS washed and 13.50% in buffer A washed 
tissue. TI in Ro nucleoids was reduced when washing with PBS (P=0.016) and 
buffer A (P=0.01) as compared with non-washed tissue. 
Magnesium concentration was measured as an additional factor that can affect 
nuclease activity. Many nucleases require magnesium as a cofactor, including 
those specific to BER as well as other non-specific ones. The crude protein 
extracts used in the assay contain both types of enzymes (MacLellan and 
Forsberg, 2001; Nishino and Morikawa, 2002; Wilson Iii, 2005; Paz-Elizur et al., 
2007; Gaivão et al., 2009). Magnesium concentration was measured in lung, 
liver and colon tissue that has been either left unwashed, washed with PBS of 
washed with buffer A. 
Highest magnesium concentration was observed in colon tissue, with lung 
showing 25% less and liver 50% less compared with colon (Table 3.3). Washing 
tissue with PBS reduced [Mg] by 32% in the lung, 15% in the colon and 28% in 
the liver. Washing tissue with buffer A reduced [Mg] by 42% in the lung, 13% in 
the colon and 18% in the liver. The changes observed in magnesium 
concentration with the different wash steps were not statistically significant for 
any of the tissues (all P>0.05). 
Tissue 
Magnesium (µg/L) 
Non-washed PBS washed Buffer A washed 
Lung 536±81 365±148 313±73 
Colon 1089±143 925±139 947±369 
Liver 808±87 578±98 660±9 
Table 3.3 Effect of washing tissue before protein extraction on magnesium concentration in the 
extract. Magnesium concentration in 1mg/ml protein extract and after washing with PBS or 
buffer A before protein extraction. Data are presented as mean of 3 replicates from a single 
assay with SD as the error bars. Changes in magnesium concentration with wash steps were 
not statistically significant. Measurements of [Mg] were conducted by Dr Kevin Waldron. 
 
62 
 
Figure 3.4 Effect of wash steps during protein extraction on comet tail intensity. Tail Intensity 
measured in noRo (black bars) and Ro (white bars) substrate DNA treated with protein extracts 
from A) mouse lung (n=3), B) mouse colon (n=3) and human colon biopsy (n=2) and C) mouse 
liver (n=2). Protein extracts have been not washed, washed with PBS or washed with buffer A 
during extraction of proteins. Data represent mean of 2 independent assays with error bars 
presenting pooled SEM. ANOVA comparison of TI with non-washed extracts: in 2.5mg/ml liver 
protein extract PBS washed (P=0.016 in Ro nucleoids) and buffer A washed (P=0.01 Ro 
nucleoids). 
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3.3.5 Effect of washing colon tissue, during dissection, on non-specific 
nuclease activity 
When collecting mouse colon tissue during dissections, faecal matter is present 
within the intestine. To remove the faecal content the colon can be flushed with 
PBS leaving a ‘clean’ tissue or the content of the colon can be scraped which 
often still leaves the tissue ‘dirty’. To determine if washing the colon tissue at 
collection has an effect on non-specific nuclease activity, TI was measures in 
‘clean’ and ‘dirty’ mouse colon tissue as well as human rectal mucosa which 
would have been thoroughly cleaned at collection. Figure 3.5 shows that when 
substrate nucleoids were incubated with protein extract from ‘dirty’ colon tissue, 
TI was 71% in noRo nucleoids and 77% in Ro nucleoids. When substrate 
nucleoids were incubated with protein extract from ‘clean’ colon tissue, TI was 
49% in noRo nucleoids and 60% in Ro nucleoids. ‘Clean’ colon showed DNA in 
comet tail to be 20% lower compared with ‘dirty’ colon (P>0.05). 
Substrate nucleoids were incubated with protein extract from human biopsies at 
two different concentrations; high (3mg/ml) and low (0.25mg/ml). TI in noRo 
nucleoids was 0.7% and 0.3% in noRo nucleoids incubated with 3mg/ml and 
0.25mg/ml respectively. TI in Ro nucleoids incubated with 3mg/ml human colon 
biopsy was 5.6% while Ro nucleoids incubated with 0.25mg/ml protein 
concentration was 1.3%. Human colon biopsy showed significantly lower TI 
levels in substrate nucleoids than those from the mouse colon (TI in substrate 
nucleoids incubated with 3mg/ml protein extract from human biopsies compared 
with pooled clean and dirty colon P=0.03 in noRo nucleoids and P=0.02 in Ro 
nucleoids). 
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Figure 3.5 Effect of washing colon tissue at collection on comet tail intensity. Tail Intensity 
measured in noRo (black bars) and Ro (white bars) substrate DNA treated with protein extracts 
from 0.5mg/ml clean mouse colon (PBS flushed at collection, n=2), 0.5mg/ml dirty colon (not 
flushed at collection n=2) and human colon biopsy (flushed at collection, n=2) at 3mg/ml and 
0.25mg/ml. Data represent mean of 3 independent assays (colon) and 2 assays (human biopsy) 
with error bars presenting pooled SEM. ANOVA comparison of TI in Ro nucleoids incubated 
with human colon biopsies compared to pooled mouse colon (P=0.02 at 3mg/ml and P=0.03 at 
0.25mg/ml colon biopsy). 
3.3.6 Effect of buffer composition on non-specific nuclease activity 
To determine if adjusting buffer composition can reduce non-specific nuclease 
activity by reducing TI selectively in noRo nucleoids, changes were made to the 
buffer which the protein extracts are prepared. A description of the buffer 
composition and the resultant TI in substrate nucleoids incubated with tissue 
with this buffer is shown in Table 3.4. The modified buffers showed little 
changes to non-specific activity (all P>0.05).  
One of the changes made to the buffer was addition of glycerol as seen in 
buffer B (used in comet based NER assay), ‘Test 1’, ‘Test 2’ and ‘Test 3’. 
However, addition of glycerol reduced the changes in TI induced by the FPG 
positive control. This effect was exacerbated when KCl was not present in the 
buffer as seen in buffer B. ATP is also usually added to the NER comet assay 
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(at 2.5mM of ATP) as a source of energy for the enzymatic reaction. 
Furthermore, ATP at 3.3mM can be used to inhibit bacterial and endogenous 
nucleases (Rosenberg, 1987). However, as seen in Table 3.4, addition of ATP 
had little effect on reducing non-specific nuclease activity. 
Increasing concentrations of Hepes, EDTA or BSA had no further effect on 
reducing non-specific nuclease activity (buffer B, ‘Test 1’, ‘Test 2’ and ‘Test 3’). 
Buffer ‘Test 1’ and buffer ‘Test 2 showed some reduction in TI in substrate 
nucleoids incubated with colon protein extract. However, this decrease was 
accompanied by an unwanted increase in TI in noRo nucleoids incubated with 
buffer alone. PolyAT was added to buffer F and ‘Test 3’ to act as an alternate 
substrate for non-specific nucleases. This addition increased the difference in TI 
between noRo and Ro nucleoids incubated with extract (i.e. assay specificity) 
but only when 5mg/ml but not 0.5mg/ml protein extract was used. Furthermore 
an increase in TI in substrate nucleoids incubated with buffer alone was 
observed under these conditions.  
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Buffer 
TI Buffer Incubation TI FPG positive control TI Colon Extract 
noRo nucleoids Ro nucleoids noRo nucleoids Ro nucleoids noRo nucleoids Ro nucleoids 
F 0.42±0.08 0.71±0.61 5.86±2.38 43.78±0.76 53.55±8.30 73.66±4.65 
B 0.95±1.03 1.11±0.09 6.77±4.29 6.42±1.19 59.28±14.37 67.29±20.15 
Test 1 2.16±0.12 3.96±2.52 11.35±7.31 54.35±3.21 69.80±2.58 87.05±4.71 
Test 2 0.80±0.07 4.03±0.01 14.15±1.07 44.32±1.64 78.74±24.13 79.12±0.00 
Test 3 1.03±0.75 3.06±0.52 5.55±2.87 46.24±5.69 70.41±34.56 83.89±15.94 
F ATP 0.55±0.34 1.72±0.41 5.47±2.15 43.16±0.63 65.58±12.51 79.05±0.62 
F polyAT 0.36±0.06 2.75±2.51 2.69±2.16 43.20±22.10 50.47±54.18 81.51±16.66 
Test 2 polyAT 1.08±1.10 2.86±2.08 17.63±6.08 43.97±11.57 56.05±50.77 77.69±23.41 
F polyAT (0.5mg/ml 
colon extract) 
2.85±3.60 1.59±0.35 6.81±2.13 40.29±0.64 41.27±57.55 48.23±57.04 
Test 2 polyAT 
(0.5mg/ml colon 
extract) 
1.33±1.30 4.40±0.43 20.50±2.68 54.28±12.44 41.62±56.70 48.21±57.70 
Table 3.4 Effect of buffer composition on Tail Intensity. TI was measured in noRo and Ro nucleoids incubated with buffer control, FPG positive control and protein 
extracts from colon. All tests were performed with 5mg/ml protein extract concentration unless otherwise stated. Buffers F and Test 2 where at pH 8 which buffer B, 
Test 1 and Test 3 were at pH 7.8.  Data are presented as mean of 2 replicates from a single assay with SD as the error bars, colon extract n=2 per assay. No 
significant differences were observed between the difference assay conditions.
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3.4 Discussion 
A robust and sensitive assay is needed to measure DNA repair activity. With 
varying repair activity between different tissue types (Cabelof et al., 2003; 
Intano et al., 2003; Mikkelsen et al., 2009), a successful assay should be 
sensitive to measure DNA repair over a wide range. Such an assay can then be 
used in investigations assessing genomic stability in conditions such as ageing 
and cancer. Assays used to measure DNA incision are sensitive to problems of 
non-specific nuclease activity ((Salles et al., 1995; Paz-Elizur et al., 2007; 
Langie et al., 2011) and discussions at the International Comet Assay 
Workshop). The comet based assay has been previously developed to quantify 
DNA incision activity in mouse brain and liver (Langie et al., 2011). However to 
use the assay for measurements of DNA incision in other tissues such as lung 
and colon further optimisation steps presented in this chapter were performed. 
3.4.1 Tissue specific differences in non-specific incision activity 
When incubating protein extract from colon, and to a lesser extent lung tissue, a 
much higher TI is observed in substrate nucleoids compared to those incubated 
with protein extract from brain and liver tissue. When heat inactivating the 
protein extract the ‘saturating’ TI is abolished suggesting that non-specific 
activity is the cause of such high TI. This observation highlights the importance 
of using a control low damage nucleoids (noRo) without which it could have 
been mistakenly concluded that DNA repair activity is much higher in colon and 
lung tissue, rather than these tissues being found to have a high non-specific 
nuclease activity (Salles et al., 1995). Non-specific nuclease activity also 
appears to be a problem in the comet assay with cultured cells (Azqueta et al., 
2009) confirming that control low damage nucleoids should be used when 
measuring DNA repair using the comet-based assay. 
The data presented here also show that this assay may not be suitable for 
making direct comparisons of DNA incision activity in different tissues as 
different protein extract concentrations have to be used for different tissues 
studied. 
3.4.2 Optimisation of the assay to increase sensitivity 
The main objective of this study was to reduce non-specific nuclease activity 
and thereby improve the specificity of the assay. One of the most successful 
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methods used to decrease non-specific nuclease activity is the addition of the 
DNA polymerase inhibitor Aphidicolin (Speit and Schütz, 2008; Vande Loock et 
al., 2010; Langie et al., 2011). In the assay developed by Langie et al. (Langie 
et al., 2011) Aphidicolin is present at a concentration of 1.5µM. In the present 
study, it was found that increasing Aphidicolin concentration up to 12µM did not 
reduce TI levels/non-specific nuclease activity any further. This may be because 
the original 1.5µM concentration used in the assay is sufficient to inhibit the 
activity of polymerases (Ikegami et al., 1978) contributing to the non-specific 
nuclease activity.  
Commercially available nuclease inhibitors are available but have not been 
tested here. However, they are unlikely to be suitable for use with the comet 
assay because of their modes of action. For example, aurintricarboxylic acid 
inhibits protein-DNA binding (Hallick et al., 1977) while DEPC becomes 
unstable in Tris and Hepes containing buffers (Material Safety Data Sheet 
CAS# 1609-47-8). Other steps such as changing buffer composition, addition of 
ATP and polyAT have previously been shown to inhibit nuclease activity (Paz-
Elizur et al., 2007). However, they showed little effect of TI levels in the comet-
based assay. 
The most effective step taken to increase sensitivity was preparation of tissue 
beforehand. Reducing the protein extract concentration from lung tissue and 
washing before protein extraction and thereby reducing magnesium 
concentration levels and non-specific nuclease activity increased sensitivity of 
the assay. This may be because lung tissue contains blood, which can be 
removed by the PBS wash. 
The most effective approach to increasing sensitivity of the assay for mouse 
colon was decreasing the protein concentration in the assay although washing 
tissues at both collection and during protein extraction, which reduced non-
specific nuclease activity. The wash steps before protein extraction were not as 
effective in reducing magnesium concentration and non-specific nuclease 
activity in the colon compared with lung tissue. It may be that non-specific 
activity observed with colon tissue occurs due to enzymes within the 
autochthonous bacteria that are closely associated with the colonic mucosa 
(Nava and Stappenbeck, 2011) and, therefore, relatively difficult to remove. 
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Interestingly, human colon biopsies did not exhibit non-specific activity as 
observed with mouse colon tissue, and this suggests that non-specific activity is 
not a problem when measuring incision activity in human biopsies. 
3.4.3 Conclusions 
Measurements of DNA repair activity in mammalian tissue are difficult. The 
observed high levels of non-specific nuclease activity which differ between 
tissues require a specific and sensitive assay. Furthermore, data suggest that 
differences in repair activity are found between species and tissues with incision 
in the human colon being much lower than in the rodent extracts. This study 
demonstrates effective approaches used to reduce non-specific nuclease 
activity in the comet-based assay. Furthermore, data presented here highlight 
the importance of including control low-damage nucleoids (such as noRo) in the 
assay to prevent misinterpretation of the findings. 
Despite the challenges arising in measuring DNA repair activity using the 
comet-based assay, with the modifications described in this Chapter, the assay 
proves to be suitable for use with a wide range of mammalian tissues. By 
selecting appropriate protein extract concentration for each tissue and 
undertaking wash steps to reduce non-specific nuclease activity the assay can 
be used to quantify BER-related incision activity. The quantified BER-related 
incision activity in these tissues is presented in Chapter 4. 
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Chapter 4: The effects of ageing and short-term dietary 
restriction on BER in mouse tissues 
4.1 Introduction 
The addition of a methyl group to cytosine residues in CpG dinucleotides is 
responsible for regulation of gene expression during embryogenesis, foetal 
development and tissue differentiation (Zawia et al., 2009). Recently the role of 
altered patterns of DNA methylation in the process of ageing and age-related 
diseases has also become of interest. Aberrant methylation patterns have been 
observed in cancer while global demethylation associated with genomic 
instability has been noted during ageing (Mathers, 2006; Fraga and Esteller, 
2007; Calvanese et al., 2009; Gonzalo, 2010; Gravina and Vijg, 2010).  
Throughout the genome, most cytosine residues in CpG dinucleotides are 
methylated. However, the cytosine residues within CpG islands found in gene 
promoters are usually unmethylated in normal healthy tissues. In many cases, 
hypermethylation at such promoter regions is associated with a closed 
chromatin structure and therefore gene silencing (Richardson, 2003). The first 
experiments suggesting a correlation between DNA methylation of a gene and 
its expression were conducted by McGhee and Ginder with work on the chicken 
β-globin gene (McGhee and Ginder, 1979). Furthermore inhibition of DNA 
methylation by 5-azacytidine reverses DNA methylation associated gene 
silencing. Since then many studies have investigated the relationship between 
gene expression and DNA methylation and, often, have sought confirmation of 
a causal relationship by using 5-azacytidine treatment to de-methylate 
methylated promoter regions (Jaenisch et al., 1985; Herman et al., 1996; 
Cameron et al., 1999).  
Accumulation of oxidative damage to DNA and to other cellular macromolecules 
plays a central role in cellular ageing. Although numerous repair mechanisms 
exist (including BER and NER) to detect and to repair DNA lesions, increased 
oxidative damage to DNA is observed with age (Mecocci et al., 1993; Sohal et 
al., 1995; Gan et al., 2012). This increase may result from greater oxidative 
stress during ageing or may be a consequence of the reported age-related 
decline in DNA repair capacity (Cabelof et al., 2003) or a combination of both 
processes. The abundance of mRNA encoding BER repair enzymes as well as 
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their protein levels appear to fall during ageing (Cabelof et al., 2002; Intano et 
al., 2003) suggesting that lower transcript levels may be responsible for the 
age-related decline in repair and, consequently, increased damage 
accumulation. Silencing of DNA repair genes (e.g. Ogg1 and Apex) by 
hypermethylation of the corresponding gene promoters may be one mechanism 
accountable for lower DNA repair capacity during ageing but, to date, there 
have been no published tests of this hypothesis.  
DR is the most widely-used experimental approach known to extend lifespan 
and to reduce age-related pathologies in several animal models and has been 
shown to alter oxidative damage and DNA repair (Weraarchakul et al., 1989; 
Hirano et al., 1996; Schmerold and Niedermüller, 2001; Cabelof et al., 2003; 
Swain and Subba Rao, 2011). Although the mechanism of action of DR is not 
yet fully elucidated, there is good evidence that it has profound effects on gene 
expression in several tissues (Lee et al., 1999) and it has been hypothesised 
that these transcription changes may in part be mediated by epigenetic 
mechanisms (Mathers, 2006).  
This Chapter describes a pilot study which was set up to test the following 
hypotheses: 
1. During ageing Ogg1 and Apex gene promoters become hypermethylated 
which causes silencing of the corresponding genes.  
2. This gene silencing results in decreased BER activity and hence 
increased DNA oxidative damage accumulation. 
3. DR ameliorates the adverse effects of age on methylation of Ogg1 and 
Apex, increases the capacity for DNA repair and reduces age-related 
accumulation of DNA oxidative damage.  
The Aims of this study were to conduct a pilot study test the above hypotheses 
in mice and to prepare for a larger, more definitive, later study (described in 
Chapter 5 and 6). 
The objectives of the present study were to: 
a) Optimise and validate a comet-based assay for quantification of DNA 
repair capacity in mouse tissues; 
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b) Using RT-qPCR, set up expression assays and quantify expression of 
Ogg1 and Apex in liver and brain of mice during ageing and in response 
to short-term DR; 
c) Set up assays to characterise and quantify methylation of specific CpG 
sites within the promoters of Ogg1 and Apex in DNA from liver and brain 
of mice during ageing and in response to short-term DR; 
d) Using HPLC-ECD measurements of 8oxodG, quantify oxidative damage 
in DNA from liver and brain of mice during ageing and in response to 
short-term DR. 
4.2 Methods 
Mice for these studies came from a colony of male C56BL6 animals. For 
investigation of the effects of ageing, mice were killed and tissue samples 
collected at 6 months, 17 months and 32 months of age (n=4-7 per age group). 
For investigation of the effects of DR, mice were exposed to 26% reduction in 
dietary energy supply for 3 months starting at age 14.2±1.2 months (n=9 per 
diet group). Tissues were collected and processed as described in Chapter 2. 
Methods for measurements of promoter methylation, gene expression, DNA 
incision and 8-oxoguanine are all as described in Chapter 2. One-way ANOVA 
was used to investigate the effects of age with the Bonferroni post-hoc test used 
to identify differences between ages. Student’s t-test analysis was used in 
comparisons of diet (AL vs DR), P<0.05 was considered statistically significant. 
4.3 Results 
These sets of pilot studies were used to test the hypothesis outlined above and 
to critically assess the assays used in these studies. This section will briefly 
summarise the characteristics of animals and tissues used to assess the effects 
of ageing and short-term DR. It will then report on the separate types of analysis 
performed: DNA methylation at Ogg1 and Apex promoter regions, Ogg1 and 
Apex mRNA expression, DNA incision activity and 8-oxoguanine 
concentrations. The techniques and findings will then be interpreted in the 
discussion. 
4.3.1 Animal information 
To show the effects of ageing, mice were divided into 3 age groups: young, mid-
aged and old representing distinctive ages of the adult life. Table 4.1 shows a 
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representation of the age and mouse weights at collection as information for all 
mice was not available. No information on organ weights from these mice was 
available. 
Measurement Young adult Mid-age Old-age 
Age (months) at tissue collection 3-6 14-17 28-32 
Body mass (g) 29.08±0.54 40.00±8.89 28.57±2.48 
Table 4.1 Body mass of mice at 3 stages of lifespan: young, mid-age and old. Data represent 
mean ± SD of a representative set of mice from the study. Data curtesy of Dr Kerry Cameron. 
In a separate study to test the effects of short-term DR mice from the C57BL6 
colony were placed on either a 26% DR or AL control diet at 14 months; after 3 
months mice were sacrificed. Table 4.2 shows the age, body weights and tissue 
weights from this study (published data (Wang et al., 2010; Cameron et al., 
2011)). 
Measurement AL DR 
Age (months) at tissue collection 16-18 16-18 
Body mass (g) (mean ± SD) 39.9±2.98 29.0±1.59 
Liver weight (g) (mean ± SD) 1.17±0.228 1.18±0.253 
Brain weight (g) (mean ± SD) 0.394±0.0681 0.3911±0.0548 
Colon weight (g) (mean ± SD) 0.457±0.0571 0.370±0.0388 
Lung weight (g) (mean ± SD) 0.230±0.0358 0.247±0.0761 
Table 4.2 Body and organ masses of mice after short-term DR and their AL controls. Data 
represent mean ± SD for s subset of mice from the study. 
4.3.2 DNA methylation 
Oxoguanine DNA glycysylase (OGG1) and apurynic/apyrimidinic endonuclease 
1 (APEX) were the chosen genes/proteins of study as representative of the first 
steps of the BER repair pathway. The details of the location and genomic 
promoter sequence of the genes encoding these murine enzymes can be found 
in Appendix A and B respectively. Promoter regions of both of these genes 
contained a CpG island each. The CpG dinucleotides in each promoter regions 
were counted; the Ogg1 and Apex promoter regions contained 44 and 53 CpG 
sites respectively. A table of transcription factors known to bind at the promoter 
regions of these genes can also be found in Appendix A and B respectively 
(data generated by the Genomatix Gene2Promoter software). Pyrosequencing 
assays were set up to measure cytosine methylation at 13 CpG sites in the 
Ogg1 promoter (of which 7 were in transcription factor binding sites) and 22 
CpG sites in the Apex promoter region (of which 16 were in transcription factor 
binding sites, validation of assays can be found in Appendix A and B 
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respectively). Cytosine methylation was measured in brain and liver from ageing 
and short-term DR mice. 
4.3.2.1 Effect of age on Ogg1 promoter DNA methylation in the brain and 
liver 
In the brain, cytosine methylation at the Ogg1 promoter ranged from 0% to 
6.2%. Lowest methylation was observed at CpG site 14 and highest at CpG site 
16. Despite overall low methylation across the promoter, methylation between 
individual CpG sites was not always correlated (Figure 4.1); therefore analysis 
for each CpG site as well as mean of all sites was performed. Mean Ogg1 
promoter methylation was 1.38% (median 1.31%, SD ±0.247%), 1.49% (median 
1.43%, SD ±0.268%), and 1.27% (median 1.32%, SD ±0.254%), in young adult, 
mid-aged and old animals respectively; no statistically significant difference was 
observed in mean methylation. A difference between the age groups was found 
only at CpG 3 and CpG 13 (Table 4.3 and 4.4). At CpG site 3 methylation 
increased by 0.38% from young to mid age but then decreased again by 0.45% 
from mid to old age (P=0.026). At CpG site 13 methylation decreased by 0.11% 
from young to mid-age mice but then increased 0.95% from mid-aged to old 
mice (P=0.013). 
 
Figure 4.1 Pearson’s correlation for % methylation between CpG sites within the Ogg1 promoter 
from the brain. Statistically significant correlation at P<0.05 (*) and P<0.01 (**). 
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In the liver, cytosine methylation at the Ogg1 promoter ranged from 0 to 8.77% 
with lowest methylation at CpG 3 and highest at CpG 16. Analysis was 
performed for each individual site as well as mean promoter methylation (Figure 
4.2).  A correlation analysis of percentage DNA methylation between the 13 
CpG sites showed much variability in DNA methylation at individual sites 
studied. Mean Ogg1 promoter methylation was 1.70% (median 1.60%, SD 
±0.873%), 1.59% (median 0.96%, SD ± 0.94%) and 0.64% (median 0.44%, SD 
± 0.60%) in young adult, mid age and old mice respectively. Mean Ogg1 
promoter methylation was higher in old animals compared with young adult and 
mid-aged however this was not statistically significant. There was a difference in 
methylation between the age groups at CpG sites 6 and 7 (Table 4.3 and 4.4). 
At CpG site 6 cytosine methylation declined by 0.52% from young to mid-aged 
mice (P=0.048) and by 0.58% from young to old mice (P=0.041). At CpG site 7 
cytosine methylation declined by 1.02% from young to mid-aged mice 
(P=0.003) and by 1.11% from young to old mice (P=0.003).  
Figure 4.2 Pearson’s correlation for % methylation between CpG sites within the Ogg1 promoter 
from male mouse livers. Statistically significant correlation at P<0.05 (*) and P<0.01 (**). 
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CpG site 
Brain Liver 
Young Mid Old Young Mid Old 
CpG 3 
Mean 0.198 0.582 0.128 0.600 0.379 0.368 
Median 0.230 0.550 0.095 0.610 0.428 0.185 
SD 0.142 0.367 0.145 0.123 0.154 0.351 
P value 0.02 >0.05 
CpG 4 
Mean 1.960 1.897 1.908 2.746 2.243 2.064 
Median 1.975 1.950 2.045 2.735 2.293 2.110 
SD 0.204 0.183 0.380 0.362 0.497 0.710 
P value >0.05 >0.05 
CpG 5 
Mean 0.793 0.900 0.717 1.023 0.842 0.837 
Median 0.770 0.930 0.685 1.030 0.840 0.848 
SD 0.114 0.179 0.182 0.143 0.255 0.347 
P value >0.05 >0.05 
CpG 6 
Mean 0.788 0.915 0.632 1.256 0.741 0.676 
Median 0.840 0.925 0.735 1.213 0.830 0.558 
SD 0.127 0.189 0.260 0.300 0.298 0.385 
P value >0.05 0.028 
CpG 7 
Mean 0.993 0.877 0.833 1.771 0.752 0.660 
Median 0.980 0.815 0.825 1.718 0.660 0.415 
SD 0.165 0.145 0.324 0.574 0.333 0.467 
P value >0.05 0.001 
CpG 8 
Mean 1.655 1.542 1.458 1.890 1.202 1.339 
Median 1.670 1.450 1.660 1.595 1.412 1.348 
SD 0.325 0.197 0.420 1.034 0.816 0.655 
P value >0.05 >0.05 
CpG 9 
Mean 1.368 1.177 1.265 1.695 1.586 0.638 
Median 1.335 1.170 1.320 1.600 0.963 0.440 
SD 0.124 0.098 0.254 0.873 0.936 0.596 
P value >0.05 >0.05 
Table 4.3 Effect of age on methylation at individual CpG sites within the Ogg1 promoter 
sequence 1 in DNA from brain (young n=4, mid-age n=6 and old n=6) and liver (young n=4, 
mid-age n=6 and old n=6). Data represent mean ± SEM for each age group. DNA methylation 
for individual animal tissues were measured in duplicate. ANOVA analysis of age was 
performed. Primer design Bartłomiej Tomaszewski and Dr Sabine Langie.  
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CpG site 
Brain Liver 
Young Mid Old Young Mid Old 
CpG 13 
Mean 0.893 0.783 0.128 0.600 0.379 0.368 
Median 0.720 0.610 0.095 0.610 0.428 0.185 
SD 0.401 0.622 0.145 0.123 0.154 0.351 
P value 0.009 >0.05 
CpG 14 
Mean 0.075 0.047 1.908 2.746 2.243 2.064 
Median 0.000 0.000 2.045 2.735 2.293 2.110 
SD 0.150 0.114 0.380 0.362 0.497 0.710 
P value >0.05 >0.05 
CpG 15 
Mean 1.448 1.553 0.717 1.023 0.842 0.837 
Median 1.380 1.705 0.685 1.030 0.840 0.848 
SD 0.508 0.477 0.182 0.143 0.255 0.347 
P value >0.05 >0.05 
CpG 16 
Mean 4.063 4.418 0.632 1.256 0.741 0.676 
Median 3.890 4.155 0.735 1.213 0.830 0.558 
SD 0.640 1.030 0.260 0.300 0.298 0.385 
P value >0.05 >0.05 
CpG 17 
Mean 0.998 1.698 0.833 1.771 0.752 0.660 
Median 0.805 1.245 0.825 1.718 0.660 0.415 
SD 0.490 1.447 0.324 0.574 0.333 0.467 
P value >0.05 >0.05 
CpG 18 
Mean 2.715 2.918 1.458 1.890 1.202 1.339 
Median 2.750 2.485 1.660 1.595 1.412 1.348 
SD 0.444 1.009 0.420 1.034 0.816 0.655 
P value >0.05 >0.05 
Table 4.4 Effect of age on methylation at individual CpG sites within the Ogg1 promoter 
sequence 2 in DNA from brain (young n=4, mid-age n=6 and old n=6) and liver (young n=4, 
mid-age n=6 and old n=6). Data represent mean ± SEM for each age group. DNA methylation 
for individual animal tissues were measured in duplicate. ANOVA analysis of age was 
performed. Primer design Bartłomiej Tomaszewski and Dr Sabine Langie.  
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4.3.2.2 Effect of age on Apex promoter DNA methylation in the brain and 
liver 
In the brain, cytosine methylation at the Apex promoter ranged from 0% to 42%. 
Lowest methylation was observed at CpG site 7 and highest at CpG site 26. A 
correlation analysis between individual sites showed variability hence further 
analysis was performed on individual CpG sites (Figure 4.3). Methylation at the 
Apex promoter was higher than at the Ogg1 promoter. Furthermore more 
variability in methylation was observed between animals compared with the 
Ogg1 promoter, as seen by the error bars. Mean Apex promoter methylation 
was 3.65% (median 3.34%, SD ± 1.23%), 4.16% (median 4.19%, SD ± 1.69%) 
and 3.79% (median, SD ± 2.17%) in young adult, mid aged and old animal 
respectively; no significant difference was seen in mean promoter methylation 
or at any individual CpG site at the different ages (Table 4.5 and 4.6). 
In the liver, cytosine methylation at the Apex promoter ranged from 0-6.53% 
with lowest methylation observed at CpG site 6 and highest at CpG site 9 
(Table 4.5 and 4.6). Correlation of methylation at individual sites was not 
constant (Figure 4.4). Mean promoter methylation was 3.33% (median 3.1%, 
SD ± 0.95%), 2.49% (median, 2.63%, SD ± 1.23%) and 1.04% (median 1.84%, 
SD ± 0.25%) in young, mid age and old animals. Mean promoter methylation 
decline with age (young vs old P=0.005). A ~1.67% decrease in cytosine 
methylation was observed in older animals compared with young at CpG sites 8 
(P=0.03), 9 (P=0.015), 11 (P=0.021), 12 (P=0.033), 14 (P=0.016), 26 (P=0.002), 
27 (P=0.03), 29 (P=0.013) and 30 (P=0.018). 
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Figure 4.3 Pearson’s correlation for % methylation between CpG sites within the Apex promoter from male mouse brains. Statistically significant correlation at 
P<0.05 (*) and P<0.01 (**). 
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Figure 4.4 Pearson’s correlation for % methylation between CpG sites within the Apex promoter from male mouse livers. Statistically significant correlation at P<0.05 
(*) and P<0.01 (**).  
CpG6 .894
**
CpG7 .584
*
.584
*
CpG8 .873
**
.854
**
.659
**
CpG9 .909
**
.874
**
.609
**
.863
**
CpG10 .830
**
.748
**
.692
**
.806
**
.816
**
CpG11 .829
**
.743
**
.733
**
.824
**
.820
**
.844
**
CpG12 .905
**
.847
**
.745
**
.856
**
.905
**
.899
**
.926
**
CpG13 .821
**
.911
**
.743
**
.896
**
.861
**
.828
**
.854
**
.910
**
CpG14 .747
**
.801
**
.749
**
.866
**
.781
**
.774
**
.920
**
.847
**
.930
**
CpG15 .779
**
.668
**
.763
**
.774
**
.805
**
.857
**
.946
**
.924
**
.823
**
.860
**
CpG16 .689
**
.723
**
.696
**
.730
**
.694
**
.721
**
.885
**
.795
**
.840
**
.887
**
.798
**
CpG17 -.197 -.295 .011 -.264 -.277 -.137 .062 -.037 -.205 -.032 .108 -.072
CpG26 .709
**
.808
**
.723
**
.842
**
.783
**
.740
**
.729
**
.751
**
.892
**
.867
**
.677
**
.677
** -.315
CpG27 .287 .434 .318 .338 .528
* .278 .303 .397 .400 .386 .301 .316 .013 .378
CpG28 .799
**
.828
**
.659
**
.799
**
.812
**
.779
**
.710
**
.797
**
.870
**
.788
**
.729
**
.648
** -.255 .892
** .336
CpG29 .835
**
.843
**
.567
*
.800
**
.948
**
.759
**
.770
**
.904
**
.838
**
.722
**
.788
**
.641
** -.135 .688
**
.552
*
.730
**
CpG30 .436 .617
**
.549
*
.536
*
.643
**
.556
* .456 .590
*
.653
**
.583
* .466 .462 -.133 .690
**
.868
**
.635
**
.653
**
CpG31 .348 .517
* .446 .380 .455 .425 .246 .388 .509
* .390 .267 .406 -.311 .569
*
.592
*
.675
** .413 .793
**
CpG32 .596
*
.742
**
.585
*
.539
*
.619
**
.658
**
.490
*
.646
**
.727
**
.579
*
.490
*
.497
* -.226 .662
** .439 .750
**
.598
*
.704
**
.751
**
CpG33 .608
** .460 .379 .382 .662
**
.711
**
.533
*
.683
** .455 .335 .662
** .387 -.026 .294 .337 .535
*
.696
** .445 .431 .547
*
CpG34 .188 .056 .126 -.009 -.014 .250 .038 .104 .046 -.048 .181 .009 -.186 -.033 -.520
* .263 -.085 -.304 .067 .256 .366
 CpG5 CpG6 CpG7 CpG8 CpG9 CpG10 CpG11 CpG12 CpG13 CpG14 CpG15 CpG16 CpG17 CpG26 CpG27 CpG28 CpG29 CpG30 CpG31 CpG32 CpG33
<-0.8 -0.79-0.6 -0.59-0.4 -0.39-0.2 -0.19-0 0-0.19 0.2-0.39 0.4-0.59 0.6-0.79 >0.8
81 
CpG site 
Brain Liver 
Young Mid Old Young Mid Old 
CpG 5 
Mean 4.191 4.662 2.726 2.985 2.187 1.909 
Median 3.078 4.583 3.035 3.075 1.620 1.980 
SD 2.983 0.719 0.756 0.263 1.036 0.337 
P value >0.05 >0.05 
CpG 6 
Mean 3.873 3.928 2.382 2.316 1.559 1.228 
Median 2.905 3.755 2.485 2.316 1.455 1.275 
SD 2.565 0.524 0.823 0.393 1.093 0.434 
P value >0.05 >0.05 
CpG 7 
Mean 2.281 0.923 0.363 2.360 2.345 1.606 
Median 0.860 1.140 0.000 2.490 2.380 1.513 
SD 2.893 0.750 0.601 0.294 0.818 0.298 
P value >0.05 >0.05 
CpG 8 
Mean 2.420 0.927 0.348 2.851 2.073 1.407 
Median 1.195 1.265 0.000 2.893 2.095 1.408 
SD 2.822 0.735 0.559 0.304 0.953 0.629 
P value >0.05 0.03 
CpG 9 
Mean 4.773 4.255 3.337 5.229 4.234 3.811 
Median 3.410 4.320 3.048 5.100 3.890 3.825 
SD 3.110 0.833 1.368 0.643 0.851 0.270 
P value >0.05 0.015 
CpG 10 
Mean 3.520 3.472 2.270 3.340 2.924 2.073 
Median 2.195 3.628 2.020 3.313 2.530 2.248 
SD 3.232 0.975 0.959 0.269 1.003 0.616 
P value >0.05 >0.05 
CpG 11 
Mean 3.583 2.378 1.824 3.093 2.029 1.171 
Median 2.033 2.275 1.685 3.148 1.585 0.843 
SD 3.364 0.829 0.697 0.296 1.277 0.634 
P value >0.05   0.021 
CpG 12 
Mean 3.584 2.503 2.003 2.966 1.961 1.167 
Median 2.470 2.285 1.738 2.965 1.700 0.975 
SD 2.691 0.718 0.865 0.341 1.277 0.675 
P value >0.05 0.033 
CpG 13 
Mean 2.495 1.461 0.721 3.113 2.694 2.001 
Median 1.333 1.623 0.503 3.100 2.480 1.840 
SD 2.330 0.788 0.840 0.270 0.903 0.408 
P value >0.05 0.048 
CpG 14 
Mean 2.936 1.004 0.446 3.614 2.662 1.404 
Median 1.735 0.803 0.000 3.680 2.170 1.058 
SD 2.676 1.124 0.723 0.377 1.441 0.711 
P value >0.05 0.016 
CpG 15 
Mean 3.439 2.515 1.186 2.821 2.133 1.345 
Median 2.688 2.340 0.888 2.943 1.940 0.935 
SD 2.526 0.855 1.229 0.346 1.044 0.790 
P value >0.05 0.049 
CpG 16 
Mean 4.220 3.733 3.342 3.244 2.446 1.747 
Median 3.175 3.685 3.560 3.305 2.345 1.295 
SD 3.180 1.271 1.143 0.833 1.712 0.790 
P value >0.05 >0.05 
CpG 17 
Mean 5.149 2.601 3.080 5.190 2.528 3.200 
Median 4.035 2.610 3.023 2.305 0.000 2.075 
SD 3.233 0.637 1.092 3.034 1.567 2.338 
P value >0.05 >0.05 
Table 4.5 Effect of age on methylation at individual CpG sites within the Apex promoter 
sequence 1 in DNA from brain (young n=5, mid n=6 and old n=6) and liver (young n=4, mid n=7 
and old n=6). Data represent mean ± SEM for each age group. DNA methylation for individual 
animal tissues were measured in duplicate. ANOVA analysis of age was performed.  
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CpG site 
Brain Liver 
Young Mid Old Young Mid Old 
CpG 26 
Mean 11.488 18.511 8.219 3.513 3.059 1.739 
Median 7.198 12.910 6.025 3.508 2.870 1.755 
SD 10.134 12.696 5.510 0.342 1.003 0.129 
P value >0.05 0.002 
CpG 27 
Mean 7.448 13.695 5.492 4.074 2.280 2.383 
Median 3.295 7.765 2.960 3.690 2.365 2.298 
SD 9.692 12.647 5.890 0.857 1.231 0.795 
P value >0.05 0.03 
CpG 28 
Mean 10.906 17.176 7.562 4.065 3.741 2.932 
Median 6.433 11.718 5.188 4.070 4.050 2.955 
SD 10.510 12.293 5.416 0.343 1.057 0.141 
P value >0.05 >0.05   
CpG 29 
Mean 8.971 14.603 6.543 4.519 3.463 3.170 
Median 4.818 9.693 4.405 4.523 3.160 2.998 
SD 9.087 11.170 4.764 0.563 0.786 0.524 
P value >0.05 0.013 
CpG 30 
Mean 7.388 13.107 4.554 3.143 1.985 0.983 
Median 3.393 7.783 1.695 3.100 1.990 0.765 
SD 9.445 12.464 6.392 0.519 1.360 0.724 
P value >0.05 0.018 
CpG 31 
Mean 9.693 16.488 7.479 2.248 2.057 1.089 
Median 5.420 10.470 6.255 2.700 1.900 1.158 
SD 9.804 13.282 5.411 1.621 1.737 0.622 
P value >0.05 >0.05 
CpG 32 
Mean 9.365 16.780 5.352 3.073 3.284 1.865 
Median 3.633 10.628 2.455 3.070 3.180 2.183 
SD 12.196 14.045 7.290 1.046 1.523 1.153 
P value >0.05 >0.05 
CpG 33 
Mean 10.569 17.169 7.093 4.256 3.396 2.909 
Median 5.685 10.993 4.596 4.465 3.250 2.993 
SD 11.219 14.132 6.383 0.926 2.016 0.818 
P value >0.05 >0.05 
CpG 34 
Mean 8.921 14.305 7.043 0.000 3.700 2.444 
Median 5.043 9.948 5.033 0.000 3.460 2.405 
SD 8.614 10.916 4.861 0.000 2.481 0.843 
P value >0.05 0.03 
Table 4.6 Effect of age on methylation at individual CpG sites within the Apex promoter 
sequence 2 in DNA from brain (young n=5, mid n=6 and old n=6) and liver (young n=4, mid n=7 
and old n=6). Data represent mean ± SEM for each age group. DNA methylation for individual 
animal tissues were measured in duplicate. ANOVA analysis of age was performed. 
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4.3.2.3 Effect of short-term DR on Ogg1 promoter DNA methylation in the 
brain and liver 
In the brain, cytosine methylation at the Ogg1 promoter varied between 0 and 
6.21% with lowest methylation observed at CpG site 14 and highest at CpG site 
16. Mean promoter methylation was 1.65% (median 1.48%, SD ± 0.28%) and 
1.57% (median 1.56%, SD ± 0.06%) in AL and DR animals respectively. No 
difference was observed between AL and DR mice at any of the CpG sites or 
with respect to mean promoter methylation (Table 4.7 and 4.8). In the liver, 
cytosine methylation at the Ogg1 promoter ranged from 0% to 3.95% (Table 4.7 
and 4.8). Mean promoter methylation was 1.48% (median 1.54%, SD ± 0.21%) 
in AL and 1.40% (median 1.42%, SD ± 0.18%) in DR animals. Methylation at 
CpG sites 9 and 17 was lower in DR animals compared with AL animals. It 
declined by 0.80% at CpG 9 (P=0.041) and by 0.47% at CpG 17 (P=0.025).  
4.3.2.4 Effect of short-term DR on Apex promoter DNA methylation in the 
brain and liver 
In the brain, mean Apex promoter methylation was 5.16% (median 6.17%, SD ± 
2.64) and 3.40% (median 3.36%, SD ± 0.92%) in AL and DR animals 
respectively. Methylation varied from 0 to 41%. Methylation at CpG sites 24-26 
was ~15% lower in DR animals compared with AL animals (Table 4.9 and 4.10). 
In the liver, cytosine methylation at the Apex promoter ranged from 0 to 11.8%, 
mean methylation was 2.18% (median 2.62%, SD ± 0.83%) and 2.97% (median 
2.86%, SD ± 0.74%) in AL and DR animals respectively (Table 4.9 and 4.10). 
Cytosine methylation was higher in DR animals at 2 CpG sites. At CpG site 6 
DR animals had 1.58% higher methylation compared with AL animals (P<0.001) 
and at CpG site 13 DR animals had 1.53% higher methylation compared with 
AL animals (P=0.034). 
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CpG site 
Brain Liver 
AL DR AL DR 
CpG 3 
Mean 0.830 1.103 0.374 0.368 
Median 0.875 1.085 0.440 0.355 
SD 0.280 0.124 0.187 0.108 
P value >0.05 >0.05 
CpG 4 
Mean 2.006 1.841 2.191 2.098 
Median 1.990 1.818 2.295 2.225 
SD 0.146 0.134 0.590 0.244 
P value >0.05 >0.05 
CpG 5 
Mean 1.040 1.229 0.789 0.877 
Median 0.970 1.185 0.840 0.890 
SD 0.162 0.183 0.265 0.130 
P value >0.05 >0.05 
CpG 6 
Mean 1.065 1.246 0.701 0.868 
Median 1.010 1.165 0.850 0.800 
SD 0.154 0.469 0.354 0.319 
P value >0.05 >0.05 
CpG 7 
Mean 0.875 0.826 0.769 0.733 
Median 0.900 0.988 0.750 0.735 
SD 0.063 0.577 0.376 0.281 
P value >0.05 >0.05 
CpG 8 
Mean 1.566 1.651 0.865 1.410 
Median 1.535 1.583 0.805 0.000 
SD 0.156 0.197 0.738 0.783 
P value >0.05 >0.05 
CpG 9 
Mean 1.204 1.325 1.624 0.598 
Median 1.195 1.352 0.760 0.000 
SD 0.113 0.114 1.029 0.265 
P value >0.05 >0.05 
Table 4.7 Effect of short-term DR on methylation at individual CpG sites within the Ogg1 
promoter sequence 1 in DNA from brain (AL n=5 and DR n=4) and liver (AL n=7 and DR n=9). 
Data represent mean ± SEM for each age group. DNA methylation for individual animal tissues 
were measured in duplicate. Primer design Bartłomiej Tomaszewski and Dr Sabine Langie. 
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CpG site 
Brain Liver 
AL DR AL DR 
CpG 13 
Mean 0.779 0.816 1.569 1.224 
Median 0.585 0.770 1.535 1.410 
SD 0.782 0.269 0.222 0.457 
P value >0.05 >0.05 
CpG 14 
Mean 0.297 0.196 1.151 0.923 
Median 0.000 0.180 1.215 0.870 
SD 0.664 0.228 0.223 0.338 
P value >0.05 >0.05 
CpG 15 
Mean 1.835 2.089 2.015 1.719 
Median 1.880 2.088 2.000 1.790 
SD 0.479 0.298 0.101 0.367 
P value >0.05 0.045 
CpG 16 
Mean 4.430 3.766 3.305 3.248 
Median 4.130 3.713 3.340 3.135 
SD 1.104 0.369 0.409 0.350 
P value >0.05 >0.05 
CpG 17 
Mean 2.274 1.263 1.484 1.014 
Median 1.705 1.228 1.435 0.960 
SD 1.405 0.403 0.314 0.407 
P value >0.05 0.021 
CpG 18 
Mean 3.154 2.668 2.334 2.411 
Median 2.865 2.695 2.370 2.550 
SD 1.041 0.207 0.286 0.516 
P value >0.05 >0.05 
Table 4.8 Effect of short-term DR on methylation at individual CpG sites within the Ogg1 
promoter sequence 2 in DNA from brain (AL n=5 and DR n=4) and liver (AL n=7 and DR n=9). 
Data represent mean ± SEM for each age group. DNA methylation for individual animal tissues 
were measured in duplicate. Primer design Bartłomiej Tomaszewski and Dr Sabine Langie. 
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CpG site 
Brain Liver 
AL DR AL DR 
CpG 5 
Mean 5.677 4.713 2.447 3.027 
Median 5.085 4.508 2.285 2.910 
SD 2.321 1.621 0.854 2.085 
P value >0.05 >0.05 
CpG 6 
Mean 5.066 5.135 2.124 3.705 
Median 4.105 5.595 2.090 3.735 
SD 2.391 1.220 0.625 0.599 
P value >0.05 <0.001 
CpG 7 
Mean 1.688 0.558 2.106 2.655 
Median 1.170 0.493 2.140 2.795 
SD 2.410 0.652 0.802 0.681 
P value >0.05 >0.05 
CpG 8 
Mean 1.769 0.000 1.929 2.745 
Median 1.320 0.000 2.095 2.600 
SD 2.510 0.000 1.208 1.979 
P value >0.05 >0.05 
CpG 9 
Mean 4.530 2.934 4.010 4.730 
Median 3.810 2.748 3.930 5.690 
SD 1.631 1.170 1.264 1.950 
P value >0.05 >0.05 
CpG 10 
Mean 4.091 3.408 2.566 3.015 
Median 3.485 3.405 2.975 3.695 
SD 1.939 1.443 1.610 2.351 
P value >0.05 >0.05 
CpG 11 
Mean 3.400 0.858 1.917 2.935 
Median 2.410 0.780 1.370 3.520 
SD 2.064 0.998 1.542 1.566 
P value >0.05 >0.05 
CpG 12 
Mean 3.457 2.450 1.621 2.412 
Median 2.470 2.568 1.245 2.270 
SD 2.172 0.643 1.579 1.316 
P value >0.05 >0.05 
CpG 13 
Mean 3.091 1.731 2.369 3.901 
Median 1.750 1.823 2.480 3.905 
SD 3.219 0.278 1.452 1.160 
P value >0.05 0.043 
CpG 14 
Mean 1.838 0.618 2.066 3.677 
Median 0.000 0.000 1.250 3.773 
SD 3.176 1.235 1.972 2.110 
P value >0.05 >0.05 
CpG 15 
Mean 3.439 2.060 1.539 2.843 
Median 2.400 2.038 1.285 3.128 
SD 2.370 1.740 1.474 1.508 
P value >0.05 >0.05 
CpG 16 
Mean 4.900 3.170 2.448 2.708 
Median 4.820 3.290 2.830 1.543 
SD 1.539 0.597 2.067 3.488 
P value >0.05 >0.05 
CpG 17 
Mean 4.208 1.796 1.795 5.758 
Median 2.760 2.150 1.1795 5.440 
SD 2.928 1.247 2.539 5.924 
P value >0.05 >0.05 
Table 4.9 Effect of short-term DR on methylation at individual CpG sites within the Apex 
promoter sequence 1 in DNA from brain (AL n=5 and DR n=4) and liver (AL n=7 and DR n=9). 
Data represent mean ± SEM for each age group. DNA methylation for individual animal tissues 
were measured in duplicate.  
87 
CpG site 
Brain Liver 
AL DR AL DR 
CpG 26 
Mean 22.645 7.218 2.669 2.987 
Median 18.085 7.465 3.020 3.010 
SD 11.269 2.401 1.548 1.235 
P value 0.036 >0.05 
CpG 27 
Mean 17.991 2.700 1.897 2.303 
Median 13.350 2.685 1.740 2.450 
SD 11.097 2.603 1.259 1.176 
P value 0.035 >0.05 
CpG 28 
Mean 20.966 6.393 3.471 4.291 
Median 17.145 6.288 3.685 4.325 
SD 11.245 2.179 1.270 1.066 
P value 0.043 >0.05 
CpG 29 
Mean 18.236 4.926 2.851 3.226 
Median 14.295 5.143 3.095 3.460 
SD 9.947 1.969 1.179 1.050 
P value 0.039 >0.05 
CpG 30 
Mean 17.471 3.245 2.117 2.301 
Median 13.830 3.078 1.870 2.520 
SD 10.823 2.229 1.196 1.101 
P value 0.041 >0.05 
CpG 31 
Mean 21.269 5.939 2.436 2.949 
Median 16.885 6.093 2.185 3.160 
SD 11.430 2.275 1.380 1.193 
P value 0.038 >0.05 
CpG 32 
Mean 21.721 4.039 3.075 3.038 
Median 26.865 3.980 2.820 3.110 
SD 12.127 2.620 1.816 1.353 
P value 0.029 >0.05 
CpG 33 
Mean 21.723 5.249 2.766 3.368 
Median 16.315 5.775 1.740 3.475 
SD 12.611 2.925 2.267 1.234 
P value 0.041 >0.05 
CpG 34 
Mean 17.967 5.601 3.886 3.602 
Median 14.375 5.700 3.6300 3.805 
SD 9.589 1.600 1.746 0.972 
P value 0.044 >0.05 
Table 4.10 Effect of short-term DR on methylation at individual CpG sites within the Apex 
promoter sequence 2 in DNA from brain (AL n=5 and DR n=4) and liver (AL n=7 and DR n=9). 
Data represent mean ± SEM for each age group. DNA methylation for individual animal tissues 
were measured in duplicate.  
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4.3.3 Expression of BER genes 
Expression of Ogg1 and Apex mRNA was measured in brain and liver from 
ageing and short-term DR mice using RT-qPCR. Sequences of cDNA for Ogg1 
and Apex can be found in Appendix A and B respectively. 
4.3.3.1 Effect of age on gene expression in the brain 
An age-related decline in expression of Ogg1 and Apex was seen in the brain 
(Figure 4.5). Expression of Ogg1 decreased by 34% from mid aged to old 
animals (P=0.004) and by 43% from young adult to old animals (P=0.001). 
Expression of Ogg1 in 32 month old animals was significantly lower than 6 
month (P=0.001) and 17 month old (P=0.004). Expression of Apex decreased 
by 75% from young to old aged animals (P=0.001) and by 63% from mid aged 
to old animals (P=0.04). 
 
Figure 4.5 Effect of age on expression of Ogg1 (A) and Apex (B) in the brain. Data represent 
mean ± SEM per group and have been multiplied by 1000 (young n=4, mid-age n=6, old n=6). 
Expression per gene was measured in duplicate for individual animal tissues. ANOVA with 
Bonferroni comparison for Ogg1 P=0.001 (young vs old) and P=0.004 (mid aged vs old) and 
Apex P=0.001 (young vs old) and P=0.04 (mid aged vs old). Ogg1 primer design Dr Sabine 
Langie, Apex primer design Joanna Górniak. 
4.3.3.2 Effect of age on gene expression in the liver 
No difference in expression of Ogg1 was observed in the liver. Expression of 
Apex was increased by 19% between young and mid aged animals and 
decreased by 59% from mid aged to old animals. However, these changes were 
not statistically significant (Figure 4.6). 
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Figure 4.6 Effect of age on expression of Ogg1 (A) and Apex (B) in the liver. Data represent 
mean ± SEM per age group (young n=4, mid-age n=4 and old n=4) and have been multiplied by 
1000. Expression per gene was measured in duplicate for individual animal tissue. Ogg1 primer 
design Dr Sabine Langie, Apex primer design Joanna Górniak. 
4.3.3.3 Effect of short-term DR on gene expression in the brain and liver  
No effect of short-term DR on expression of Ogg1 and Apex was found in the 
brain (Figure 4.7) or liver (Figure 4.8).  
Figure 4.7 Effect of short-term DR on expression of Ogg1 (A) and Apex (B) in the brain. Data 
represent mean ± SEM per dietary group (AL n=5 and DR n=4). Expression per gene was 
measured in duplicate for individual animal tissue. Ogg1 primer design Dr Sabine Langie, Apex 
primer design Joanna Górniak. 
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Figure 4.8 Effect of short-term DR on expression of Ogg1 (A) and Apex (B) in the liver. Data 
represent mean ± SEM per dietary group (AL n=7 and DR n=7) and have been multiplied by 
1000. Expression per gene was measured in duplicate for individual animal tissue. Ogg1 primer 
design Dr Sabine Langie, Apex primer design Joanna Górniak. 
4.3.4 DNA incision activity 
DNA repair was measured as DNA incision activity using a comet-based assay. 
Incision activity was measured in the brain, liver, lung and colon from ageing 
mice and in brain and liver from short-term DR mice. 
4.3.4.1 Effect of age on DNA incision activity in ageing tissues 
DNA incision activity varied between the tissues, with activity being highest in 
liver > colon > lung > brain. Biological variation was observed in each age group 
and this was demonstrated by the large error bars. Correcting for protein 
concentration and proliferative nature showed that DNA incision activity was 
more than 2 fold higher in proliferative tissues (colon and liver) compared with 
non-proliferative (brain and lung). 
In the brain, BER-related incision activity was 15.4AU in young, 12.0AU in mid 
and 11.6AU in young animals. A 25% decrease in incision activity was observed 
between young and old animals; however, no significant difference was 
detected between the groups (Figure 4.9A). In the liver, BER-related incision 
activity increased significantly with age, activity was double in old animals (32 
months) compared with young animals (P=0.024, Figure 4.9B). In the lung, 
DNA incision activity was 6.9AU in young, 8.4AU in mid and 4.5AU in old aged 
animals. DNA incision increased by 22% from young to mid aged animals but 
then it decreased by 45% from mid aged to old animals. However, these 
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differences were not statistically significant (Figure 4.9C). In the colon, DNA 
incision activity was 12.2AU, 19.6AU and 6.6AU in young, mid and old aged 
animals respectively (Figure 4.9D). Incision activity increased 61% between 
young and mid aged animals but decreased ~66% in old animals compared 
with mid aged ones. None of these values differed between age groups with 
statistical significance. 
 
Figure 4.9 Effect of age on DNA incision activity in brain (A), liver (B), lung (C) and colon (D). 
Data represent mean of two individual assays ± SEM for each age group. DNA incision activity 
per age group n=4-6 brain, n=6 liver, n=6 lung, n=3 colon. ANOVA with Bonferroni post hoc 
comparison P=0.024 (young vs old). Figure published in (Gorniak et al., 2013) 
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4.3.4.2 Effect of short-term DR on DNA incision activity in the brain and 
liver 
No difference in DNA incision activity was observed in the brain. Activity was 
27.7AU and 28.5AU in AL and DR animals respectively (Figure 4.10A). DNA 
incision activity in the liver was 15.9AU in AL animals and 23.6AU in DR 
animals (Figure 4.10B). DR caused a 1.5 fold increase in repair activity 
(P=0.032).  
Figure 4.10 Effect of short-term DR on DNA incision activity in brain (A) and liver (B). Data 
represent mean of 2 individual assays ± SEM for each dietary group. DNA incision activity per 
group n=5-6 brain and n=7 liver. Student’s t-test comparison of AL vs DR: P=0.032. Data for this 
Figure have been kindly provided by Sabine Langie. 
4.3.5 Oxidative damage 
Oxidative damage was measured as number of 8-oxoguanine bases using 
HPLC-ECD. 8-oxoguanine lesions were measured in the brain, liver, lung and 
colon from ageing and short-term DR mice.  
4.3.5.1 Effect of age on 8-oxoguanine concentration in mouse tissues 
Concentration of 8-oxoguanine lesions was different between the 4 organs 
studied (P<0.001). The highest number of lesions was found in the liver > lung 
> brain > colon. Oxidative damage in the brain increased with age (Figure 
4.11A). In young animals 15.5 8-oxoguanines per 106 guanine molecules were 
detected. The number of oxidised guanines increased by 1.8 fold in mid-aged 
compared with young mice (P=0.012) and by 1.6 fold in old compared with 
young mice (P=0.046). The concentration of 8-oxodG in DNA from liver was 
similar at all ages. Mean values were 48.8, 37.8 and 43.4 8oxodG/106dG for 
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animals from young, mid-aged and old age groups respectively (Figure 4.11B). 
In the lung, similar levels of oxidative damage were observed in young and mid 
aged animals. 29.0 and 32.4 8-oxoguanines per 106 guanine molecules were 
detected in young and mid-aged animals respectively (Figure 4.11C). 
Interestingly, the concentration of 8-oxoguanine decreased in the oldest age 
group and was 40% lower compared with the mid-aged animals (P=0.006). 
Oxidative lesions in the colon decreased by 25.6% in the mid-aged compared to 
young animals (P=0.009) but increased again 1.43 fold in old animals compared 
to mid-aged animals (P=0.006, Figure 4.11D). 
 
Figure 4.11 Effect of age on 8-oxoguanine concentration in brain (A), liver (B), lung (C) and 
colon (D). Data represent mean ± SEM for each age group, measurements were taken in 
duplicate. 8-oxoguanine measured per age group in brain n=4-10, liver n=3-6, lung n=6-12 and 
colon n=6-12. ANOVA with Bonferroni post hoc analysis in the brain P=0.012 (young vs mid) 
and P=0.046 (young vs old); in the lung P=0.006 (mid vs old); in the colon P=0.009 (young vs 
mid) and P=0.006 (mid vs old). Data collected by Maastricht University, in collaboration with Dr 
Roger Godschalk.  
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4.3.5.2 Effect of short-term DR on 8-oxoguanine concentration in the 
mouse tissues 
Short-term DR had little effect on oxidative damage in the brain, liver or lung. 
Highest concentration of 8-oxoguanine was in the liver > lung > brain > colon. In 
the brain there were 21.0 and 23.4 8oxodG/106dG in AL and DR animals 
respectively (Figure 4.12A). Levels of 8-oxoguanine were ~44 and 34 per 106 
guanines in the liver (Figure 4.12B) and lung (Figure 4.12C) respectively. In the 
colon DR caused a 2 fold increase in 8-oxoguanine lesions (P<0.001) 
compared with AL (Figure 4.12D). 
 
Figure 4.12 Effect of short-term DR on 8-oxogyuanine concentration in brain (A), liver (B), lung 
(C) and colon (D) from mice. Data represent mean ± SEM for each age group. . 8-oxoguanine 
measured per age group in brain n=5, liver n=9, lung n=8-9 and colon n=8-9. Student’s t-test 
comparison of AL vs DR: P<0.001. Data collected by Maastricht University, in collaboration with 
Dr Roger Godschalk. Graphs in panels A and B curtesy of Sabine Langie. 
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4.4. Discussion 
The purpose of this chapter was to optimise assays to test BER related activity 
and epigenetic and transcription profiling of DNA repair genes Ogg1 and Apex 
in mouse brain and liver. Furthermore this study was set out as a pilot to test 
the effects of age and short-term dietary restriction in mouse tissues. In this 
discussion I will primarily focus on evaluation of the assays selected for this 
study. I will then discuss the results in light of the hypothesis. 
4.4.1 Evaluation of experimental techniques 
4.4.1.1 Pyrosequencing 
DNA methylation as a regulator of gene expression has been of interest for 
some time. Recently this mechanism has been implicated as playing an 
important role in ageing. OGG1 and APEX were chosen as the 2 enzymes 
representative of the first step of BER. The pyrosequencing assay for Ogg1 was 
designed and validated previously (Langie et al., 2013) while the design and 
validation of Apex assay can be found in the Appendix. Both assays show 
strong specific amplification of the PCR product and no non-specific 
amplification. It is evident from the pyrosequencing assays that promoter 
methylation of Ogg1 and Apex are low at all ages and near the lower limit of 
detection of the Pyrosequencer. The CpG sites covered in these assays are 
only a representation of the total number of sites in each of the promoters as it 
is not possible to look at all of them. 
4.4.1.2 RT-qPCR 
RT-qPCR is the gold standard for quantifying gene expression. The above 
experiments were conducted using the MIQE guidelines to ensure the best 
quality results (Bustin et al., 2009). Stringent criterion for RNA quality ensured 
degradation of RNA was minimal and results were conducted on intact mRNA. 
Furthermore, a check assay was run after cDNA synthesis to ensure no 
genomic DNA contamination occurred. The results from gene expression 
studies were expressed using a modification of the 2-ΔΔCt method i.e. 2-ΔCt, as no 
true control group was present. Assays gave good amplification of product with 
no non-specific amplification as demonstrated by the melt curves. By assessing 
DNA methylation as well as expression of Ogg1 and Apex a relationship 
between methylation at CpG sites studied and their effect on expression could 
be explored. 
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4.4.1.3 Comet in-vitro repair assay 
The comet-based in-vitro repair assay is a sensitive technique for 
measurements of repair of singlet oxygen induced DNA damage (Langie et al., 
2011). This assay may require multiple optimisation steps as demonstrated in 
Chapter 3.Optimal concentrations of protein extracts to use in the comet assay 
were 5mg/ml for both brain and liver, 1.25mg/ml for lung and 0.5mg/ml for colon 
Here I show that the comet assay is able to detected age-related changes in 
DNA repair as observed in the liver, and also differences in repair profiles of 
other tissues. Many other assays able to measure incision activity focus on 
repair of a single modified base in an oligonucleotide or a plasmid. Although this 
may give a more controlled assay it can be speculated that the comet assay 
gives a more realistic view of DNA incision (Langie et al., 2011). 
4.4.1.4 HPLC 
Finally 8-oxodG has been used as a marker of oxidative damage. It is 
implicated in mutagenic GC to TA transversions. Different methods have been 
used to measure oxidative damage and problems arise when comparing results 
from each of the tests. HPLC is a sensitive method used in detection although it 
has been speculated that high levels are detected as a result of oxidation during 
the DNA extraction process. In comparison measurements using the basic 
comet assay show much lower estimates of oxidative damage but one may 
speculate where this is because of inability of enzymes to reach damage in 
tightly wound DNA.  
4.4.2 Effects of age 
Although no age or diet changes have been reported here, a small but 
significant increase in Ogg1 promoter methylation in the aged brain has 
previously been shown (unpublished data by Sabine Langie). As mentioned in 
this Chapter, not all CpG sites in the promoter region were studied here. It may 
be likely that methylation at specific CpG sites is of more relevance to 
transcription silencing of these genes. Although a lack of change in promoter 
methylation was observed for both Ogg1 and Apex the expression of the genes 
was shown to decline with age. The observed decrease in transcript levels is 
highly significant in the aged brain and the effects may have arisen due to other 
epigenetic modifications. A decline in BER gene expression has been 
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previously shown in ageing rat lens (Zhang et al., 2010) and carcinoma (Kumar 
et al., 2012). 
DNA repair is linked with accumulation of DNA damage and genomic instability 
although this view is controversial as not all studies have found increased 
damage with age. A direct comparison of repair cannot be made between all 
tissues as they were tested at different concentrations. Both liver and brain 
were measured at 5mg/ml protein concentration and data show that liver has 
higher incision activity than the brain. It has been suggested that the 
proliferative nature of the tissue may have an influence on repair. Here liver and 
colon represent mitotic tissue while lung and brain represent post-mitotic tissue; 
however; no clear pattern is seen in either cell type, indicating that tissue-
specific (rather than proliferative nature of the cell) changes in repair may occur 
during ageing. 
Interestingly an increase in incision activity was observed in the liver in older 
animals and this has previously also been reported (Mikkelsen et al., 2009). 
Furthermore although DNA repair activity has often been said to decline with 
age no statistically significant changes in repair was observed here in brain, 
liver or colon and lack of age-related effect on repair has also been reported 
before (Hirano et al., 1996). 
The data suggest that concentrations of oxidative damage as measured by 8-
oxodG vary between tissues and with age. Overall (data pooled from all ages), 
highest levels were observed in the liver followed by lung, brain and colon. It 
has been previously demonstrated that oxidative damage accumulation is tissue 
dependant (Schmerold and Niedermüller, 2001). Increase in oxidative damage 
accumulation has been reported in brain and liver (Sohal et al., 1994a) but this 
has not always been confirmed (1990). 
4.4.3 Effects of short-term DR 
Data presented here have not found an effect of short-term DR on DNA 
methylation or gene expression and one can speculate whether this is due to 
the short period of DR the mice were subjected to or more likely that the 26% 
DR is relatively low compared with other studies (Weraarchakul et al., 1989; 
Cabelof et al., 2003; Gedik et al., 2005). Furthermore the results from the aged 
study suggest that the biggest change is observed in the oldest age group in 
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which case more informative results may have been acquired if an additional 
group of animals was kept alive (on DR or AL diet) until 30 months of age. 
Multiple studies have reported a decline in DNA repair. PARP, a polymerase 
involved in DNA repair, has been shown be less active in rat frontal cortex and 
this was attenuated by DR (Hiona and Leeuwenburgh, 2004). Similarly 
unscheduled DNA synthesis as measured by incorporation of a radiolabelled 
cytosine nucleotide at a G:U mismatch has been shown to decline in rodent 
tissue with age while DR animals displayed higher repair compared with AL 
controls (Cabelof et al., 2003; Intano et al., 2003). Furthermore, DR was 
observed to reduce oxidative damage levels in multiple organs (Chung et al., 
1992; Sohal et al., 1994a). 
4.4.4 Study design 
A major limitation to the ‘pilot study’ arises from the selection of samples that 
were used, which although they came from the same strain of mice bred at the 
university have all come from slightly different studies. Furthermore a more 
stringent statistical analysis could not be used as the samples tested in the 
brain and the liver did not come from the same animal. Thus caution should be 
taken when looking at the differences between the tissues. In Chapter 5 and 6; 
the long-term DR study this issue will be overcome as tissue samples under 
comparison have been taken from the same animal. 
4.5 Conclusions 
To conclude, CpG islands have been found in the promoters of both Ogg1 and 
Apex genes and assays for measuring DNA methylation at sites in these CpG 
islands have been developed. Furthermore any changes in gene expression 
can be studied using the Ogg1 and Apex gene expression assays. Studies of 
age-related accumulation of oxidative damage are still conflicting and damage 
accumulation will in part depend on efficiency of DNA repair hence it is 
important to assess both the repair capacity and damage accumulation. Finally 
the data presented here support further studies into ageing and long-term 
dietary restriction. 
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Chapter 5: The effects of ageing and of long-term dietary 
energy restriction (DR) on base excision repair (BER) in the 
brain 
5.1 Introduction 
Preliminary data described in Chapter 4 suggest that age and short-term dietary 
restriction (DR) affect base excision repair (BER) in the brain. In this chapter I 
describe the changes in BER in the brain of male and female mice exposed to 
long-term DR. 
5.1.1 Epigenetic regulation of chromatin 
Epigenetic marks control the chromatin structure thereby regulating 
transcription activity of genes. While cytosine methylation is accompanied by 
gene silencing specific histone modifications are also associated with particular 
transcription states. Addition of acetyl groups to histone tails opens chromatin 
structure which allows transcription factors to bind to the gene promoter regions 
and initiate transcription (Struhl, 1998). On the other hand, methylation marks 
on histone tails have been implicated in both transcription activation and 
repression dependent on the site of methylation. Tri-methylation of the lysine 
residue at position 27 of histone 3 (H327Me3) in particular is associated with 
repression of the corresponding gene (Zhang and Reinberg, 2001). Although 
the mechanism for H3K27Me3 is not fully understood it is known that this 
histone modification associates with polycomb repressive complexes which 
cause repression of transcription possibly by preventing transcription elongation 
(Simon and Kingston, 2009). 
DNA methylation and histone modifications are two independent mechanisms 
and although the hierarchy of epigenetic events is not known, it is evident that 
cross-talk occurs between these epigenetic marks. Cytosine hypermethylation 
often occurs together with histone deacetylation and either event can initiate 
gene silencing by 1) directly preventing binding of transcription factors or 2) 
indirectly by binding proteins, e.g. those containing a methyl binding domain, 
that prevent transcription initiation (Vaissière et al., 2008). Furthermore, 
enzymes responsible for epigenetic changes form complexes, such as the 
association of DNA cytosine-5-methyltransferase 1 (DNMT1) with histone 
deacetylase 1 (HDAC1). These epigenetic enzymes can also affect numerous 
epigenetic marks; e.g. a mutation in dim-5, encoding a  histone 3 
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methyltrasferase, in Neurospora abolishes DNA cytosine methylation (Fuks et 
al., 2000; Robertson et al., 2000; Tamaru and Selker, 2001). 
This multiplayer regulation has led me to explore additional epigenetic marks 
such as histone 4 acetylation (H4Ac) and H3K27me3 as well as cytosine 
methylation at the Ogg1 and Apex promoter regions. 
5.1.2 Enzymes regulating epigenetic marks 
These epigenetic changes are a result of the activity of enzymes such as DNA 
methyltrasferases (DNMT), histone acetyltransferases (HAT) and histone 
deacetylases (HDAC) (2009). Therefore the age-related changes in expression 
and function of these enzymes play a part in the observed epigenetic 
alterations. An age-related decline in expression of DNMT1 and DNMT3a and 
an increase in DNMT3b has been reported in fibroblasts (Lopatina et al., 2002; 
Casillas et al., 2003). These findings can in-part explain the changes in global 
and promoter specific methylation seen in ageing (D’Aquila et al., 2013). 
Multiple classes of HAT and HDAC enzymes exist. Decreases in HATs p300 
and CBP are seen with increased population doubling in human melanocytes 
(Bandyopadhyay et al., 2002). Decline in HDAC expression has been reported 
in senescent stem cells compared with young cells (Jung et al., 2010). 
Furthermore the Sirtuin family of HDACs has been linked to life extension; e.g. 
via Sir2 over-expression in yeast. The mammalian homologue SIRT1 is down-
regulated in senescent fibroblast cells (Sasaki et al., 2006). Furthermore, 
evidence supports HDAC activation as one of the modes of action for dietary 
restriction as DR was not able to extend lifespan in yeast cells not expressing 
Sir2 (Lin et al., 2000), suggesting that Sir2 and DR act within the same 
pathway. In addition, DR attenuates the age-related increase in DNMT3a 
expression observed in mouse hippocampus (Chouliaras et al., 2011). 
5.1.3 Redox-sensitive transcription factors 
It is well documented that redox-sensitive transcription factors (TF), such as 
forkhead box protein (FOXO) and hydrogen peroxide-inducible clone-5 (HIC-5), 
are up-regulated during ageing and DR (Lee et al., 1999; Weindruch et al., 
2001; Greer and Brunet, 2008). Furthermore hypoxia-inducible factor 1-alpha 
(HIF1α) increases with age in rodent brain and liver (Kang et al., 2005; 
Benderro and LaManna, 2011) while DR prevents this response (Kang et al., 
2005). These TFs initiate transcription of cellular response genes such as those 
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coding for DNA repair proteins. A number of such transcription factors have 
binding sequences in Ogg1 and Apex promoters. A comprehensive list of these 
TFs can be found in Appendix A and B. Of these, nuclear transcription factor Y 
subunit A (NFYA) has been more thoroughly studied in the context of Ogg1 
activation. Decreased expression of NFYA was associated with decreased 
OGG1 protein concentration in renal cancer and tuberous sclerosis complex 
disease (Habib, 2009). Treatment of kidney cells with rapamycin (mTOR 
inhibitor) resulted in increased NFYA and OGG1 protein expression (Habib et 
al., 2010). HIF1α and NFYA are two known TFs that bind both in the Ogg1 and 
Apex promoter regions. Exploring the expression of these TFs during ageing 
and DR could provide insight into BER related expression. 
5.1.4 Aims and Objectives 
The study described in this chapter aimed to test the following hypotheses: 
1. During ageing, epigenetic changes at Ogg1 and Apex gene promoters 
cause silencing of these genes.  
2. This gene silencing results in decreased BER activity and hence 
increased DNA oxidative damage accumulation. 
3. DR ameliorates the adverse effects of age on epigenetic modifications at 
Ogg1 and Apex promoters, by mediating changes in enzyme activity, 
DNA repair, expression of redox-sensitive TFs and reducing 
concentration of DNA oxidative damage. 
The objectives of the present study were to: 
a) Characterise and quantify methylation of specific CpG sites within the 
promoters of Ogg1 and Apex in DNA from the brain of mice during 
ageing and in response to long-term DR; 
b) Characterise and quantify histone acetylation and methylation associated 
with Ogg1 and Apex promoters in DNA from the brain of mice during 
ageing and in response to long-term DR; 
c) Quantify histone acetyltransferase and histone deacetylase activity in 
extracts from the brain of mice during ageing and in response to long-
term DR; 
d) Using RT-qPCR, quantify expression of the transcription factors Hif1α 
and Nfya which are associated with Ogg1 and Apex gene activation, in 
the brain of mice during ageing and in response to long-term DR; 
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e) Using RT-qPCR, quantify expression of Ogg1 and Apex in the brain of 
mice during ageing and in response to long-term DR; 
f) Quantify BER-related incision activity in mouse brain tissue using the in 
vitro comet-based repair assay; 
g) Using ELISA quantify OGG1 and APEX protein expression in extracts 
from the brain of mice during ageing and in response to long-term DR; 
h) Using HPLC-ECD measurements of 8-oxoguanine, quantify oxidative 
damage in DNA from the brain of mice during ageing and in response to 
long-term DR. 
5.2 Materials and Methods 
Male and female mice for the long-term DR main study were of the C57BL6 
strain. At 3 months of age, mice were allocated at random to either the ad 
libitum (AL) feeding regime or to DR. Dietary restricted mice were placed on 
40% by weight food restriction i.e. the DR mice received 60% of the food 
consumed by the AL mice. Mice were killed at ages 3, 12, 24 and 30 months of 
age and brain and liver tissues were removed, snap frozen in liquid nitrogen 
immediately and stored at -80˚C. Figure 5.1 provides an overview of the design 
of the animal study. This chapter describes epigenetic changes observed in 
brain tissue and Chapter 6 will discuss epigenetic changes in liver tissue. 
Figure 5.1 Schematic overview of long-term DR mouse study. 
The laboratory methods have been described in detail in Chapter 2. Briefly, 
ground frozen tissue was used for extraction of DNA and mRNA for promoter 
DNA methylation and gene expression studies respectively. Protein extracts 
from ground tissue were also used for the in vitro comet-based repair assay and 
to quantify concentration of OGG1 and APEX proteins using ELISA kits plus 
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HAT and HDAC activity using colorimetric kits. Ground tissue was also used for 
the chromatin immunoprecipitation assay to quantify histone 4 acetylation 
(H4Ac) and histone 3 lysine 27 tri-methylation (H3K27Me3) relative to the Ogg1 
and Apex promoter regions. 
ANOVA general linear model (ANOVA GLM) was used for statistical analysis 
testing effects of age, diet and sex and their interactions when data were 
normally distributed. Bonferroni post-hoc test was used for comparisons of all 
groups. When data were not normally distributed the non-parametric Kruskal-
Wallis test was used except when analysing individual CpG site methylation in 
which case ANOVA GLM was performed despite no normality. Non-parametric 
Mann-Whitney U test, with a correction for multiple testing (significance 
α=0.05/number of comparisons made), was used as a post hoc test in non-
normally distributed data. Where no statistically significant difference was seen 
between AL and DR animals at same age, the two diet groups were pooled 
together to increase the power for age related calculations. Similarly when no 
statistically significant difference was seen with age, the age groups were 
grouped together to increase the power for diet related calculations.  
5.3 Results 
5.3.1 Animal and organ characteristics 
The long-term DR mouse study from which tissues were obtained for the 
present investigation was designed and managed by the Centre for Integrative 
Systems Biology of Ageing and Nutrition (CISBAN) to investigate the ageing 
process and its amelioration by DR. At 3 months of age, when mice are 
considered adult, the animals were randomised to ad libitum (AL) feeding or to 
the 40% dietary restricted (DR) regime. A parallel longitudinal study, designed 
for phenotyping purposes, run at the same time as the long-term DR study, 
found mean lifespan for female mice was increased by 2.3 months (P<0.001, 
mean lifespans of 26.9±0.4 and 29.2±0.4 months for AL and DR mice 
respectively). The increase in lifespan in DR compared with AL male mice was 
greater by 3 months (P<0.001) i.e. 26.1±0.1 and 29.1±0.4 months for AL and 
DR mice respectively. Overall, lifespan for male and female mice was not 
significantly different (unpublished data from Kerry Cameron and Thomas von 
Zglinicki). 
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Group 
Male Female 
Body mass 
(g) 
Brain 
(g) 
Brain mass 
(%) 
Body mass 
(g) 
Brain 
(g) 
Brain mass 
(%) 
3AL 
29.2 
±2.04 
0.426 
±0.0055 
1.46 
±0.049 
22.9 
±1.53 
0.398 
±0.0312 
1.74 
±0.099 
12AL 
36.7 
±4.12 
0.422 
±0.0154 
1.16 
±0.046 
25.2 
±3.12 
0.423 
±0.0136 
1.70 
±0.087 
12DR 
24.8 
±2.75 
0.428 
±0.0175 
1.75 
±0.086 
17.1 
±1.91 
0.418 
±0.0140 
2.47 
±0.105 
24AL 
47.9 
±3.85 
0.488 
±0.0426 
1.02 
±0.046 
35.9 
±3.20 
0.483 
±0.0146 
1.35 
±0.050 
24DR 
25.3 
±2.12 
0.420 
±0.0730 
1.66 
±0.088 
19.2 
±0.32 
0.448 
±0.0479 
2.33 
±0.091 
30AL 
35.1 
±2.60 
0.395 
±0.1085 
1.12 
±0.137 
28.4 
±4.38 
0.467 
±0.0158 
1.68 
±0.144 
30DR 
23.0 
±2.94 
0.387 
±0.0517 
1.70 
±0.150 
18.1 
±1.04 
0.429 
±0.0244 
2.37 
±0.039 
Table 5.1 Body masses and weights of brains from a subset of male and female mice in the 
CISBAN longitudinal phenotyping study. Specific data for the animals from which tissues were 
used in the present study are not available. Data represent mean ± SEM, n=5-7, 3AL – 3 month 
old AL fed mice, 12AL – 12 month old AL fed mice, 12DR – 12 month old DR fed mice, 24AL – 
24 month old AL fed mice, 24DR – 24 month old DR fed mice, 30AL – 30 month old AL fed mice 
and 30DR – 30 month old DR fed mice. Data courtesy of Dr Kerry Cameron and Professor 
Thomas von Zglinicki. 
Data for body mass and brain weights in male and female mice are shown in 
Table 5.1. In both male and female mice, body mass increased with age to 
reach a maximum at 24 months and then declined at 30 months. DR reduced 
body mass at all ages in both males and females (P<0.001). Brain weights were 
similar between dietary regimes and across ages although the brain weight was 
reduced by DR in female but not in male mice. Furthermore when measured as 
tissue mass as a percentage of body weight DR actually increased brain weight. 
5.3.2 Epigenetic regulation of Ogg1 and Apex promoters in the brain 
To determine the underlying mechanisms of the effects of age and of long-term 
DR on base excision repair, I measured epigenetic marks at the promoter 
regions of Ogg1 and Apex genes. This included quantification of cytosine 
methylation, H4Ac and H3K27Me3 in the brain from mice from the CISBAN 
long-term DR study. 
5.3.2.1 DNA methylation of the Ogg1 promoter 
As described in Chapter 4, DNA methylation was quantified at 13 CpG sites in 
the Ogg1 gene promoter and 22 CpG sites in the Apex gene promoter. 
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Measurements were made at all ages (3, 12, 24 and 30 months) and in both AL 
and DR animals. Cytosine methylation data are prone to non-normal 
distribution. Furthermore, a Box-Cox power transformation was unable to 
transform the data to a normal distribution. The factorial (age and diet) design of 
the study meant that non-parametric tests were not powerful to test for trends 
and interactions. As the ANOVA is a robust test, able to withstand deviations 
from normality (Glass et al., 1972; Sawilowsky, 1990), I used the ANOVA GLM 
for analysis of individual CpG sites despite violation for normality of data. 
Figure 5.2 and 5.3 show methylation at individual CpG sites and mean 
methylation across the CpG sites in the Ogg1 promoter in male and female 
mice respectively. Overall, levels of methylation were quite low and ranged from 
0-12.7%. In the Ogg1 promoter, average methylation across all 7 groups was 
lowest in CpG 3 at 0.14% in males and 0.07% in females and highest in CpG 16 
at 2.67% in males and 3.16% in females. CpG 4, 16 and 18 showed 
consistently higher methylation levels compared with other CpG sites 
measured. Supplementary Tables for mean and median cytosine methylation 
values per CpG site can be found in Appendix A. 
Mean Ogg1 promoter methylation in the brain was normally distributed, 
although methylation at most individual CpG sites was not. There were 
differences between the sexes (P<0.001), with females showing overall higher 
methylation compared with males and so further analyses considered data for 
male and female animals separately. Correlation of methylation at individual 
CpG sites are shown in Figure 5.4 and Figure 5.5 for male and female mice 
respectively. The correlation between the different sites varied from -0.122 to 
0.793 in males and -0.264 to 0.753 in females. Overall the correlation between 
CpG sites was not high; therefore, mean methylation may not be ideal for 
presenting these data and analysis were also run at individual CpG sites. 
In male mice cytosine methylation at 6 CpG sites decreased with age in a linear 
trend: CpG 3 (Pa=0.002), CpG 6 (Pb=0.005), CpG 7 (Pd<0.001), CpG 13 
(Pe=0.027), CpG 14 (Pf=0.013) and CpG 15 (Ph=0.026). Cytosine methylation 
at 4 CpG sites was lower in DR fed animals compared with AL fed controls by: 
0.16% at CpG 6 (Pc=0.002), 0.18% at CpG 14 (Pg=0.031), 0.25% at CpG 17 
(Pi=0.042) and 0.41% at CpG 18 (Pj=0.029). Mean Ogg1 promoter methylation 
across the 13 CpG sites decreased with age in a linear trend (Pk=0.016). In 
107 
addition, overall Ogg1 promoter methylation was significantly lower in DR 
animals (Pl=0.014) although the absolute difference of 0.23% was quite 
modest. 
In female mice, only cytosine methylation at CpG 8 changed with age in a 
quadratic trend (Pa=0.01). In addition, cytosine methylation at CpG 3 and 17 
was 0.09% (Pb=0.014) and 0.33% (Pc=0.025) lower in DR compared with AL 
fed animals respectively. There was no evidence that mean methylation of the 
Ogg1 promoter in DNA from the brains of female mice was affected by either 
age or diet.  
5.3.2.2 DNA methylation of the Apex promoter 
Figure 5.6 and 5.7 show methylation at individual CpG sites and mean 
methylation across the CpG sites in the Apex promoter in male and female mice 
respectively. Overall, levels of methylation were quite low and ranged from 0-
13.9%. In the Apex promoter CpG 30 showed least methylation in male mice at 
0.95% while CpG 27 showed least methylation in female mice at 0.26%. CpG 
28 was most methylated in males at 4.57% while CpG 9 was most methylated 
in females at 2.73%. CpG sites 9, 17, 28, 29 and 34 showed consistently higher 
methylation compared with other CpG sites. A supplementary table with mean 
and median cytosine methylation at individual CpG sites can be found in 
Appendix B. 
 
108 
Figure 5.2 Effect of age and DR on methylation at individual CpG sites within the Ogg1 promoter in DNA from male brain. Data represent mean ± SEM per treatment 
group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 30AL (light 
grey bars, n=5) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM analysis for 
age and diet: Pa=0.002, Pb=0.005, Pc=0.002, Pd<0.001, Pe=0.027, Pf=0.013, Pg=0.031, Ph=0.026, Pi=0.042, Pj=0.029, Pk=0.016 and Pl=0.014. Primer design 
Bartłomiej Tomaszewski and Dr Sabine Langie. Data collected by Joanna Górniak.
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Figure 5.3 Effect of age and DR on methylation at individual CpG sites within the Ogg1 promoter in DNA from female brain. Data represent mean ± SEM per 
treatment group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 
30AL (light grey bars, n=7) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM 
analysis for age and diet: Pa=0.014, Pb=0.010 and Pc=0.025.  Primer design Bartłomiej Tomaszewski and Dr Sabine Langie. data collected by Joanna Górniak.
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Figure 5.4 Pearson’s correlation for % methylation between CpG sites within the Ogg1 promoter 
from male mouse brains. Statistically significant correlation at P<0.05 (*) and P<0.01 (**). 
Figure 5.5 Pearson’s correlation for % methylation between CpG sites within the Ogg1 promoter 
from female mouse brains. Statistically significant correlation at P<0.05 (*) and P<0.01 (**). 
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Mean Apex promoter methylation in the brain was normally distributed and DNA 
methylation varied between the sexes (P=0.001). Correlation of methylation at 
individual CpG sites are shown in Figure 5.8 and Figure 5.9 in male and female 
mice respectively. The correlation between the different sites varies from -0.226 
to 0.728 in males and 0.029 to 0.779 in females. Overall the correlation 
between CpG sites was not high therefore mean methylation may not be ideal 
for presenting these data and analysis were also run at individual CpG sites. 
In male mice cytosine methylation at 3 CpG sites declined with age in a linear 
trend: CpG 31 (Pa=0.01), CpG 32 (Pb=0.036) and CpG 33 (Pc<0.001). In male 
mice no CpG sites in the Apex promoter were affected by diet. No difference 
was detected in mean methylation across the CpG sites between the seven 
groups, mean methylation was 1.44% ranging from 1.26% in 24DR group to 
1.64% in 3AL group. 
In female mice, cytosine methylation at 5 CpG sites was lower in DR fed animal 
compared with AL fed controls by: 0.33% at CpG 6 (Pa=0.01), 0.28% at CpG 7 
(Pb=0.027), 0.43% at CpG 10 (Pe=0.009), 0.61% at CpG 17 (Ph=0.032) and 
0.28% at CpG 27 (Pj=0.037). Furthermore 10 CpG sites were affected by age. 
Cytosine methylation decreased in a linear trend at: CpG 10 (Pd=0.007), CpG 
27 (Pi=0.023), and CpG 33 (Pn=0.023). Cytosine methylation varied in a 
quadratic trend at: CpG 28 (Pk=0.005), CpG 29 (Pl=0.041), CpG 30 
(Pm=0.007) and CpG 34 (Po=0.02). Lastly, cytosine methylation varied in a 
cubic trend at: CpG 9 (Pc=0.011), CpG 14 (Pf=0.005), and CpG 17 (Pg=0.024). 
In female mice age did not have an effect on mean Apex promoter methylation 
however, DR fed females had 0.28% lower methylation levels compared with 
AL fed animals (Pp=0.021). 
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Figure 5.6 Effect of age and DR on methylation at individual CpG sites within the Apex promoter in DNA from male brain. Data represent mean ± SEM per treatment 
group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 30AL (light 
grey bars, n=5) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM analysis for 
age and diet: Pa=0.010, Pb=0.036 and Pc<0.001. 
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Figure 5.7 Effect of age and DR on methylation at individual CpG sites within the Apex promoter in DNA from female brain. Data represent mean ± SEM per 
treatment group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 
30AL (light grey bars, n=7) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM 
analysis for age and diet: Pa=0.010, Pb=0.027, Pc=0.011, Pd=0.007, Pe=0.009, Pf=0.005, Pg=0.024, Ph=0.032, Pi=0.023, Pj=0.037, Pk0.05, Pl=0.041, Pm=0.007, 
Pn=0.023, Po=0.020 and Pp=0.021. 
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Figure 5.8 Pearson’s correlation for % methylation between CpG sites within the Apex promoter from male mouse brains. Statistically significant correlation at 
P<0.05 (*) and P<0.01 (**). 
CpG5
CpG6 .251
CpG7 .588
** .273
CpG8 .435
**
.480
**
.460
**
CpG9 .614
** .203 .462
**
.405
**
CpG10 .376
*
.405
**
.302
*
.461
**
.459
**
CpG11 .388
**
.471
**
.452
**
.498
**
.452
**
.539
**
CpG12 .303
*
.431
**
.491
**
.536
**
.360
*
.579
**
.674
**
CpG13 .305
* .192 .414
** .289 .463
**
.529
**
.451
**
.346
*
CpG14 .322
* .265 .422
**
.475
** .278 .343
*
.472
**
.374
* .202
CpG15 .388
**
.459
**
.466
**
.470
**
.341
*
.443
**
.501
**
.436
** .243 .522
**
CpG16 .404
**
.547
**
.437
**
.618
**
.334
*
.324
*
.659
**
.433
** .206 .564
**
.410
**
CpG17 .388
**
.529
**
.454
**
.489
**
.378
*
.484
**
.488
**
.507
**
.476
**
.367
*
.549
**
.333
*
CpG26 -.046 -.006 -.134 -.112 .264 .156 -.098 .099 .044 -.167 -.197 -.021 -.152
CpG27 -.137 .267 -.014 .123 .032 .065 .200 .201 .004 -.032 .194 .164 .124 .113
CpG28 -.087 .010 -.113 .068 .187 .453
** .235 .122 .324
* -.011 .204 -.001 .186 .389
** .249
CpG29 -.128 .233 -.039 .061 .210 .093 .065 .119 .072 .026 .024 -.008 .064 .255 .559
** .164
CpG30 -.041 .011 -.162 -.029 .288 .135 -.066 .153 -.018 -.159 -.045 -.099 .016 .440
** .243 .331
*
.456
**
CpG31 .054 .053 .044 .094 .140 .086 -.226 -.023 -.131 -.061 .084 -.074 .220 -.011 .477
** .144 .260 .248
CpG32 -.060 .247 .070 .119 .160 .162 .064 .130 .025 .047 .145 .165 .163 .088 .728
** .120 .443
** .098 .649
**
CpG33 .345
* .060 .213 .114 .379
* .242 .102 .146 .266 .039 .226 .015 .316
* .081 .461
**
.306
*
.312
* .274 .612
**
.555
**
CpG34 .352
* -.041 .154 .244 .653
** .191 .019 .095 .212 .165 -.033 -.034 .261 .343
* .046 .197 .292 .331
* .237 .144 .448
**
CpG6 CpG7 CpG8 CpG9 CpG10 CpG11 CpG12 CpG13 CpG14 CpG15 CpG16 CpG17 CpG26 CpG27 CpG28 CpG29 CpG30 CpG31 CpG32 CpG33 CpG34
<-0.8 -0.79-0.6 -0.59-0.4 -0.39-0.2 -0.19-0 0-0.19 0.2-0.39 0.4-0.59 0.6-0.79 >0.8
115 
Figure 5.9 Pearson’s correlation for % methylation between individual CpG sites within the Apex promoter from female mouse brains. Statistically significant 
correlation at P<0.05 (*) and P<0.01 (**).
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5.3.2.3 Histone acetylation at the Ogg1 promoter 
To assess the effect of age and of DR on chemical modifications to histone 
tails, histone modifications were measured in 3 groups i.e. 3 month old mice, 30 
month old AL mice and 30 month old DR mice. Histone 4 acetylation (H4Ac) 
and histone 3 lysine 27 trimethylation (H3K27Me3) were measured as 
prominent examples of epigenetic marks associated with transcription activation 
and repression respectively. 
At the Ogg1 promoter, H4Ac in the brain was higher in female compared with 
male mice therefore subsequent analyses were performed for each sex 
separately. In male mice there was a significant difference in H4Ac between the 
3 groups (P=0.02, Figure 5.10A), a Bonferroni post hoc test for age (3AL vs 
30AL) and for diet (30AL vs 30DR) was performed. A 2.5 fold enrichment of 
H4Ac was observed in older animals compared with the young (n.s) 
furthermore, at age 30 months, DR animals showed a 3 fold decrease in H4Ac 
levels compared with AL fed controls (P=0.02). In female mice, the pattern of 
H4Ac was the mirror image of that seen for the males. The lowest H4Ac values 
were observed in the 30AL female mice and, in comparison with this group, 
acetylation was enriched by 1.8 fold and 2.6 fold in 30DR and 3AL mice 
respectively but, given the substantial inter-individual variation, these 
differences were not statistically significant (Figure 5.10B). 
5.3.2.4 Histone acetylation at the Apex promoter 
At the Apex promoter, H4Ac was higher in female compared with male mice; 
therefore, subsequent analyses were performed for each sex separately. No 
difference between the 3 groups was observed at the Apex promoter in males 
(Figure 5.11A), although a 2.4 fold enrichment of H4Ac was seen in 30AL 
compared with 3AL animals. Furthermore at 30 months, AL animals had 3.3 fold 
higher H4Ac enrichment compared with DR fed animals. No significant effect of 
age or diet was observed in the Apex promoter of female mice where H4Ac was 
lowest in the 30AL group and was enriched by 1.4 fold in both 3AL and 30DR 
animals when compared with 30AL group (Figure 5.11B).  
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Figure 5.10 Effects of age and of DR on histone 4 acetylation at the Ogg1 promoter in brain of 
male (A) and female (B) mice. Data represent mean enrichment ± SEM. ChIP-qPCR was 
performed in duplicate per animal, n=5 per age group. H4Ac was normalised to IgG. Univariate 
ANOVA-GLM analysis with Bonferroni post hoc test: 3AL vs 30AL P=0.035 and 30AL vs 30DR 
P=0.02. Primer design by Dr Jelena Mann, data collection Joanna Górniak. 
 
Figure 5.11 Effects of age and of DR on histone 4 acetylation at the Apex promoter in brain of 
male (A) and female (B) mice. Data represent mean enrichment ± SEM. ChIP-qPCR was 
performed in duplicate per animal, n=5 per age group. H4Ac was normalised to IgG. Primer 
design by Dr Jelena Mann, data collection Joanna Górniak. 
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5.3.2.5 Histone methylation at the Ogg1 promoter 
In the brain there was no overall effect of sex on H3K27Me3 but there were 
interactions between sex and both age and diet therefore subsequent analyses 
were performed separately for each sex. No significant difference was seen 
between the groups in the brain of male mice. Despite this nearly a 2 fold 
enrichment in H3K27Me3 was observed in the 30AL group compared with both 
3AL and 30DR groups (Figure 5.12A). In contrast, in females no enrichment of 
H4Ac was observed with age but 30DR animals did show 1.4 fold enrichment 
compared with 30AL animals, although this difference was not significant 
(Figure 5.12B). 
Figure 5.12 Effects of age and of DR on histone 3 lysine 27 tri-methylation at the Ogg1 
promoter in brain of male (A) and female (B) mice. Data represent mean enrichment ± SEM. 
ChIP-qPCR was performed in duplicate per animal, n=5 per age group. H3K27Me3 was 
normalised to IgG. Primer design by Dr Jelena Mann, data collection Joanna Górniak. 
5.3.2.6 Histone methylation at the Apex promoter 
A difference between sexes was not observed for methylation at the Apex 
promoter; however, an interaction of sex and diet was observed; therefore, 
sexes were analysed separately. No difference between the groups in either 
male or female mice was observed. In male mice H3K27Me3 was enriched 
nearly 2 fold in the 30AL group compared to the others (Figure 5.13A). In 
female mice H3K27Me3 was enriched 6.7 fold and 4.1 fold in 30DR group 
compared to 3AL and 30DR respectively (Figure 5.13B). 
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Figure 5.13 Effects of age and of DR on histone 3 lysine 27 tri-methylation at the Apex promoter 
in brain of male (A) and female (B) mice. Data represent mean enrichment ± SEM. ChIP-qPCR 
was performed in duplicate per animal, n=5 per age group. H3K27Me3 was normalised to IgG. 
Primer design by Dr Jelena Mann, data collection Joanna Górniak. 
5.3.2.7 HAT and HDAC activity 
To assess the effect of age and of DR on HAT and HDAC, enzyme activity was 
measured in 3 groups: 3AL, 30AL and 30DR. No difference in HAT activity was 
observed between the sexes. Age or diet did not have an effect on HAT activity, 
which was around 7AU (Figure 5.14). However, DR animals showed slightly 
higher levels of HAT activity (n.s.).  
 
Figure 5.14 Effect of age and DR on HAT activity in the brain. Data represent mean ± SEM from 
a single assay, n=10 per group (pooled for male and female mice). 
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HDAC activity was different between the sexes with male mice showing higher 
activity. In male mice, HDAC activity was 7 fold higher in older animals 
compared with 3 month old animals (P=0.047), but no effect of diet was 
observed (Figure 5.15A). In female mice, age did not have an effect on HDAC 
activity; however, activity was 2.6 fold higher in 30DR group compared with 
30AL group (P=0.049, Figure 5.15B). 
Figure 5.15 Effect of age and DR on HDAC activity in the brain of male (A) and female (B) mice. 
Data represent mean ± SEM absorbance from a single assay, n=5 per group. In males, Mann-
Whitney U test between 3AL vs 30A: P=0.047. In females, univariate ANOVA-GLM analysis 
between groups with Bonferroni post hoc between 30AL vs 30DR: Pe=0.049. 
5.3.2.8 Expression of transcription factors 
To assess the effect of age and DR on the expression of Hif1α and Nfya TFs, 
mRNA expression was measured in 3AL, 30AL and 30DR groups. Hif1α 
expression was different between the sexes with male mice showing higher 
expression levels. In male mice, expression of Hif1α was 2 fold higher in the 
30AL group compared with 3AL (P=0.012) but DR did not have an effect on 
expression (Figure 5.16A). In female mice, no effect of age or diet are observed 
although the 30AL group had ~30% lower expression compared with the other 2 
groups (Figure 5.16B). No difference in Nfya expression was seen between the 
sexes; therefore, data were pooled. Although a significant difference between 
the groups was observed (P=0.007) a post hoc comparison did not show an 
effect of age or diet (Figure 5.17). 
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Figure 5.16 Effect of age and DR on expression of Hif1α in male (A) and female (B) mice in in 
the brain. Univariate ANOVA-GLM analysis with Bonferroni post hoc comparison 3AL vs 30AL: 
P=0.012. 
 
Figure 5.17 Effect of age and DR on expression of Nfya in in the mouse brain. Data represent 
mean ± SEM, n=10 per group (pooled sexes). Kruskal-Wallis analysis between groups: 
P=0.007.  
  
122 
5.3.3 BER gene expression 
Expression of the 2 BER-related genes Ogg1 and Apex was measured in 
mRNA extracted from the brain in 3AL, 12AL, 12DR, 24AL, 24DR, 30AL and 
30DR groups. In all cases, assays were conducted on mRNA from individual 
animals and data are presented as 2-ΔCt. 
5.3.3.1 Ogg1 expression in the brain 
Overall, Ogg1 expression was higher in males compared with females. 
Expression of Ogg1 was 1.4 fold and 1.3 fold higher in the 3AL group compared 
with 30AL groups in male and female mice; however, this trend in decline was 
not statistically significant in either sex (Figure 5.18). On the other hand in both 
male and female mice, DR animals had significantly higher Ogg1 expression 
levels compared with AL fed animals (Pmale=0.034 and Pfemale=0.019). There 
were no interactions between age and diet for either sex which suggests that 
the effect of DR in raising Ogg1 expression occurs across the life-course in all 
mice.  
5.3.3.2 Apex expression in the brain 
No difference was observed in expression between sexes, with no interactions 
between age, diet or sex; therefore, the data were pooled from both male and 
female mice. Apex expression in the brain is shown in Figure 5.19. An age-
related decline in expression was observed (P=0.003), which followed a linear 
trend (R²=0.091, P=0.004). Furthermore DR animals showed higher levels of 
Apex gene expression compared to AL controls (P=0.005). A Bonferroni post 
hoc analysis between the groups revealed that expression was 1.7 fold higher 
in 3AL (P=0.038), 1.7 fold higher in 12AL (P=0.046), 1.9 fold higher in 12DR 
(P=0.001), 1.4 fold higher in 24AL (n.s.), 1.7 fold higher in 24DR group 
(P=0.044) and 1.6 fold (n.s.) compared with 30AL group.  
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Figure 5.18 Effect of age and of DR on expression of Ogg1 at the mRNA level in the brain of 
male (A) and female (B) mice. Solid line with round symbols represents AL fed animals dotted 
line with square symbols represents DR fed animals. Data represent mean ±SEM, n=5-7 per 
group. Univariate ANOVA-GLM analysis for diet: male mice P=0.034 and female mice P=0.019. 
Primer design Dr Sabine Langie. Data collection Joanna Górniak. 
 
Figure 5.19 Effect of age and of DR on expression of Apex at the mRNA level in the brain. Solid 
line with round symbols represents AL fed animals and dotted line with square symbols 
represents DR fed animals. Data represent mean ± SEM. n=10 per group (data pooled for male 
and female mice. Univariate ANOVA-GLM analysis for age (P=0.003) and diet (P=0.005). 
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5.3.4 Base excision repair (BER)-related DNA incision activity in the brain 
BER-related DNA repair activity was quantified as incision of DNA at sites of 
damage, induced by photosensitiser Ro 19-8022, using the in vitro comet-based 
repair assay, which measures the first step (incision of the strand) of the repair 
process. DNA incision was measured in protein extracts from brain from 
individual animals in all 7 groups. 
DNA incision activity was highly variable between animals. For example, for the 
brain this ranged from 0.02 to 17.92 AU with a mean of 4.8AU. These data were 
skewed to the left with only a few animals showing high rates of incision activity. 
No difference in DNA incision activity was observed between male and female 
mice and so data for both sexes were pooled for subsequent analyses. No 
detectable effects of age or diet on DNA incision activity were observed. 
ANOVA-GLM show an interaction between these 2 factors (P=0.042, Figure 
5.20). This is likely because DNA incision in the 24AL group was 2.28AU higher 
compared with 24DR but at 30 months there was a cross over and incision was 
1.94AU higher in 30DR group compared with 30AL.  
Figure 5.20 Effects of age and of DR on DNA incision activity in the brain. Solid line with round 
symbols represents AL fed animals. Dotted line with square symbols represents DR fed animals 
Data represent mean ± SEM, n=10-14 per group (pooled for male and female mice). Assay 
design by Dr Sabine Langie. Data collection Joanna Górniak. 
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5.3.5 Expression of OGG1 and APEX at the protein level in brain 
Protein concentration of OGG1 and APEX were measured in extracts of brain 
from 3AL, 30AL and 30DR groups. For both proteins, concentration did not 
differ significantly between male and female mice, therefore the data were 
pooled for further analyses. OGG1 protein concentration was increased with 
age but no effect of diet was observed (Table 5.2). A 20% increase in protein 
concentration was seen in the 30AL group compared with the 3AL group 
(P=0.049). Furthermore OGG1 protein concentration was 1.8 fold higher in the 
30DR group compared with the 3AL group. A difference in APEX concentration 
was seen between the 3 groups tested (P<0.001). Post hoc analysis revealed a 
1.7 fold increase with age (Mann Whitney U test 3AL vs 30AL, P=0.002) and a 
>2 fold higher APEX concentration in DR fed animals compared with AL fed 
controls (Mann Whitney U test 30AL vs 30DR, P<0.001, Table 5.3). 
OGG1 
(ng/ml) 
Male Female All mice 
3AL 0.61±0.10 0.40±0.03 0.51±0.02 
30AL 0.96±0.09 0.68±0.01 0.58±0.03* 
30DR 1.00±0.02 0.82±0.02 0.90±0.03 
Table 5.2 Effects of age and of DR on OGG1 protein concentrations in brain. Data represent 
mean ± SEM from a single assay, n=5 per group. Univariate ANOVA-GLM with Bonferroni post 
hoc comparison in 3AL vs 30AL: P=0.049. 
APEX 
(ng/ml) 
Male Female All mice 
3AL 0.13±0.03 0.16±0.04 0.15±0.07 
30AL 0.27±0.02 0.24±0.02 0.25±0.05** 
30DR 0.72±0.14 0.42±0.07 0.55±0.26*** 
Table 5.3 Effect of age and DR on APEX protein concentrations in the brain. Data represent 
mean ± SEM from a single assay, n=5 per group. Kruskal-Wallis analysis with Mann Whitney U 
test comparison; 3AL vs 30AL P=0.002 and 30AL vs 30DR P<0.001. 
To investigate relationships with function, protein concentration as well as 
mRNA levels of Ogg1 and Apex were correlated with BER-related DNA incision 
activity. Figure 5.21 shows correlation plots for both protein vs repair and mRNA 
vs repair. There were positive and significant correlations between incision 
activity and concentrations of both OGG1 protein (R2=0.167, P=0.028) and 
APEX protein (R2=0.163, P=0.03) but no significant relationships with the 
corresponding mRNA abundances. 
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Figure 5.21. Correlations between BER-related DNA repair (incision activity) and OGG1 protein 
(A) APEX protein (B) Ogg1 mRNA (C) and Apex mRNA (D) in the brain. Data represents mean 
± SEM for all animals in the 3AL, 30AL and 30DR groups. The correlations with DNA incision 
activity were positive and significant for both OGG1 (P=0.028) and APEX (P=0.03) protein 
concentrations but there were no significant correlations between incision activity and mRNA 
abundance. 
5.3.6 Effects of age and DR on oxidative damage to DNA in the brain 
Oxidative damage in the brain was measured in the form of 8-oxoguanine in all 
7 groups using HPLC-ECD. No difference in oxidative damage lesions were 
detected between males and females thus for further analyses the data from 
both sexes were pooled. As summarised in Table 5.4, mean values for 8-
oxodG/106dG were lowest (11.7) in the 12 month old DR mice and highest 
(20.1) in the 30 month old DR animals. There were statistically significant 
differences in 8-oxoguanine concentration between the 7 groups (P=0.014). 
Multiple Mann-Whitney post hoc tests were performed between the groups, 
adjusting for multiple comparisons (α<0.024). At this significance level the only 
difference detected was a 1.7 fold increase in 8-oxoguanine concentration in the 
30DR group compared with the 12DR (P<0.001). Interestingly highest damage 
was observed in 3 month old animals but then fell to lowest levels in 12 month 
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old animals, after which there was a progressive increase. A quadratic model of 
age-related 8-oxoguanine concentration was fitted to the data (R²=0.095, 
P=0.023) and can be seen in Figure 5.22. 
Group Age (months) Diet 8-oxodG/106dG 
3AL 3 AL 18.6±4.15 
12AL 12 AL 15.8±2.35 
12DR 12 DR 11.7±0.67 
24AL 24 AL 14.9±1.04 
24DR 24 DR 13.7±1.02 
30AL 30 AL 16.4±2.53 
30DR 30 DR 20.1±2.48*** 
Table 5.4 Effects of age and of DR on 8-oxoguanine concentrations in the brain. Data represent 
mean ± SEM, n=10-14 per group (data pooled for male and female mice). Kruskal-Wallis 
analysis between the groups (P=0.014) with multiple Mann-Whitney U test post hoc comparison 
(adjusted α<0.024): 12DR vs 30DR P<0.001. Data collected by Maastricht University, in 
collaboration with Dr Roger Godschalk. 
Figure 5.22 Effects of age on DNA oxidative damage in the brain. Data represent mean ± SEM, 
n=10-28 (pooled for both male and female and for AL and DR animals). Quadratic trend 
(R²=0.095, P=0.023). Data collected by Maastricht University, in collaboration with Dr Roger 
Godschalk.  
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5.4 Discussion 
In this chapter I have investigated age and DR-related epigenetic changes 
(DNA methylation and histone marks) at promoter regions of genes coding for 
the BER-related proteins: oxoguanine DNA glycosylase (OGG1) and 
apurinic/apyrimidinic endonuclease (APEX). I quantified the resultant changes 
in Ogg1 and Apex transcription levels (mRNA abundance) and their repair 
capability (assessed as BER-related incision activity). 
Two types of epigenetic marks, and their effect on BER gene expression, were 
measured: DNA methylation and histone post-translational modification (histone 
4 acetylation and histone 3 lysine 27 tri-methylation) as it has been suggested 
that these may work in unison to mediate transcription changes (Vaissière et al., 
2008). Figure 5.23 shows the conceptual model for epigenetic regulation of 
BER-related genes investigated in this chapter, where during ageing BER-
related genes are silenced by an increase in DNA methylation and H3K27 tri-
methylation as well as a decrease in H4 acetylation and DR is able to 
ameliorate these changes. In addition a brief investigation of the modes of 
action for epigenetic changes were undertaken. The effect of age and long-term 
DR on activity of epigenetic enzymes HAT and HDAC as well as TF expression 
were studied.  
The subsequent changes in BER protein, repair activity and number of 8-
oxoguanine lesions were also measured to understand the effect on the 
epigenetic through to phenotypic profile. These observations were studied in 
two contrasting tissues in the mouse: the brain, which is largely post-mitotic, 
and the liver, which retains capacity for cell proliferation throughout much of the 
life-course. The decision to investigate 2 contrasting tissues was taken since 
age-related epigenetic changes are tissue specific (Thompson et al., 2010) and 
so is damage and repair activity (Sohal et al., 1994a; Karahalil et al., 2002; 
Intano et al., 2003). This chapter describes epigenetic changes observed in 
brain tissue and Chapter 6 will discuss epigenetic changes in liver tissue. 
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Figure 5.23 Schematic overview of proposed epigenetic mechanisms through which age and 
DR may influence expression of BER-related genes. 
With the complexity of this study I have designed this conceptual model to 
simplify the data. The brain and liver tissues studied will be discussed 
separately in Chapters 5 and 6 respectively and comparisons between the 
results will be made in Chapter 6 and the general discussion in Chapter 8. I will 
discuss the data based on the model, identify gaps, conflicts and anomalies. 
However, I will do this for a selection of the data to present a story that is more 
streamlined. I will discuss: a) the observed epigenetic changes in reference to 
gene expression, b) epigenetic mechanisms that may be involved i.e. epigenetic 
enzyme activity and TF expression and finally, c) the phenotypic changes 
observed in repair activity and oxidative damage. 
5.4.1 Epigenetics and BER-related gene expression 
5.4.1.1 Effect of age and DR on DNA methylation 
Epigenetic changes have been proposed as one of the hallmarks of ageing 
(López-Otín et al., 2013). Decline in global DNA methylation during ageing has 
been well documented and evidence shows that decrease in global DNA 
methylation contributes to age-related genomic instability (Bell et al., 2012). In 
addition, alterations of epigenetic marks at gene promoter regions may be 
responsible for the transcription changes occurring with age. Ageing is 
characterised by down-regulation of cell cycle and maintenance genes and up-
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regulation of inflammatory and stress response genes (Lee et al., 2000). The 
age-related decline in genomic maintenance is one of the factors that facilitate 
the accumulation of macromolecular damage seen during ageing (Kirkwood, 
2008). 
I hypothesised that there would be an increase in cytosine methylation (at BER-
related gene promoters) with age, which would cause silencing of BER-related 
genes. DNA methylation at most CpG sites within both Ogg1 and Apex 
promoter regions was low. In a given DNA molecule a specific cytosine residue 
within a CpG dinucleotide is either methylated or not and; therefore, to a first 
approximation, the values for methylation reported in this chapter correspond to 
the proportion of genomes (i.e. cells within the sample) at which the 
investigated CpG sites are methylated (Mathers and Ford, 2009). Overall, only 
a small percentage of the cells found in the brain had methylated cytosine 
bases in the promoter regions of Ogg1 and Apex. A group of enzymes known 
as Ten-eleven-translocation (TET) proteins convert methylated cytosine to 5-
hydroxymethylcytosine. It is hypothesised that 5-hydroxymethylcytosine 
prevents binding of methyl binding proteins and DNMTs. Furthermore, TET 
enzymes themselves may bind to unmethylated DNA and prevent DNA 
methylation by DNMTs (Xu et al., 2011). In the mouse neurons TET1 together 
with a deaminase and thymine DNA glycosylase causes DNA demethylation 
(Cortellino et al., 2011; Guo et al., 2011). Although I did not quantify levels of 5-
hydroxymethylcytosine there is evidence for increased levels in the ageing 
mouse hippocampus (Chen et al., 2012) and human brain (Wen et al., 2014). 
Such a phenomenon may explain the low levels of DNA methylation in the 
studied promoters. 
Interestingly, contrary to my hypothesis I found that the differentially methylated 
cytosines within CpG dinucleotides experienced an age related demethylation 
and this was accompanied by decline of Ogg1 and Apex expression. 
Investigation of cytosine methylation often centres around hypermethylation and 
the related gene silencing; however, demethylated genes are also observed 
during ageing (Takasugi, 2011). Demethylation of the Ogg1 gene correlated 
with increased expression in rat liver (Tsubota et al., 2008) and human breast 
cancer cells (Singh et al., 2012). Growing evidence highlights methylation at 
other sites such as gene bodies and CpG island shores and shelves in 
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regulating transcription activity (Suzuki and Bird, 2008; Sanyal et al., 2012). For 
example, non-promoter DNA methylation enhances transcription of genes 
involved in neurogenesis by inhibiting repressive polycomb proteins (Wu et al., 
2010). Similarly, non-promoter methylation could be responsible for the 
regulation of expression of Ogg1 and Apex genes. 
I hypothesised that DR can attenuate an-age related increase in methylation. I 
observed that the promoter regions of the chosen genes remain demethylated 
throughout chronological age and that DR animals had lower methylation levels. 
Furthermore at a number of CpG sites studied demethylation occurred in DR 
fed animals independently of age. Therefore rather than prevent age-related 
methylation changes I show here that DR potentiates this phenomenon. It has 
previously been reported that in the hippocampus, DR prevented the age-
related increase in DNMT3a protein (Chouliaras et al., 2011) through the Sirtuin 
pathway, as these deacetylases associate with DNA methyltransferases (Fuks 
et al., 2000; Fuks et al., 2001). 
A possible mode of action for DNA methylation is the prevention of binding of 
transcription factors. I used the Genomatix software to determine the TF factors 
binding at the Ogg1 and Apex promoters. Comparison of differentially 
methylated CpG sites with age at the Ogg1 promoter (sites 15, 17 and 18) 
mapped to cut-like homeobox and its homolog factors (CLOX), core promoter 
motif ten element (MTEN), neuron-restrictive silencer factor (NRSF), v-ERV and 
RAR-related orphan receptor alpha (RORA), GLI zinc finger family (GLIF), zinc 
binding protein factors (ZBPF) and Huntington’s disease gene regulatory region 
binding protein (HDBP) transcription factors. CpG sites showing age-related 
methylation at Ogg1 promoter site 3 mapped to hypoxia inducible factor (HIFF) 
and 14 mapped to general transcription factor II (T2D), CCAAT binding factors 
(CAAT), CLOX, MTEN and NRSF. In the Apex promoter, sites CpG 10 and 27 
were affected by both age and DR and these mapped to activator protein 2 
(AP2F), insulinoma associated factors (INSM), cAMP-responsive element 
binding proteins (CREB) and NRSF transcription factors. The common factors 
between both promoters were CAAT, NRSF, HDBP. These transcription factors 
represent both positive and negative regulators of transcription initiated by 
oxidative stress and DNA damage response pathways ((Christmann and Kaina, 
2013) and search of NCBI gene database). Overall DNA methylation data could 
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not provide implicit relationship with expression; therefore, I went on to look at 
histone modification marks relative to the repair genes. 
5.4.1.2 Effect of age and DR on histone post-translational modification 
The histone code provides another level of epigenetic regulation of 
transcription. In the present project, I investigated H4 acetylation and 
H3K27Me3, which have been correlated with transcription activation and 
repression respectively (Akhtar and Becker, 2000; Asp et al., 2011). I observed 
both a repressive H3K27Me3 and active H4Ac modification at the promoters of 
BER-related genes, implying a tight regulation of transcription as is observed in 
development to allow rapid activation of gene expression (Bernstein et al., 
2006). 
I found that histone modifications with age and DR were sex specific and 
although strong trends were observed these were not significant.  Non-normality 
of the data and use of a non-parametric test which is not as robust as ANOVA 
may have masked the biological effects. The large variation within the data 
could have arisen because whole brain tissue rather than individual sub-regions 
was used in this study. It has been demonstrated that age-related cytosine 
methylation changes in cortical tissue correlated with the pons but not with the 
cerebellum (Hernandez et al., 2011). Furthermore, histone methylation does not 
correlate between sub-regions of the hippocampus and these react differently to 
stress stimuli (Hunter et al., 2009). 
In the brain of male mice, in both the promoter regions studied H4Ac and 
H3K27Me3 increased with age and DR prevented this increase. Global histone 
modification changes occur during ageing (Feser and Tyler, 2011). However, 
here I focus on changes observed in relevance to Ogg1, and Apex promoters. 
The fact that antagonistic histone marks changed in opposite directions may be 
predicted to result in there being no effect on transcription activity. This 
prediction is supported by the observed expression of Ogg1 which did not 
change with age. On the other hand expression of Apex declined with age 
despite the theoretically neutralising effect of the histone modifications 
measured. One explanation for this could be that the overall histone code at the 
Apex promoter displays a silencing signal; however, because only 2 of the 
histone marks were studied, this did not report on the overall signal (Strahl and 
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Allis, 2000; Dong et al., 2012). While H3K27Me3 is very well correlated with 
repression of transcription (Barski et al., 2007), H4Ac can initiate activation or 
repression of transcription depending on the initiator molecule (Deckert and 
Struhl, 2001). Furthermore, in yeast inducible genes can be marked by histone 
acetylation even in the inactive chromatin state (Roh et al., 2004) thus 
highlighting the complexity of the histone code.  
What is striking about the data is that DR is able to prevent these age-related 
changes in histone modifications and the histone modifications measured in 
30DR mice were comparable to 3AL mice. This is not surprising since sirtuins 
(NAD dependant histone deacetylases) are one of the pathways of DR action 
(Lin et al., 2000). Interestingly, here H4 acetylation (H4Ac) showed i) little 
change with age consistent with no changes in HAT activity and ii) DR 
decreased H4AC consistent with higher HDAC activity in the brain of DR fed 
animals. Changes in specific HAT and HDAC enzyme families could have 
occurred, but were not detected here since the overall activity was measured. 
However, previously no changes in CBP and p300 HAT enzyme activity were 
observed in the ageing brain (Li et al., 2002). Furthermore the sex specific 
changes may be attributed to differential expression of histone demethylases, 
such as UTX, which is present at much higher levels in the female mice 
compared with male mice (Xu et al., 2008b). 
Based on the present results it is likely that these epigenetic mechanisms 
interact with each other to give rise to the specific expression pattern. 
Furthermore microRNAs have also been classed as an epigenetic mechanism 
since they act post transcription to inhibit or break down the transcript mRNA 
thus further complicating the transcription regulatory mechanisms. Multiple 
miRNAs targeting DNA repair genes have been identified. MiRNA 182-5p 
targets genes of the homologous recombination repair pathway (Krishnan et al., 
2013). Furthermore, miR 31-5p targets the hMLH1 gene, which encodes a 
protein of the mismatch repair pathway, and miR overexpression is associated 
with MLH1 protein decrease and cell cycle arrest (Zhong et al., 2013). In 
addition, numerous miRNAs are differentially expressed in older individuals and 
these changes affect expression of miRNA target genes (Noren Hooten et al., 
2010). Ogg1 and Apex have been identified as predicted targets of multiple 
miRNAs in the human (Helwak et al., 2013). However, there has been no 
134 
detailed study on miRNA modulation of BER genes during ageing. Such an 
investigation would bring important epigenetic regulatory information and could 
identify whether down-regulation of BER genes such as Apex (as identified in 
this study) is dependent on miRNA regulation. 
On a gene specific level it seems that despite aberrant changes observed with 
ageing the cell attempts to counteract these changes by maintaining active 
expression of genes coding for repair enzymes through DNA hypomethylation 
and histone acetylation, in what can be explained as a survival effect. 
Furthermore, DR marks its own effect on the epigenome by further enhancing 
DNA demethylation and preventing and age-related histone changes, thus 
giving higher expression of BER-related proteins compared with AL fed 
controls. 
5.4.2 Effect of age and DR on TF expression 
I was able to detect changes in the expression of redox-sensitive transcription 
factors, which are involved in activation of BER-related gene expression. 
However, the quantified TF mRNA levels did not give an indication of the 
binding of these TFs to the promoter region and therefore ChIP studies might 
give more insight on this matter. 
However, more surprisingly, no reduction in TF expression was observed in DR 
animals in the current study, while short-term DR showed trends to increase 
expression (Appendix C). DR has been proposed to reduce oxidative stress 
(Sohal and Weindruch, 1996) and therefore lower levels of redox-sensitive 
transcription factors may have been expected. On the other hand, maybe 
oxidative stress is lower in DR animals because they have higher levels of 
redox-responsive TFs which activate stress response enzymes that can 
maintain lower oxidative stress. This implies that DR might decrease age-
related oxidative stress/damage via the activation of redox-sensitive 
transcription factors such as nuclear factor-kB (NFkB) and hypoxia inducible 
factor 1 (HIF-1) (Kim et al., 2002).  
Redox-sensitive transcription factors; e.g. FOXO (Greer and Brunet, 2008) and 
Hic-5 (Lee et al., 1999; Weindruch et al., 2001) are up-regulated by ageing. 
Data presented here show increased Hif1α and Nfya expression in old brain. 
Age-related increase in HIF1α has been well documented (Kang et al., 2005; 
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Benderro and LaManna, 2011), though, no change of human NFYA levels were 
observed (Matuoka and Chen, 2000). An increase in expression of redox-
responsive genes, involved in BER activation, was not surprising in relation to 
the well-known implications of oxidative damage in ageing (Harman, 1956).  
Data presented here show that the expression of redox-sensitive transcription 
factors was up-regulated with age (Hif1α) and DR (Nfya), which suggests that 
ageing and DR represent a state of oxidative stress, leading to the cell inducing 
expression of redox-sensitive transcription factors. The TFs may in turn induce 
expression of genes through response elements, such as in BER-related genes. 
5.4.3 Effects of age and of DR on BER-related DNA incision activity 
The observed changes in expression of BER-related genes would suggest 
alterations in the repair activity. I was unable to detect any changes in incision 
activity in the brain. I did however show an increase in OGG1 protein in cell 
lysates from older animals, which has been previously demonstrated (Szczesny 
et al., 2004). Together these observations may suggest that the capacity of 
OGG1 to repair DNA lesions decreases with age, but the cell attempts to 
compensate by increasing the level of enzyme expression. A large number of 
protein post translational modifications regulate activity of repair enzymes, such 
as phosphorylation of OGG1 and acetylation of APEX. Thus any changes in 
post-translational modification of OGG1 and APEX will affect their function (Hu 
et al., 2005; Almeida and Sobol, 2007; Busso et al., 2010). Furthermore DR 
may exert its effect on DNA incision not only via epigenetic modulation but also 
via post-translational modification of repair enzymes by interaction with e.g. 
sirtuins. Search of the literature shows that the theory of age-related decline in 
repair has multitude of contradictory reports. Resveratrol, a DR mimetic, has 
been shown to increase activity of the APEX enzyme suggesting more abasic 
sites should be observed in DR treated animals (Yamamori et al., 2010). 
Although I did not observe a statistical difference in incision activity in DR 
compared to AL animals, 30 month old AL animals showed a fall in incision 
activity whereas DR animals showed increased activity. These data suggest 
that DNA incision activity in the brain is maintained throughout mouse lifespan 
and only falls in the oldest mice. Furthermore, DR showed a potentially 
protective role by increasing incision activity in the oldest age group. It is difficult 
to say why this occurred but one possibility is that the 30 month group could 
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show ‘survival’ phenotype, having reached such a high age because of their 
cellular repair capacity. Cabelof et al. found the response of BER after exposure 
to oxidative stress is blunted with age (Cabelof et al., 2006). Could this mean 
that basal repair is unaffected but any additional stressors in the older animals 
are not as quickly (well) removed as in the young? Again, such a report is 
contradictory to that of Hamilton et al. who found that repair after gamma 
irradiation did not alter in liver, brain or kidney from young or old mice (Hamilton 
et al., 2001). 
An increase in BER-related proteins was observed in response to age and DR. 
However others have not seen such changes (Intano et al., 2003; Imam et al., 
2006; Kisby et al., 2010; Swain and Subba Rao, 2011). Kisby et al. found no 
significant difference in APE, Pol-β or DNA ligase III (Kisby et al., 2010) 
although they did find a decrease in activity. Imam et al. found no age-related 
change in APE and DNA ligase III in mouse cortex, hippocampus or cerebellum 
(Imam et al., 2006) but they did find an age-related decline in OGG1 activity. 
Intanto et al. found no changes in DNA ligase I or III, XRCC-1 or APE 
concentration but did see a decline in Pol-β in aged mice (Intano et al., 2003) 
while Swain et al. found that a decrease in DNA ligase I and III, APE and Pol-β 
protein expression in old rat cortical neurones (Swain and Subba Rao, 
2011).The contradictory observation seen in the present study may have arisen 
because the protein concentration was measured in whole cell lysates, thus 
quantifying expression of nuclear as well as cytosolic proteins. 
The comet assay was used to quantify BER-related repair activity. The damage 
induced in substrate cells by Ro 19-8022 is comparable to that induced by 
singlet oxygen, producing mainly 8-oxoguanine (Will et al., 1999). The incision 
reaction is performed on nucleoids and therefore is much more representative 
of BER in a cell than incision of an oligonucleotide containing a single damaged 
base. On the other hand the comet-based assay, although a sensitive technique 
for measurements of DNA incision, suffers from non-specific nuclease activity 
(Chapter 3) and with high biological variability it may be difficult to obtain 
statistically significant changes.  
Two separate groups have also shown that supplementation with one or more 
components of the BER pathway is required to restore DNA repair function 
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(Krishna et al., 2005; Swain and Subba Rao, 2011), but the lack of changes in 
protein expression observed here suggests that function of the protein may be 
impaired, rather than expression affected.  
Lastly there is ample evidence that NER has been shown to act as a back-up 
for removal of DNA oxidative damage. For example, mice lacking the Ogg1 
gene are able to minimise 8-oxodG related mutations, (Klungland et al., 1999; 
Osterod et al., 2001). This supports the notion that other repair mechanisms 
can be used to remove 8-oxo damage and may be another reason why no 
change was observed in repair but a decline in gene expression was seen with 
age. In the future it would be important to measure other BER as well as NER-
related proteins to determine age-related changes.  
5.4.4 Effect of age and DR on oxidative damage 
The brain is a highly metabolically active tissue with a large glucose 
consumption, moderate ROS production and low antioxidant defences (Sohal et 
al., 1990b). Many studies report an age-related increase in DNA oxidative 
damage in support of the free radical theory of ageing (Hirano et al., 1996; 
Kaneko et al., 1997; Nakae et al., 2000). Similarly, evidence points to DR 
having a protective role in oxidative stress, with lower damage levels reported in 
DR fed animals (Sohal et al., 1994a; Hamilton et al., 2001). However, a 
reasonable number of studies do not report any changes in DNA oxidative 
damage, with changes being tissue, sex and species specific. (Hamilton et al., 
2001; Schmerold and Niedermüller, 2001). The present study, supports (in part) 
the age-related increase in DNA oxidative damage. Strikingly I observe highest 
8-oxoguanine levels in the youngest mice which could be a result of an 
oxidative insult from birth or acquired at 3 months. If such an increase was the 
result of an endogenous oxidative damage source, it could be verified by 
measuring ROS production. However, this has to be performed on fresh tissue; 
therefore, is unfeasible. In mice at 3 months of age the repair capacity in the 
brain tissue was enough to remove the high levels of damage and by 12 months 
of age the number of 8-oxoguanine lesions was reduced. Furthermore from 12 
months of age there is a minor increase in DNA oxidative damage with age.  
The function of DNA oxidative damage during ageing remains unclear. Perhaps 
the problem lies in the damage lesions quantified. Although 8-oxoguanine is the 
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primarily damaging lesion formed, and readily used as a biomarker of DNA 
oxidative damage, it should be noted that other mutagenic lesions such as 5-
hydroxy-2’-cytosine are formed as a result of ROS and also possess their own 
DNA glycosylase for repair (Kasai, 1997). Furthermore ROS can also form 
lesions such as 8,5’-cyclopurine-2’-deoxynucleoside, which is a bulky oxidative 
lesion repaired by the NER pathway (Wang et al., 2012a). The comet assay 
could also be used to test damage in frozen tissue, but this requires steps to be 
taken to reduce damage induced during cryopreservation by freezing specific 
buffers (Hu et al., 2002). Damage as measured by strand breaks using the 
comet assay was higher in neurones from older animal compared with young 
ones (Swain and Subba Rao, 2011). It should be noted that accumulation of 
damage depends on: nature of damaging agent, metabolic rate, presence of 
oxygen, efficiency of antioxidant systems, efficiency of DNA repair and rate of 
cell proliferation (Fraga et al., 1990). Diane Cabelof suggests that mutation 
frequency is highest in tissues with low BER activity such as liver and lower 
mutation frequency is found in tissues with higher BER activity such as the brain 
(Cabelof et al., 2002). Based on this the authors suggest that the decline seen 
with ageing may be attributed to the intrinsic BER activity of the tissue and not 
its proliferative nature. To date the role of oxidative damage and repair of such 
lesions has remained unresolved.  
5.4.5 Conclusions 
Key findings in the brain: 
o Multiple CpG sites in Ogg1 and Apex promoters were demethylated with 
age. 
o DR fed mice showed lower cytosine methylation compared to AL controls. 
o Histone modifications at Ogg1 and Apex promoters were enriched in older 
animals. 
o DR prevented the age-related enrichment in histone modifications. 
o Transcription active state of chromatin is maintained in the promoter of 
Ogg1 and Apex during ageing and DR. 
o DR animals had higher mRNA levels of Ogg1 and Apex. 
o There was a minor age-related decline in Ogg1 and Apex mRNA. 
o OGG1 and APEX protein concentration increased with age and were 
higher in DR fed animals compared with AL controls. 
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o DNA incision activity remained constant through-out chronological age. 
o DNA oxidative damage increased with age and was not affected by DR. 
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Chapter 6: The effects of ageing and of long-term dietary 
energy restriction (DR) on base excision repair (BER) in the 
liver 
6.1 Introduction  
Preliminary data described in Chapter 4 suggest that age and short-term dietary 
restriction (DR) enhance base excision repair (BER) in the liver of male mice. In 
this chapter I describe the changes in BER in male and female mouse liver 
exposed to long-term DR. I will report on outcomes from studies of liver similar 
to those investigated in Chapter 5 for brain tissue. In addition, I will compare the 
differences in epigenetic profiling at repair gene promoters and DNA incision 
activity in the brain and liver. The study described in this chapter aimed to test 
the following hypotheses: 
1. During ageing, epigenetic changes at Ogg1 and Apex gene promoters 
cause silencing of these genes.  
2. This gene silencing results in decreased BER activity and hence 
increased accumulation of DNA oxidative damage. 
3. DR ameliorates the adverse effects of age on cytosine methylation and 
histone modifications at Ogg1 and Apex promoters, mediates changes in 
activity of enzymes responsible for modifications in epigenetic marks, 
increases the capacity for DNA repair, up-regulates expression of redox-
sensitive TFs and reduces age-related accumulation of DNA oxidative 
damage. 
The objectives of the present study were to: 
a) Characterise and quantify methylation of specific CpG sites within the 
promoters of Ogg1 and Apex in DNA from liver of mice during ageing 
and in response to long-term DR; 
b) Characterise and quantify histone acetylation and methylation relative to 
Ogg1 and Apex promoters in DNA from liver of mice during ageing and in 
response to long-term DR; 
c) Quantify histone acetyltransferase and histone deacetylase activity in 
extracts from liver of mice during ageing and in response to long-term 
DR; 
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d) Using RT-qPCR, quantify expression of transcription factors Hif1α and 
Nfya associated with Ogg1 and Apex gene activation in the liver of mice 
during ageing and in response to long-term DR, 
e) Using RT-qPCR, quantify expression of Ogg1 and Apex in the liver of 
mice during ageing and in response to long-term DR; 
f) Quantify BER-related incision activity using the comet-based assay; 
g) Using HPLC-ECD measurements of 8oxodG, quantify oxidative damage 
in DNA from the liver of mice during ageing and in response to long-term 
DR. 
6.2 Materials and Methods 
Details of the animal study are given in Chapter 5.2.  
6.3 Results 
6.3.1 Animal and organ characteristics 
Data for body mass and liver weights in male and female mice are shown in 
Table 6.1. As expected, DR mice were lighter than AL mice at all ages and for 
both sexes. Proportional differences in liver weight between AL and DR animals 
were greater than for total body mass in male mice only (P<0.001).  
Group 
Male Female 
Body 
mass (g) 
Liver (g) 
Liver mass 
(%) 
Body 
mass (g) 
Liver (g) 
Liver mass 
(%) 
3AL 
29.2 
±2.04 
1.50 
±0.127 
5.14 
±0.13 
22.9 
±1.53 
1.16 
±0.074 
5.07 
±0.10 
12AL 
36.7 
±4.12 
2.06 
±0.667 
5.50 
±0.47 
25.2 
±3.12 
1.07 
±0.138 
4.16 
±0.11 
12DR 
24.8 
±2.75 
0.98 
±0.166 
3.94 
±0.13 
17.1 
±1.91 
0.70 
±0.071 
4.10 
±0.04 
24AL 
47.9 
±3.85 
2.43 
±0.436 
5.04 
±0.21 
35.9 
±3.20 
1.53 
±0.234 
4.28 
±0.26 
24DR 
25.3 
±2.12 
1.18 
±0.181 
4.68 
±0.19 
19.2 
±0.32 
0.77 
±0.048 
4.04 
±0.08 
30AL 
35.1 
±2.60 
2.91 
±1.344 
8.38 
00.19 
28.4 
±4.38 
1.39 
±0.252 
4.87 
±0.09 
30DR 
23.0 
±2.94 
1.12 
±0.290 
4.81 
±0.39 
18.1 
±1.04 
0.88 
±0.082 
4.85 
±0.16 
Table 6.1 Body masses and weights of livers from male and female mice in the CISBAN study. 
These are data from a subset of animals. Specific data for the animals used in the present study 
are not available. Data represent mean ± SEM, n=5-7, 3AL – 3 month old AL fed mice, 12AL – 
12 month old AL fed mice, 12DR – 12 month old DR fed mice, 24AL – 24 month old AL fed 
mice, 24DR – 24 month old DR fed mice, 30AL – 30 month old AL fed mice and 30DR – 30 
month old DR fed mice.  Univariate ANOVA-GLM analysis for diet: P<0.001. Data curtesy of Dr 
Kerry Cameron and Professor Thomas von Zglinicki. 
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6.3.2 Epigenetic regulation of Ogg1 and Apex promoter in the liver 
To determine the effects of age and of long-term dietary restriction on BER, I 
measured epigenetic marks at the promoter regions of Ogg1 and Apex genes. 
This included quantification of cytosine methylation, histone 4 acetylation and 
histone 3 lysine 27 tri-methylation in the liver from mice from the CISBAN long-
term DR study. Cytosine methylation data were not always normally distributed 
and Box-Cox power transformation was unable to transform the data to a 
normal distribution. With the assumption that the ANOVA is a robust test which 
is able to withstand deviations from normality (Glass et al., 1972; Sawilowsky, 
1990), the ANOVA GLM was used for analysis of methylation data at individual 
CpG sites. 
6.3.2.1 DNA methylation of the Ogg1 promoter 
DNA methylation was quantified at 13 CpG sites in the Ogg1 gene promoter. 
Measurements were made at all ages (3, 12, 24 and 30 months) and in both AL 
and DR animals. Figures 6.1 and 6.2 show methylation at individual CpG sites 
and mean methylation across the CpG sites in the Ogg1 promoter for male and 
female mice respectively. Overall, levels of methylation were quite low and 
ranged from 0-16.72%. Methylation at CpG 3 was lowest at 0.2% in male and 
0.14% in female mice (average across all 7 experimental groups). Methylation 
at Cp16 was highest at 3.17% in male and 3.84% in female mice (average 
across 7 groups). In addition, in male mice CpG 4, CpG16 and CpG18 showed 
consistently higher methylation levels compared with other CpG sites measured 
while CpG 4, CpG 8, CpG 15, CpG 16 and CpG 18 showed consistently higher 
methylation levels in female mice. 
A difference in cytosine methylation was observed between the sexes 
(P<0.001) with female mice showing overall higher methylation; therefore, 
further analyses were run for males and females separately. Correlations 
between cytosine methylation at individual CpG sites are shown in Figure 6.3 
and Figure 6.4 for male and female mice respectively. The correlation between 
different sites varied from 0.499 to 0.829 in male mice and -0.428 to 0.629 in 
female mice. Overall, correlations between the sites were high in males but not 
in females and so effects of treatments on methylation of individual CpG sites 
as well as mean methylation across the sites were analysed.  
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In male mice methylation at CpG 8 (Pa=0.015), CpG 13 (Pb=0.007) and CpG 
16 (Pc=0.007) decreased progressively with age. No effect of DR on cytosine 
methylation was observed in male mice at any CpG sites although CpG 7 
showed an interaction between age and diet (P=0.007). Furthermore there was 
an age-related decline in mean methylation across the 13 CpG sites in male 
mice (Pd=0.018). DR had no effect on mean methylation across the Ogg1 
promoter in male mice. 
In female mice cytosine methylation increased with age at CpG 9 (Pb=0.032) 
and CpG 16 (Pd=0.015). Furthermore, cytosine methylation was lower in DR 
animals compared with AL fed controls by: 0.35% at CpG 6 (Pa=0.032) and 
0.40% at CpG 9 (Pc=0.023). In addition, there were significant interactions 
between age and diet at 4 CpG sites which appeared to be due to the higher 
cytosine methylation observed in 24AL group compared with all other groups 
(CpG 6, P=0.041; CpG 8, P=0.018; CpG 17, P=0.038 and CpG 18, P=0.049). 
There were no effects of age or diet on mean methylation across the 13 CpG 
sites in the Ogg1 gene promoter but, there was an interaction between these 
variables (P=0.025). 
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Figure 6.1 Effect of age and DR on methylation at individual CpG sites within the Ogg1 promoter in DNA from male liver. Data represent mean ± SEM per treatment 
group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 30AL (light 
grey bars, n=5) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM analysis for 
age and diet: Pa=0.015, Pb=0.007, Pc=0.007 and Pd=0.028. Primer design by Bartłomiej Tomaszewski and Dr Sabine Langie. Sample analysis and data collection 
Joanna Górniak. 
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Figure 6.2 Effect of age and DR on methylation at individual CpG sites within the Ogg1 promoter in DNA from female liver. Data represent mean ± SEM per 
treatment group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 
30AL (light grey bars, n=7) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM 
analysis for age and diet: Pa=0.032, Pb=0.032, Pc=0.023 and Pd=0.015. Primer design by Bartłomiej Tomaszewski and Dr Sabine Langie. Sample analysis and 
data collection Joanna Górniak. 
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Figure 6.3 Pearson’s correlation for % methylation between CpG sites within the Ogg1 promoter from male mouse liver. Statistically significant correlation at P<0.05 
(*) and P<0.01 (**). 
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Figure 6.4 Pearson’s correlation for % methylation between CpG sites within the Ogg1 promoter from female mouse liver. Statistically significant correlation at 
P<0.05 (*) and P<0.01 (**).
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6.3.2.2 DNA methylation of the Apex promoter 
DNA methylation was quantified at 22 CpG sites in the Apex gene promoter. 
Measurements were made at all ages (3, 12, 24 and 30 months) and in both AL 
and DR animals. Patterns of methylation of the Apex promoter differed between 
sexes. For example, CpG 7 showed lowest methylation in males at 0.92% while 
CpG 27 showed lowest methylation in females at 0.22%. CpG 9 was most 
methylated in males at 3.93% while CpG 28 was most methylated in females at 
3.07%. Overall, CpG sites 9, 17, 28, 29 and 34 showed consistently higher 
methylation compared with the other CpG sites. Cytosine methylation at 
individual CpG sites and overall methylation across these sites in the liver from 
male and female mice are shown in Figures 6.5 and 6.6 respectively. 
Methylation was significantly different between sexes at CpG 5 and 28 and 
analyses of effects of treatment on methylation at all CpG sites were performed 
for each sex separately. Correlations between methylation at individual CpG 
sites are shown in Figure 6.7 and Figure 6.8 for male and female mice 
respectively. The correlations between the different sites ranged from -0.035 to 
0.903 in males and -0.226 to 0.910 in females. As for the Ogg1 gene promoter, 
analyses of methylation data were run for individual CpG sites and for overall 
mean across all sites. 
In the male mice methylation at individual CpG sites was low, ranging from 0% 
to 9.31%, and there was no significant effect of age or diet on methylation at 
any of the CpG sites investigated. On the other hand, in female mice age 
affected cytosine methylation at 11 CpG sites. Cytosine methylation decreased 
in linear trend at: CpG 6 (Pa=0.044), CpG 7 (Pb=0.001), CpG 8 (Pc=0.006), 
CpG 11 (Pf=0.006), CpG 12 (Pg=0.004) and CpG 16 (Ph=0.035). Cytosine 
methylation varied with age in a quadratic trend at CpG 10 (Pd=0.018), CpG 26 
(Pj=0.003), CpG 27 (Pk=0.009), CpG 29 (Pl=0.006) and CpG 30 (Pm=0.011). 
Furthermore, cytosine methylation in DR fed animals was lower compared with 
AL fed animals by: 0.70% at CpG 10 (Pe=0.007) and 0.82% at CpG 17 
(Pi=0.011). Mean methylation across the CpG sites declined with age in a linear 
trend (Pn=0.002). An interaction between age and diet was observed at CpG 16 
(P=0.016) and CpG 0.019 (P=0.019). 
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Figure 6.5 Effect of age and DR on methylation at individual CpG sites within the Apex promoter in DNA from male liver. Data represent mean ± SEM per treatment 
group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 30AL (light 
grey bars, n=5) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. 
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Figure 6.6 Effect of age and DR on methylation at individual CpG sites within the Apex promoter in DNA from female liver. Data represent mean ± SEM per 
treatment group, 3AL (white bars, n=5), 12AL (black bars, n=7), 12DR (black checker bars, n=7), 24AL (dark grey bars, n=7), 24DR (dark grey checker bars, n=7), 
30AL (light grey bars, n=5) and 30DR (light grey checker bars, n=7). Methylation for individual animal tissues were measured in duplicate. Univariate ANOVA-GLM 
analysis for age and diet: Pa=0.044, Pb=0.001, Pc=0.006, Pd=0.018, Pe=0.007, Pf=0.006, Pg=0.004, Ph=0.035, Pi=0.011, Pj=0.003, Pk=0.009, Pl=0.006, 
Pm=0.011 and Pn=0.002. 
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Figure 6.7 Pearson’s correlation for % methylation between CpG sites within the Apex promoter from male mouse livers. Statistically significant correlation at P<0.05 
(*) and P<0.01 (**). 
CpG6 .876
**
CpG7 .805
**
.859
**
CpG8 .735
**
.836
**
.799
**
CpG9 .544
**
.628
**
.651
**
.623
**
CpG10 .840
**
.848
**
.769
**
.794
**
.730
**
CpG11 .767
**
.813
**
.803
**
.764
**
.622
**
.786
**
CpG12 .773
**
.833
**
.818
**
.806
**
.703
**
.873
**
.849
**
CpG13 .823
**
.875
**
.875
**
.822
**
.703
**
.845
**
.796
**
.879
**
CpG14 .757
**
.720
**
.743
**
.737
**
.625
**
.823
**
.726
**
.740
**
.710
**
CpG15 .770
**
.787
**
.752
**
.718
**
.614
**
.789
**
.821
**
.850
**
.841
**
.758
**
CpG16 .838
**
.858
**
.775
**
.797
**
.650
**
.834
**
.846
**
.812
**
.832
**
.724
**
.855
**
CpG17 .634
**
.730
**
.654
**
.605
**
.563
**
.672
**
.769
**
.656
**
.625
**
.593
**
.703
**
.758
**
CpG26 .375
*
.484
**
.327
*
.448
**
.381
**
.525
**
.438
**
.493
**
.376
*
.398
**
.394
**
.465
**
.447
**
CpG27 .412
**
.471
**
.345
*
.390
**
.315
*
.550
**
.369
*
.510
**
.416
**
.398
**
.397
**
.396
** .292 .822
**
CpG28 .218 .194 -.035 .137 .065 .338
*
.297
* .273 .193 .157 .297
* .209 .185 .499
**
.577
**
CpG29 .420
**
.410
** .280 .358
* .237 .524
**
.342
*
.472
**
.337
*
.391
**
.397
**
.372
* .272 .771
**
.818
**
.571
**
CpG30 .484
**
.549
**
.388
**
.489
**
.403
**
.682
**
.496
**
.612
**
.522
**
.457
**
.476
**
.506
**
.400
**
.811
**
.903
**
.654
**
.853
**
CpG31 .462
**
.489
**
.343
*
.400
**
.382
**
.645
**
.435
**
.593
**
.491
**
.433
**
.515
**
.497
**
.404
**
.757
**
.794
**
.602
**
.767
**
.851
**
CpG32 .466
**
.534
**
.356
*
.426
**
.314
*
.613
**
.451
**
.580
**
.469
**
.440
**
.476
**
.417
**
.368
*
.783
**
.892
**
.671
**
.800
**
.904
**
.852
**
CpG33 .376
*
.433
**
.403
**
.406
**
.300
*
.502
** .291 .428
**
.416
** .267 .218 .260 .175 .565
**
.726
**
.481
**
.662
**
.788
**
.635
**
.715
**
CpG34 .226 .359
* .150 .350
*
.366
*
.459
**
.302
*
.374
*
.296
* .292 .276 .266 .273 .758
**
.742
**
.684
**
.687
**
.733
**
.694
**
.767
**
.570
**
CpG6 CpG7 CpG8 CpG9 CpG10 CpG11 CpG12 CpG13 CpG14 CpG15 CpG16 CpG17 CpG26 CpG27 CpG28 CpG29 CpG30 CpG31 CpG32 CpG33 CpG34
<-0.8 -0.79-0.6 -0.59-0.4 -0.39-0.2 -0.19-0 0-0.19 0.2-0.39 0.4-0.59 0.6-0.79 >0.8
152 
Figure 6.8 Pearson’s correlation for % methylation between CpG sites within the Apex promoter from female mouse livers. Statistically significant correlation at 
P<0.05 (*) and P<0.01 (**).   
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6.3.2.3 Histone acetylation at the Ogg1 promoter 
To assess the effect of age and of DR on chemical modifications to histone tails 
measurements were taken in 3 groups i.e. 3 month old mice, 30 month old AL 
mice and 30 month old DR mice. Histone 4 acetylation (H4Ac) and histone 3 
lysine 27 trimethylation (H3K27Me3) were measured as prominent examples of 
epigenetic marks associated with transcription activation and repression 
respectively. 
Overall, there was no effect of sex on acetylation of histone 4 at the Ogg1 
promoter. However both diet and age interacted with sex suggesting that males 
and females were differentially affected by these factors. In male mice, H4Ac 
enrichment was statistically different between the 3 groups (P=0.025). H4Ac 
enrichment was similar in the young (3AL) and old (30AL) groups but was 
enriched 3.5 fold in DR fed animals compared with age matched AL fed animals 
(P=0.021. Figure 6.9A). In female mice, H4Ac was also significantly different 
between the 3 groups (P=0.021). However, H4Ac was enriched 5.2 fold in older 
(30AL) compared with younger (3AL) animals (P=0.021) and H4Ac was 4 fold 
lower in DR fed animals compared with age matched AL fed animals, although 
this difference was not statistically significant (Figure 6.9B). 
Figure 6.9 Effects of age and of DR on histone 4 acetylation at the Ogg1 promoter in liver of 
male (A) and female (B) mice. Data represent mean enrichment ± SEM. ChIP-qPCR was 
performed in duplicate per animal, n=5 per age group. H4Ac was normalised to IgG. Kruskal-
Wallis analysis with post hoc Mann-Whitney U comparison: in male mice 30AL vs 30DR 
P=0.021 and in female mice 3AL vs 30AL  P=0.021. Primer design by Dr Jelena Mann, data 
collection Joanna Górniak. 
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6.3.2.4 Histone acetylation at the Apex promoter 
No effect of sex was observed on acetylation of histone 4 at the Apex promoter. 
However both diet and age were shown to interact with sex suggesting that 
males and females were differentially affected by these factors; therefore, 
analysis was performed separately for each sex.  
In male mice, neither age nor diet affected H4Ac (Figure 6.10A). Lowest H4Ac 
levels were observed in the 30DR group, there was a ~2.5 fold H4Ac 
enrichment in both AL groups compared with 30DR. In female mice, a 
difference between the 3 groups was observed (P=0.021). H4Ac was 7.9 fold 
higher older animals (P=0.021) and 5.8 fold higher in the 30AL group compared 
with the 30DR group (P=0.022, Figure 6.10B). 
Figure 6.10 Effects of age and of DR on histone 4 acetylation at the Apex promoter in brain of 
male (A) and female (B) mice. Data represent mean enrichment ± SEM. ChIP-qPCR was 
performed in duplicate per animal, n=5 per age group. H4Ac was normalised to IgG. Kruskal-
Wallis analysis between groups (P=0.021) with Mann-Whintey U comparison for 3AL vs 30AL 
P=0.021 and 30AL vs 30DR P=0.022. Primer design by Dr Jelena Mann, data collection Joanna 
Górniak. 
6.3.2.5 Histone methylation at the Ogg1 promoter 
No effect of sex was observed on H3K27Me3 at the Ogg1 promoter in the liver. 
However, there were interactions of sex with age and sex with diet therefore 
data were analysed separately. In male mice, H3K27Me3 was 25% lower in 
older mice compared with young (P=0.037, Figure 6.11A) but no difference was 
observed with diet. In female mice, age did not have an effect on H3K27Me3 
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however, histone methylation was 20% lower in DR fed animals compared with 
age matched AL fed animals (P=0.037 Figure 6.11B). 
Figure 6.11 Effects of age and of DR on histone 3 lysine 27 tri-methylation at the Ogg1 
promoter in liver of male (A) and female (B) mice. Data represent mean enrichment ± SEM. 
ChIP-qPCR was performed in duplicate per animal, n=5 per age group. H3K27Me3 was 
normalised to IgG. Univariate ANOVA-GLM analysis with Bonferroni post hoc comparison: 3AL 
vs 30AL P=0.037 in male mice. Kruskal-Wallis analysis with Mann-Whitney U test comparison: 
30AL vs 30DR P=0.037 in female mice. Primer design by Dr Jelena Mann, data collection 
Joanna Górniak. 
6.3.2.6 Histone methylation at the Apex promoter 
At the Apex promoter in the liver no difference in H3K27Me3 was observed 
between the sexes but, sex interacted with age; therefore, the analyses were 
run separately for males and females. In male mice H3K27Me3 decreased with 
age, with 3 month old animals showing 10.7 fold higher levels compared with 30 
month old AL fed animals although this difference was not statistically 
significant. Diet did not have an effect on H3K27Me3 levels (Figure 6.12A). In 
female mice, no effect of age or diet was observed. H3K27Me3 was 13% higher 
in 3AL compared to 30DR group and 30AL was 2.3 fold higher than 30DR 
group (Figure 6.12B). 
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Figure 6.12 Effects of age and of DR on histone 3 lysine 27 tri-methylation at the Apex promoter 
in brain of male (A) and female (B) mice. Data represent mean enrichment ± SEM. ChIP-qPCR 
was performed in duplicate per animal, n=5 per age group. H3K27Me3 was normalised to IgG. 
Primer design by Dr Jelena Mann, data collection Joanna Górniak. 
6.3.2.7 HAT and HDAC activity in the liver 
To assess the effect of age and of DR on HAT and HDAC, enzyme activity was 
measured in 3 groups; 3AL, 30AL and 30DR. No difference in HAT or HDAC 
activity was observed between males and females; therefore, data were pooled 
for further analysis. No difference was observed in HAT activity between the 3 
different groups; activity was 6.46AU in 3AL, 6.07AU in 30AL and 5.29AU in 
30DR group (Figure 6.13A). A significant difference in HDAC activity between 
the 3 groups was observed (P=0.034). No change in HDAC activity was 
observed with age; however, 30 month old DR fed mice had a 60% higher 
activity compared with 30 month old AL fed mice (P=0.017, Figure 6.13B). 
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Figure 6.13 Effect of age and DR on HAT (A) and HDAC (B) activity in the liver. Data represent 
mean ± SEM absorbance from a single assay, n=10 per group (pooled for male and female 
mice). Kruskal-Wallis analysis between the groups (P=0.034) with Mann-Whitney post hoc 
comparison between 30AL and 30DR: P=0.017. 
6.3.2.8 Expression of transcription factors in the liver 
The next step was to determine the effect of age and DR on the expression of 
the redox-sensitive transcription factors Hif1α and Nfya in the liver. Expression 
was measured at the mRNA level in 3AL, 30AL and 30DR groups. Expression 
of both TFs was affected by sex, with female mice having on average higher 
expression of Hif1α and Nfya compared with males. In male mice, expression of 
Hif1α did not change with age; however, 30DR animals had 1.75 fold higher 
expression compared with 30AL animals although this was not significant 
(Figure 6.14A). In female mice, there was a difference between the 3 groups 
tested. Hif1α expression was 2.4 fold higher in the 30AL compared to 3AL 
group and 1.6 fold higher in the 30DR compared to 30AL group; however, 
neither of these were statistically significant when post hoc comparisons were 
made (Figure 6.14B). In male mice neither age nor DR had an effect on Nfya 
expression (Figure 6.15A). In female mice, expression in 30 month old AL fed 
mice was 2.8 fold higher compared with 3 month old mice (P=0.011) and 1.6 
fold higher compared with 30 month old DR fed mice (n.s., Figure 6.15B).  
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Figure 6.14 Effect of age and DR on expression of Hif1α in male (A) and female (B) mice in in 
the liver. Data represent mean ± SEM, n=5 per group. Univariate ANOVA-GLM analysis 
between groups: P=0.011. 
Figure 6.15 Effect of age and DR on expression of Nfya in male (A) and female (B) mice in in 
the liver. Data represent mean ± SEM, n=5 per group. Univariate ANOVA-GLM analysis with 
Bonferroni comparison: 3AL vs 30AL P=0.011.  
6.3.3 Ogg1 and Apex gene expression 
Expression of the 2 BER-related genes Ogg1 and Apex was measured in mRNA 
extracted from liver in all 7 groups. In all cases, assays were conducted on mRNA 
from individual animals and data are presented as 2-ΔCt. 
6.3.3.1 Ogg1 expression in the liver 
Ogg1 was differently expressed between the sexes with expression in the 
female being higher compared with males (P<0.001). No effect of age was 
observed but DR animals showed lower expression compared with AL animals 
(P=0.001). In addition, there was an interaction between age and diet, which 
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may have appeared because in the oldest mice there was a divergent effect 
between the different diets. 30AL animals showed an increase in expression 
while 30DR animals showed a decrease in expression of Ogg1 (Figure 6.16A). 
No differences between the different age and diet groups were found in female 
mice, although DR mice appeared to have lower Ogg1 expression compared 
with AL mice especially at older age (Figure 6.16B). 
6.3.3.2 Apex expression in the liver 
Expression of Apex in the liver was significantly different between the sexes 
with female mice showing higher expression levels (P=0.02). In male mice, 
there was no effect of age on Apex expression but DR animals had on average 
22% lower levels of Apex mRNA compared to AL animals although this was not 
statistically significant (Figure 6.17A). In female mice, a difference between the 
seven groups was observed (P=0.019, Figure 6.17B). Post hoc Mann-Whitney 
U comparisons with adjusted α<0.024 did not reveal a significant difference. It is 
likely that this change arose because expression of Apex in the DR animals 
appears to be lower (especially at the oldest age group) compared to AL fed 
animals. 
Figure 6.16 Effect of age and of DR on expression of Ogg1 at the mRNA level in the liver of 
male mice (A). Solid line with round symbols represents AL fed animals dotted line with square 
symbols represents DR fed animals. Data represent mean ± SEM, n=5-7 per group. Univariate 
ANOVA-GLM analysis for diet P=0.001. Effect of age and of DR on expression of Ogg1 at the 
mRNA level in the liver of female mice (B). Solid line with round symbols represents data pooled 
for AL and DR fed animals. Data represent mean ± SEM, n=5-14 per group. Primer design Dr 
Sabine Langie, data collection Joanna Górniak. 
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Figure 6.17 Effect of age and of DR on expression of Apex at the mRNA level in the liver of 
male (A) and female (B) mice. Solid line with round symbols represents AL fed animals; dotted 
line with square symbols represents DR fed animals. Data represent mean ± SEM, n=5-7 per 
group. Kruskal-Wallis analysis between the groups P=0.019. 
6.3.4 Base excision repair (BER)-related DNA incision activity in the liver 
BER-related DNA repair activity was quantified as the DNA incision of damage; 
induced by photosensitiser Ro 19-8022, using the comet-based assay which 
measures the first step (incision of the strand) of the repair process. DNA 
incision was measured in protein extracts from liver from individual animals in 
all 7 groups. There was a statistically significant difference between male and 
female mice, with male mice showing 2-fold higher activity compared with 
female mice (P<0.001). No effect of age or diet was observed in the males 
(Figure 6.18A) or females (Figure 6.18B). In males the mean incision activity 
was 14.2AU (range 4.7-24.5AU). Average incision activity of ~15AU was similar 
between 3 months, 24 months and 30 months old animals but was slightly lower 
in 12 months old animals (~12AU). In females mean incision activity was 7.1AU 
(range 0.4-13.8AU) where incision was slightly higher in 12 months old group 
(7.8AU) compared to the other ages (6.6-7.0AU). 
161 
Figure 6.18 Effect of age and DR on DNA incision activity in the liver of male (A) and female (B) 
mice. Data represents mean ± SEM, n=5-14 per group (pooled from AL and DR animals at each 
age group). Assay design Dr Sabine Langie, data collected by Kirstin Halley-Hogg (male liver) 
and Joanna Górniak (female liver). 
6.3.5 Expression of OGG1 and APEX at the protein level in the liver 
Protein concentration of OGG1 and APEX were measured in extracts of liver 
from 3AL, 30AL and 30DR groups. Differences between groups were 
determined using ANOVA GLM and Bonferroni post hoc test for the predefined 
comparisons of 3 AL v. 30 AL and 30 AL v. 30 DR groups. The most dramatic 
finding was that protein concentrations of OGG1 and APEX were ~20 fold 
higher in the liver compared with brain tissue (P<0.001 for both enzymes), data 
for brain are shown in Chapter 5 in Table 5.2 and 5.3. In the liver there was 
significantly higher concentration of OGG1 (P<0.001) and APEX (P<0.001) in 
males compared with females. No effect of age or DR on OGG1 or APEX 
protein concentration was observed between the three different groups in males 
or females (Table 6.2 and 6.3 respectively). Average OGG1 concentration in 
males was 16.4ng/ml (range 15.0-18.9ng/ml) while in females average 
concentration was 10.2ng/ml (range 5.5-13.7ng/ml). Average APEX 
concentration in males was 10.6ng/ml (range 7.5-13.4ng/ml) while in females 
average concentration was 5.5ng/ml (range 2.0-9.2ng/ml). 
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OGG1 
(ng/ml) 
Male Female All mice 
3AL 16.75±0.61 8.65±0.13 12.70±0.48 
30AL 16.59±0.41 9.96±0.93 13.28±0.38 
30DR 15.90±0.38 12.03±0.61 13.96±0.23 
Table 6.2 Effect of age and DR on OGG1 protein concentrations in the liver. Data represent 
mean ± SEM from a single assay, n=5 per group. 
APEX 
(ng/ml) 
Male Female All mice 
3AL 10.60±0.85 6.915±1.00 8.759±2.76 
30AL 10.54±0.75 4.116±0.73 7.326±3.73 
30DR 10.56±1.18 5.479±0.16 8.022±3.22 
Table 6.3 Effect of age and DR on APEX protein concentrations in the liver. Data represent 
mean ± SEM from a single assay, n=5 per group. 
Similarly to the brain, in the liver protein concentration but not mRNA levels of 
Ogg1 and Apex were correlated with repair. Figure 6.19 shows correlation plots 
for protein vs repair and mRNA vs repair. Positive correlation was observed for 
both OGG1 protein and repair (R2=0.370, P<0.001) and APEX protein and 
repair (R2=0.440, P<0.001) and negative correlation was observed for Ogg1 
mRNA expression and repair (R2=0.0145, P=0.041). 
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Figure 6.19 Correlation between DNA repair and OGG1 protein (A) APEX protein (B) Ogg1 
mRNA (C) and Apex mRNA (D) in the liver. Data represents mean ± SEM, pooled for male and 
female, data from 3AL, 30AL and 30DR groups. Correlation POGG1 protein*DNA repair <0.001, PAPEX 
protein*DNA repair<0.001 and POgg1 mRNA*DNA repair=0.041. 
6.3.6 Effects of age and DR on oxidative damage to DNA in the liver 
Oxidative damage in the brain was measured in the form of 8-oxoguanine using 
HPLC-ECD in all 7 groups. A statistically significant difference between the 
sexes was observed with females showing higher 8-oxoguanine levels 
(P<0.001). In male mice, there was a statistically significant effect of age 
(P=0.007) and DR (P=0.002) on 8-oxoguanine (Figure 6.20A); furthermore, 
there was an interaction between age and diet (P<0.001). A Bonferroni post hoc 
analysis between groups showed significant differences between 3AL and 12AL 
(P=0.005), 3AL vs 30AL (P=0.035), 12AL vs 12DR (P<0.001), 12AL vs 24AL 
(P<0.001), 12AL vs 30DR (P=0.008), 12DR vs 30AL (P=0.001) and 24AL vs 
30AL (P<0.001, P=0.049). In female mice, there was a significant decrease in 
8-oxoguanine concentration with age (P<0.001) but no effect of diet (Figure 
6.20B). 30 month old animals showed a 38% decrease compared with 3 month 
old and 40% decrease compared with 12 month old animals (P<0.001). There 
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was a significant linear reduction in 8-oxoguanine concentration with age 
(R²=0.375, P<0.001).  
 
Figure 6.20 Effect of age and of DR on 8-oxoguanine concentration in the liver of male mice, 
(A). Solid line with round symbols represents AL fed animals dotted line with square symbols 
represents DR fed animals. Data represent mean ± SEM, n=5-7 per group. Univariate ANOVA-
GLM analysis for age P=0.007 and diet P=0.002. Effect of age and of DR on 8-oxoguanine 
concentration in the liver of female mice (B). Solid line with round symbols represents data 
pooled for AL and DR fed animals. Data represent mean ± SEM, n=5-14 per group. Univariate 
ANOVA-GLM analysis for age P<0.001. Data collected by Maastricht University, in collaboration 
with Dr Roger Godschalk. 
6.4 Discussion 
In this Chapter I have investigated age and DR-related epigenetic changes 
(DNA methylation and histone marks) at promoter regions of the BER-related 
proteins: oxoguanine DNA glycosylase (OGG1) and Apurinic/apyrimidinic 
endonuclease (APEX) in the liver. In addition, I quantified the associated 
changes in Ogg1 and Apex transcript levels (mRNA abundance) and the DNA 
repair capability (assessed as BER-related incision activity). A conceptual 
model for epigenetic regulation of the BER-related genes investigated in this 
chapter has been presented in Chapter 5.4, Figure 5.23. I will discuss: a) the 
observed epigenetic changes with reference to gene expression, b) the 
epigenetic mechanisms that may be involved in modulation of transcription i.e. 
epigenetic enzyme activity and TF expression c) the phenotypic changes 
observed in repair activity and oxidative damage and finally d) compare results 
from brain and liver tissue. 
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6.4.1 Epigenetics and BER-related gene expression 
6.4.1.1 Effect of age and DR on epigenetic regulation of transcription 
Tissue specific changes in DNA methylation are observed during ageing 
(Thompson et al., 2010). These, or other, alterations of epigenetic marks at 
gene promoter regions may be responsible for the transcription changes 
occurring with age, in particular the age-related down-regulation of cell cycle 
and maintenance genes (Lee et al., 2000).  
I hypothesised that there would be an increase in cytosine methylation (at BER-
related gene promoters) with age, which would cause silencing of BER-related 
genes. I found that similarly to the brain, in the liver DNA methylation within the 
CpG sites measured was low at both Ogg1 and Apex promoter regions 
suggesting that these genes are constitutively expressed in both tissues. In fact 
the qPCR data showed a consistent presence of Ogg1 and Apex mRNA in both 
brain and liver. Furthermore, the lowly methylated promoter regions imply that 
DNA methylation is involved in maintenance of transcription rather than in 
switching  these genes on (Feng et al., 2006). Different methylation of specific 
CpG sites was observed with age and DR in both genes but the expression of 
the corresponding genes remained constant throughout lifespan. Application of 
the demethylating agents 5-aza-2-deoxycitidine and zebularine to cancer cell 
lines increases Ogg1 and Apex expression respectively, confirming that DNA 
methylation plays a part in regulation of transcript expression of DNA repair 
genes (Peng et al., 2006; Singh et al., 2012). 
It is likely that not all CpG sites within the promoter region are important in 
epigenetic regulation of gene transcription. Of more interest with respect to 
promoter methylation are those CpG sites which are found within transcription 
factor consensus binding sequences. Based on the information from the 
bioinformatics tool Genomatix, at the Ogg1 promoter only CpG 16, which was 
affected by both age and DR, occurs in the binding sequence of a transcription 
factor; neuron-restrictive silencer factor (NRSF). On the other hand in the Apex 
promoter, multiple transcription factors bind at sequences containing 
differentially methylated CpG sites. CpG site 10, which was affected by both 
age and DR, is within the binding sequence for activator protein 2 (AP2F), 
insulinoma associated factors (INSM) and cAMP-responsive element binding 
protein (CREB) transcription factors. Furthermore, the 6 CpG sites differentially 
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methylated with age only, lay within binding sequence for 9 different 
transcription factors. Figure 6.21 shows the transcription factors that bind to 
sequences containing differentially methylated regions in Ogg1 and Apex 
promoters in brain and liver tissue. Furthermore, the Venn diagram highlights 
the TFs that are shared between the tissues for each of the target genes. 
Unsurprisingly, many of the TFs found to bind BER gene promoters are redox-
responsive (Lavrovsky et al., 2000; Haddad, 2002). Furthermore some have 
been independently shown to regulate BER-genes e.g. NFYA transcription 
factor belongs to the CAAT binding factors and upregulates Ogg1 in 
lymphocytes and kidney cells. (Habib et al., 2010; von der Lippen et al., 2015). 
Thus the low levels of promoter methylation observed in all animals in the 
present study may act to maintain expression of the corresponding DNA repair 
genes by permitting binding of these specific transcription factors. 
Figure 6.21 Venn diagram showing transcription factors binding at differentially methylated 
regions in the Ogg1 (A) and Apex (B) promoters in brain and liver tissue. AP2F, activator protein 
2; CAAT, CCAAT binding factors; CDEF, cell cycle regulators; CLOX, Cut-like homeobox and 
CLOX homology factors; CREB, cAMP-responsive element binding proteins; E4FF, ubiquitous 
GLI Kureppel like zinc finger; EBOX, E-box binding factors; GLIF, GLI zinc finger family; HDBP, 
Huntington’s disease gene regulatory region binding protein; HIFF, hypoxia inducible factor; 
INSM, insulinoma associated factors; MTEN, core promoter motif ten elements; NKXH, NKX 
homeodomain factors; NRSF, neuron-restrictive silencer factor; PARF, PAR/bZIP family; RORA, 
v-ERV and RAR-related orphan receptor alpha; TF2D, general transcription factor II D; ZBDF, 
zinc binding protein factors. 
In addition to cytosine methylation, I also investigated H4Ac and H3K27Me3 as 
a mechanism for regulation of transcription of the DNA repair genes. These two 
histone marks are associated with transcription activation and repression 
respectively (Akhtar and Becker, 2000; Asp et al., 2011). In male mice 
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H3K27Me3 was lower in older animals at both promoters suggesting that 
activation of transcription during ageing occurs via demethylation of H3 lysine 
27. In C. elegans H3K27Me3 declines with age and knockdown of UTX, a 
histone demethylase, increased lifespan in this worm (Maures et al., 2011). 
Thus factors such as DR, which affect age-related methylation of promoters and 
hence expression of repair genes, may modulate the ageing process. 
Furthermore in female mice DR was able to reduce H3K27Me3. The effect of 
DR on histone methylation is not as well explored as that of histone acetylation, 
although it is possible that histone demethylases are targets for one of the 
downstream enzymes of DR. This is unlikely to be SIRT1 as it has been found 
to be readily associated with increase in chromatin repressive marks (Vaquero 
and Reinberg, 2009). Interestingly the DR-related histone demethylation was 
seen only in females suggesting that female hormones may be at play. In fact, 
oestrogen is able to reduce levels of H3K27Me3 via the PI3/AKT pathway 
(Bredfeldt et al., 2010); thus, perhaps during ageing in conditions of dietary 
restriction oestrogen is also able to exert this role. Not surprisingly, DR fed 
animals showed lower histone acetylation levels for both genes. This is 
consistent with the role of Sirtuin family of HDACs which have been 
demonstrated as one of the modes of action of dietary restriction (Lin et al., 
2000; Cohen et al., 2004; Kenyon, 2010). Deacetylation could explain the lower 
levels of repair gene expression in DR animals, although this was not always 
significant. In contrast, acetylation of the Ogg1 promoter was enhanced in male 
DR fed mice, but this was not accompanied by the expected higher levels of 
Ogg1 mRNA. Despite the observed changes in histone marks with age, 
expression of Ogg1 and Apex in the liver did not change with age suggesting 
that other (epigenetic) regulators may counter-balance these changes in histone 
marks. This observation, also made in the brain, highlights the importance of 
studying a larger epigenetic landscape as epigenetic marks may work together 
to create an open/closed chromatin state (Vaquero and Reinberg, 2009). In 
addition, expression of Ogg1 and Apex was lower in DR fed animals which, is 
opposite to results observed in the brain (Chapter 5) emphasising the 
importance of considering tissue-specific changes occurring with age and DR. It 
is not surprising that tissue specific changes have been found at the epigenetic 
level. Much work has already shown differential patterns of expression and DNA 
repair in different tissues (Karahalil et al., 2002; Intano et al., 2003). 
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Overall it appears that in the liver expression of BER-related genes remains 
constant throughout age and that this may occur due to the maintenance of an 
open chromatin structure induced by a consortium of epigenetic enzymes and 
other binding proteins which together maintain the euchromatin state.  
6.4.1.2 Effect of age and DR on epigenetic enzymes 
Only one previous study was found to assess HAT activity in ageing mouse 
tissues. The study reported an age-related decline in p300/CBP HAT activity in 
the liver, muscle and testes and no effect of age on p300/CBP HAT activity in 
kidney, heart, brain, lung and spleen. Furthermore when measuring overall HAT 
activity no difference was observed (Li et al., 2002). In support of this, Chapters 
5 and 6 demonstrate no age or DR related changes in HAT activity. Although 
the role of HATs in ageing is not as clearly understood as that of HDACs, it is 
not redundant as RNAi inhibition of cpb-1 in C. elegans accelerates ageing and 
attenuates lifespan enhancing effects of DR (Zhang et al., 2009). 
A decline in HDAC expression has been reported in adult stem cells; however, 
here I show no effect of age on HDAC activity in mouse brain or liver. On the 
other hand, I have shown that DR enhanced HDAC activity in both tissues. This 
is not surprising since Sirtuins (NAD dependant histone deacetylases) have 
been previously linked to DR (Lin et al., 2000). Furthermore, the increase in 
HDAC activity in DR animals corresponds with the observed decline in histone 4 
acetylation. More difficult to interpret are the age-related changes observed in 
acetylation as neither HAT or HDAC activity was altered with age. It is possible 
that changes in specific HAT and HDAC enzyme families could have occurred, 
but were not detected here since the overall activity was measured. Such a 
phenomenon was observed by Li et al. (Li et al., 2002).  
These results provide a partial view of the function of enzymes responsible for 
epigenetic marks and focus only on the aspect of histone acetylation. Further 
work could explore the enzymes involved in methylation of DNA and associated 
histones including: DNMT, TET, histone metyltransferases and demethylases. 
Such a study of multiple epigenetic enzymes could be particularly valuable 
because epigenetic enzymes work together to give rise to the epigenetic code 
(Ikegami et al., 1978; Kondo, 2009). Moreover, the above results suggest that 
specific enzyme activity rather than overall activity should be studied as the 
latter is too general.  
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6.4.1.3 Effect of age and DR on TF expression 
I detected changes in the expression of redox-sensitive transcription factors, 
which are involved in activation of BER-related gene expression. Whilst neither 
age nor diet had an effect on Hif1α or Nfya expression in male mice, in female 
mice both transcription factors were up-regulated with age. No effect of age or 
DR on Hif1α in male rats has also been previously reported. Despite the lack of 
effect on mRNA transcripts lower HIF1α activity in DR compared with AL 
animals at all ages has been reported (Kang et al., 2005). This observation 
suggests that with some TFs, DR enhances activity of this TF rather than 
causing up-regulation of expression. Redox-sensitive transcription factors e.g. 
FOXO (Greer and Brunet, 2008) and Hic-5 (Lee et al., 1999; Weindruch et al., 
2001) are up-regulated by ageing. I also observed Hif1α and Nfya up-regulation 
with age in female mice (Harman, 1956). However, more surprisingly I did not 
observe changes in DR animals. DR reduces age-related oxidative stress 
(Sohal and Weindruch, 1996) possibly via the activation of redox-sensitive 
transcription factors such as nuclear factor-kB (NFkB) and hypoxia inducible 
factor 1 (HIF-1)(Kim et al., 2002). 
The data presented here show that, at least in female mice, expression of 
redox-sensitive TFs is up-regulated with age. In future it would be helpful to 
study both expression and function of TFs in response to ageing and DR since 
there may be changes in activity in the absence of change in transcription. 
6.4.2 Effects of age and of DR on BER-related DNA incision activity 
As expected from the lack of changes in Ogg1 and Apex expression, no 
changes in incision activity nor OGG1 and APEX protein levels were observed 
with age or DR. Other repair proteins such as DNA ligase I and II, XRCC1, β-
Polymerase and REF-1 also do not alter in the ageing liver (Intano et al., 2003). 
Interestingly the liver has much higher repair protein concentration than the 
brain and this is in line with liver also having a higher incision rate compared 
with the brain. Furthermore, activity of repair enzymes was also high in testis 
and kidney and low in muscle and heart (Karahalil et al., 2002). On a cellular 
level repair activity was higher in proliferative cells compared with non-
proliferating cells (Akbari et al., 2009). In addition, in the brain OGG1 and APEX 
proteins seem to accumulate with age where as in the liver this does not occur. 
In fact, reports show greater protein degradation in the liver in comparison with 
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the brain (Dasuri et al., 2009) and it has been argued that the proliferative 
nature of the tissue is responsible for this protective mechanism (Stroikin et al., 
2005). Although it is suggested that DR enhances genomic stability by 
increasing repair activity I did not observe such effects here. Previous reports 
show higher incision in the liver of DR fed animals (Cabelof et al., 2003), but not 
always at a statistically significant level (Stuart et al., 2004). Furthermore, the 
results presented show that DR does not have an effect on mRNA expression 
of BER genes. This is a tissue-specific effect as in the brain DR up-regulated 
expression of Ogg1 and Apex mRNA (Chapter 5). Nevertheless, in this animal 
model DNA incision activity in the ageing liver is at least as good as in young 
animals and DR does not provide any further benefit. 
Therefore the liver maintains its DNA incision activity and is able to recycle the 
repair proteins unlike the brain which without any proliferative activity, 
accumulates repair proteins. The brain may maintain vital oxidative damage 
removal via other repair pathways such as NER.  
6.4.3 Effect of age and DR on oxidative damage 
The free radical theory of ageing is supported by many studies reporting age-
related increase in oxidative damage and by, numerous studies showing that 
DR attenuates this increase (Hamilton et al., 2001). However, the accumulation 
of DNA oxidative damage with age has not always been reported (Chung et al., 
1992; Hirano et al., 1996; Anson et al., 1999) leading to controversy about the 
role of oxidative damage during ageing. A summary of studies reporting 8-
oxoguanine concentration is shown in Table 6.9. By and large, these studies 
show increases in oxidative damage in the brain but not always in the liver. It 
can be speculated that this tissue difference is a result of the proliferative nature 
of the liver, where during cell division additional detection and removal of 
oxidative damage in DNA may occur. 
I have shown that the concentration of 8-oxoguanine is higher in the liver tissue 
than the brain and this has also been reported by others (Schmerold and 
Niedermüller, 2001). Other damaging lesions such as abasic sites were also 
more abundant in the liver compared with the brain (Atamna et al., 2000). This 
may be counter intuitive as it is often suggested that the brain is an organ with 
high oxygen consumption and little proliferative activity. Furthermore, higher 
damage accumulation is observed in the brain with age compared with other 
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tissues such as liver, kidney, spleen, lung and small intestine (Hirano et al., 
1996). However, it should be noted that accumulation of damage depends on: 
nature of damaging agent, metabolic rate, presence of oxygen, efficiency of 
antioxidant systems, efficiency of DNA repair and rate of cell proliferation (Fraga 
et al., 1990). Studies of the antioxidant defence system of tissue found that 
superoxide dismutase activity was higher in the liver compared with the brain 
(Sohal et al., 1990a). The high SOD activity together with efficient incision 
activity can in part explain the age-related decrease in oxidative lesions in the 
liver of female mice observed in this study. In male mice an ambiguous pattern 
in oxidative damage was observed; it could be speculated that the 24 month old 
mice experienced oxidant insult that resulted in higher 8-oxoguanine lesions. 
Furthermore DR did not have a protective effect in either male or female mouse 
livers. This is the first study to report a decline in 8-oxoguanine during ageing. 
This observation may highlight that this strain of mice is able to resist oxidative 
damage. However, somatic DNA mutations accumulate in the ageing liver 
(Dolle et al., 1997) thus suggesting that the liver may be prone to damaging 
lesions other than 8-oxoguanine. 
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Author Age Species and Sex Methods Age Effect DR 
Gorniak et al. 
(Thesis) 
3, 12, 24 and 
30 months 
Male and female C57Bl6 
mice 
HPLC-ECD 
Phenol 
DNA extraction 
(↑) Brain (12 to 30mo, both 
male and female) 
(Δ) Liver (male) 
(↓) Liver (female) 
(-) Brain (male and female) 
(Δ) Liver (male) 
(-) Liver (female) 
(Schmerold and 
Niedermüller, 
2001). 
5 and 30 
months 
Male Sprague-Dawley rats HPLC-ECD 
(-) Brain 
(↑) Liver 
NA 
(Nakae et al., 
2000) 
0 days to 104 
weeks 
Male F344 rats 
Immunohistochemistry and 
HPLC-ECD 
(↑) Brain 
(-) Liver 
NA 
(Hirano et al., 
1996) 
3 weeks, 
5 months and 
30 months 
Male Sprague-Dawley  rats HPLC-ECD 
(↑) Brain 
(-) Liver 
NA 
(Kaneko et al., 
1997) 
2, 6, 12, 24, 
27, 30 and 33 
months 
Male F344 rats 
HPLC-ECD 
Ultrapure Phenol DNA 
extraction 
(↑) Brain 
(↑) Liver 
(↓) Brian (only at 30mo) 
(↓) Liver (only at 30mo) 
(Hamilton et al., 
2001) 
6, 18 and 24 
months (rats) 
6 and 25/26 
months (mice) 
Male B6D2F1 mice 
Male F344 rats 
Female C57Bl6 mice 
Male C57Bl6 mice 
Male F344 rats 
HLPC-ECD 
NaI DNA extraction 
(↑) Brain (all species) 
(↑) Liver (all species) 
 
(↓) Brain (rat) 
(↓) Brian (mouse) 
(↓) Liver (mouse) 
(-) Liver (rat) 
 
Table 6.4 Comparison of studies reporting 8-oxoguanine during ageing and DR in the brain and liver.
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To conclude the liver is resistant to accumulation of oxidative lesions during 
ageing likely due to its proliferative state, which provides an extra level for DNA 
repair. This is contrary to the brain which shows accumulation of DNA oxidative 
damage during ageing. Overall, oxidative damage appears to play a larger role 
in the ageing of the brain than of the liver while the liver may be vulnerable to 
other forms of damage. 
6.4.4 Conclusions 
Key findings: 
o Transcription active state of chromatin is maintained in the promoter of 
Ogg1 and Apex during ageing and DR. 
o Neither age nor DR had an effect on BER gene or protein expression in 
the liver. 
o DNA repair in the liver remained constant throughout ageing.  
o DNA oxidative damage in the liver declined with age and was not 
affected by DR. 
o Tissue specific changes occurred at the epigenetic, transcription and 
phenotypic level. 
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Chapter 7. Base excision repair in specific brain regions 
7.1 Introduction 
Ageing is associated with decline in brain functions such as cognition and with 
increased risk of neurodegenerative disease. As in other tissues, ageing in the 
brain is characterised by the accumulation of unrepaired molecular damage. 
Although relatively little is understood about the age-associated molecular 
changes occurring in the nervous system (Bohr et al., 2007; Weissman et al., 
2007a; Rolseth et al., 2008). Due to its low antioxidant status, high metabolic 
activity and thus high oxygen demand, the brain appears to be particularly 
vulnerable to oxidative damage (Halliwell, 1992; Driver et al., 2000). 
Until recently, the brain had been assumed to be largely a post-mitotic tissue 
that is unable to regenerate by cellular proliferation (Sohal et al., 1990a). 
However, we now know that neurogenesis occurs in brain regions such as the 
hippocampus (Lee et al., 2012). Furthermore, sub-regions of the brain have 
defined roles and most have been reported to alter with age. The magnitude of 
such change in size or function may be region specific. Region specific 
differences in age-related neuronal loss have been observed, with the 
cerebellum being more prone to loss compared with the hippocampus (Kennard 
et al., 2013). The hippocampus plays a role in memory formation. During ageing 
the volume of the hippocampus decreases and this is accompanied by an 
underperformance in hippocampus-related tasks. Furthermore, the 
hippocampus shows an increase in oxidative damage with age (Driscoll et al., 
2003; Navarro et al., 2008; Woodruff-Pak et al., 2010). The cortex is important 
for spatial memory formation as well as in thought and language, while the 
cerebellum plays a role in motor control and learning. Both these regions in 
mice have been reported to accumulate oxidative damage in form of protein 
carbonyls, which is associated with decreased performance in cognitive and 
motor skill related tasks (Forster et al., 1996; Woodruff-Pak et al., 2010). 
Subcortical regions (containing the amygdala, caudate nucleus, pallidus, 
putamen, thalamus and others), which serve as connections and are also 
associated with motor skills, memory and learning, show a decline in volume 
with age that correlates with a decrease in function (Walhovd et al., 2005). 
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In rodents, an age-related reduction in coordination and balance correlates with 
increased 8-oxoguanine (8-oxodG) levels in the cerebellum and caudate 
putamen (Cardozo-Pelaez et al., 1999). In addition, age-related accumulation of 
DNA damage has been reported in neurones and in astrocytes (Swain and 
Subba Rao, 2011). Although all brain regions exhibit age-related increases in 
DNA damage, its magnitude was region-specific with cortex exhibiting highest 
increase followed by hippocampus, striatum, hypothalamus and lastly 
cerebellum (Juliet et al., 2005). The central nervous system contains numerous 
types of neurones (Weissman et al., 2007a) and these may be affected 
differentially by ageing due to the differences in cell structure and composition. 
Among the different cell types found in the brain, Purkinje neurones are 
characteristic of the cerebellum, pyramidal neurones are found in the cortex, 
hippocampus and amygdala, while non-neuronal cell such as astrocytes can be 
found through-out the brain (Byrne and Roberts, 2009). 
OGG1, the primary protein for removal of oxidised guanine bases, is expressed 
ubiquitously throughout the brain (Verjat et al., 2000). However, differing repair 
activity was detected in brain sub-regions. Furthermore an age-related decline 
in DNA repair is observed in both cortical neurones and in astrocytes (Verjat et 
al., 2000; Rolseth et al., 2008; Swain and Subba Rao, 2011).  
To date only one study has investigated the effect of dietary restriction (DR) on 
DNA repair in different brain regions and did so by quantifying AP endonuclease 
(APE) activity (Kisby et al., 2010). These authors demonstrated that APE 
activity in the cortex, hypothalamus, midbrain, brain stem and cerebellum 
declined with age in rats fed ad libitum. However, whilst APE activity also 
declined with age in DR animals, this measure of repair capacity remained 
higher than that in ad libitum-fed rats, and this apparently protective effect of DR 
was observed in all brain regions investigated except the hypothalamus. 
Furthermore 8-oxodG adducts in the cortex were lower in the DR group at all 
ages up to 25 months. Apart from this study, little is understood about the 
effects of age and of DR on expression of BER-related genes and on capacity 
for DNA repair in different brain regions. 
I hypothesise that the BER repair pathway in specific sub-regions of the brain is 
differentially affected by age and by DR. To test this hypothesis, I quantified 
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BER-related DNA incision activity as well as Ogg1 and Apex mRNA levels in 
the hippocampus, cortex, cerebellum and subcortical tissues of young (3 
months old) and old (24 months old) mice which had been fed either ad libitum 
(AL) or exposed to 40% reduction in dietary energy intake from age 3 months 
(DR). 
7.2 Materials and Methods 
Male and female C57BL6 mice aged 3 months and 24 months were obtained 
from the long-term DR main Study (described in Chapter 5), which included 
mice fed AL throughout their lives and those exposed to 40% DR from age 3 
months. When the mice were killed, the brain was removed and initially 
dissected into left and right hemispheres, followed by further dissection of each 
hemisphere into the cerebellum, hippocampus, cortex and subcortical tissue 
(rest of brain). The anatomical location of these regions is illustrated in Figure 
7.1. Tissues were snap frozen in liquid nitrogen and stored at -80˚C. Tissue 
from one hemisphere was used for mRNA extraction and from the other 
hemisphere for protein extraction. 
 
Figure 7.1 Diagram of the mouse brain showing the location of sub-brain regions. For the 
purpose of this study, the brain was dissected into cortex, cerebellum, hippocampus and 
subcortical regions (rest of brain). Image from Brain Atlas (Heintz, 2004) last accessed 3rd 
December 2014 at http://www.gensat.org/imagenavigator.jsp?imageID=33832.  
Protein extraction from brain tissues was performed as described in Chapter 2, 
except for cortex and hippocampus which were too small to permit grinding and 
sub-sampling. Instead, for these brain regions, the whole tissue from 1 
hemisphere was used. When extracting protein from tissue 75μl of buffer A and 
22.5μl of buffer A1 was added to all tissues, except the hippocampus. Since the 
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mouse hippocampus weighs less than 15mg (Cameron et al., 2011), the 
volumes of buffer A and buffer A1 added were reduced proportionally to 25μl 
and 10μl, respectively. The comet-based BER repair assay was performed as 
described in Chapter 2 with protein extracts for all brain sub-regions tested at 
5mg/ml. RNA extraction for quantification of BER gene expression by qPCR 
was performed as described in Chapter 2. 
ANOVA GLM was used to investigate the primary effects of age (3 month old v. 
24 month old) and of feeding regime (24AL v. 24DR) and to test for possible 
interactions between age and feeding regime. Bonferroni post hoc comparison 
was used to test for differences in brain regions. P<0.05 was considered 
statistically significant. 
7.3 Results 
The results summarised in Chapter 5 did not reveal any significant age-related 
changes in DNA incision activity when measured on whole brain tissue. Since 
such measurements on whole brain might mask region-specific changes in DNA 
repair, in the present study BER-related DNA incision activity as well as Ogg1 
and Apex gene expression were measured in the following brain areas: 
hippocampus, cortex, cerebellum and subcortical regions. Measurements were 
made on tissues from 3 groups of animals i.e. 3 month old animals fed AL 
(3AL),  24 months old animals fed AL (24AL) and 24 months old which had 
been diet restricted from age 3 months (24DR). 
7.3.1 BER-related DNA incision activity in specific brain regions 
DNA incision activity differed between sexes (P<0.001) and between the 
different brain regions (P<0.001). DNA incision activity (pooled across all 3 
groups: 3AL, 24AL and 24DR) in the cortex tissue was 2.5-fold higher in male 
compared with female animals (P=0.003). Incision activity in the hippocampus 
and cerebellum were similar for the two sexes, while DNA incision activity in 
subcortical tissue was 1.9-fold higher in male compared with female mice 
(P=0.013). Because of these effects of sex further analysis was performed on 
each sex separately.  
In male mice, overall BER-related DNA incision activity was lowest in 
subcortical tissue and increased in the order hippocampus < cerebellum < 
cortex. DNA incision activity was more than 2 fold higher in the cortex than in all 
178 
other brain regions (P<0.001), but differences between the hippocampus, 
cerebellum and subcortical regions were not statistically significant. In female 
mice, overall BER-related DNA incision activity was lowest in the subcortical 
tissues, as was reported above for male mice, and increased in the order 
cerebellum < cortex < hippocampus. However, these differences in DNA 
incision activity between the different brain regions were not statistically 
significant for females. 
7.3.1.1 Effect of age 
There were no detectable effects of age on DNA incision activity in brain 
regions of male mice. However, DNA incision activity varied quite widely 
between male mice from 0.38-9.97AU in the hippocampus, 5.02-28.99AU in the 
cortex, 1.45-7.08AU in the cerebellum and 1.02-12.95AU in subcortical tissue 
(Figure 7.2). Similarly to male mice, no effect of age was observed in the 
hippocampus of female mice and individual mice varied considerably in DNA 
incision activity from 0-14.2AU across all 3 groups. In contrast, DNA incision 
activity in the cortex declined by 55% in older animals compared with young 
ones (P=0.028). In the cerebellum DNA incision activity was 2.6-fold higher in 
24AL group compared with the 3AL group, but this difference was not 
statistically significant. DNA incision activity in subcortical tissue from 24 month 
old female mice was nearly double compared with 3 month old mice but this 
difference was not statistically significant (Figure 7.3). 
7.3.1.2 Effect of DR 
There were no effects of DR on DNA incision activity in male hippocampus or 
cerebellum. In contrast, DR fed male mice showed a 2-fold increase in DNA 
incision activity in cortex (P=0.031) and subcortical tissue (P=0.019) compared 
with AL animals (Figure 7.2). In female mice, an effect of DR was observed only 
in the cerebellum where there was a significant 2-fold increase in DNA incision 
activity in 24DR compared with 24AL animals (P=0.021). No effect of DR was 
observed in the hippocampus, cortex or subcortical tissue (Figure 7.3).  
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Figure 7.2 DNA incision activities in specific brain regions of male mice. Bars represent mean ± 
SEM, groups 3AL (black bars), 24AL (grey bars), 24 DR (white bars), n=5/group. Univariate 
ANOVA-GLM analysis of AL vs DR in the cortex P=0.031 and in subcortical tissue P=0.019. 
Data collected by Joanna Górniak (hippocampus and cortex) and Manon Lecardonnel 
(cerebellum and subcortical regions). 
Figure 7.3 DNA incision activities in specific brain regions of female mice. Bars represent mean 
±SEM, groups 3AL (black bars), 24AL (grey bars), 24 DR (white bars), n=5/group. Univariate 
ANOVA-GLM analysis in the cortex 3 month vs 24 month P=0.028 and in the cerebellum AL vs 
DR P=0.021. Data collected by Joanna Górniak (hippocampus and cortex) and Manon 
Lecardonnel (cerebellum and subcortical regions). 
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7.3.2 BER-related gene expression in specific brain regions 
Expression of Ogg1 and Apex differed significantly between brain regions 
(P<0.001) and sexes (P<0.001). In the cortex expression of Ogg1 was 10 fold 
higher in female mice compared with male mice (P<0.001) while in the 
subcortical regions expression of Ogg1 was 1.8 fold higher in female compared 
with male mice (P=0.002). Ogg1 mRNA transcript levels in the hippocampus 
were similar for both sexes. On the other hand, in the cerebellum expression of 
Ogg1 was 1.5 fold higher in male mice compared to female mice (P=0.006). 
Similarly to Ogg1, expression of Apex in the cortex was 9 fold higher in females 
compared with males (P<0.001) and in the subcortical region Apex mRNA was 
1.4 fold higher in females compared with males (P=0.001). Apex mRNA levels 
were similar in hippocampi from both sexes. Lastly, expression of Apex in the 
cerebellum was 1.4 fold higher in males compared with females (P=0.01). 
7.3.2.1 Effect of age on Ogg1 expression in specific brain regions 
In male mice, overall expression of Ogg1 was lowest in the cortex and 
increased in the order hippocampus < cerebellum < subcortical. Compared with 
the cortex expression of Ogg1 was 8.8 fold higher in the hippocampus 
(P=0.003), 16 fold higher in the cerebellum (P<0.001) and 19 fold higher in the 
subcortical regions (P<0.001). In addition as compared with the hippocampus, 
expression of Ogg1 was 1.8 fold higher in the cerebellum (P=0.008) and 2.2 
fold higher in the subcortical regions (P<0.001). Ogg1 transcript levels were 
similar in the cerebellum and subcortical region. There was an age-related 
decline in Ogg1 expression in the hippocampus, cortex and cerebellum. In the 
hippocampus, expression of Ogg1 was 36% lower in 24 month old compared 
with 3 month old animals, although this was not statistically significant. 
Expression of Ogg1 in the cortex decreased by 17% (P=0.011) and in the 
cerebellum by 45% (P=0.05) in 24 month old animals compared with 3 month 
old animals (Figure 7.4). In female mice (Figure 7.5), overall expression of 
Ogg1 mRNA was highest in subcortical regions and was approximately 3.7 fold 
higher compared with the three other tissues (P<0.001). There was no effect of 
age on Ogg1 expression in the cortex but Ogg1 expression declined with age in 
the cerebellum and subcortical tissues. A 23% decline in expression is 
observed in 24AL animal compared to 3AL animal in the subcortical tissue 
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although this is not statistically significant. In the cerebellum there was a 38% 
decline in expression in 24AL animal compared with 3AL (P=0.001).  
7.3.2.2 Effect of DR on Ogg1 expression in specific brain regions 
24DR male mice had only 7% lower expression of Ogg1 in the cerebellum 
compared with 3AL animals, suggesting that DR can attenuate the age-related 
decline in expression. No effect of DR was observed in any other regions in 
male mouse brain (Figure 7.4). In the hippocampus, cerebellum and the 
subcortical region of female mice, DR was able to up-regulated expression 
(Figure 7.5). Ogg1 mRNA levels increased by 57% in the hippocampus 
(P=0.032), 10% in the cerebellum (P=0.008) and 65% in subcortical tissue 
(P=0.031) in DR animals compared with AL animals. No effect of DR was 
observed on the cortex of female mice. 
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Figure 7.4 Expression of Ogg1 in specific brain regions in male mice. Bars represent mean ± 
SEM, groups 3AL (black bars), 24AL (grey bars), 24 DR (white bars), n=5/group. Univariate 
ANOVA-GLM analysis for 3 month vs 24 month in the cortex P=0.011 and in the cerebellum 
P=0.05. Data collected by Joanna Górniak (hippocampus and cortex) and Manon Lecardonnel 
(cerebellum and subcortical regions). 
Figure 7.5 Expression of Ogg1 in specific brain regions in female mice. Bars represent mean ± 
SEM, groups 3AL (black bars), 24AL (grey bars), 24 DR (white bars), n=5/group. Univariate 
ANOVA-GLM in the hippocampus AL vs DR P=0.032, in the cerebellum 3 month vs 24 month 
P=0.001 and AL vs DR P=0.008 and in the subcortical tissue AL vs DR P=0.031. Data collected 
by Joanna Górniak (hippocampus and cortex) and Manon Lecardonnel (cerebellum and 
subcortical regions). 
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7.3.2.3 Effect of age on Apex expression in specific brain regions 
In male mice, expression of Apex was lowest in the cortex and increased in the 
order cerebellum < subcortical < hippocampus. Expression of Apex was 2.8 fold 
higher in the hippocampus (P<0.0001) and 2.5 fold higher in subcortical tissue 
(P=0.009) compared with the cortex. Furthermore expression in the 
hippocampus was also 1.6 fold higher compared with the cerebellum (P=0.01). 
An age-related decline in Apex expression was observed in the hippocampus, 
cortex and cerebellum. Expression of Apex declined by 50% in the 
hippocampus (P=0.047), 16% in the cortex (P=0.049) and 30% in the 
cerebellum (P=0.009) from 24 month old animals compared with 3 month old 
animals. No difference in expression was observed between the 3 groups in 
subcortical tissue (Figure 7.6). In female mice, expression of Apex was lowest 
in the cerebellum and increased in the order hippocampus < subcortical < 
cortex (Figure 7.7). Expression in the cortex was 2.9-fold higher compared with 
the hippocampus (P<0.001), 7.3 fold higher compared with the cerebellum 
(P<0.001) and 2.5 fold higher compared with subcortical regions (P<0.001). No 
difference in Apex mRNA levels was observed between the hippocampus or 
subcortical regions. However, expression of Apex was 2.5 fold higher in the 
hippocampus (P=0.003) and 2.9 fold higher in the subcortical regions (P<0.001) 
compared with the cerebellum. No effects of age on Apex expression were 
observed in the hippocampus, cortex or the subcortical tissue in these females. 
However, in the cerebellum Apex expression decreased by 36% in 24 month 
old compared to 3 month old animals (P<0.001).  
7.3.2.4 Effect of DR on Apex expression in specific brain regions 
In both male and female mice DR had no effect on Apex expression in any of 
the brain regions studied (Figure 7.6 and 7.7 respectively) except in the 
cerebellum of female mice where expression was higher in DR fed animals 
(P=0.004). Similarly to whole brain extracts there was no correlation between 
expression of Ogg1 or Apex and DNA incision activity for any of the brain 
regions studied for males or females. 
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Figure 7.6 Expression of Apex in specific brain regions in male mice. Bars represent mean ± 
SEM, groups 3AL (black bars), 24AL (grey bars), 24 DR (white bars), n=5/group. Univariate 
ANOVA-GLM for 3 month vs 24 month in the hippocampus P=0.047, cortex P=0.049 and 
cerebellum P=0.009. Data collected by Joanna Górniak (hippocampus and cortex) and Manon 
Lecardonnel (cerebellum and subcortical regions). 
Figure 7.7 Expression of Apex in specific brain regions in female mice. Bars represent mean ± 
SEM, groups 3AL (black bars), 24AL (grey bars), 24 DR (white bars), n=5/group. Univariate 
ANOAV-GLM in the cerebellum for 3 month vs 24 month P<0.001 and AL vs DR P=0.004 P. 
Data collected by Joanna Górniak (hippocampus and cortex) and Manon Lecardonnel 
(cerebellum and subcortical regions). 
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7.4 Discussion 
Repair of DNA damage is a critically important cellular defence mechanism for 
all tissues including the brain. Although it is clear that accumulation of DNA 
damage contributes to brain ageing and to the risk of developing age-related 
neurological disease (Martin, 2008), little is known about age-related changes in 
the capacity for DNA repair in different brain regions. Given the distinct 
functional roles of each brain region, understanding changes in DNA repair 
capacity with age in each brain region may help to provide a molecular basis for 
clinical observations. In addition, it will be important to discover whether 
interventions such as DR can affect the capacity for DNA repair in different 
brain regions. Until the present study was undertaken, there had been only one 
previous relevant study (Kisby et al., 2010) that quantified the effect of DR on 
DNA repair in different brain regions using an assay to study APE activity. The 
present study extended that work considerably by quantifying i) BER-related 
incision activity and ii) expression of 2 BER-related genes Ogg1 and Apex in 
young (3 months) and old (24 months) mice and also investigated the effect of 
long-term DR on expression of these genes. 
7.4.1 Effect of sex on DNA incision activity and gene expression 
In the present study, I show that capacity for DNA repair incision differs 
between brain regions with cortex showing highest incision activity, which likely 
results because of the high oxidative damage and low antioxidant levels 
reported in this tissue (Cardozo-Pelaez et al., 2000). I observed that DNA 
incision activity in the brain was lower in female mice compared with male mice. 
This is the first direct comparison of DNA repair activity between the sexes in 
the mammalian brain. Interestingly even though female mice exhibit lower 
behavioural deficits compared with males (Dumont et al., 2011) male C57BL6 
mice show longer lifespan than female mice from this strain (Kunstyr and 
Leuenberger, 1975; Rowlatt et al., 1976). Nevertheless, in the present study 
there was no difference between the sexes  in lifespan (unpublished data Kerry 
Cameron, Chapter 5). Sex hormones have been linked to oxidative stress and 
neurodegeneration, with oestrogen showing a protective role and testosterone 
showing no protection (Razmara et al., 2007; Lewis and Dluzen, 2008). The 
protective role of oestrogens has been well documented. The antioxidant 
properties of oestrogens are one of the modes for neuroprotection by this 
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hormone (Green and Simpkins, 2000). Furthermore oestrogens activate the 
MAPK pathway, which is in part involved in up-regulation of Ogg1 (Green and 
Simpkins, 2000; von der Lippen et al., 2015); in fact, in this study Ogg1 and 
Apex mRNA levels are higher in female cortex compared with male. In addition, 
oestrogen can translocate OGG1 to subcellular compartments (Araneda et al., 
2005). It is then possible that oestrogens provide a protective role by up-
regulating Ogg1 and other oxidative damage response genes, provide 
antioxidant properties and compartmentalise repair proteins. Furthermore, the 
higher incision activity observed in male mice could result from a need for 
enhanced DNA repair in response to higher oxidative stress/damage in males.  
7.4.2 Effect of age on DNA incision activity and gene expression 
The effects of age differed between specific brain sub-regions studied. Although 
an age-related decline in DNA repair activity has previously been reported 
(Kisby et al., 2010), here I have not observed any such changes except in 
cortex of female mice suggesting that differences in repair capacity are species 
specific. In fact, no other age related effects on incision activity were observed. 
It could be speculated that the assay was not sensitive enough to detect such 
change, but this is unlikely to be the case as the assay shows as high as 2 fold 
increases in DNA incision of cortex and subcortical tissue of males and 
cerebellum of females. Therefore, it is more likely that the incision step of the 
repair pathway is not affected by age. No age-related changes in incision of 8-
oxoguanine were also reported in caudate nucleus, frontal cortex and 
hippocampus (Imam et al., 2006). It has been previously speculated that 
enzymatic activity downstream in the BER pathway declines with age (Cabelof 
et al., 2003). In further studies it would be interesting to observe also activity 
and/or expression of β-polymerase and DNA ligase. Interestingly, contrary to 
the incision data, mRNA expression of BER-related proteins declined with age 
in all regions studied. It is not the first time that DNA repair activity and gene 
expression levels do not correlate (Mikkelsen et al., 2009). It can be speculated 
that basal levels of the repair proteins may be relatively stable and hence a 
small decline in their expression would not have major effects on the repair 
activity. In support of this hypothesis, no age-related changes in protein 
expression of AP endonuclease or DNA ligase III were seen in hippocampus, 
frontal cortex or cerebellum in C57BL6 mice (Imam et al., 2006). Epigenetic 
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changes which result in gene silencing can be the reason for the observed age-
related decline in BER-related gene expression. Region and dietary specific 
changes in cytosine methylation are observed in young mice (Langie et al., 
2013). Furthermore, epigenetic regulation of BER-gene expression has been 
explored in whole brain tissue in Chapter 5 and provided evidence in support of 
the above hypothesis. Unfortunately, due to the large amount of tissue required 
for the ChIP assay, epigenetic marks have not been explored here.  
Overall, it can be said that despite an age-related decline in mRNA expression of 
BER-related proteins, the incision activity in brain sub-regions is unaffected by 
age because repair protein expression remains stable. 
7.4.3 Effect of DR on DNA incision activity and gene expression 
Interestingly, DR increased incision activity in cortex, subcortical tissue and the 
cerebellum. No such DR-related changes were seen when looking at the whole 
brain (Chapter 5), thus highlighting importance of studying sub-regions of the 
brain. Furthermore, the results reported here support the previously 
demonstrated DR-related increase in APE incision activity in multiple brain 
regions (Kisby et al., 2010). In addition, DR up-regulated expression of Ogg1 in 
the hippocampus, cerebellum and subcortical tissue although it did not have 
similar effects on Apex expression. Together this suggests that DR may affect 
mRNA as well as protein levels. DR is thought to act via nutrient sensing 
pathways. With multiple down-stream effectors it is possible that these 
pathways may control DNA repair at multiple levels. DR mimetics resveratrol 
and rapamycin up-regulate Ogg1 via NRF2 transcription factor and AMPK 
activation respectively. In addition, OGG1 activity is increased upon 
phosphorylation by Cdk4 (Hu et al., 2005) and this post-translation modification 
of the enzyme is required for binding to chromatin (Dantzer et al., 2002). 
Therefore, it is plausible that DR enhances DNA repair on a transcription level 
via redox-responsive transcription factors such as NRF2 and on a protein level 
by phosphorylation of BER-related proteins which enhances their activity. 
Furthermore, oestrogen provides additional protective effect in females via up-
regulation and compartmentalisation of OGG1. 
7.4.4 Conclusions 
To conclude, the present data suggest the importance of studying the brain 
specific regions in the context of ageing. Data presented here show that in the 
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mouse, ageing has no effect on the incision step of DNA repair process. More 
interestingly DR enhanced DNA repair by upregulated repair enzymes at mRNA 
transcript level and by enhancing DNA repair related incision, supporting the 
hypothesis that one of the beneficial effects of DR on the ageing brain is 
enhanced DNA repair. 
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Chapter 8: General Discussion 
8.1 Overview 
The accumulation of molecular damage is one of the characteristic features of 
ageing and contributes to the cellular dysfunction which results in the 
development of age-related frailty, disability and disease. In particular, oxidative 
damage to DNA may be deleterious because of its effect on genomic stability 
and on patterns of gene expression. This accumulation of oxidative damage to 
DNA is due to numerous factors such as altered antioxidant status and decline 
in DNA repair capacity with age (Freitas and de Magalhães, 2011). Base 
excision repair (BER) is the primary mechanism involved in recognition and 
repair of small oxidative lesions in DNA. Defective BER has been implicated in 
ageing (Cabelof et al., 2006; Swain and Rao, 2012) as well as in the aetiology 
of age-related disease such as Alzheimer’s disease (Weissman et al., 2007b). 
Epigenetic marks at promoter regions in genes can regulate expression of the 
corresponding gene. However, there is accumulating evidence for aberrant 
changes in epigenetic marks in candidate genes and genome-wide epigenetic 
changes in ageing (Rakyan et al., 2010; Tapp et al., 2013). I hypothesised that 
such age-related changes in epigenetic marks could be responsible for age-
related decline in BER-gene expression. Furthermore epigenetic events occur 
in a tissue-dependent manner as shown with the repair BRCA1 gene which is 
only silenced by DNA hypermethylation in ovarian and breast tumours and 
remains unmethylated in other tumour types (Esteller et al., 2000). Finally, the 
plastic nature of the epigenome suggests that dietary interventions may exert 
their beneficial effects on ageing via the epigenetic code (Mathers et al., 2010). 
The purpose of this project was to discern the epigenetic changes at base 
excision repair-related genes that occur with age and in response to dietary 
energy restriction. Furthermore, I investigated the effects of such epigenetic 
changes on transcription of BER-related genes and on functional activity (BER-
related incision capacity). In addition, the net effects of these processes on the 
quantity of oxidative damage in DNA was also addressed. Since ageing may 
affect individual tissues to different extents, I tested my hypothesis in two 
tissues: brain and liver.  
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8.2 Evaluation of the Hypothesis 
BER was chosen as the DNA repair pathway for study because of the evidence 
of 8-oxoguanine accumulating with age and contributing to the ageing process 
(Sohal and Weindruch, 1996; Nie et al., 2013). There are multiple enzymes in 
the BER pathway and two were studied here: oxoguanine DNA glycosylase 
(OGG1) and AP endonuclease (APEX). These enzymes were chosen for study 
because they catalyse the initial steps of BER removal of oxidative damage and 
it is argued that changes in the genes encoding these enzymes would be likely 
to have consequences for the overall BER pathway. OGG1 recognises and 
removes an oxidised guanine base after which APEX excises the DNA 
backbone. OGG1 is the principle enzyme for removal of 8-oxoguanine lesions 
although other DNA glycosylases such as NEIL are also able to remove DNA 
oxidative damage. Furthermore, other DNA repair mechanisms such as NER 
can act as back-up for BER. The redundancy illustrated by these multiple 
pathways shows that cells are well equipped for removal of oxidative damage to 
DNA and BER alone may not be critical in determining the rate of ageing. 
However, evidence from multiple studies supports the hypothesis that DNA 
repair capacity falls with age and that this may contribute to the ageing process. 
In addition, a recent study using a data-mining approach attempted to classify 
DNA repair genes into those which were age-related and those which were not 
age-related and predicted that in humans the DNA repair genes which are age–
associated include: APEX1, ERCC5, RPA1, XRCC5 (Ku80), XRCC6, NEIL1, 
MUTYH and WRN (Freitas et al., 2011). Whilst the latter study postulated that 
DNA oxidative damage is central to ageing, there is significant evidence 
suggesting that such oxidative damage is not the key factor in determining rate 
of ageing. Several studies have shown that DNA oxidative damage does not 
accumulate with age in either nuclear or mitochondrial DNA (Chung et al., 1992; 
Hirano et al., 1996; Nakae et al., 2000; Kennedy et al., 2013). Nonetheless 
genomic instability plays a part in age-related cellular degeneration and 
therefore studies of DNA repair pathways such as BER are likely to be 
important in explaining the biology of ageing. 
Epigenetic alterations have also been implicated as a hallmark of ageing 
(López-Otín et al., 2013). Thus epigenetic changes which control the 
transcription state of chromatin may play a role in aberrant gene expression 
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during ageing. Changes in epigenetic marks at sites controlling transcription 
activity of the genes encoding BER enzymes may alter their expression and 
hence explain any age-related decline in repair activity that is observed. In this 
study I focussed on promoter regions as these tend to be CpG rich implying 
DNA methylation control and also because this is where binding of transcription 
factors that initiate the transcription process occurs. By looking at promoter 
regions we omit the gene body and other regions that affect transcription 
activation and therefore could have missed more complex epigenetic changes. 
Looking at all epigenetic marks would not be feasible and with the strong 
support for promoter related changes I opted to look at this region and to 
measure multiple epigenetic marks: cytosine methylation, histone acetylation 
and histone methylation. To summarise, although oxidative damage and its 
repair have been well documented in ageing research there is still much 
disagreement concerning its role in ageing. Furthermore, this is the first study to 
explore epigenetic mechanisms as a regulator of BER-gene expression during 
ageing and the effects of DR on epigenetic marks at these genes. 
8.3 Evaluation of the animal model and techniques 
As a mammalian system, mice belong to short-lived species (surviving up to 3 
years) compared with humans who can live past 100 years. Furthermore 
telomere attrition is one of the hallmarks of ageing but mice have relatively long 
telomeres with high telomerase activity. Thus these factors among many others 
suggest that differences in ageing mechanisms between mice and humans are 
inevitable. However, animal models are essential for our understanding of 
ageing. The animal model chosen here was the C57BL6 mouse. This animal 
has often been used for studies of ageing as it is relatively free of age-related 
pathologies such as cancer (Swindell, 2012); it is a well-established mouse 
model of ageing at Newcastle University. Furthermore, manipulations of lifespan 
by dietary energy restrictions can provide further insight into the mechanisms of 
ageing and DR was able to extend lifespan in mice used in this study.  
To determine an appropriate sample size for the main study a prior power 
calculation performed from DNA incision activity in young and old livers 
suggested  n=6 per treatment group. This would suggest that sample groups 
with 5 to 7 animals should have given enough power to this study. The 
statistical programme often informed of low power in the test performed. 
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Furthermore, the main study contained 7 treatment groups; therefore, error 
could occur from multiple testing and care has to be taken when analysing 
results with a p value close to 0.05. 
A strength of this study is that I was able to make measurements and 
comparisons in two tissue types: brain and liver and also in sub-regions of the 
brain. I was able to recognize the effects of age and diet at different levels 
based on measurements of epigenetic, transcription and phenotypic changes. 
In addition the study was of a longitudinal nature allowing comparison at 4 
separate stages of mouse lifespan and in both ad libitum and dietary restricted 
mice.  
There are limitations to techniques used to in this study which have been 
covered in Chapter 4. As discussed previously, the pyrosequencing assays are 
limited to looking at < 50% of CpG sites found in Ogg1 and Apex promoters. I 
cannot be certain that the CpG sites studied here are essential to control 
transcription activation. However, pyrosequencing permits precise estimation of 
measurements of methylation at individual CpG level and with much higher 
accuracy than other techniques such as high resolution melting or methylation 
specific PCR. Similarly to number of CpG sites there are also a large number of 
histone modifications that exist; two were studied here as they are associated 
with transcription silencing and/or activation. The comet-based assay which 
measures the initial incision step of a repair process may demonstrate well the 
activity of OGG1 and APEX but is not ideal in terms of measuring overall BER 
capacity. Finally, HPLC-ECD was used to measure 8-oxoguanine concentration 
in these tissues; however; with this technique being prone to oxidation of DNA 
during extraction absolute 8-oxoguanie levels may not be directly representative 
of those found in the cell. While limitations to techniques exist I can be certain 
that those used here are appropriate for the quantifications made in this study. 
Overall, this study and the techniques used here present a good model for 
robust studies of ageing and its modulation by dietary restriction. 
8.4 Principal findings  
I have demonstrated that BER-related epigenetic changes are observed with 
age in a tissue-specific manner. The difference observed between these organs 
was not surprising as tissue specific age-related changes have previously been 
demonstrated on a functional and transcription level (Lee et al., 2000). The 
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primary hypothesis explored the changes in DNA methylation at BER-related 
gene promoters in response to age (Chapter 4). This is the first study exploring 
epigenetic changes in promoter regions of Ogg1 and Apex during age. Using 
the Genomatix software, the promoter regions of genes encoding Ogg1 and 
Apex were identified; the promoter regions were both confirmed to contain CpG 
islands. Therefore, cytosine methylation at these promoters could theoretically 
be involved in their transcription activation. Chapters 4-6 showed that DNA 
methylation levels of Ogg1 and Apex promoters were very low; this was not 
surprising as promoters of transcription active genes are generally 
unmethylated (Maegawa et al., 2010). Lack of age-related changes in the 
methylome suggested other epigenetic mechanism may be involved. Histone 
modifications, in particular histone 4 acetylation and histone 3 lysine 27 tri-
methylation, were quantified as this explored both chromatin active and 
silencing marks respectively (Chapter 5 and 6). Because increased DNA 
methylation is associated with gene silencing I hypothesised that during ageing 
there is an increase in cytosine methylation at Ogg1 and Apex promoters which 
caused an age-related decline in their transcription. Interestingly, I observed a 
decrease in DNA methylation with age suggesting that the cell maintains 
expression of BER genes required in the DNA damage response. Furthermore, 
changes in contrasting histone marks were also observed with age. Since 
during ageing aberrant changes in the epigenome are observed on a global 
level (Maegawa et al., 2010; Peleg et al., 2010; Han and Brunet, 2012), gene 
specific changes in epigenetic marks must occur to preserve an open chromatin 
state and maintain expression of BER genes (Figure 8.1 proposed mechanism). 
Interestingly, the liver was more resistant to epigenetic changes compared with 
the brain. Furthermore DR, which prevents genomic instability, further 
potentiates the epigenetic code to give euchromatin. Such changes are a result 
of activity of epigenetic enzymes such as HDAC, HAT, HMT, DNMT, TET and 
histone demethylase; in fact, changes in activity of these enzymes are observed 
with ageing and HDAC is a known element of the DR mechanism (McMahon et 
al., 2007; Chouliaras et al., 2011; Jin et al., 2011; Zhang et al., 2013). 
Interestingly gene expression is maintained throughout age in the liver but a 
decline was seen in the brain. Two possible mechanisms can explain this 
unexpected observation. Firstly, it is now also known that DNA methylation 
elsewhere such as enhancer regions or gene body can also affect transcription 
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activity and methylation at these sites has not been explored here. Secondly, 
miRNAs have been found that degrade BER-relate mRNA transcripts. 
Although data suggest an open chromatin structure at the BER-promoters these 
studies would not be able to directly show whether transcription occurs as other 
factors such as binding of proteins that would inhibit transcription or binding of 
transcription factors have not been addressed. Transcription factor expression 
has been reported to correlate well with the occupancy of its binding sites ('An 
integrated encyclopedia of DNA elements in the human genome,' 2012). I 
measured expression of two redox-sensitive transcription factors: Hif1α and 
Nfya and found that their expression increased with age suggesting that these 
TF are up-regulated in response to oxidative stress and could initiate BER-
related gene transcription activation. Up-regulation of TFs was observed in old 
DR fed animals, thus suggesting DR mediates its effects via reduction of 
oxidative stress by initiating oxidative stress responses. In Chapter 5 I have also 
shown that DR may exert one of its neuro-protective roles by maintaining levels 
of repair enzyme transcripts at higher levels compared with AL animals. 
Furthermore, Ogg1 and Apex genes are also up-regulated via NFYA, NRF2, 
p53, NF-κB, MiTF, heat shock protein 70 (Kenny et al., 2001; Mendez et al., 
2003; Chatterjee et al., 2005; Liu et al., 2008; Habib et al., 2010; Jung et al., 
2013; Song et al., 2013; Singh et al., 2014; von der Lippen et al., 2015). 
Upon assessing the expression of Ogg1 and Apex, I wanted to confirm the 
effects on functional activity of the repair proteins. Chapter 3 showed that the 
comet-based assay can be used to measure BER-related DNA incision activity 
in a number of mouse tissues. I have confirmed that DNA incision activity is 
tissue-specific, likely to be due to the proliferative nature of the tissue and is 
higher in liver compared with brain. In Chapter 5 and 6 I have shown that in the 
brain and liver, no significant effect of age or diet was observed on DNA incision 
activity. Therefore these proteins maintain their activity throughout age. 
Independently of their gene up-regulation, it has been shown that acetylation 
and phosphorylation of these proteins can enhance their activity (Dantzer et al., 
2002; Hu et al., 2005; Bhakat et al., 2006; Bhattaracharyya et al., 2009; Lirussi 
et al., 2012). A wealth of data on DNA repair activity are found in the literature 
but these reports are contradictory. A main finding from this study is that BER-
related DNA incision activity did not change with age or diet; however, there 
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was an increase in protein concentration with age in the brain but not liver. One 
suggestion is that in the brain there is an accumulation of damaged protein 
resulting from lack of cell division related autophagy. I have not measured the 
other repair enzymes/processes that are also able to remove oxidative damage. 
An important hypothesis for ageing research postulates that ROS and the DNA 
oxidative damage induced by these molecules are a major contributor to 
genomic instability associated with ageing; however, here 8-oxoguanine a 
marker of oxidative damage did not support this statement. Currently a large 
number of studies provide no support for oxidative damage during ageing (most 
recently (Kennard et al., 2013)). Thus if damage accumulation is a key player in 
the ageing process other repair enzymes such as those that are involved in 
repair of larger lesions or double strand breaks and that maintenance of 
genomic stability may be more noteworthy. 
 
Figure 8.1 Proposed mechanism for epigenetic regulation of BER gene expression during 
ageing. During ageing the cell attempts to maintain BER gene expression by altering epigenetic 
marks to maintain an open chromatin structure. BER, base excision repair; DNMT, DNA 
methyltransferase; H3K27Me3, histone 3 lysine 27 trimethylation; H4Ac, histone 4 acetylation; 
HAT, histone acetyltransferase; HDAC, histone deacetylate; HMT, histone methyltransferase; 
TET, Ten-eleven translocation methylcytosine dioxygenase. 
An important conclusion that can be drawn from these studies is that phenotypic 
changes should be measured as well as epigenetic and transcription changes 
as it is evident that a clear relationship is not always seen. Studies often report 
only the epigenetic changes occurring with a treatment. However, they fail to 
back up the data with effects on the transcription profile (gene expression) of 
the genes or further on the actual functional effect of the protein encoded by the 
gene. I have demonstrated that changes occur at the epigenetic and 
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transcription level; however, little was seen in DNA repair activity. Furthermore, 
although protein expression and incision activity in the liver are higher than the 
brain, an accumulation of BER-related proteins is observed in the brain but not 
liver. This suggests that in this study age and diet do not affect DNA repair 
capacity and highlights that epigenetic changes do not necessarily translate to 
functional effects on the cell and care should be taken not to over interpret 
epigenetic data. 
8.5 Future studies 
Genomic instability is one of the hallmarks of ageing (López-Otín et al., 2013) 
and accumulation of damage often observed with age is in part a result in 
deficient DNA repair activity (Lombard et al., 2005). No changes in DNA incision 
activity were observed in this study; however, this is just the representation of 
the first step of the repair pathway. Evidence points to a deficiency of the gap 
filling step with age (Cabelof et al., 2002). It would be informative to confirm this 
observation using a gap filling assay/β polymerase activity (Cabelof et al., 
2003). A modification of the comet assay can also be used. Collins et al. 
previously measured the repair process including gap filling using the comet 
assay and supplementation of nucleotides (Collins et al., 1995) although this 
would have to be optimised for use with animal tissues. Furthermore, numerous 
studies implicate NER in removal of oxidative damage (Wang et al., 2012a; 
Melis et al., 2013). Modifications of the in vitro comet repair assay for 
quantifying NER are available (Langie et al., 2006). Thus in future studies it 
would be interesting to quantify the activity of other repair enzymes e.g. β-
polymerase, XRCC1, DNA Ligase IV, PCNA, GADD45, ERCC1, XP A-G as well 
as to test epigenetic changes at promoter regions of these genes in response to 
age and DR. 
This study shows a potential role for epigenetic maintenance of BER gene 
expression but it would benefit from a more detailed exploration of the 
mechanism. Numerous approaches can be taken to explore this. Firstly it would 
be useful to confirm using a promoter and binding assay in a vector system that 
DNA methylation changes can affect transcription of BER genes (Klug and 
Rehli, 2006). However, because both genes studied displayed low DNA 
methylation, mapping of the epigenome could be more informative, such as has 
been shown for epigenetic changes associated with X chromosome inactivation 
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(Marks et al., 2009). Such an analysis of the epigenetic landscape can be used 
for correlative studies with transcription and could clarify the ambiguous 
epigenetic changes observed in this study. No work has looked at whether DR 
affects global DNA methylation. For example, can it promote genomic stability 
via silencing transposable elements? This could be explored by analysis of DNA 
methylation at Alu or LINE1 transposable elements (Lisanti et al., 2013). 
Multiple groups, and the data presented here, show DR induced changes in 
DNA methylation at promoter regions confirming that DR can at least contribute 
to genomic stability on a loci specific level. Furthermore, Ten-eleven-
translocation (TET) proteins convert methylated cytosine to 5-
hydroxymethylcytosine (5-hmC). As I observe an age related decrease in DNA 
methylation at both promoters it would be interesting to confirm whether this 
was a result of an increase in 5-hmC. An age-related increase in 5-hmC has 
already been reported in the brain (Chen et al., 2012; Wen et al., 2014). Global 
5-hmC can be measured using HPLC or enzymatic assay (Szwagierczak et al., 
2010). More interestingly, the bisulphite sequencing method has recently been 
optimised to measure 5-hmC and it can do so at individual CpG sites  (Booth et 
al., 2012).  
Finally, only a small part of this study looked at the potential mechanisms of 
epigenetic changes and their effect on gene expression. I have quantified 
activity of HAT and HDAC enzymes and measured expression of TFs involved 
in up-regulation of BER-related gene. To develop on this, activity of other 
enzymes should also be studied e.g. DNMT (Chouliaras et al., 2011), TET 
(Zhang et al., 2013), HMT (McMahon et al., 2007) and histone demethylases 
(Sun et al., 2010; Jin et al., 2011). However, these studies should be specific to 
individual enzymes. In addition, the TF studies should be improved by analysing 
TF binding to promoters. ChIP-sequencing can be used for global mapping of 
transcription factor binding sites and has been used so in the ENCODE project 
(Wang et al., 2012b). The ChIP assay can also identify TF binding at promoters 
using antibodies specific to TF of interest (Gade and Kalvakolanu, 2012). 
8.6 Conclusions 
This study confirms that ageing is associated with aberrant epigenetic changes 
that can alter expression of BER-related genes. I have shown that promoter 
regions of BER-related genes Ogg1 and Apex are dynamic and undergo 
198 
changes with age and diet. Changes in multiple and contrasting epigenetic 
marks were observed suggesting that regulation of transcription is controlled by 
multiple mechanisms. I have demonstrated that epigenetic changes do occur at 
BER-related genes in a tissue and sex specific fashion however no clear 
correlation with the gene expression was observed highlighting that epigenetic 
regulation is only one aspect of the complex regulation of transcription of genes. 
Furthermore this study fails to show a decline in BER-related DNA incision 
activity with age suggesting that at least in these mice DNA repair activity is 
sustained throughout life and hence there is maintenance of DNA oxidative 
damage levels during ageing. 
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Appendix A – Oxoguanine DNA glycosylase (OGG1) 
A.1 Ogg1 promoter DNA Sequence with numbered CpG sites 
Ogg1 (Chromosome 6, Locus ID GXL 88306, Gene ID 18294) Mus musculus: 
ATGAGATTCTTT1CGGTTTATTTCTTGAGACAGAGTCT2CGCCATGAAGCCCAGCCTAGTTAA
GCTTCAAA3CGTGCCTCC4CGCCTCTGCCTAC5CGAGTTCTGGGA6CGAC7CGGTGTGTACC
ACTA8CGCCC9CGCAATGATGTGGCTCCAGTG10CGGGCCAGCA11CGAGAAGTTGCAGGCA
GGCCCTGAGATTGCAC12CGAAAGCCCTGAAATGGCAGAGC13CGGGTCTCTGGCAGCCAA
T14CGCCAAGCAG15CGAGGCCAGCAGGCCAAC16CGCTCCCACCTCACAGGCC17CGCCCAC
TC18CGGCACTCC19CGAGTTCTCATTGGTGCTT20CGTACTTTCTTCT21CGGATTGGCTACCT
CTAGGGTCAAATAAG22CGGGAGCAAGGATCTACTTC23CGGTGGGAGTAAACTGGGACC24C
GGAAGAACCATACTGG25CG26CGCCTTTCCAAACCT27CGAGGGCTG28CGCAGGAGGAGGA
GG29CG30CG31CGC32CGGGAGGTCCTGGGGG33CGGGGCCA34CGTC35CGGAGGAAGAGG36
CGGGG37CGTGCTGCA38CGGGAGAG39CGGAGTGGGG40CGTTTAGGGGTTTGGTGGTGTG4
1CGAGAGGCTTTCCTA42CGAGGAGAGGGAAATTCATTCAACAGGGACTCAAATTAAAATTA
CAC43CGGACCCATAAGCTAGGACCCA44CGGTGCTA 
A.2 Transcription factor binding at the Ogg1 promoter 
Genomatix generated transcription factor consensus sequence binding on the 
positive strand of the Ogg1 promoter. 
TF Description 
Spans Assay 
CpG 
DEAF 
Homolog to deformed epidermal autoregulatory factor-1 from 
D. melanogaster 
- 
HIFF Hypoxia inducible factor, bHLH/PAS protein family 3 
HESF Vertebrate homologues of enhancer of split complex - 
HEAT Heat shock factors - 
TF2D General transcription factor IID, GTF2D 14 
CAAT CCAAT binding factors 14 
CLOX CLOX and CLOX homology (CDP) factors 14, 15 
MTEN Core promoter motif ten elements 14, 15 
NRSF Neuron-restrictive silencer factor 14, 15, 16 
RORA v-ERV and RAR-related orphan receptor alpha 15 
GLIF GLI zinc finger family 17 
ZBPF Zinc binding protein factors 17 
HDBP Huntington’s disease gene regulatory region binding proteins 18 
YBXF Y-box binding transcription factors - 
XCPE 
Activator-, mediator- and TBP-dependent core promoter 
element for RNA polymerase II transcription from TATA-less 
promoters 
- 
E2FF E2F-myc activator/cell cycle regulator - 
ZF35 Zinc finger protein ZNF35 - 
MOKF Mouse Krueppel like factor - 
EGRF EGR/nerve growth factor induced protein C & related factors - 
ZF5F ZF5 POZ domain zinc finger - 
EBOX E-box binding factors - 
SP1F GC-Box factors SP1/GC - 
CHRE Carbohydrate response elements - 
KLFS Krueppel like transcription factors - 
PDRM PRDI-BF1 and RIZ homologous (PR) domain proteins (PRDM) - 
Table A.1. TFs binding at the Ogg1 promoter, expressed in brain, liver or ubiquitously. 
Highlighted TFs are ones present in the Ogg1 pyrosequencing assay. 
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A.3 Pyrosequencing Assay Validation 
Ogg1 pyrosequencing assay optimisation has been performed previously by 
Bartłomiej Tomaszewski and Dr Sabine Langie. No data on nested PCR 
product representing Ogg1 promoter, synthesis of an in vitro 100% methylated 
promoter or pre and post methylation dilution series are available. Figure A.1 
shows example gel from pyro PCR of Ogg1 sequences 1 and 2. 
A 
 
B 
 
Figure A.1 Example of agarose gel from pyro PCR of Ogg1 sequence 1: 134bp (A) and sequence 
2: 184bp (B) performed with BM DNA from the brain. 
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A.4 Pyrosequencing Pyrograms 
Example of Pyrogram read outs from pyrosequencing reactions of Ogg1 
sequence 1 and 2.  
A 
 
B 
Figure A.2 Example of a pyrogram reading for Ogg1 sequence 1 (A) and sequence 2 (B). 
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A.5 Cytosine methylation at individual CpG sites in the Ogg1 
promoter 
Mean and median cytosine methylation from animals in the long term-term DR 
study (Chapter 5 and 6) as pleasured by pyrosequencing. Methylation in the 
brain of male mice (Table A.2), brain of female mice (Table A.3), liver of male 
mice (Table A.4) and liver of female mice (Table A.5). 
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CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
3 
Mean 0.2280 0.2843 0.1864 0.1050 0.0986 0.0740 0.0000 
Median 0.2650 0.3800 0.2050 0.1550 0.1500 0.0000 0.0000 
SD 0.1609 0.1974 0.1438 0.1010 0.0946 0.1019 0.0000 
P value All > 0.05 
4 
Mean 1.7640 1.9400 1.7400 1.6457 1.4857 1.6850 1.4007 
Median 1.8050 1.9600 1.7900 1.6950 1.4750 1.7050 1.4050 
SD 0.2283 0.1413 0.5614 0.3615 0.4583 0.1125 0.2941 
P value All > 0.05 
5 
Mean 0.6980 0.7443 0.6536 0.6293 0.5743 0.6630 0.4907 
Median 0.6600 0.7350 0.7250 0.6750 0.6250 0.6700 0.5550 
SD 0.1000 0.0596 0.2811 0.1439 0.2025 0.1370 0.1548 
P value All > 0.05 
6 
Mean 0.7250 0.8214 0.6736 0.6414 0.5786 0.6500 0.3321 
Median 0.7250 0.7950 0.7600 0.7250 0.6000 0.7000 0.3150 
SD 0.0639 0.1453 0.1761 0.2534 0.1954 0.1724 0.0449 
P value 1.000 >0.05 >0.05 >0.05 >0.05 >0.05 0.006 
7 
Mean 1.0440 0.9250 0.8536 0.6943 0.7021 0.6820 0.3914 
Median 1.0300 0.9300 0.8800 0.4950 0.5850 0.7650 0.3750 
SD 0.1069 0.1187 0.2191 0.3132 0.2458 0.2799 0.0634 
P value 1.000 >0.05 >0.05 >0.05 >0.05 >0.05 <0.001 
8 
Mean 1.3630 1.3929 1.2864 1.2993 1.2829 1.0620 1.0371 
Median 1.4450 1.4150 1.3900 1.3650 1.2000 1.1400 1.1650 
SD 0.2475 0.1313 0.3535 0.3706 0.4021 0.1227 0.3627 
P value All > 0.05 
9 
Mean 0.6670 0.7921 0.7671 0.6843 0.5864 0.9940 0.6886 
Median 0.7100 0.9250 0.7950 0.7800 0.5950 1.0450 0.6650 
SD 0.4519 0.3709 0.3551 0.2315 0.3222 0.2502 0.7066 
P value All > 0.05 
13 
Mean 1.7470 1.7443 1.2957 1.4150 1.2093 1.0420 0.7457 
Median 1.6450 1.9950 1.4550 1.5400 1.1400 1.3050 0.6350 
SD 0.1804 0.8232 0.5734 0.5394 0.4777 0.4742 0.3218 
P value All > 0.05 
14 
Mean 0.5090 0.8300 0.5321 0.5336 0.4300 0.4130 0.2786 
Median 0.4250 0.9200 0.4600 0.5050 0.4250 0.4250 0.3750 
SD 0.2096 0.2942 0.1654 0.2958 0.3569 0.0404 0.1942 
P value All > 0.05 
15 
Mean 1.5030 1.6136 1.0386 1.3757 1.2364 0.7600 0.8664 
Median 1.5650 1.7100 1.0350 1.4800 0.8900 0.5450 0.8200 
SD 0.3222 0.4092 0.3269 0.3784 0.7178 0.6649 0.2998 
P value All > 0.05 
16 
Mean 2.9250 2.9114 2.6857 2.6279 2.6336 2.8480 2.1550 
Median 2.8550 2.7900 2.6850 2.7950 2.8950 2.6900 2.3200 
SD 0.3386 0.3734 0.9441 0.8005 1.0613 0.3728 0.7355 
P value All > 0.05 
17 
Mean 0.8340 1.1914 0.7421 0.7379 0.6814 0.7020 0.4814 
Median 0.7950 1.3000 0.6250 0.6350 0.5550 0.6300 0.5600 
SD 0.2625 0.3860 0.4118 0.2878 0.5302 0.2349 0.2373 
P value All > 0.05 
18 
Mean 2.1520 2.3671 2.0114 1.9607 1.8136 2.0440 1.3457 
Median 2.0850 2.1600 2.1500 2.1050 1.9300 2.0650 1.5550 
SD 0.2401 0.3402 0.8061 0.6079 0.7194 0.4107 0.3604 
P value All > 0.05 
Overall 
Mean 1.2765 1.3861 1.1332 1.1282 1.0450 1.0665 0.8093 
Median 1.3075 1.4025 1.225 1.2025 0.9500 1.1075 0.8650 
SD 0.0833 0.1693 0.2916 0.2905 0.3600 0.1457 0.1490 
P value 1.000 >0.05 >0.05 >0.05 >0.05 >0.05 0.043 
Table A.2 Percentage cytosine methylation in the brain from male mice from long-term DR study. 
Comparison to 3AL (1.000), significance level <0.05. 
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CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
3 
Mean 0.1100 0.1521 0.0164 0.0650 0.0243 0.1286 0.0200 
Median 0.0000 0.1350 0.0000 0.0000 0.0000 0.0000 0.0000 
SD 0.1597 0.1702 0.0435 0.0812 0.0643 0.1866 0.0529 
P value All > 0.05 
4 
Mean 2.0160 1.7321 1.6364 1.7486 1.5300 1.8629 1.8129 
Median 1.6900 1.5650 1.6950 1.7400 1.7100 1.7500 1.8200 
SD 0.6525 0.3443 0.1865 0.2433 0.7015 0.3195 0.2445 
P value All > 0.05 
5 
Mean 0.8670 0.7657 0.5307 0.7550 0.5621 0.5336 0.6579 
Median 0.7750 0.8000 0.6200 0.7900 0.6250 0.3800 0.6800 
SD 0.1795 0.1661 0.2971 0.2058 0.2906 0.2205 0.3384 
P value All > 0.05 
6 
Mean 1.0010 0.8571 0.9393 0.7650 0.5479 0.6007 0.8621 
Median 1.0450 0.7800 0.6900 0.8450 0.5700 0.4650 0.7550 
SD 0.1419 0.1303 0.7108 0.1654 0.2944 0.1854 0.5161 
P values All > 0.05 
7 
Mean 0.9060 0.6757 0.5293 0.5600 0.3564 0.6271 0.6650 
Median 0.8950 0.6800 0.6700 0.4850 0.3900 0.5350 0.4850 
SD 0.2800 0.2086 0.2739 0.2279 0.1624 0.2164 0.6000 
P value All > 0.05 
8 
Mean 1.4560 1.1650 1.0621 1.2229 1.1293 1.4321 1.7986 
Median 1.3200 1.1950 1.1850 1.2700 1.2150 1.4850 1.5350 
SD 0.5570 0.1010 0.4956 0.1032 0.5528 0.2178 0.5762 
P value All > 0.05 
9 
Mean 1.0590 0.9336 1.1971 1.1400 0.7329 1.1586 1.1971 
Median 0.9150 0.9100 0.8850 1.1200 0.8500 1.1750 1.2150 
SD 0.3867 0.1787 1.1367 0.0623 0.4322 0.2149 0.3312 
P value All > 0.05 
13 
Mean 1.7300 1.6571 1.5064 1.4971 1.2750 1.1064 1.2564 
Median 1.6050 1.6900 1.5950 1.4650 1.0550 1.1850 1.2800 
SD 0.4927 0.4190 0.3055 0.2869 0.5976 0.5042 0.3531 
P value All > 0.05 
14 
Mean 0.5480 0.5514 0.3493 0.4679 0.4971 0.5593 0.3979 
Median 0.3600 0.6200 0.3550 0.4550 0.4250 0.4100 0.3500 
SD 0.4661 0.2315 0.2960 0.2932 0.1608 0.3863 0.3175 
P value All > 0.05 
15 
Mean 1.7760 1.7093 1.5321 1.6007 1.5871 1.9429 1.5807 
Median 1.6650 1.7800 1.5300 1.6100 1.7350 1.9800 1.5450 
SD 0.4585 0.4288 0.3167 0.2248 0.3910 0.3532 0.2958 
P value All > 0.05 
16 
Mean 3.6280 2.8279 3.0186 2.9607 2.8943 3.3179 3.6129 
Median 3.6050 2.8000 3.2400 2.9200 2.9000 3.4500 3.5600 
SD 1.4633 0.3742 0.4242 0.2488 0.9081 0.4095 0.7727 
P value All > 0.05 
17 
Mean 1.4290 1.2736 1.0250 1.2479 0.9286 1.4693 1.0993 
Median 1.2900 1.2400 1.0900 1.2450 0.8250 1.4100 1.0950 
SD 0.4409 0.2544 0.3909 0.3672 0.3300 0.7009 0.4199 
P value All > 0.05 
18 
Mean 2.0810 2.1150 1.9107 2.0000 2.1329 2.1936 2.2371 
Median 1.9700 2.0850 1.9850 2.0600 2.4000 2.3250 2.3250 
SD 0.6888 0.2398 0.4385 0.3450 0.6722 0.2365 0.3456 
P value All > 0.05 
Overall 
Mean 1.4630 1.2936 1.2014 1.2629 1.1843 1.3361 1.3496 
Median 1.3350 1.3700 1.2025 1.2000 1.1875 1.4250 1.3250 
SD 0.4664 0.1709 0.0653 0.1336 0.2561 0.2416 0.1813 
P value All> 0.05 
Table A.3 Percentage cytosine methylation in the brain from female mice from long-term DR 
study. Comparison to 3AL (1.000), significance level <0.05. 
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CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
3 
Mean 0.2910 0.2100 0.1264 0.2250 0.2729 0.1200 0.1467 
Median 0.0000 0.2000 0.0000 0.2175 0.0000 0.0000 0.1875 
SD 0.4574 0.1855 0.1748 0.2330 0.4077 0.2683 0.1211 
P value All > 0.05 
4 
Mean 2.5110 1.9057 1.7164 2.2525 2.1379 1.6740 1.8625 
Median 2.4600 1.7850 1.8200 2.2650 2.1850 1.5350 1.8500 
SD 0.3249 0.3909 0.4104 0.2370 0.7683 0.4643 0.3305 
P value All > 0.05 
5 
Mean 0.7800 0.5836 0.8007 0.7792 0.7893 0.5720 0.6075 
Median 0.6400 0.7200 0.8350 0.8100 0.7700 0.7150 0.6075 
SD 0.2493 0.4272 0.3406 0.2104 0.4556 0.3787 0.1564 
P value All > 0.05 
6 
Mean 0.8730 0.7336 0.8350 0.5867 0.9436 0.7260 0.6475 
Median 0.8450 0.8000 0.7450 0.7025 0.9400 0.7700 0.6725 
SD 0.2849 0.1669 0.4502 0.3641 0.5400 0.2679 0.2363 
P value All > 0.05 
7 
Mean 1.3760 1.1921 0.6986 0.6642 1.1236 0.8730 0.7600 
Median 1.2000 1.1650 0.7050 0.4950 1.0400 0.7750 0.8500 
SD 0.4373 0.4652 0.2982 0.3395 0.5087 0.2650 0.3412 
P value 1.000 >0.05 >0.05 0.48 >0.05 >0.05 >0.05 
8 
Mean 2.2100 1.5107 1.9257 1.4958 1.6829 1.4020 1.3550 
Median 2.1550 1.6100 1.6450 1.4625 1.6800 1.3700 1.2900 
SD 0.3276 0.2359 0.6566 0.2757 0.7833 0.1053 0.4656 
P value All > 0.05 
9 
Mean 1.3630 0.8943 1.1521 0.8783 1.2257 1.0540 0.5317 
Median 1.3850 1.1100 0.9050 0.9075 1.1850 0.9250 0.4400 
SD 0.1947 0.4794 1.2352 0.3769 0.4536 0.3241 0.5302 
P value All > 0.05 
13 
Mean 1.7790 0.9221 0.6964 0.9333 0.7486 0.3100 0.4392 
Median 1.3800 1.0700 0.6550 1.0350 0.4950 0.4350 0.5125 
SD 0.9706 0.5579 0.3453 0.9039 0.7374 0.2875 0.2501 
P values 1.000 >0.05 >0.05 >0.05 >0.05 0.016 0.026 
14 
Mean 0.9580 1.1664 0.8886 1.2667 0.9786 1.1880 0.8583 
Median 0.9200 1.1550 0.8050 1.1250 0.8850 1.3150 0.9275 
SD 0.3405 0.3590 0.5033 0.6103 0.4265 0.6880 0.3403 
P value All > 0.05 
15 
Mean 1.7650 2.0164 1.1800 0.9858 1.6521 1.7230 1.5350 
Median 1.5000 2.3700 1.3650 0.9925 1.8100 1.8650 1.1325 
SD 0.5945 0.9140 0.5378 0.4356 0.9459 0.9296 1.0669 
P value All > 0.05 
16 
Mean 4.7450 3.1921 3.0029 2.5667 3.8329 2.4260 2.4717 
Median 4.3900 3.5300 3.3650 2.7775 3.7400 2.7100 2.2925 
SD 1.0502 0.7898 1.2869 1.1755 1.7320 0.7608 0.8435 
P value All > 0.05 
17 
Mean 1.3950 0.7457 0.7457 0.7817 0.8107 0.8270 0.8183 
Median 1.6000 1.0900 0.8600 0.7125 0.7600 0.6700 0.6725 
SD 0.6059 0.5923 0.3841 0.5908 0.5270 0.3980 0.3454 
P value All > 0.05 
18 
Mean 3.7080 2.6207 2.7550 2.3025 2.4707 2.7520 2.2900 
Median 2.7200 2.6150 2.6450 2.2275 2.5550 2.6050 2.2850 
SD 1.5989 0.2439 0.9465 0.4212 1.4715 0.3892 0.4420 
P value All > 0.05 
Overall 
Mean 1.7630 1.3914 1.2914 1.2279 1.3704 1.1905 1.1067 
Median 1.7325 1.4425 1.2525 1.2275 1.0925 1.1725 1.0088 
SD 0.2414 0.1428 0.2940 0.1135 0.6087 0.1012 0.2738 
P value 1.000 >0.05 >0.05 0.041 >0.05 >0.05 >0.05 
Table A.4 Percentage cytosine methylation in the liver from male mice from long-term DR study. 
Comparison to 3AL (1.000), significance level <0.05. 
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CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
3 
Mean 0.0000 0.0000 0.1200 0.2033 0.0000 0.0321 0.0336 
Median 0.0000 0.0000 0.0000 0.2775 0.0000 0.0000 0.0000 
SD 0.0000 0.0000 0.2137 0.1617 0.0000 0.0850 0.0888 
P value All > 0.05 
4 
Mean 1.3900 1.5329 1.4129 2.0433 1.6943 1.8550 1.8600 
Median 1.4650 1.5500 1.2150 1.7625 1.3700 2.0650 1.7400 
SD 0.1303 0.4631 0.7011 0.6089 0.8777 0.5866 0.6215 
P value All > 0.05 
5 
Mean 0.4530 0.6329 0.6829 0.9258 0.5071 0.7586 0.7879 
Median 0.4600 0.7400 0.6600 0.9175 0.4900 0.8550 0.8350 
SD 0.3401 0.3358 0.3115 0.1220 0.4057 0.3295 0.3519 
P value All > 0.05 
6 
Mean 0.5730 0.8136 0.5593 1.0983 0.4829 0.6271 0.7129 
Median 0.4150 0.9150 0.4050 0.9650 0.5100 0.5000 1.0000 
SD 0.2977 0.2704 0.4318 0.2776 0.3333 0.2961 0.4304 
P value All > 0.05 
7 
Mean 0.5630 0.9136 0.5943 1.1717 0.6050 0.5807 0.7971 
Median 0.4100 1.0450 0.5200 1.0975 0.4450 0.5000 0.5450 
SD 0.2362 0.5482 0.1669 0.2926 0.4180 0.5388 0.6054 
P value All > 0.05 
8 
Mean 1.5520 1.5686 1.9229 2.1633 1.7400 1.6129 2.0121 
Median 1.5150 1.6250 1.8500 2.1750 1.9050 1.6350 1.9100 
SD 0.1568 0.3908 0.2747 0.4406 0.5372 0.4996 0.3495 
P value >0.05 
9 
Mean 0.7760 1.2414 0.9421 1.6683 1.1486 1.2686 0.9557 
Median 0.7450 1.2250 0.6150 1.5825 1.1250 1.2200 0.9200 
SD 0.3726 0.5722 0.5321 0.6837 0.6115 0.4739 0.4300 
P value >0.05 
13 
Mean 1.7020 1.6200 1.3936 1.9317 1.0993 1.2664 1.1343 
Median 1.8600 1.5850 1.2500 1.9250 0.9800 1.1750 1.1150 
SD 0.3837 0.2636 0.5686 0.7765 0.3736 0.4239 0.3320 
P value >0.05 
14 
Mean 0.2960 0.1943 0.1436 0.4750 0.3864 0.0360 0.3164 
Median 0.0000 0.0000 0.0000 0.6075 0.4050 0.0000 0.3250 
SD 0.4127 0.2462 0.2459 0.3911 0.3175 0.1682 0.3784 
P value >0.05 
15 
Mean 2.0450 2.2657 2.2993 2.8733 2.1921 2.2307 2.1707 
Median 2.0450 2.3950 2.2400 2.7700 1.9050 2.2450 2.2500 
SD 0.3901 0.5312 0.3430 0.4185 0.6204 0.4393 0.6328 
P value >0.05 
16 
Mean 2.4570 3.0279 2.9329 4.9542 3.6229 3.7207 4.0871 
Median 2.5000 3.1200 3.1800 4.0550 3.8250 3.8500 4.1950 
SD 0.6137 0.4081 0.8304 2.0457 1.1507 0.8759 1.0170 
P value 1.000 >0.05 >0.05 0.023 >0.05 >0.05 >0.05 
17 
Mean 0.8320 1.0743 1.0279 1.8100 0.8229 1.0500 1,3914 
Median 0.7900 1.3250 0.6850 1.7600 0.5700 0.6950 1.4900 
SD 0.6852 0.6488 0.6164 0.7825 0.6732 0.6918 0.5940 
P value >0.05 
18 
Mean 2.4840 2.1871 2.6236 3.3158 2.2443 2.8650 2.8679 
Median 2.4000 2.1600 2.8700 2.7725 2.4000 3.2250 3.0750 
SD 0.3645 0.3230 0.8403 1.2858 0.9147 0.8807 0.6049 
P value >0.05 
Overall 
Mean 1.6370 1.7293 1.7386 2.5600 1.7286 1.8671 1.9950 
Median 1.5750 1.7150 1.7450 2.2175 1.5700 1.7850 2.0400 
SD 0.3303 0.2271 0.3123 0.8060 0.5207 0.4612 0.4467 
P value >0.05 
Table A.5 Percentage cytosine methylation in the liver from female mice from long-term DR study. 
Comparison to 3AL (1.000), significance level <0.05. 
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A.6 Validation of primers for ChIP-qPCR 
Primers for amplification of Ogg1 promoter region were validated with liver 
genomic DNA from the ChIP input reaction. A qPCR reaction shows good 
amplification for a dilution series of DNA and the primers. Primers were 
designed by Dr Jelena Mann. 
Figure A.3 Validation of assay used for ChIP-qPCR. Efficiency 102.3, slope -3.27. 
A.7 Ogg1 cDNA Sequence acquired from Genomatix software 
GAGGCGGGGCGTGCTGCACGGGAGAGCGGAGTGGGGCGTTTAGGGGTTTGGTGGTGTG
CGAGAGGCTTTCCTACGAGGAGAGGGAAATTCATTCAACAGGGACTCAAATTAAAATTACA
CCGGACCCATAAGCTAGGACCCACGGTGCTACACTCCCGGTGTGTGTGGTCACTTGTGTG
CGAGGCTTTAGGACTTGGGAAAGTCGAGTTCTGATTGGACAGTGCCGTAATGGGCTGGGG
CTGCTAGCCGAATGTTATTCCGTTCCTGGCTGCCTAGCAGCATGAGACATCGCACCCTAAG
CTCCAGCCCGGCCCTCTGGGCCTCTATCCCGTGTCCACGCTCTGAGCTGCGTCTGGACTT
GGTTTTAGCTTCTGGACAGTCCTTCCGGTGGAAGGAGCAGAGCCCTGCTCACTGGAGTGG
CGTGCTGGCAGATCAAGTATGGACACTGACTCAGACGGAGGACCAGCTCTATTGCACTGT
GTACCGAGGAGACGACAGCCAGGTCAGCAGGCCCACCCTAGAGGAGCTGGAAACCCTAC
ACAAGTACTTTCAGCTAGATGTCAGCCTGGCACAGCTGTATAGCCACTGGGCTTCTGTAGA
CTCCCACTTCCAAAGAGTGGCCCAGAAATTCCAAGGTGTGAGACTGCTGAGACAAGACCC
CACTGAGTGCCTTTTCTCTTTCATCTGTTCCTCCAACAACAACATTGCTCGCATTACTGGCA
TGGTGGAACGGCTCTGCCAGGCCTTTGGACCTCGACTCATTCAGCTTGATGATGTCACTTA
TCATGGCTTCCCAAACCTCCATGCCCTGGCTGGTCCAGAAGCAGAGACTCACCTGAGGAA
GTTGGGCCTGGGGTACCGTGCCCGCTATGTACGTGCCAGTGCCAAAGCCATCCTCGAAGA
GCAAGGTGGGCCAGCTTGGCTGCAGCAGCTTCGAGTGGCCCCTTATGAAGAGGCCCACA
AGGCCCTCTGCACCCTGCCCGGGGTGGGCGCCAAGGTGGCTGACTGCATCTGCTTAATG
GCCCTTGACAAACCCCAGGCTGTGCCCGTGGATGTCCATGTATGGCAGATTGCCCATCGT
GACTACGGCTGGCATCCTAAGACATCCCAGGCTAAGGGCCCGAGCCCTTTGGCCAACAAA
GAACTGGGAAACTTTTTCCGGAATCTGTGGGGACCTTATGCTGGCTGGGCCCAAGCAGTG
CTGTTCAGTGCTGACCTTCGCCAACCAAGCCTGTCTCGGGAGCCACCAGCAAAGCGCAAA
AAGGGATCTAAGAGGCCAGAGGGCTAGGTAGGGCTCAGGGGCAAAAGGTCTTTTTTCCTT
TGTTCTCCATTTCTTTCCCTTGTCTCTCCCCCCCCCCCAACCCCCGACCCCTAAGTCTCAA
GTCAGAAAGACTTAACACTCCCACCTCAGAGGCCAGAACCCCAAATCAAAGTCAGTTTTTA
CAATAGGGAAAAAGGAAGCTATTTGAGCAAACGGAACTGTCTTGTTTTATCTTCCCTTTATT
ACAAGAAGGAACAATAAAATAGAAACATTTGTATGGAAAA 
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A.8 Ogg1 expression qPCR primer validation 
Primer validation for Ogg1 expression with cDNA dilution series. Primers 
designed by Dr Sabine Langie. 
Assay Efficiency factor Efficiency (%) Slope 
Ogg1 (Target) 1.94 93.80 -3.480 
Hprt (Reference) 1.96 96.03 -3.421 
B2m (Reference) 1.92 92.49 -3.516 
Table A.6 qPCR assay efficiency as tested with cDNA from liver. 
A.9 OGG1 ELISA assay 
Protein extract concentration at 5mg/ml and 1mg/ml were tested in the OGG1 
ELISA assay to optimise extract concentration to be used. Kit standard was 
used to set up a standard curve. 
Figure A.4 Optimisation of assay OGG1 ELISA, protein extracts from brain (red) and liver 
(green) at 5mg/ml and 1 mg/ml were tested versus assay standard (blue) to determine 
concentration of extract to use in the assay. 
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Appendix B – Apurinic/apyrimidinic endonuclease 1 (APEX) 
B.1 Apex promoter DNA Sequence with numbered CpG sites 
Apex (Chromosome 14, Locus ID GLX 98783, Gene ID 11792) Mus musculus: 
AAAACAAAACCTGAA1CGAACCCA2CGTGACCTAGCCCCAGGTGTCTGACTCTTCTAGTCAA
AAGTTACCAACCAAA3CGCACAATCAGGGGAGTCTGGAGTGGGGAAGCCTGTAAAATCTGA
CATAGGCAACAGTGTGGAATAT4CGGACAGAACAAAACTGGACAAGGAGC5CGGGAAG6CG7
CGGC8CGCAGCCACTCAC9CGGTGCC10CGGGGC11CGTGA12CGTAAGTG13CGC14CG15CGG
GTT16CGCCAGCAC17CGTGC18CGT19CG20CGGACCA21CGCCCA22CGC23CGATCTTGTTGG24
CGCTGCCTT25CGAACCCCAGCAC26CG27CGGGCATGGTGCCTCA28CGGCTCC29CGGT30CG
TGAGGC31CGAGTGA32CGAGCTGTAAC33CGGCACTACCA34CGAACAACCCAGAACCAAG35
CGAAGGGACTTT36CGGG37CGCCAGAAGTTATGTCA38CGAGGTGCCAGGAGGACCAATCAT
39CG40CGCTCCAGAACCA41CGTGGGGG42CGGAGCCCT43CGAATCA44CGTGACCACACCAA
T45CGCCCA46CGTGGGAACAGGCAGACTCCATTCTTTGTGC47CGTGAGGGTCTCTGGCTT48
CGTTGGGAGGTCAGGTACCTTGTTCTAG49CG50CGTTT51CG52CGACCCTGCT53CG 
B.2 Transcription factor binding at the Apex promoter 
Genomatix generated transcription factor consensus sequence binding on the 
positive strand of the Apex promoter. 
TF Description 
Spans Assay 
CpG 
EBOX E-box binding factors 9 
HIFF Hypoxia inducible factor, bHLH/PAS protein famiy - 
HESF Vertebrate homologues of enhancer of split complex - 
MTEN Core promoter motif ten elements - 
CAAT CCAAT binding factors 8, 9 
AP2F Activator protein 2 10, 11 
INSM Insulinoma associated factors 10, 11 
CREB cAMP-responsive element binding proteins 
10, 11, 12, 13, 31, 
32 
PARF PAR/bZIP family 11, 12, 13 
E4FF 
Ubiquitous GLI - Krueppel like zinc finger involved in cell cycle 
regulation 
12, 13 
NKXH NKX homeodomain factors 12, 13, 14, 15 
CDEF Cell cycle regulators: Cell cycle dependent element 13, 14, 15, 16 
NRSF Neuron-restrictive silencer factor 26, 27, 28 
HDBP Huntington's disease gene regulatory region binding proteins 33, 34 
E2FF E2F-myc activator/cell cycle regulator - 
ZF01 C2H2 zinc finger transcription factors 1 - 
BRN5 Brn-5 POU domain factors - 
RORA v-ERB and RAR-related orphan receptor alpha - 
NF1F Nuclear factor 1 - 
CLOX CLOX and CLOX homology (CDP) factors - 
EGRF EGR/nerve growth factor induced protein C & related factors - 
KLFS Krueppel like transcription factors - 
SP1F GC-Box factors SP1/GC - 
XCPE 
Activator-, mediator- and TBP-dependent core promoter 
element for RNA polymerase II transcription from TATA-less 
promoters 
- 
RXRF RXR heterodimer binding sites - 
Table B.1 TFs binding at the Apex promoter, expressed in brain, liver or ubiquitously. 
Highlighted TFs are ones that are contained within the Apex pyrosequencing assay. 
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B.3 In vitro methylation of nested PCR product (Apex promoter) 
Nested PCR was used to generate a product as close to full length of Apex 
promoter region as possible (Figure B.1A). Synthesis of an in vitro 100% 
methylated Apex promoter was confirmed using a methylation specific restriction 
enzyme digest. HpaII enzymes was used, the predicted sites of cleavage are 
shown in Figure B.1B. A predicted and actual gel of Apex promoter digest are 
shown in Figure B.1C and B.1D respectively.  
A B 
C 
 
D 
 
Figure B.1 Apex promoter, example of nested PCR gel (A), restriction sites of HpaII as 
generated by NEB Cutter Tool (B), virtual gel of predicted HpaII digest as generated by the NED 
Cutter Tool (C) and actual gel of HpaII digest (D). 
B.4 Pyrosequencing Assay Validation 
One forward and reverse primer were used to generate a product of 296bp and 
2 separate sequencing primers were used to give the 2 Apex pyrosequencing 
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assays. Information on the primers can be found in Chapter 2. Figure B.2 shows 
example gel from pyro PCR of Apex sequences 1 and 2. 
A B 
 
Figure B.2 Example of agarose gel from pyro PCR of Apex sequence 1: 296bp (A) and sequence 
2: 296bp (B) with BM DNA from the liver. 
Pre and post pyro-PCR dilution series, required to validate the assays, plotting 
observed versus expected methylation should yield an R2 >0.9 to confirm 
specificity and sensitivity (Figure B.3). 
A B 
C D 
Figure B.3 Apex assay sequence 1 pre-PCR dilution series (A), sequence 1 post-PCR dilution 
series (B), sequence 2 pre-PCR dilution series (C) and sequence 2 post-PCR dilution series 
(D).  
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B.5 Pyrosequencing pyrograms 
Example of pyrograms from pyrosequencing of Apex sequence 1 and 2 (Figure 
B.4). 
A 
B 
Figure B.4. Example of a pyrogram reading for Apex sequence 1 (A) and sequence 2 (B). 
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B.6 Cytosine methylation at individual CpG sites 
Mean and median cytosine methylation from animals in the long term-term DR 
study (Chapter 5 and 6) as pleasured by pyrosequencing. Methylation in the 
brain of male mice (Table B.2), brain of female mice (Table B.3), liver of male 
mice (Table B.4) and liver of female mice (Table B.5). 
CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
5 
Mean 2.3630 2.5886 2.8264 2.2171 2.1371 1.8790 2.1579 
Median 2.2350 2.3850 2.9750 2.3550 2.2000 1.8200 2.1700 
SD 0.9429 0.5208 1.4253 0.3302 0.6715 1.0541 0.4637 
P value All > 0.05 
6 
Mean 1.6150 0.8964 0.7057 1.3243 0.6100 1.2120 1.1929 
Median 1.6000 1.0200 0.7750 1.3050 0.6150 0.7850 1.2750 
SD 0.3723 0.5066 0.4195 0.2919 0.5090 1.1243 0.4317 
P value All > 0.05 
7 
Mean 0.9530 1.2250 1.1307 0.7250 1.1064 1.0460 1.2364 
Median 1.1950 1.2100 1.2100 0.6150 1.2250 0.7250 1.2900 
SD 0.3793 0.3812 0.5810 0.5275 0.4295 1.2786 0.2981 
P value All > 0.05 
8 
Mean 1.3570 1.6914 1.1186 1.1600 1.0929 1.4190 1.3964 
Median 1.1700 1.6550 1.2100 1.0800 1.0650 0.9200 1.4350 
SD 0.5359 0.2636 0.7081 0.5393 0.4295 1.4523 0.4177 
P value All > 0.05 
9 
Mean 3.0970 3.1721 3.2750 2.7429 2.7786 3.1980 2.5614 
Median 2.8450 3.0800 3.0950 2.6800 2.6500 3.1500 2.6600 
SD 0.4191 0.6498 1.0532 0.8142 0.8578 0.9674 0.4371 
P value All > 0.05 
10 
Mean 1.2830 1.5964 1.4429 1.8407 1.3107 1.4920 1.0164 
Median 1.3600 1.7100 1.6050 1.6700 1.1050 0.9550 0.7700 
SD 0.8701 0.5014 0.7568 0.6520 0.4896 1.0856 0.5553 
P value All > 0.05 
11 
Mean 0.8810 0.5793 0.8586 0.7657 0.7657 0.6130 0.6307 
Median 0.9200 0.5900 0.7350 0.9200 0.7050 0.0000 0.6850 
SD 0.6001 0.5997 0.7310 0.3556 0.1217 1.3707 0.3452 
P value All > 0.05 
12 
Mean 0.4890 0.7500 0.5943 0.8364 0.3907 0.7390 0.9057 
Median 0.0000 0.7550 0.7250 0.8250 0.6100 0.0000 0.6550 
SD 0.7208 0.6889 0.4466 0.5382 0.3673 1.3195 0.5642 
P value All > 0.05 
13 
 
Mean 1.3650 1.6307 2.1650 1.6164 1.4121 1.5120 1.5450 
Median 1.3150 1.5250 1.6200 1.6550 1.5950 1.0600 1.8250 
SD 0.4711 0.2390 2.2845 0.5284 0.6090 1.1000 0.4308 
P value All > 0.05 
14 
Mean 1.0960 1.3257 0.8950 0.8600 0.9143 1.3390 0.8593 
Median 1.0250 1.6750 0.8350 0.8200 0.9050 0.6700 0.8150 
SD 0.7414 0.6440 0.7407 0.7415 0.7675 1.3833 0.6883 
P value All > 0.05 
15 
Mean 1.6160 1.0150 0.9393 0.9757 0.5350 1.1320 1.0636 
Median 1.6250 0.9450 1.1050 0.6850 0.6250 0.8400 1.2700 
SD 0.6469 0.6043 0.9479 0.7853 0.5369 1.3564 0.5954 
P value All > 0.05 
16 
Mean 0.7580 0.6907 0.3021 0.2064 0.4764 0.8660 0.2929 
Median 0.8800 0.6950 0.0000 0.0000 0.6750 0.0000 0.0000 
SD 0.7561 0.5378 0.7994 0.3526 0.4531 1.3898 0.3656 
P value All > 0.05 
17 Mean 3.5550 2.7443 2.1971 2.6393 1.9614 2.2430 2.3907 
214 
Median 3.5400 2.6650 2.4750 2.8700 1.7750 2.2100 2.3450 
SD 0.4342 0.6167 1.1807 0.9856 0.6262 1.1663 0.3639 
P value 1.000 >0.05 >0.05 >0.050 0.044 >0.05 >0.05 
26 
Mean 1.7090 1.7871 1.8386 1.9786 1.8207 2.0420 1.7007 
Median 1.7000 1.6650 1.6600 2.0400 1.9700 2.1850 1.6250 
SD 0.4172 0.2984 0.4761 0.3471 0.5621 0.5072 0.2389 
P value All > 0.05 
27 
Mean 0.4990 0.3343 0.1186 0.1129 0.0636 0.0700 0.3793 
Median 0.3350 0.3050 0.0000 0.0000 0.0000 0.0000 0.0000 
SD 0.5506 0.3448 0.2238 0.1928 0.1682 0.1565 0.7040 
P value All > 0.05 
28 
Mean 3.2460 3.0321 3.1936 3.1543 2.9693 3.2340 2.7421 
Median 3.1850 3.2150 3.0700 3.1200 2.9600 3.1950 2.6050 
SD 0.7180 0.3860 0.4531 0.5102 0.5600 0.3205 0.4867 
P value All > 0.05 
29 
Mean 1.7290 1.4229 1.5357 1.4829 1.3757 1.8930 1.6679 
Median 1.6950 1.4850 1.4700 1.5400 1.3600 1.9000 1.5900 
SD 0.3201 0.3992 0.5629 0.0969 0.5548 0.2234 0.8667 
P value All > 0.05 
30 
Mean 0.9050 0.7450 0.8464 0.8736 0.5793 1.2890 0.9307 
Median 0.8050 0.8650 0.7250 0.9100 0.4950 1.5200 0.8550 
SD 0.6406 0.5451 0.4114 0.2272 0.3853 0.5749 0.3981 
P value All > 0.05 
31 
Mean 1.5480 1.4793 0.9607 0.7764 0.9814 1.0180 0.9536 
Median 1.5600 1.4800 1.0850 0.7800 0.9600 1.0200 1.0150 
SD 0.0948 0.2553 0.3306 0.4651 0.2329 0.4187 0.4775 
P value 1.000 >0.005 0.014 >0.05 >0.05 >0.05 >0.05 
32 
Mean 1.4330 1.2979 0.7386 0.4386 0.9350 0.5910 0.9014 
Median 1.2500 1.5050 0.7200 0.5700 1.0450 0.7350 0.5800 
SD 0.5238 0.4953 0.4295 0.3149 0.5084 0.3332 0.8089 
P value 1.000 >0.05 >0.05 0.047 >0.05 >0.05 >0.05 
33 
Mean 2.1760 2.0529 2.0243 1.2743 1.2907 1.3800 1.3843 
Median 2.0350 1.9700 2.1900 1.3600 1.2600 1.2900 1.2350 
SD 0.2848 0.3781 0.6378 0.2912 0.4652 0.4982 0.7564 
P value All > 0.05 
34 
Mean 2.4350 2.5150 2.6193 2.2536 2.1429 2.4730 2.0371 
Median 2.4600 2.5150 2.9400 2.2150 2.0900 2.4750 2.1200 
SD 0.4902 0.4761 0.7279 0.7073 0.7774 0.2114 0.2879 
P value All > 0.05 
Overall 
Mean 1.6413 1.5715 1.4694 1.3752 1.2568 1.4855 1.3612 
Median 1.5245 1.5452 1.4564 1.3777 1.3970 1.2255 1.3225 
SD 0.3154 0.2396 0.4952 0.2304 0.2642 0.5775 0.2411 
P value All > 0.05 
Table B.2 Percentage cytosine methylation in the brain from male mice from long-term DR 
study. Comparison to 3AL group (1.000), statistically significant difference <0.05. 
CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
5 
Mean 1.2450 1.5857 1.1529 1.8383 0.7121 0.9550 1.0264 
Median 1.2750 1.2700 0.9450 1.2150 0.4600 1.1200 0.8800 
SD 0.7126 0.8387 0.6171 1.8267 0.4813 0.7096 0.4288 
P value All > 0.05 
6 
Mean 1.0600 1.1350 0.9207 1.0967 0.5293 1.0393 0.8250 
Median 1.2750 1.1100 0.9250 1.1275 0.4450 0.7600 0.8350 
SD 0.5112 0.1794 0.2152 0.1329 0.3968 0.6002 0.6090 
P value All > 0.05 
7 
Mean 0.6170 0.9993 0.5450 0.8942 0.3379 0.7021 0.7193 
Median 0.9250 0.8350 0.4200 0.8650 0.3050 0.5650 0.6700 
SD 0.5700 0.6577 0.3927 0.1921 0.3830 0.4542 0.6520 
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P value All > 0.05 
8 
Mean 1.1390 0.9329 1.0029 0.6683 0.1164 0.8521 0.8507 
Median 1.2600 0.9700 0.9450 0.5325 0.0000 0.4450 0.7150 
SD 0.2552 0.0879 0.2781 0.1038 0.0430 0.5272 0.2730 
P value 1.000 >0.05 >0.05 >0.05 0.033 >0.05 >0.05 
9 
Mean 0.5052 0.2965 0.5273 0.3221 0.2075 0.7261 0.5225 
Median 2.7610 2.8671 2.6864 2.7092 1.4886 3.2543 3.3400 
SD 2.3400 2.7250 2.9350 2.6000 1.4550 3.2550 3.1100 
P value All > 0.05 
10 
Mean 1.6302 0.4781 0.7917 0.4438 0.9471 0.9428 0.9580 
Median 1.5320 1.4350 1.0950 0.9650 0.5064 1.1750 0.9200 
SD 1.6900 1.4150 1.1000 1.0200 0.5350 1.3400 0.9300 
P value 1.000 >0.005 >0.05 >0.05 0.003 >0.05 >0.05 
11 
Mean 0.5202 0.4441 0.4047 0.3769 0.4291 0.5427 0.1341 
Median 0.5950 0.8400 0.4564 0.3242 0.4507 0.8221 0.7021 
SD 0.5600 0.9350 0.4450 0.2125 0.0000 1.0650 0.7600 
P value All > 0.05 
12 
Mean 0.6396 0.2986 0.4990 0.4139 0.5684 0.6804 0.4067 
Median 0.9120 1.0050 0.9686 0.9692 0.8250 1.0979 1.0571 
SD 0.7550 1.0200 0.9800 1.0650 0.5700 1.0400 1.1050 
P value All > 0.05 
13 
 
Mean 0.3570 0.6233 0.1923 0.2856 0.4624 0.6014 0.6599 
Median 1.5400 1.4350 1.1443 1.3883 0.9179 1.4057 1.6200 
SD 1.5300 1.5050 1.2700 1.3625 1.0650 1.2550 1.4600 
P value All > 0.05 
14 
Mean 0.1437 0.1855 0.3979 0.2710 0.4060 0.5736 0.4222 
Median 1.2520 1.3871 1.1614 0.9508 0.3871 1.1900 1.1893 
SD 1.5800 1.4850 1.3200 0.7125 0.5300 0.7450 1.4000 
P value All > 0.05 
15 
Mean 0.4926 0.3337 0.3978 0.4996 0.3888 0.6837 0.3565 
Median 0.6150 0.8100 0.6957 0.3350 0.2621 0.3529 0.7036 
SD 0.9550 0.5650 0.6300 0.2175 0.3950 0.0000 0.5950 
P value All > 0.05 
16 
Mean 0.5659 0.6878 0.5782 0.4307 0.2477 0.6120 0.4394 
Median 0.7900 0.6750 0.5200 0.5325 0.1914 0.5464 0.7464 
SD 0.9100 0.5850 0.5550 0.5800 0.0000 0.4900 0.6150 
P value All > 0.05 
17 
Mean 0.4782 0.5558 0.5397 0.4802 0.2417 0.6421 0.3067 
Median 3.0730 2.9107 2.5664 2.4392 1.3421 3.0079 2.8379 
SD 2.7450 2.7550 2.8650 2.4650 1.0950 2.7600 2.6850 
P value 1.000 >0.05 >0.05 >0.05 0.026 >0.05 >0.05 
26 
Mean 0.9528 0.4251 0.8271 0.4979 1.0101 1.2984 0.5514 
Median 1.3870 1.0079 1.1193 1.1808 0.6607 1.0014 0.9321 
SD 1.2800 1.0100 1.0700 1.1425 0.4400 0.9250 0.8400 
P value All > 0.05 
27 
Mean 0.6005 0.1458 0.1823 0.3788 0.4549 0.6397 0.4073 
Median 0.7360 0.4357 0.0850 0.2408 0.0429 0.2136 0.1864 
SD 0.5900 0.4550 0.0000 0.1350 0.0000 0.0000 0.2300 
P value 1.000 >0.05 0.007 >0.05 0.003 >0.05 0.043 
28 
Mean 0.3887 0.4406 0.1464 0.2934 0.1134 0.2958 0.1881 
Median 2.7100 2.4543 2.4600 2.3733 1.7579 2.3543 2.7943 
SD 2.6050 2.4300 2.5000 2.3775 1.6950 2.3250 2.7100 
P value 1.000 >0.05 >0.05 >0.05 0.003 >0.05 >0.05 
29 
Mean 0.4890 0.4644 0.3170 0.3347 0.4313 0.3942 0.2821 
Median 2.0760 1.7371 1.8114 1.7733 1.5186 2.0800 1.9386 
SD 2.2100 1.7100 1.8350 1.8325 1.5350 2.0600 1.8450 
P value All > 0.05 
30 
Mean 0.4038 0.3191 0.2413 0.1993 0.3725 0.4905 0.3084 
Median 1.0220 0.5871 0.3936 0.4925 0.1850 0.5529 0.6679 
SD 1.0100 0.5050 0.4550 0.4475 0.0000 0.5550 0.6050 
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P value 1.000 >0.05 0.031 >0.05 0.001 >0.05 >0.05 
31 
Mean 0.2360 0.3762 0.1857 0.2132 0.2587 0.3983 0.4049 
Median 1.4450 1.2114 0.9529 1.1125 0.6650 0.7943 0.9529 
SD 1.5250 1.0950 0.7750 1.2100 0.5300 0.6150 0.9450 
P value 1.000 >0.05 >0.05 >0.05 0.048 >0.05 >0.05 
32 
Mean 0.2739 0.1898 0.4527 0.3561 0.3172 0.5927 0.4849 
Median 1.2930 1.0629 0.6929 0.9783 0.7893 0.9536 0.6743 
SD 1.2250 0.9900 0.5100 1.0700 0.6250 0.6050 0.7550 
P value All > 0.05 
33 
Mean 0.4918 0.3649 0.2856 0.4075 0.3250 0.7521 0.3594 
Median 2.0760 1.5250 1.1079 1.2933 0.6900 1.0264 1.0886 
SD 2.0850 1.6150 1.0850 1.3150 0.6150 0.7400 1.1750 
P value 1.000 >0.05 >0.05 >0.05 0.003 >0.05 >0.05 
34 
Mean 0.4065 0.7387 0.4003 0.6445 0.2842 0.8039 0.3533 
Median 2.5660 2.1629 1.8136 1.9092 1.1800 2.0800 2.1593 
SD 2.4750 2.2750 1.9950 1.8775 1.3700 1.9250 2.1000 
P value 1.000 >0.05 >0.05 >0.05 0.003 >0.05 >0.05 
Overall 
Mean 0.7452 0.2258 0.5392 0.3880 0.6856 0.7767 0.2972 
Median 1.4748 1.3730 1.1523 1.2030 0.7073 1.2479 1.2696 
SD 1.3450 1.2890 1.2590 1.2780 0.6320 1.2000 1.2180 
P value 1.000 >0.05 >0.05 >0.05 0.003 >0.05 >0.05 
Table B.3 Percentage cytosine methylation in the brain from female mice from long-term DR 
study. Comparison to 3AL (1.00), statistically significant difference <0.05. 
CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
5 
Mean 2.1190 1.2750 2.4471 1.5864 0.5071 0.4770 1.0429 
Median 2.2550 1.3400 1.0000 1.5950 0.3800 0.3600 0.4700 
SD 1.1838 1.2493 2.9621 0.8913 0.4817 0.5712 1.3303 
P value All > 0.05 
6 
Mean 1.4060 1.0850 1.9079 1.3907 0.6936 0.6640 1.2750 
Median 1.5550 0.8550 1.3750 1.4350 0.3300 0.3600 1.0250 
SD 0.8236 0.8277 2.8127 0.9500 0.8768 0.6263 0.9875 
P value All > 0.05 
7 
Mean 0.9690 1.1479 1.5836 1.0729 0.4221 0.1930 0.8793 
Median 1.4850 1.1250 1.3400 1.0400 0.0000 0.0000 0.0000 
SD 0.8915 1.2663 2.2412 0.9714 0.7229 0.2669 1.2092 
P value All > 0.05 
8 
Mean 1.0170 1.6964 2.1564 1.3329 1.1350 1.2850 2.0329 
Median 1.4700 1.5750 0.9300 1.5600 1.1400 1.3800 1.9600 
SD 0.9474 0.9934 3.2031 0.8652 0.6826 0.2557 1.6205 
P value All > 0.05 
9 
Mean 4.1760 4.1386 4.9171 4.6043 2.7236 2.9440 3.7614 
Median 3.4350 4.1400 4.3700 4.6950 2.4500 3.1300 3.4250 
SD 1.5088 1.6514 2.1065 1.9585 1.1557 0.8839 1.9217 
P value All > 0.05 
10 
Mean 2.0130 1.9321 2.3900 1.7200 0.8771 0.8500 1.3121 
Median 2.2300 1.6450 1.6150 1.6350 1.1200 0.9400 0.8850 
SD 1.1106 1.3805 2.4573 0.9890 0.5453 0.6172 1.1909 
P value All > 0.05 
11 
Mean 1.3060 1.6257 2.1893 1.5000 1.3364 0.5300 1.3443 
Median 0.5250 2.1050 1.4950 1.9300 1.4100 0.5650 1.2300 
SD 1.9862 1.5744 3.0198 1.3949 1.2733 0.5491 1.3624 
P value All > 0.05 
12 
Mean 0.9950 1.3707 1.7200 1.2864 0.4221 0.3930 0.9879 
Median 0.6650 1.4400 1.3850 1.6050 0.4450 0.0000 1.1150 
SD 1.5036 0.9698 2.2635 0.9228 0.4243 0.6468 0.8727 
P value All > 0.05 
13 Mean 2.2350 2.3043 2.7364 2.0100 1.3621 1.7110 2.0414 
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 Median 2.1000 2.2400 2.3600 2.1250 1.3100 1.7750 1.5650 
SD 0.8333 0.7865 2.2372 0.8564 0.4696 0.2755 0.9189 
P value All > 0.05 
14 
Mean 2.3200 1.9479 2.4893 2.5743 1.3271 1.2290 2.2843 
Median 2.4500 1.7850 1.9400 3.0650 1.4150 0.8200 1.8350 
SD 1.2441 1.4403 2.5088 1.2665 0.9860 1.2557 2.2232 
P value All > 0.05 
15 
Mean 1.5000 1.7057 1.7229 1.3364 0.6671 1.1240 1.6979 
Median 1.3250 1.9350 1.7600 1.3750 0.7100 1.1550 1.4400 
SD 1.0221 1.1018 1.8661 0.7899 0.5564 0.3197 1.1246 
P value All > 0.05 
16 
Mean 1.8100 1.9214 2.2950 1.5829 0.9243 1.2550 1.4357 
Median 1.5950 2.1700 1.7050 1.8300 0.5750 0.9400 1.0550 
SD 0.9574 1.3552 3.1368 1.1066 1.2714 0.7739 1.2077 
P value All > 0.05 
17 
Mean 4.0360 4.1929 4.6171 3.7214 3.8143 3.6540 3.3386 
Median 4.0000 4.4100 3.7000 3.5700 3.5150 3.3750 2.7900 
SD 0.7125 1.6569 2.3332 1.7058 2.5103 0.6036 1.3338 
P value All > 0.05 
26 
Mean 2.3570 1.6136 2.3321 2.3021 1.3000 1.7120 1.5379 
Median 3.6150 1.5050 1.6800 1.9950 0.3450 1.8450 1.4300 
SD 1.9958 1.2242 2.1285 1.5800 1.4432 1.2247 0.6790 
P value All > 0.05 
27 
Mean 1.5080 1.4364 2.0036 2.3486 0.5721 0.6820 0.8571 
Median 0.0000 1.2600 1.6900 0.9900 0.0000 0.0000 0.7950 
SD 2.0777 1.2050 2.4187 2.1851 1.5137 1.3635 0.6857 
P value All > 0.05 
28 
Mean 4.2820 4.4050 3.7314 3.4271 3.3229 3.4860 2.6571 
Median 2.5850 3.9900 3.5400 2.9450 2.9900 3.4150 2.8350 
SD 3.6271 2.6664 0.9942 1.4500 1.5890 0.9555 0.4639 
P value All > 0.05 
29 
Mean 3.0190 2.5129 3.1343 3.1757 1.8679 2.3110 2.5286 
Median 3.7900 2.4700 2.3800 1.9250 1.4950 1.9100 2.6300 
SD 1.6050 1.0908 2.1930 2.0552 0.9671 1.0261 0.7747 
P value All > 0.05 
30 
Mean 1.7550 1.3364 1.8150 1.6329 0.6400 0.8540 0.8800 
Median 0.4650 1.1400 1.5450 0.9550 0.4500 0.4750 0.8900 
SD 2.0168 1.0397 1.8866 1.4217 0.7433 1.0149 0.6350 
P value All > 0.05 
31 
Mean 2.5790 1.8029 2.1764 1.3136 0.7643 1.3760 0.9164 
Median 2.4400 1.3000 1.6450 1.0250 0.5600 0.8850 0.6750 
SD 1.7725 1.4253 1.6928 1.1247 0.9880 1.4687 0.6871 
P value All > 0.05 
32 
Mean 2.1620 1.7271 2.8029 2.3929 1.1750 1.8140 1.3693 
Median 0.5750 1.1950 2.1400 1.7600 0.7850 0.9300 1.7400 
SD 2.4639 1.5138 1.9731 1.3757 1.2461 1.5300 0.6666 
P value All > 0.05 
33 
Mean 2.7890 3.3421 3.6421 2.5793 1.2914 1.1830 1.8229 
Median 1.7000 3.0250 2.3900 1.3500 1.0100 0.7400 2.2300 
SD 3.1851 2.0547 2.3443 2.5577 1.2297 1.2139 0.8552 
P value All > 0.05 
34 
Mean 3.3830 2.6236 3.0893 3.2950 2.4871 3.1310 2.5329 
Median 3.8200 2.3600 3.0800 2.6850 2.4450 2.9600 2.7100 
SD 3.3758 1.1518 1.5823 1.6359 1.8932 0.8594 1.0864 
P value All > 0.05 
Overall 
Mean 2.2600 2.0629 2.6200 2.1829 1.3471 1.4940 1.7529 
Median 1.4300 2.1200 1.9700 1.8100 1.1400 1.3000 1.6200 
SD 1.2704 0.6689 2.1362 0.8851 0.5744 0.5310 0.8692 
P value All > 0.05 
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Table B.4 Percentage cytosine methylation in the liver from male mice from long-term DR study. 
Comparison to 3AL (1.000), statistically significant difference <0.05. 
CpG site 
Cytosine methylation (%) 
3AL 12AL 12DR 24AL 24DR 30AL 30DR 
5 
Mean 2.7810 2.5807 2.5257 1.8257 1.9343 1.6686 3.2057 
Median 2.4250 2.4700 2.0900 1.4050 1.4200 1.3700 1.4600 
SD 1.9353 1.0530 1.0362 1.0836 1.2623 0.6750 4.7983 
P value All > 0.05 
6 
Mean 1.8430 1.7686 1.6436 1.6414 1.3736 0.5157 1.0314 
Median 1.8550 2.2450 1.4900 1.5350 1.0450 0.4450 0.6550 
SD 0.6630 0.8035 1.0991 0.6865 1.1966 0.5305 1.2774 
P value All > 0.05 
7 
Mean 1.3410 1.8193 1.6879 1.3864 0.6850 0.3971 0.6886 
Median 1.6050 1.8850 1.3350 1.2350 0.5350 0.3000 0.7200 
SD 0.7785 0.9289 0.8605 0.6001 0.5488 0.5465 0.6425 
P value All > 0.05 
8 
Mean 1.8990 2.1557 1.6814 2.0943 1.0450 0.4943 0.8979 
Median 1.8400 2.2650 1.4500 2.1500 0.9550 0.0000 0.7150 
SD 1.2063 1.0149 1.0947 0.7188 0.8361 0.6885 0.6478 
P value All > 0.05 
9 
Mean 3.6450 4.5150 3.9686 4.3679 4.6143 2.2500 3.6007 
Median 3.9400 3.9450 3.9700 4.0900 4.6550 2.3250 4.0700 
SD 0.5735 1.1309 1.4091 1.2386 3.0159 1.4695 1.7677 
P value All > 0.05 
10 
Mean 1.7280 2.9529 1.7957 2.5414 1.4193 1.3714 1.2193 
Median 2.0350 3.0100 1.8100 2.2550 0.9550 1.7250 1.0550 
SD 0.7370 1.0272 0.8373 1.0479 0.9409 0.9617 0.8199 
P value All > 0.05 
11 
Mean 2.0470 2.3529 1.9971 1.7736 1.4471 0.7207 1.1479 
Median 2.0450 2.4850 1.7650 1.5700 1.3750 0.5500 0.9800 
SD 0.6953 0.8388 1.2426 0.8699 1.2198 0.5317 0.5086 
P value All > 0.05 
12 
Mean 1.9010 2.3321 1.7257 1.4886 1.0364 0.7614 0.7436 
Median 2.1150 2.4850 1.2450 1.4600 0.5700 0.5600 0.7750 
SD 0.7927 1.0348 1.1217 0.7365 0.9090 0.7625 0.7691 
P value All > 0.05 
13 
 
Mean 2.1130 2.7493 2.3364 2.3021 1.6807 1.5093 1.9607 
Median 2.0600 2.3500 1.9500 1.9450 1.7450 1.3300 1.7800 
SD 0.4010 1.0494 1.0791 0.9427 0.3580 0.3743 0.7733 
P value All > 0.05 
14 
Mean 2.5800 2.9514 2.6357 2.7014 1.8357 1.6457 2.0900 
Median 2.5250 2.5650 2.4500 2.5750 1.4450 1.6650 1.9200 
SD 0.7762 1.0296 1.1221 0.8851 1.0090 0.8588 0.6473 
P value All > 0.05 
15 
Mean 1.7330 2.4186 1.6421 1.7614 1.3964 1.3500 1.4621 
Median 1.8200 2.3500 1.4100 1.5700 1.4750 1.3750 1.4950 
SD 0.3625 0.7428 0.9474 0.5412 0.4106 0.3931 0.6410 
P value All > 0.05 
16 
Mean 2.4820 2.7057 1.9971 2.3407 1.6521 1.3943 1.2886 
Median 2.0100 2.7350 2.0650 2.0750 1.4900 1.3500 1.4450 
SD 1.4646 1.1090 0.9988 0.7674 0.7096 0.6056 0.6075 
P value All > 0.05 
17 
Mean 4.2960 4.7207 3.9971 4.7671 3.5336 3.7779 3.1921 
Median 4.1150 4.7550 3.2050 4.8300 3.3650 3.1800 3.2800 
SD 0.9193 0.6598 1.5275 1.1395 0.9525 1.0174 0.7238 
P value All > 0.05 
26 
Mean 1.3330 2.8236 3.4929 3.0814 1.5807 1.6600 2.0621 
Median 1.5150 2.3600 2.7150 2.9050 1.7050 1.3550 2.0500 
SD 0.5173 1.1269 1.6646 0.9922 1.0126 0.7954 0.4855 
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P value 1.000 >0.05 0.02 >0.05 >0.05 >0.05 >0.05 
27 
Mean 0.2000 1.9786 2.0629 1.5200 0.2886 0.2200 0.5171 
Median 0.0000 1.3500 1.8900 0.7000 0.0000 0.0000 0.0000 
SD 0.2857 2.2103 2.2154 1.1354 0.3664 0.5821 0.8183 
P value All > 0.05 
28 
Mean 3.3700 3.9800 5.3421 5.2800 4.4429 4.9500 4.2507 
Median 3.4950 3.8200 5.5700 4.7250 4.2850 5.3150 4.3400 
SD 0.3437 0.7645 1.1716 1.0600 1.6242 0.9930 1.1387 
P value All > 0.05 
29 
Mean 1.5040 3.2064 3.6857 3.0836 1.8857 1.5686 2.3279 
Median 1.3100 2.6000 3.3500 2.7750 2.2250 1.3900 2.1850 
SD 0.5499 1.9464 1.5705 1.0283 0.9592 1.0169 0.6609 
P value All > 0.05 
30 
Mean 0.2990 1.5271 2.1729 1.4271 0.3336 0.3364 0.3871 
Median 0.0000 0.7500 1.9650 0.8700 0.0000 0.0000 0.0000 
SD 0.6686 1.9091 1.8108 1.2298 0.4526 0.6373 0.5705 
P value All > 0.05 
31 
Mean 1.1540 2.4243 2.6864 2.5993 1.3243 1.1593 1.6479 
Median 1.3050 1.7200 2.7250 2.5900 1.1300 1.0150 1.5950 
SD 0.8823 1.8218 1.6967 0.9781 0.8675 0.8875 1.1985 
P value All > 0.05 
32 
Mean 1.8570 2.8007 3.3379 3.0871 1.8593 1.8057 1.8329 
Median 1.9400 2.7000 3.1200 2.7150 1.8650 1.5000 1.6800 
SD 0.7116 1.7684 1.5940 1.3549 0.8669 1.1088 0.7755 
P value All > 0.05 
33 
Mean 1.0880 2.5300 2.9736 3.2814 1.1664 0.9264 1.8471 
Median 1.0050 2.2250 2.4050 3.7000 1.2600 0.0000 1.5200 
SD 0.8459 2.5406 2.1872 1.0423 1.0521 1.1584 0.9513 
P value All > 0.05 
34 
Mean 1.8620 3.3079 3.6221 4.0650 2.6850 2.1586 3.0714 
Median 2.0150 3.4550 3.2500 4.0800 1.8100 1.9750 2.9250 
SD 0.6405 1.5402 1.3619 0.5849 1.9135 1.4182 0.6191 
P value All > 0.05 
Overall 
Mean 1.9572 2.7544 2.6823 2.6554 1.7829 1.4837 1.8397 
Median 2.0130 2.7650 2.5450 2.5100 2.0300 1.3630 1.5770 
SD 0.5451 1.0194 0.8588 0.6662 0.4593 0.3755 0.4895 
P value All > 0.05 
Table B.5 Percentage cytosine methylation in the liver from female mice from long-term DR study. 
Comparison to 3AL (1.00), statistically significant difference <0.05. 
B.7 Validation of primers for ChIP-qPCR 
Primers for amplification of Apex promoter region were validated with liver 
genomic DNA from the ChIP input reaction. A qPCR reaction shows good 
amplification for a dilution series of DNA and the primers. Primers were 
designed by Dr Jelena Mann. 
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Figure B.5 Validation of assay used for ChIP-qPCR. Efficiency 98.2, slope -3.37 
B.8 Apex cDNA Sequence acquired from Genomatix software 
CACGTGACCACACCAATCGCCCACGTGGGAACAGGCAGACTCCATTCTTTGTGCCGTGAG
GGTCTCTGGCTTCGTTGGGAGGCAGCGCAGTAAACACTGCTTCGGTGCTCCAGGAGCCTA 
AGGGCTTTCGTCACAGCGATGCCAAAGCGGGGAAAGAAAGCGGCGGCCGACGACGGGGA
AGAACCCAAGTCGGAGCCAGAGACCAAGAAGAGTAAGGGGGCAGCAAAGAAAACCGAGA
AGGAGGCCGCGGGAGAGGGCCCTGTCCTGTACGAGGACCCTCCAGATCAGAAAACCTCA
CCCAGTGGCAAATCTGCCACACTCAAGATATGCTCCTGGAATGTGGATGGGCTTCGAGCC
TGGATTAAAAAGAAAGGTTTGGATTGGGTAAAGGAAGAAGCACCAGATATCTTGTGCCTCC
AAGAGACCAAGTGCTCGGAGAACAAACTCCCGGCTGAACTGCAAGAGCTGCCTGGACTCA
CCCATCAGTACTGGTCAGCTCCGTCAGACAAAGAAGGATACAGTGGTGTGGGCCTACTTT
CCCGCCAGTGCCCGCTAAAAGTCTCTTATGGCATTGGCGAGGAAGAACATGATCAAGAAG
GCCGGGTGATTGTGGCTGAATTTGAGTCCTTTGTCCTGGTAACAGCCTATGTTCCCAATGC
AGGCAGGGGTCTGGTAAGACTGGAATACCGACAGCGTTGGGATGAAGCCTTCCGAAAGTT
TCTAAAGGACTTGGCTTCCAGAAAGCCTCTTGTGCTATGTGGGGATCTCAATGTGGCTCAT
GAAGAAATTGACCTCCGTAACCCCAAAGGAAACAAAAAGAATGCTGGCTTTACTCCCCAGG
AGCGCCAAGGTTTTGGGGAACTGCTACAAGCTGTACCATTGGCTGACAGCTTCCGGCATC
TCTACCCCAACACTGCTTACGCTTACACTTTCTGGACTTACATGATGAATGCCCGCTCTAAG
AATGTTGGTTGGCGCCTTGATTACTTTTTGCTTTCCCACTCTCTTTTACCTGCATTGTGTGA
CAGCAAGATCCGGTCCAAGGCTCTTGGCAGTGACCACTGTCCCATCACCCTTTACCTAGCA
CTGTGATACCCTCCTGCAGTAGCTTCCTGCCTGGGAGATGGCTCTCTCTGCAGAAGTCTG
GTGTTTTAGCCTTCAGGTGTTTGGTTTTGTATGTGCTCCCTCATTTTAAACATTAAACCAAAC
TTCTGGTTTCCTTTAGACAATCCAAGAGAAATAAAAGGCCCTACTTTCAGCTTGGCTTTCTT
TGTCCCTTTGTGAAAACTACATATTCCCTTTTTCAT 
B.9 Apex expression qPCR primer validation 
Validation of primers for qPCR assay. Primer design Joanna Górniak (Apex) 
and Dr Sabine Langie (Hprt and B2m). 
Assay Efficiency factor Efficiency (%) Slope 
Apex (Target) 2.01 101.44 -3.855 
Hprt (Reference) 1.96 96.37 -3.412 
B2m (Reference) 1.90 90.22 -3.581 
Table B.6 Primer test and assay efficiency as tested with cDNA from liver. 
221 
B.10 APEX ELISA assay 
Protein extract concentration at 5mg/ml and 1mg/ml were tested in the APEX 
ELISA assay to optimise extract concentration to be used (Figure B.6). Kit 
standard was used to set up a standard curve. 
 
Figure B.6 Optimisation of assay APEX ELISA, protein extracts from brain (red) and liver 
(green) at 5mg/ml and 1 mg/ml were tested versus assay standard (blue) to determine 
concentration of extract to use in the assay. 
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Appendix C RNA quality and TF expression validation 
C.1 RNA check 
RNA quality was tested for purity using the Nanodrop with values for 260/280 
and 230/260 of >1.8. In addition, RNA was tested for degradation by agarose 
gel electrophoresis. 2 clear bands or rRNA indicated intact RNA. 
A mRNA from brain 
 
B mRNA from liver 
 
Figure C.1 Example of RNA extracted from brain (A) and liver (B). Two clear strong bands for 
ribosomal RNA confirm intact RNA. 
C.2 cDNA check (Gapdh primers, +RT and –RT) 
A PCR for Gapdh gene amplification was used to test for genomic 
contamination after cDNA synthesis (2 reactions were set up: reverse 
transcriptase positive and RT negative). Product in RT positive reaction 
indicated successful cDNA synthesise while no product in RT negative reaction 
indicated no genomic DNA contamination. 
A RT positive 
 
B RT negative 
 
Figure C.2 Example of cDNA synthesis confirmation PCR, GAPDH amplification (495bp product) 
with reverse transcriptase (A) and without reverse transcriptase (B) to confirm synthesis of cDNA 
and no genomic DNA contamination. 
C.3 TF mRNA expression assay validation (TaqMan) 
Expression of 2 transcription factors was quantified as these are bind to and  
initiate up-regulation of Ogg1 and Apex expression. 
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Figure C.3 A scheme showing the binding of Nfya (green) and Hif1α (purple) transcription factors 
at Ogg1 gene promoter region. Schemes generated via Genomatix software. 
 
Figure C.4 A scheme showing the binding of Nfya (green) and Hif1α (purple) transcription factors 
at Apex gene promoter region. Schemes generated via Genomatix software. 
Study of transcription factor expression, HIf1α and Nfya expression were 
quantified using B2m and Hprt as reference genes. Expression was quantified 
with TaqMan Probe assay, inventoried in the table. 
Assay Gene Code 
Hif1α 
murine hypoxia inducible factor 1, alpha 
subunit 
Mm00468869_m1 
Nfya nuclear transcription factor-Y alpha Mm00477820_m1 
B2m beta-2 microglobulin Mm00437762_m1 
Hprt 
hypoxanthine guanine phosphoribosyl 
transferase 
Mm01545399_m1 
Table C.1 Name and code of Mus musculus TaqMan assays used. 
A standard curve with cDNA was set up for each TaqMan probe to test the 
efficiency of the reaction. 
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Figure C.5 Validation of assays used for qPCR. HIf1α (dotted blue line), efficiency 104.2, slope -
3.22; Nfya (dotted red line), efficiency 93.8, slope -3.48; B2m (dotted purple line), efficiency 114.6, 
slope -3.02; Hprt (dotted green line), efficiency 105.3, slope -3.20. 
C.4 TF mRNA expression in brain and liver of short-term DR 
Expression of TF was measured in tissues from long-term DR mice (Chapter 5 
and 6) and also in tissues from short-term DR mice, figure below. 
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A B 
C D 
Figure C.6 The effect of short-term DR on expression of Hif1α in the brain (A), Nfya in the brain 
(B),Hif1α in the liver (C) and Nfya in the liver (D). 
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